data_2klr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2klr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.669 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 31.3 t70 . . . . . 0 CA--C 1.484 -1.563 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -94.37 117.57 30.32 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' ASN . 51.0 t80 -110.7 142.65 42.33 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.6 m -137.58 131.57 31.85 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.382 0.61 . . . . 0.0 111.641 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.627 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 47.6 t -118.9 141.68 37.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -111.78 143.82 42.09 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.974 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 3.1 mm? -119.99 127.6 52.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.468 ' CG ' HH12 ' B' ' 107' ' ' ARG . 0.6 OUTLIER -117.2 127.26 53.93 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.597 -175.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.85 116.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 103.344 -2.836 . . . . 0.0 103.344 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.4 -54.34 41.97 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.316 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -150.43 121.97 7.97 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.41 171.65 18.69 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 126.943 2.097 . . . . 0.0 106.983 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -112.87 141.13 24.95 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.89 -28.31 13.0 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 125.131 3.887 . . . . 0.0 116.361 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -73.98 -19.78 60.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.042 0.449 . . . . 0.0 111.227 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -98.25 18.1 17.11 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.921 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.18 147.96 44.26 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.499 0.666 . . . . 0.0 111.166 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -138.24 124.7 20.66 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 p -109.83 129.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -129.96 130.67 45.36 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 121.384 0.611 . . . . 0.0 111.244 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.8 117.81 52.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.64 90.94 2.71 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.312 0.577 . . . . 0.0 109.727 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 -111.82 4.44 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.855 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.87 -4.91 59.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.77 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.03 137.61 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.423 HG21 ' HB2' ' A' ' 122' ' ' TYR . 4.0 tp -124.72 119.94 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -138.18 149.71 46.09 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.357 -173.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.5 m -124.33 134.23 67.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -123.92 124.71 43.22 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.901 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.25 142.65 14.26 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -143.04 126.56 16.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -136.32 141.01 43.76 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.531 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.21 120.81 26.28 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -82.22 -62.47 1.61 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 123.562 0.745 . . . . 0.0 111.289 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' B' ' 80' ' ' ASP . 39.3 mtm180 -141.67 125.13 16.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.867 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 131.24 49.54 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.47 171.96 13.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 119.255 -0.403 . . . . 0.0 110.378 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 13.59 -83.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 127.652 2.381 . . . . 0.0 114.468 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.24 30.06 1.05 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -131.86 131.05 6.15 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.448 -1.705 . . . . 0.0 109.32 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -121.35 149.47 42.91 Favored 'General case' 1 C--N 1.238 -4.265 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.441 HG12 ' CD ' ' B' ' 120' ' ' ARG . 16.5 mt -123.3 132.97 70.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.1 m -129.23 158.42 39.1 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.109 0.481 . . . . 0.0 110.33 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -133.97 148.52 51.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -132.49 150.24 52.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.78 125.06 42.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -132.16 122.12 24.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.741 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.428 ' HG3' HG12 ' B' ' 114' ' ' ILE . 70.1 ttt180 -112.27 137.4 50.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.454 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 24.7 pttm -129.51 129.94 45.18 Favored 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.76 0.662 . . . . 0.0 110.76 -172.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.423 ' HB2' HG21 ' A' ' 98' ' ' ILE . 5.6 m-85 -128.63 145.1 51.25 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -128.05 98.91 5.28 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.537 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.9 pt -136.26 105.13 9.41 Favored Pre-proline 0 C--N 1.285 -2.219 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.259 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.82 -40.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.462 2.108 . . . . 0.0 112.021 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.07 -19.52 64.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -108.45 -17.3 14.02 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 64.6 t -128.31 121.11 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 150' ' ' LYS . 12.1 t70 -122.23 121.17 27.93 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 168.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.93 -15.53 39.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 114.777 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.34 -25.28 36.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.974 0.416 . . . . 0.0 111.384 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 129' ' ' ASP . 8.1 t -119.19 -21.31 7.63 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.3 126.91 42.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 34.4 p -122.47 168.04 12.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.644 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 m -126.27 133.72 51.36 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.152 0.501 . . . . 0.0 111.164 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.447 ' O ' HD21 ' A' ' 143' ' ' LEU . 24.1 p -118.7 150.51 39.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.8 142.34 42.93 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.783 0.72 . . . . 0.0 112.477 -174.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.4 t -100.38 161.59 13.5 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -68.85 -20.12 64.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.834 0.853 . . . . 0.0 112.9 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -85.79 -10.67 55.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 112.06 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.28 1.11 23.59 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.532 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.5 t -77.2 124.23 35.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 136' ' ' SER . 2.7 tm? -119.5 132.25 55.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.1 m -121.34 127.42 51.25 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 121.639 -0.663 . . . . 0.0 110.749 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.627 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 19.2 m -102.01 122.64 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 3.9 p-10 -138.58 155.48 48.31 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.782 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.11 171.69 17.32 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 41.5 Cg_exo -51.1 142.59 34.6 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.759 2.306 . . . . 0.0 111.995 171.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -90.66 165.97 13.42 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.37 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 76.6 tttt . . . . . 0 C--O 1.271 2.226 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . 0.657 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 31.0 t70 . . . . . 0 CA--C 1.482 -1.644 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -95.02 117.35 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' B' ' 146' ' ' ASN . 50.7 t80 -110.62 142.92 41.82 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 35.1 m -137.82 131.2 30.78 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.243 0.544 . . . . 0.0 111.641 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 52.7 t -118.72 141.77 36.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.5 144.27 41.0 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.164 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' B' ' 143' ' ' LEU . 3.1 mm? -120.02 127.52 52.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 107' ' ' ARG . 0.6 OUTLIER -117.15 127.77 54.45 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.419 -1.312 . . . . 0.0 112.717 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -118.83 117.15 53.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 167.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.72 -54.21 44.92 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.265 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -150.44 121.7 7.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.57 171.87 18.18 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.796 2.038 . . . . 0.0 107.103 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.1 m -113.2 141.21 25.32 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.15 -28.09 13.71 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 125.044 3.83 . . . . 0.0 116.362 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.53 -20.34 60.68 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.353 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -98.37 18.43 16.5 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.723 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.34 147.75 44.62 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.829 0.823 . . . . 0.0 111.273 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -138.05 124.53 20.72 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -109.63 129.58 64.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -130.36 130.72 44.76 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.417 0.627 . . . . 0.0 111.091 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.91 118.16 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.5 tp -135.48 91.18 2.69 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-O 121.17 0.51 . . . . 0.0 109.716 -173.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.05 -111.92 4.53 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.022 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -86.56 -4.79 59.23 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.227 1.011 . . . . 0.0 112.022 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.84 137.74 47.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.535 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . 0.431 HG21 ' HB2' ' B' ' 122' ' ' TYR . 4.0 tp -124.87 120.03 57.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 174.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.16 149.72 46.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.151 0.501 . . . . 0.0 110.323 -173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 20.1 m -124.22 134.34 66.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -123.95 124.66 43.08 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.04 142.87 14.5 Favored Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -143.08 126.36 16.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -136.23 140.6 43.61 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.548 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -82.48 120.73 25.85 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -81.9 -63.76 1.32 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 123.512 0.725 . . . . 0.0 111.008 -173.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.468 HH12 ' CG ' ' A' ' 80' ' ' ASP . 39.8 mtm180 -140.9 125.42 17.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.961 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -103.24 130.4 50.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -139.16 172.47 12.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.39 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 12.86 -84.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 127.673 2.389 . . . . 0.0 114.27 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -145.85 30.19 1.08 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -132.1 130.18 5.83 Favored Glycine 0 N--CA 1.403 -3.53 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.403 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -120.43 149.86 41.7 Favored 'General case' 1 C--N 1.24 -4.156 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.428 HG12 ' HG3' ' A' ' 120' ' ' ARG . 16.9 mt -123.61 133.34 69.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.8 m -129.98 159.14 37.57 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.049 0.452 . . . . 0.0 110.174 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -134.17 148.55 50.94 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -126.03 125.03 41.97 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -132.06 122.22 25.1 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.785 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.441 ' CD ' HG12 ' A' ' 114' ' ' ILE . 70.0 ttt180 -112.3 137.36 50.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.459 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 24.1 pttm -129.37 129.83 45.27 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.717 0.635 . . . . 0.0 110.72 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' TYR . . . . . 0.431 ' HB2' HG21 ' B' ' 98' ' ' ILE . 6.1 m-85 -128.25 145.57 51.0 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.489 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -128.19 98.86 5.24 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.537 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 3.9 pt -136.38 105.2 9.3 Favored Pre-proline 0 C--N 1.284 -2.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.193 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.49 -40.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.542 2.161 . . . . 0.0 112.081 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.01 -19.86 64.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 111.513 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -108.36 -17.18 14.06 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.444 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 63.6 t -128.46 121.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . 0.485 ' HB2' ' HD2' ' B' ' 150' ' ' LYS . 12.2 t70 -122.35 121.32 27.78 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 168.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.17 -15.2 38.31 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.466 2.777 . . . . 0.0 114.632 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 tp -81.47 -25.87 35.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.461 . . . . 0.0 111.157 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' THR . . . . . 0.435 HG22 ' HB3' ' B' ' 129' ' ' ASP . 9.7 t -119.05 -21.14 7.79 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.14 127.12 42.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 33.4 p -122.5 167.72 13.0 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.839 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.7 m -126.28 133.96 51.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.436 ' O ' HD23 ' B' ' 143' ' ' LEU . 14.8 p -119.13 149.61 41.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 142.66 44.24 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.465 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.62 161.6 13.49 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -68.81 -19.59 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.603 0.761 . . . . 0.0 112.953 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.68 -10.14 54.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.041 0.448 . . . . 0.0 111.734 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.3 0.75 23.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.43 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.62 124.11 34.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . 0.436 HD23 ' O ' ' B' ' 136' ' ' SER . 2.7 tm? -119.59 132.27 55.68 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 35.3 m -121.46 126.99 50.61 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.6 -0.688 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . 0.633 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 19.0 m -101.71 122.65 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' B' ' 75' ' ' PHE . 4.0 p-10 -138.51 154.97 48.8 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.775 -173.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.13 18.22 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 50.3 Cg_exo -50.8 142.3 33.12 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 122.745 2.297 . . . . 0.0 111.973 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -90.18 165.8 13.74 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.413 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' B' ' 129' ' ' ASP . 76.2 tttt . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' OD2' ' HD3' ' A' ' 149' ' ' ARG . 31.5 t70 . . . . . 0 CA--C 1.492 -1.258 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -128.72 145.28 51.21 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.793 -170.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 t -116.67 130.44 56.73 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.446 ' HB ' HG23 ' A' ' 145' ' ' VAL . 23.7 t -114.46 131.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.15 147.05 35.75 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.455 ' O ' HG22 ' A' ' 81' ' ' VAL . 6.7 mp -118.5 129.06 55.15 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -74.22 125.27 28.03 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.542 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 82' ' ' LYS . 32.9 t -138.97 142.67 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.65 ' O ' HG12 ' A' ' 81' ' ' VAL . 16.7 tptm -98.33 -177.34 3.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 7.8 t60 -77.63 124.98 28.64 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.841 -1.543 . . . . 0.0 113.412 -167.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.511 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 0.0 OUTLIER -132.67 172.45 12.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.148 172.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -77.57 117.82 68.03 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -53.09 -27.76 38.11 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 124.024 3.149 . . . . 0.0 114.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -87.14 -35.31 18.7 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.343 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -91.35 58.91 3.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.296 0.57 . . . . 0.0 110.593 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 pp -143.21 160.43 40.48 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.09 0.471 . . . . 0.0 111.175 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -135.63 124.61 24.22 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.18 122.87 58.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -129.07 133.29 47.63 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.416 0.626 . . . . 0.0 111.948 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.73 122.1 59.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.96 91.71 3.09 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.29 -112.12 4.17 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.751 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -93.2 -0.25 56.92 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.689 1.196 . . . . 0.0 110.96 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.7 136.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.574 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 16.6 mt -125.1 120.66 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.81 149.22 49.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.2 0.524 . . . . 0.0 110.84 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -129.8 120.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -113.56 120.06 39.67 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.43 ' HA3' ' CD2' ' A' ' 84' ' ' PHE . . . -136.98 154.79 22.4 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -138.56 143.28 39.35 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 117.454 0.627 . . . . 0.0 111.05 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 84' ' ' PHE . 81.1 t60 -137.97 127.86 25.52 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 170.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 114' ' ' ILE . 32.1 mt-10 -86.01 121.33 28.48 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.437 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 23.7 mt-10 -55.06 -80.82 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -166.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.437 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 51.5 mtm-85 -147.63 153.82 39.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -83.01 128.19 34.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -94.39 -172.32 2.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -39.87 -66.16 0.33 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.361 1.464 . . . . 0.0 112.634 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -142.74 28.06 1.62 Allowed 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.463 ' HA3' ' CE1' ' B' ' 122' ' ' TYR . . . -132.95 153.53 20.75 Favored Glycine 1 N--CA 1.369 -5.788 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.39 149.05 30.8 Favored 'General case' 1 C--N 1.243 -4.025 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.455 ' O ' ' HB3' ' A' ' 105' ' ' GLU . 35.5 mm -124.25 135.48 63.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.987 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.0 m -128.18 140.97 51.62 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -128.65 147.04 50.71 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.13 150.73 51.14 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.058 0.456 . . . . 0.0 110.105 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 84' ' ' PHE . 73.2 m-85 -124.96 133.67 52.93 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -127.1 121.94 32.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.607 ' CZ ' ' HA ' ' A' ' 81' ' ' VAL . 67.2 mtt-85 -117.02 136.88 52.62 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.4 tttp -134.82 128.38 32.65 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.756 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 98' ' ' ILE . 13.3 m-85 -131.42 135.2 46.96 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.867 0.867 . . . . 0.0 110.543 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -128.23 98.7 5.18 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.629 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 5.0 pt -135.94 106.43 9.67 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.73 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -87.67 -39.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.027 1.818 . . . . 0.0 112.508 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.42 72.26 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 121.451 0.643 . . . . 0.0 111.76 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' A' ' 149' ' ' ARG . 9.3 m-20 -91.99 -16.25 26.78 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.709 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 12.6 t -131.38 120.42 46.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -171.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.68 111.73 35.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.63 13.46 0.46 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.403 2.735 . . . . 0.0 116.215 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.79 -45.23 75.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.5 t -120.45 9.49 10.95 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 121.609 -0.682 . . . . 0.0 112.564 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.547 ' CD1' HG12 ' A' ' 128' ' ' VAL . 50.2 mt -67.8 132.51 32.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.418 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.8 p -121.58 165.89 15.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.901 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 144' ' ' THR . 15.1 m -130.09 134.06 47.1 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 120.971 0.415 . . . . 0.0 111.14 -177.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.5 m -116.52 145.44 43.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.7 tp -121.74 137.17 54.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.505 0.193 . . . . 0.0 110.756 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -96.62 164.24 12.68 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.528 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.4 t -60.21 -33.97 72.99 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.523 1.056 . . . . 0.0 113.055 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 19.7 t70 -81.25 -11.09 59.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.542 0.687 . . . . 0.0 110.331 -177.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 8.13 24.07 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.68 132.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.33 134.39 55.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -168.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 135' ' ' SER . 20.3 m -121.51 128.1 51.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.446 HG23 ' HB ' ' A' ' 77' ' ' VAL . 15.7 m -114.86 125.4 72.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.6 p-10 -132.25 138.62 47.97 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.444 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.77 -144.8 6.45 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.529 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -91.66 139.03 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.069 2.513 . . . . 0.0 114.392 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 73.9 ttt180 -103.76 137.41 41.82 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--N 1.297 -1.702 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -175.493 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 CA--C 1.497 -1.063 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -96.08 125.74 40.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.4 ' CB ' ' HB2' ' B' ' 149' ' ' ARG . 53.0 t80 -128.88 145.81 51.11 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.738 -170.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.4 t -117.6 130.06 56.15 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.453 ' HB ' HG21 ' B' ' 145' ' ' VAL . 23.2 t -114.32 131.03 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -111.09 147.15 35.46 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' LEU . . . . . 0.469 ' O ' HG22 ' B' ' 81' ' ' VAL . 6.7 mp -118.5 128.83 54.96 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -73.67 125.32 27.78 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.402 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.648 HG11 ' O ' ' B' ' 82' ' ' LYS . 31.6 t -139.23 142.18 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 O-C-N 123.911 0.757 . . . . 0.0 109.107 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.648 ' O ' HG11 ' B' ' 81' ' ' VAL . 16.9 tptm -97.72 -177.42 3.77 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 7.6 t60 -77.7 124.76 28.37 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 117.89 -1.524 . . . . 0.0 113.4 -167.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.514 ' HB3' ' CE1' ' B' ' 118' ' ' PHE . 0.0 OUTLIER -132.55 172.5 12.43 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.174 172.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -77.54 118.05 69.49 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.2 -27.69 38.79 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 124.045 3.163 . . . . 0.0 114.036 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -87.22 -35.18 18.68 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.461 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -92.04 58.51 3.37 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.543 0.687 . . . . 0.0 110.42 -174.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.51 160.34 40.47 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.153 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -135.67 124.56 24.08 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.78 122.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -129.04 134.3 48.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.279 0.562 . . . . 0.0 111.744 -174.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 p -128.45 120.86 53.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.0 tp -129.93 91.78 3.19 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.63 -111.99 4.19 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.944 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -93.17 0.06 57.06 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 124.45 1.1 . . . . 0.0 111.003 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 97.6 t -110.06 136.33 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.526 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' B' ' 122' ' ' TYR . 17.1 mt -125.07 120.53 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.55 149.09 49.34 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.23 0.538 . . . . 0.0 110.759 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 94.0 t -129.54 120.93 51.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -113.52 120.14 39.96 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . 0.425 ' HA3' ' CD2' ' B' ' 84' ' ' PHE . . . -137.07 154.59 22.35 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.33 143.26 39.83 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.508 0.67 . . . . 0.0 110.998 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' B' ' 84' ' ' PHE . 82.0 t60 -137.92 127.72 25.4 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 170.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' B' ' 114' ' ' ILE . 34.7 mt-10 -85.5 121.14 27.77 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.406 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 23.3 mt-10 -54.88 -80.7 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -166.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.406 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 51.6 mtm-85 -148.0 153.72 39.35 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -83.31 129.09 34.98 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -94.71 -172.53 2.76 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -39.5 -66.4 0.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.131 1.372 . . . . 0.0 112.958 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -142.69 27.95 1.64 Allowed 'General case' 0 CA--C 1.461 -2.472 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.45 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -132.81 153.57 20.74 Favored Glycine 1 N--CA 1.37 -5.761 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -177.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -110.41 149.04 30.83 Favored 'General case' 1 C--N 1.244 -4.018 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.458 ' O ' ' HB3' ' B' ' 105' ' ' GLU . 34.8 mm -124.21 135.53 63.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.127 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.6 m -128.18 141.09 51.57 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -128.64 147.17 50.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.3 150.44 50.98 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.128 0.489 . . . . 0.0 110.139 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' B' ' 84' ' ' PHE . 72.5 m-85 -124.77 133.92 52.98 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -127.38 121.88 32.14 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.595 ' CZ ' ' HA ' ' B' ' 81' ' ' VAL . 67.6 mtt-85 -117.18 137.02 52.62 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -135.16 128.3 31.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.774 -1.17 . . . . 0.0 110.697 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' B' ' 98' ' ' ILE . 13.5 m-85 -131.46 134.99 46.75 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.973 0.909 . . . . 0.0 110.672 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -127.78 98.67 5.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.631 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 5.0 pt -135.72 106.59 9.85 Favored Pre-proline 0 C--N 1.29 -1.979 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.739 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -40.32 0.06 OUTLIER 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.26 1.973 . . . . 0.0 112.544 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.69 -32.05 71.58 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.612 0.72 . . . . 0.0 111.794 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -92.15 -16.08 26.78 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.927 -0.483 . . . . 0.0 110.783 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 13.0 t -131.45 119.88 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -170.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.05 111.68 36.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.82 15.29 0.38 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 123.456 2.771 . . . . 0.0 115.887 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.06 -45.13 71.14 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.101 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 12.8 t -120.61 9.88 10.93 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . 0.542 ' CD1' HG13 ' B' ' 128' ' ' VAL . 50.0 mt -68.11 132.92 32.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.393 -170.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.7 p -121.98 166.18 14.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.733 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' B' ' 144' ' ' THR . 14.5 m -130.97 134.05 46.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.97 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 19.7 m -116.35 145.32 43.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -121.97 137.0 54.96 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 25.3 m -96.39 164.41 12.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.435 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -60.44 -34.07 73.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.448 1.022 . . . . 0.0 113.077 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 19.9 t70 -81.39 -10.73 59.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.43 0.633 . . . . 0.0 110.342 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.09 8.33 23.88 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.349 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 46.2 t -71.85 132.75 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.66 134.37 55.11 Favored 'General case' 0 C--O 1.209 -1.066 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.178 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' B' ' 135' ' ' SER . 20.1 m -121.4 127.87 51.62 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . 0.453 HG21 ' HB ' ' B' ' 77' ' ' VAL . 15.7 m -114.88 125.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 21.8 p-10 -132.47 138.14 47.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.465 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 179.69 -144.52 6.09 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -91.64 139.15 2.22 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.145 2.563 . . . . 0.0 114.383 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' B' ' 75' ' ' PHE . 71.5 ttt180 -103.8 137.89 41.18 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.492 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.866 0.365 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -113.09 120.17 40.37 Favored 'General case' 0 CA--C 1.471 -2.063 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.34 150.64 25.02 Favored 'General case' 0 N--CA 1.393 -3.323 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.595 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 p -137.13 144.34 42.96 Favored 'General case' 0 N--CA 1.402 -2.851 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.087 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.444 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 32.8 t -116.05 132.55 65.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -110.97 136.89 49.3 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HG ' ' OH ' ' A' ' 122' ' ' TYR . 6.0 mp -119.67 128.08 53.49 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.78 138.73 50.85 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 122.727 0.411 . . . . 0.0 109.911 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.42 165.99 5.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.72 -164.75 0.09 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.483 0.583 . . . . 0.0 110.441 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -77.41 123.94 27.21 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.003 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.58 143.11 15.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 m -74.02 124.73 90.33 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 123.477 0.485 . . . . 0.0 110.983 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.43 -30.96 75.75 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.865 3.043 . . . . 0.0 114.046 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -74.59 -26.58 60.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.861 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.81 0.84 51.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.291 0.567 . . . . 0.0 111.398 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.22 147.67 44.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -126.21 126.26 43.76 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.38 126.69 52.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -129.57 138.37 51.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.438 0.637 . . . . 0.0 109.417 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.16 90.44 3.34 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.91 -112.17 4.73 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.148 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.4 -0.55 57.31 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.355 1.062 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.69 135.74 42.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.44 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 59.0 mt -122.0 119.53 58.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 39.1 mt-10 -136.38 137.02 40.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.61 0.719 . . . . 0.0 111.705 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 60.6 t -119.05 124.78 73.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -127.76 128.74 45.86 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.84 156.66 27.11 Favored Glycine 0 C--N 1.283 -2.384 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -143.37 134.16 25.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 124.056 0.504 . . . . 0.0 109.921 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.403 ' CD2' ' HG2' ' A' ' 106' ' ' GLU . 62.4 t60 -136.77 127.72 27.59 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.55 0.34 . . . . 0.0 110.327 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 12.5 pt-20 -87.03 137.05 32.68 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.403 ' HG2' ' CD2' ' A' ' 104' ' ' HIS . 28.3 mt-10 -106.78 -53.98 2.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.331 -173.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -148.34 152.92 37.88 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 47.7 tt0 -111.76 122.24 47.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.453 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -75.2 -67.35 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -179.22 106.19 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' B' ' 122' ' ' TYR . 37.6 m80 60.1 25.29 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.027 0.918 . . . . 0.0 109.208 -175.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.642 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -156.4 119.13 0.89 Allowed Glycine 1 N--CA 1.39 -4.392 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -175.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 108' ' ' GLN . 11.7 p90 -119.28 153.54 34.88 Favored 'General case' 1 C--N 1.243 -4.033 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 pt -121.04 140.87 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 15.5 m -134.44 157.09 47.34 Favored 'General case' 0 N--CA 1.404 -2.749 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.974 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.9 ttp85 -126.65 146.46 50.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.7 mt-10 -136.87 153.69 50.69 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -128.54 133.6 48.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 26.6 t-80 -131.56 122.48 26.16 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.483 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.427 HH21 HG13 ' A' ' 100' ' ' VAL . 30.8 mtm180 -115.72 138.4 51.15 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.612 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 51.0 tttp -136.03 128.04 29.61 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.684 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 30.3 m-85 -132.17 142.32 49.42 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.104 0.878 . . . . 0.0 109.024 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -128.48 98.57 5.08 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.7 pt -137.33 106.21 8.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.328 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.49 -45.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.886 0 C-N-CA 122.642 2.228 . . . . 0.0 113.366 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 150' ' ' LYS . . . -67.54 -28.19 67.59 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -91.16 -18.0 25.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 77.8 t -132.81 127.6 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.574 ' H ' ' HB3' ' A' ' 148' ' ' PRO . 5.6 m-20 -121.62 109.6 34.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.233 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.505 ' HA ' ' CG2' ' A' ' 133' ' ' ILE . 20.8 Cg_endo -59.92 -12.26 18.08 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 124.239 3.293 . . . . 0.0 114.744 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.55 -40.34 96.74 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.177 0.513 . . . . 0.0 111.237 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.1 t -118.42 9.16 12.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.663 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.505 ' CG2' ' HA ' ' A' ' 130' ' ' PRO . 10.4 tt -77.26 141.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.992 0.425 . . . . 0.0 110.065 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 4.9 p -138.79 154.77 48.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 144' ' ' THR . 22.9 t -131.02 133.21 45.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.169 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 p -119.64 130.33 55.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.401 ' H ' HD21 ' A' ' 137' ' ' LEU . 1.4 pt? -130.13 137.23 50.04 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.01 0.434 . . . . 0.0 112.099 -169.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.3 p -99.91 168.0 10.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.358 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.4 m -67.13 -10.97 55.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.38 1.472 . . . . 0.0 112.308 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.38 20.07 19.42 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-O 121.789 0.804 . . . . 0.0 110.516 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.21 -5.34 63.51 Favored Glycine 0 C--O 1.261 1.791 0 CA-C-N 115.568 -0.742 . . . . 0.0 114.813 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.8 119.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.9 pp -129.94 135.55 48.45 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 135' ' ' SER . 13.5 p -107.31 133.08 52.38 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.483 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 134' ' ' THR . 12.5 m -111.82 121.52 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -137.38 164.75 27.88 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.361 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.494 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . 128.1 -49.06 0.94 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.41 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.574 ' HB3' ' H ' ' A' ' 129' ' ' ASP . 55.5 Cg_endo -62.29 169.72 7.55 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 123.241 2.628 . . . . 0.0 114.989 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -106.26 154.88 20.1 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 126' ' ' ALA . 81.5 tttt . . . . . 0 C--N 1.285 -2.207 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.117 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.038 0.447 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -112.87 120.04 40.06 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.43 150.7 25.04 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.57 -172.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.7 p -137.36 144.24 42.41 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.186 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.456 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 33.3 t -116.0 132.91 64.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.35 136.72 50.06 Favored 'General case' 0 C--N 1.269 -2.928 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' LEU . . . . . 0.457 ' HG ' ' OH ' ' B' ' 122' ' ' TYR . 6.0 mp -119.53 128.16 53.68 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.76 138.63 50.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.48 165.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.37 -164.46 0.08 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.444 0.565 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -77.67 124.22 27.66 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.807 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.77 142.62 15.29 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.5 m -73.5 124.49 90.45 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 123.349 0.405 . . . . 0.0 111.057 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.4 -31.2 76.54 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.725 2.95 . . . . 0.0 113.993 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.77 -26.42 60.64 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.47 0.91 53.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.133 0.492 . . . . 0.0 111.398 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.29 147.52 44.89 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -125.98 125.89 43.43 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -98.5 127.14 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.808 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -129.88 140.01 51.06 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 117.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.95 90.19 3.28 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.34 -112.31 4.87 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.65 -0.19 56.53 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 124.417 1.087 . . . . 0.0 111.946 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 65.3 t -106.22 135.91 42.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.591 -0.693 . . . . 0.0 110.314 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 59.3 mt -122.18 119.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 39.1 mt-10 -136.23 136.91 40.29 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.661 0.743 . . . . 0.0 111.637 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 119' ' ' HIS . 61.1 t -118.99 124.41 73.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -127.25 128.73 46.5 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.15 156.62 27.07 Favored Glycine 0 C--N 1.286 -2.242 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -143.31 134.0 25.14 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 122.648 0.379 . . . . 0.0 110.024 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' HIS . . . . . 0.401 ' CD2' ' HG2' ' B' ' 106' ' ' GLU . 61.2 t60 -136.63 127.68 27.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 122.561 0.344 . . . . 0.0 110.311 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 12.0 pt-20 -86.72 137.05 32.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.401 ' HG2' ' CD2' ' B' ' 104' ' ' HIS . 27.8 mt-10 -106.74 -54.33 2.49 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.254 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -148.13 153.11 38.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -111.7 122.64 48.34 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.593 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.98 -67.99 0.59 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.769 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -178.7 106.16 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 39.1 m80 60.61 24.17 13.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.937 0.875 . . . . 0.0 109.158 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.684 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -154.99 120.26 1.0 Allowed Glycine 2 N--CA 1.389 -4.485 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -177.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -119.34 153.6 34.87 Favored 'General case' 1 C--N 1.241 -4.146 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 pt -121.06 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 14.5 m -134.4 157.08 47.32 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.108 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -126.42 146.49 50.05 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 37.1 mt-10 -136.83 153.59 50.75 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -172.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -128.63 133.43 48.27 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 121.186 0.517 . . . . 0.0 110.669 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 28.2 t-80 -131.49 122.43 26.18 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.469 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.429 HH21 HG11 ' B' ' 100' ' ' VAL . 30.1 mtm180 -115.81 138.43 51.15 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.609 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 50.3 tttp -136.13 128.06 29.44 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.312 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' TYR . . . . . 0.642 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 29.9 m-85 -132.22 142.56 49.47 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 124.013 0.821 . . . . 0.0 108.92 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -128.41 98.57 5.1 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.508 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -137.26 106.19 8.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.499 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -89.46 -44.53 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.638 2.225 . . . . 0.0 113.403 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' B' ' 150' ' ' LYS . . . -68.12 -27.74 66.73 Favored 'General case' 0 C--O 1.198 -1.639 0 O-C-N 122.049 -0.407 . . . . 0.0 111.959 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.66 -18.17 24.39 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 76.7 t -132.75 127.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . 0.59 ' H ' ' HB3' ' B' ' 148' ' ' PRO . 7.1 m-20 -121.34 110.42 34.22 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.164 168.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.49 ' HA ' ' CG2' ' B' ' 133' ' ' ILE . 20.7 Cg_endo -60.66 -12.02 19.71 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 124.026 3.151 . . . . 0.0 114.737 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.93 -40.14 95.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.093 0.473 . . . . 0.0 111.078 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 6.9 t -118.14 9.02 12.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . 0.49 ' CG2' ' HA ' ' B' ' 130' ' ' PRO . 10.9 tt -76.84 141.9 15.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.6 p -138.92 154.43 48.35 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.629 0.772 . . . . 0.0 109.2 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.0 t -130.82 132.9 45.5 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.19 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 2.6 p -119.74 130.09 54.82 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . 0.404 ' H ' HD21 ' B' ' 137' ' ' LEU . 1.4 pt? -130.06 136.97 49.95 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -169.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 76.8 p -99.55 168.14 10.15 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.487 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 6.9 m -67.62 -11.15 57.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.397 1.479 . . . . 0.0 112.092 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.22 20.04 19.53 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.677 0.751 . . . . 0.0 110.424 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.12 -4.72 65.53 Favored Glycine 0 C--O 1.26 1.725 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.28 119.79 33.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -130.12 135.77 48.57 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.828 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' B' ' 135' ' ' SER . 11.6 p -107.49 133.29 52.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.271 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' B' ' 134' ' ' THR . 12.4 m -111.85 121.56 64.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -137.56 164.82 27.82 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 122.179 -0.326 . . . . 0.0 110.163 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' B' ' 148' ' ' PRO . . . 127.93 -49.03 0.94 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.785 -1.197 . . . . 0.0 114.311 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.59 ' HB3' ' H ' ' B' ' 129' ' ' ASP . 55.6 Cg_endo -62.88 169.48 8.78 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.953 2.435 . . . . 0.0 115.05 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -105.22 155.51 18.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 79.9 tttt . . . . . 0 C--N 1.285 -2.217 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -95.5 139.76 31.31 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 128' ' ' VAL . 20.2 t80 -106.62 140.02 40.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.727 -170.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 t -137.91 129.14 27.6 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.71 130.79 72.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.44 155.95 22.39 Favored 'General case' 0 C--N 1.257 -3.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 16.6 tp -118.67 127.86 53.97 Favored 'General case' 0 N--CA 1.381 -3.916 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -104.32 130.27 52.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 p -156.56 162.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.494 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -93.42 -162.89 0.98 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.367 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.705 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 62.3 t-80 -76.58 123.78 26.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 117.334 -1.746 . . . . 0.0 112.296 -169.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.37 133.72 19.59 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -73.6 149.14 88.28 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -47.74 -34.79 22.13 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.921 2.414 . . . . 0.0 115.513 -171.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.31 -17.99 53.48 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.61 -20.06 44.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -120.95 151.12 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.426 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.481 ' HB2' ' HZ3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -138.19 136.2 36.38 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.03 139.97 37.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.588 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -132.55 139.51 47.89 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.241 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 98' ' ' ILE . 2.4 p -129.94 112.96 25.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.77 101.78 5.04 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.97 -111.74 4.0 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.002 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 125' ' ' PRO . 8.4 p-10 -93.94 -5.92 46.7 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 124.731 1.212 . . . . 0.0 111.431 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.92 135.57 54.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.071 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.446 ' HB ' ' CE2' ' A' ' 122' ' ' TYR . 3.0 mp -131.81 120.05 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.8 mt-10 -133.43 147.87 51.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 120.992 0.425 . . . . 0.0 111.686 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.65 129.44 71.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -136.0 133.37 37.42 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.95 147.0 17.92 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.02 134.52 45.66 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -130.53 131.14 44.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.3 pt-20 -87.18 120.85 28.88 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.598 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 30.5 mm-40 -67.6 -70.68 0.24 Allowed 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.308 -173.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.598 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 0.8 OUTLIER -144.17 154.89 43.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -111.26 128.59 55.98 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -93.88 -168.44 1.88 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 3.6 mp0 -57.6 -68.72 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.967 1.307 . . . . 0.0 109.539 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -122.18 14.84 10.59 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' B' ' 122' ' ' TYR . . . -115.54 142.32 17.51 Favored Glycine 1 N--CA 1.384 -4.773 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.393 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.75 139.57 53.85 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 107' ' ' ARG . 5.6 mt -123.7 131.98 72.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 23.3 t -137.16 157.46 46.61 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.093 0.473 . . . . 0.0 110.545 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -134.1 147.72 50.9 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 171.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -130.94 154.35 48.21 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 122.19 0.196 . . . . 0.0 110.483 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -122.1 128.28 51.13 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -131.25 122.04 25.82 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -126.63 137.86 53.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.496 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 23.6 mtpp -134.57 127.11 30.61 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.173 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.468 ' HB3' ' CA ' ' B' ' 112' ' ' GLY 0.305 1.3 p90 -134.7 133.72 40.31 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 173.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -109.9 101.68 10.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.448 0.642 . . . . 0.0 110.557 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.4 pt -135.52 106.91 10.01 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.463 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 59.2 Cg_endo -108.95 -37.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 122.7 2.267 . . . . 0.0 116.154 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.41 ' H ' ' HD2' ' A' ' 125' ' ' PRO . . . -68.03 -29.76 68.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.763 -0.585 . . . . 0.0 112.382 -172.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.06 8.18 20.01 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.525 0.679 . . . . 0.0 109.37 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.46 HG23 ' CE2' ' A' ' 75' ' ' PHE . 56.3 t -131.16 127.43 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.644 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.68 103.36 40.74 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.21 8.85 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 123.684 2.923 . . . . 0.0 116.167 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.91 -39.81 95.67 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.6 t -119.36 9.29 11.59 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.388 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 42.9 mt -68.36 122.46 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.703 0.763 . . . . 0.0 112.296 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.76 167.27 18.33 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.034 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 143' ' ' LEU . 19.0 p -127.2 135.64 50.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -116.46 129.54 56.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -129.29 127.95 42.2 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 123.16 0.288 . . . . 0.0 111.111 -171.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.8 m -99.84 163.98 12.22 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.643 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.0 m -55.14 -30.64 60.23 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.705 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 25.3 t70 -88.33 -11.79 45.32 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.841 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.35 62.01 0.81 Allowed Glycine 0 N--CA 1.409 -3.127 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.23 122.28 67.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 79' ' ' LEU . 15.9 tp -127.2 134.93 50.06 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -173.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.43 ' N ' HD11 ' A' ' 143' ' ' LEU . 41.3 m -121.43 118.93 30.64 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.368 171.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.451 HG11 ' CG2' ' A' ' 133' ' ' ILE . 13.6 t -106.72 120.39 57.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 9.4 p30 -139.47 159.69 41.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.9 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.47 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.69 -136.66 2.97 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -104.28 149.74 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.449 2.766 . . . . 0.0 113.72 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -101.11 153.94 19.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 23.7 t0 . . . . . 0 N--CA 1.437 -1.106 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -95.31 140.14 30.63 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' B' ' 128' ' ' VAL . 19.7 t80 -107.19 139.95 40.83 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.686 -170.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -137.92 129.3 27.81 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.12 130.92 72.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.39 155.98 22.3 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' B' ' 143' ' ' LEU . 16.6 tp -118.66 127.68 53.8 Favored 'General case' 1 N--CA 1.379 -4.002 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.76 130.47 51.28 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.08 162.04 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.254 -3.548 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.96 -162.81 0.97 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.157 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . 0.73 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 61.4 t-80 -76.59 123.73 26.53 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 117.65 -1.62 . . . . 0.0 112.417 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -147.48 134.06 19.84 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -73.81 148.74 87.51 Favored Pre-proline 0 C--N 1.283 -2.314 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.69 -34.69 21.55 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.91 2.406 . . . . 0.0 115.556 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.22 -17.86 54.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 120.843 0.354 . . . . 0.0 111.624 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.89 -20.08 42.98 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -121.01 150.45 41.12 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.545 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.493 ' HZ2' ' HB2' ' B' ' 90' ' ' LYS . 0.1 OUTLIER -137.4 135.88 37.35 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 p -113.56 139.94 36.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.714 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.456 ' HZ2' ' HB3' ' B' ' 92' ' ' LYS . 0.2 OUTLIER -132.62 139.88 47.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.269 178.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.426 HG22 HG13 ' B' ' 98' ' ' ILE . 2.4 p -129.98 112.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.533 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.67 102.77 5.4 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.324 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.66 -111.55 4.04 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.009 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' B' ' 125' ' ' PRO . 8.6 p-10 -94.12 -5.9 46.19 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 124.499 1.12 . . . . 0.0 111.519 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.74 135.53 54.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.026 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . 0.433 ' HB ' ' CE2' ' B' ' 122' ' ' TYR . 3.0 mp -131.64 120.01 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.485 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 37.1 mt-10 -133.47 147.42 51.67 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.665 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.02 129.58 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -136.1 133.34 37.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.82 147.56 18.82 Favored Glycine 0 C--N 1.286 -2.228 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.96 134.3 45.47 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -130.16 132.06 45.9 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.5 pt-20 -88.34 120.51 29.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.598 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 31.7 mm-40 -67.09 -71.14 0.21 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 112.683 -2.053 . . . . 0.0 110.281 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.598 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 0.7 OUTLIER -143.71 154.99 44.05 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.19 128.68 55.99 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -94.13 -169.09 1.99 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' B' ' 110' ' ' GLU . 3.5 mp0 -56.95 -68.4 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.117 1.367 . . . . 0.0 109.635 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -122.33 14.93 10.47 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 122' ' ' TYR . . . -115.51 142.59 17.69 Favored Glycine 1 N--CA 1.385 -4.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.328 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.3 139.27 54.07 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' B' ' 107' ' ' ARG . 5.6 mt -123.7 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 22.8 t -137.03 157.56 46.45 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.265 0.555 . . . . 0.0 110.611 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -134.18 147.75 50.8 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 171.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -131.01 154.26 48.37 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -121.77 128.13 51.39 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -131.11 121.7 25.38 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -126.07 138.04 53.68 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.485 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 23.7 mtpp -134.68 127.07 30.35 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.226 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' TYR . . . . . 0.442 ' HB3' ' CA ' ' A' ' 112' ' ' GLY 0.312 1.3 p90 -134.72 134.05 40.62 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 174.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -110.53 101.51 10.18 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.452 0.644 . . . . 0.0 110.299 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 2.4 pt -135.58 106.9 9.96 Favored Pre-proline 0 C--N 1.292 -1.915 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.494 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.457 ' HB3' ' HB3' ' B' ' 96' ' ' ASP . 59.1 Cg_endo -109.03 -37.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.691 2.261 . . . . 0.0 116.455 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.404 ' H ' ' HD2' ' B' ' 125' ' ' PRO . . . -68.24 -29.44 68.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.98 8.24 20.16 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.731 0.777 . . . . 0.0 109.409 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.463 HG23 ' CE2' ' B' ' 75' ' ' PHE . 53.3 t -131.44 127.19 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.716 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -121.7 103.33 40.74 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.14 8.46 1.41 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.775 2.983 . . . . 0.0 116.166 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.56 -39.43 93.65 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 14.7 t -119.57 9.17 11.42 Favored 'General case' 0 C--O 1.252 1.189 0 O-C-N 121.229 -0.919 . . . . 0.0 111.233 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 42.7 mt -68.4 121.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.886 0.85 . . . . 0.0 112.342 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.74 167.13 17.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.52 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.411 ' HB2' HD13 ' B' ' 143' ' ' LEU . 21.9 p -126.99 135.71 51.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t -116.72 129.91 56.41 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 60.6 tp -130.19 127.02 38.83 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.682 0.277 . . . . 0.0 111.07 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 13.7 m -98.64 163.95 12.44 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.676 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.2 m -55.17 -30.49 59.97 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -169.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . 0.73 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 22.8 t70 -88.92 -11.67 43.84 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.554 0.692 . . . . 0.0 110.713 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.57 61.82 0.8 Allowed Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -172.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.72 121.94 66.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' B' ' 79' ' ' LEU . 16.1 tp -126.85 135.03 50.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.441 ' N ' HD12 ' B' ' 143' ' ' LEU . 42.4 m -121.66 118.21 28.59 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.352 171.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . 0.446 HG11 ' CG2' ' B' ' 133' ' ' ILE . 13.1 t -106.09 120.53 57.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.1 p30 -139.54 160.09 40.67 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.839 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.457 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 178.2 -136.91 3.12 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -104.06 150.29 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.443 2.762 . . . . 0.0 113.644 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -101.74 154.25 19.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt . . . . . 0 C--N 1.292 -1.896 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.831 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 65.5 mtp180 -94.42 119.17 32.74 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -124.85 155.38 39.55 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.659 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.3 p -129.44 140.28 51.36 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.191 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.461 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 45.4 t -115.37 136.26 52.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -111.14 139.49 46.47 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.444 ' HG ' ' CZ ' ' A' ' 122' ' ' TYR . 6.1 mp -119.93 128.55 53.71 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.38 119.43 25.09 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 141' ' ' GLY . 40.4 t -133.67 141.08 45.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 174.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -83.33 -171.15 3.41 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.538 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -76.13 125.04 28.4 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -158.16 166.63 31.94 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -74.97 113.41 24.54 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 123.719 0.637 . . . . 0.0 110.294 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.94 -29.81 83.68 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.787 2.991 . . . . 0.0 115.055 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.39 -7.98 57.11 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.999 -0.438 . . . . 0.0 111.392 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.411 ' HA ' ' OE1' ' A' ' 88' ' ' GLU . 5.5 mm-40 -93.18 2.74 56.54 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.679 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.58 147.25 45.44 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -124.26 126.61 46.36 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.89 122.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.17 131.12 54.89 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.143 0.497 . . . . 0.0 111.07 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.13 125.03 72.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.98 91.73 2.72 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.569 0.7 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.76 -112.4 4.73 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.742 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -95.26 11.48 32.35 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.743 0.817 . . . . 0.0 111.515 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.34 137.21 55.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.821 -0.549 . . . . 0.0 110.314 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.51 HG22 ' HB2' ' A' ' 122' ' ' TYR . 2.3 tp -125.99 120.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.3 mt-10 -132.2 150.04 52.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.138 0.494 . . . . 0.0 110.453 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.7 t -126.84 124.2 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -128.36 133.19 48.6 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.63 150.94 23.24 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 128.07 17.69 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -138.27 134.16 34.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 111.216 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -80.89 120.45 24.73 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.17 -55.94 5.0 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.024 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HG2' HD12 ' A' ' 114' ' ' ILE . 30.7 ptt180 -148.59 155.38 41.02 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -82.24 113.58 20.16 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -93.98 -148.86 0.27 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.891 -164.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -72.85 83.62 1.21 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.496 0.589 . . . . 0.0 109.786 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 74.53 -52.65 0.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.076 1.75 . . . . 0.0 110.321 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.36 173.22 54.27 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.189 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.91 149.27 41.86 Favored 'General case' 0 C--N 1.255 -3.517 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.51 HD11 ' NH2' ' B' ' 120' ' ' ARG . 38.1 pt -122.88 137.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.195 -175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -134.47 154.24 51.51 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.22 0.533 . . . . 0.0 111.244 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.402 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 6.8 ttp180 -127.3 147.05 50.24 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -134.13 153.45 51.82 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.509 ' HD2' ' NH1' ' A' ' 120' ' ' ARG . 50.1 m-85 -128.26 126.41 40.82 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.494 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.75 122.52 27.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' NH2' HD12 ' B' ' 114' ' ' ILE . 26.3 mtt85 -126.94 138.21 53.25 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -138.66 128.88 25.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.908 0.755 . . . . 0.0 111.541 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 98' ' ' ILE . 3.7 m-85 -133.1 123.67 26.15 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.084 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -107.56 99.42 8.92 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.481 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 4.3 pt -135.93 105.8 9.68 Favored Pre-proline 0 C--N 1.303 -1.452 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.774 -177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.53 -38.67 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.91 2.407 . . . . 0.0 112.122 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 150' ' ' LYS . . . -68.63 -32.32 72.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.292 0.567 . . . . 0.0 111.338 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.99 -18.27 22.06 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.727 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 70.3 t -131.71 114.38 24.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.42 127.04 27.91 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 168.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.32 16.01 0.48 Allowed 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 122.665 2.244 . . . . 0.0 116.402 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.1 tp -81.84 -48.18 11.88 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.277 3.0 t -122.27 10.74 9.99 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.2 pp -67.28 129.28 31.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.1 p -132.56 166.38 22.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 52.9 p -127.87 134.12 49.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 121.03 0.443 . . . . 0.0 110.912 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -125.09 129.96 51.29 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.8 148.46 44.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.5 m -100.37 163.86 12.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.9 m -64.32 -21.57 66.65 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.767 0.827 . . . . 0.0 112.384 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.83 5.15 22.62 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 121.274 0.559 . . . . 0.0 110.467 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.617 ' O ' ' HB ' ' A' ' 81' ' ' VAL . . . 96.64 -20.54 50.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.868 173.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.85 123.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.766 0.793 . . . . 0.0 110.454 -175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.65 136.26 49.51 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.583 -175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.0 t -109.72 135.68 50.26 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.461 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 31.1 m -105.9 122.16 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 3.6 p-10 -132.89 143.48 49.53 Favored 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.171 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 74' ' ' ARG . . . 174.34 -138.09 4.27 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -91.76 147.08 3.25 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.379 2.053 . . . . 0.0 112.813 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -100.57 151.47 21.56 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 126' ' ' ALA . 87.1 tttt . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 N--CA 1.441 -0.908 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' B' ' 147' ' ' GLY . 66.3 mtp180 -94.3 119.08 32.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -124.99 154.87 40.55 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.697 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.3 p -128.56 140.34 51.84 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.428 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.464 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 44.6 t -115.24 136.57 51.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -111.14 139.65 46.35 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' LEU . . . . . 0.435 ' HG ' ' CZ ' ' B' ' 122' ' ' TYR . 6.1 mp -120.12 128.63 53.62 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -84.5 119.24 24.93 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.63 ' HB ' ' O ' ' B' ' 141' ' ' GLY . 41.0 t -134.1 140.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 103.01 -2.959 . . . . 0.0 103.01 174.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -82.87 -170.93 3.26 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.671 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -75.9 125.11 28.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -158.24 166.62 31.92 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -74.82 113.29 23.05 Favored Pre-proline 0 N--CA 1.435 -1.211 0 O-C-N 123.777 0.673 . . . . 0.0 110.253 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.93 -30.07 84.65 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.806 3.004 . . . . 0.0 114.969 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.25 -7.15 58.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.023 0.44 . . . . 0.0 111.476 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' B' ' 88' ' ' GLU . 5.4 mm-40 -94.26 2.82 55.84 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.14 0.495 . . . . 0.0 111.53 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.35 147.01 45.58 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.84 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -124.57 125.71 44.62 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -96.27 122.05 47.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -120.34 130.96 54.65 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.67 125.14 71.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -135.84 91.87 2.75 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.0 -112.26 4.6 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.898 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.64 11.43 33.32 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.548 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.51 137.21 55.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.452 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' B' ' 122' ' ' TYR . 2.3 tp -125.99 120.25 56.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 174.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 38.2 mt-10 -132.33 149.93 52.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.11 0.481 . . . . 0.0 110.467 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 88.0 t -126.64 124.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -128.17 132.97 48.86 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.0 151.0 23.35 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 128.09 17.65 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -138.29 134.12 33.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.405 -0.809 . . . . 0.0 111.208 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.73 120.58 24.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -77.21 -55.98 4.95 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.061 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.462 ' HG2' HD13 ' B' ' 114' ' ' ILE . 30.2 ptt180 -148.65 155.46 41.08 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -82.06 113.6 20.05 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.09 -148.53 0.27 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.928 -163.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.55 82.57 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.602 0.637 . . . . 0.0 110.021 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 75.41 -51.46 0.65 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.245 1.818 . . . . 0.0 110.078 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.408 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -77.53 173.2 55.08 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.142 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -118.65 149.59 41.14 Favored 'General case' 0 C--N 1.255 -3.52 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.522 HD12 ' NH2' ' A' ' 120' ' ' ARG . 37.7 pt -122.92 137.03 57.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.315 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -134.59 153.92 51.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.404 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 6.3 ttp180 -127.11 147.05 50.18 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.05 153.35 51.85 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.515 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.5 ' HD2' ' NH1' ' B' ' 120' ' ' ARG . 49.9 m-85 -128.23 126.75 41.54 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.356 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -131.03 122.62 27.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.51 ' NH2' HD11 ' A' ' 114' ' ' ILE . 25.8 mtt85 -126.96 138.1 53.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -138.36 128.88 26.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 124.023 0.827 . . . . 0.0 111.474 -177.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' TYR . . . . . 0.508 ' HB2' HG22 ' B' ' 98' ' ' ILE . 4.1 m-85 -133.11 124.7 28.03 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.027 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -108.79 99.27 8.64 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 4.1 pt -136.06 106.0 9.58 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.772 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -84.9 -38.83 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 111.92 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' B' ' 150' ' ' LYS . . . -67.84 -32.32 72.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.73 -18.14 21.55 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.582 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 70.7 t -131.87 114.31 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -174.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -109.3 127.56 27.01 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.55 15.96 0.52 Allowed 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 122.759 2.306 . . . . 0.0 116.374 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -81.9 -48.39 11.58 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' THR . . . . . . . . . . . . 0.272 4.4 t -122.14 10.55 10.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.2 pp -67.46 128.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -175.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 12.1 p -130.6 166.7 20.08 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.653 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 55.9 p -127.67 134.69 49.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.065 0.46 . . . . 0.0 110.859 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 18.4 m -125.37 129.81 50.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 pp -122.3 148.32 45.16 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 16.3 m -100.07 163.73 12.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 18.6 m -64.1 -21.87 66.71 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 112.439 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.43 4.19 25.16 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 123.182 0.593 . . . . 0.0 110.484 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . 0.63 ' O ' ' HB ' ' B' ' 81' ' ' VAL . . . 97.3 -20.34 51.14 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.755 173.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.79 123.64 26.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.757 0.789 . . . . 0.0 110.432 -175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.71 136.12 49.3 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.475 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -109.29 135.65 50.03 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . 0.464 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 31.5 m -105.74 122.24 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 3.6 p-10 -133.02 142.73 48.97 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.941 0.401 . . . . 0.0 111.349 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' B' ' 74' ' ' ARG . . . 174.76 -138.02 4.17 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -91.65 146.9 3.31 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.474 2.116 . . . . 0.0 112.887 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -100.62 151.41 21.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' B' ' 126' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.108 0.48 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -112.43 149.6 32.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 9.3 t80 -134.22 158.66 43.15 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.908 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.3 t -131.85 133.81 45.06 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.95 137.77 47.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -110.2 135.27 51.24 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.631 HD23 ' CE1' ' A' ' 122' ' ' TYR . 1.8 mt -120.46 128.86 53.54 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -107.45 134.88 49.84 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.878 0.847 . . . . 0.0 111.82 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.23 -179.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 172.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 54.9 mtpt -100.08 -163.21 1.01 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 120.325 1.421 . . . . 0.0 110.666 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -77.78 125.9 30.04 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.156 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 47.9 m-85 -142.47 146.75 35.1 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.876 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 m -66.54 129.41 94.13 Favored Pre-proline 0 N--CA 1.407 -2.599 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.87 -31.96 21.38 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.229 3.286 . . . . 0.0 115.094 -173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.37 -4.45 58.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.526 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.4 mm-40 -100.11 -0.14 39.57 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.56 147.53 45.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.34 126.03 30.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.49 122.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.02 137.5 53.49 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.079 0.466 . . . . 0.0 110.831 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.51 115.5 44.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.934 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.67 95.01 4.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.67 -112.81 4.86 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.045 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -95.92 11.23 34.6 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 123.186 0.594 . . . . 0.0 111.394 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.42 135.79 57.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.297 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 27.1 mm -121.68 120.57 62.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.46 136.9 39.87 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.701 0.682 . . . . 0.0 112.753 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 46.8 t -107.25 117.17 52.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -113.67 119.05 36.1 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -123.83 135.64 9.87 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 25.4 ttpp -120.21 133.41 55.49 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -134.6 128.67 33.66 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.59 120.92 35.58 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -75.1 -66.26 0.78 Allowed 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.873 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -139.51 124.38 18.61 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.192 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.89 112.62 21.31 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 103.02 -2.956 . . . . 0.0 103.02 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 112' ' ' GLY . 5.4 t70 -114.35 -163.06 0.84 Allowed 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.138 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -74.24 -76.58 0.13 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.051 0.54 . . . . 0.0 111.237 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -109.87 -15.54 14.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 109' ' ' ASP . . . -130.58 113.58 1.45 Allowed Glycine 0 C--O 1.2 -1.995 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.659 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -94.07 137.22 33.51 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' B' ' 120' ' ' ARG . 3.0 tt -125.24 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -131.56 162.76 29.55 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.485 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -127.58 149.61 50.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.631 1.172 . . . . 0.0 108.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 36.6 tt0 -135.83 141.18 44.65 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.448 ' CZ ' ' HD3' ' A' ' 82' ' ' LYS . 9.2 m-85 -126.73 124.96 40.97 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.0 p80 -133.05 125.58 29.96 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.063 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' B' ' 114' ' ' ILE . 24.8 ttt85 -112.63 136.91 51.64 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.425 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 28.1 mtmm -130.05 130.45 44.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.78 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.631 ' CE1' HD23 ' A' ' 79' ' ' LEU . 45.4 m-85 -121.55 131.6 54.23 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 123.418 0.687 . . . . 0.0 110.089 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -117.82 99.07 6.69 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 9.0 pt -135.48 105.51 10.05 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.099 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.67 -33.54 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.443 2.096 . . . . 0.0 111.341 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 150' ' ' LYS . . . -69.23 -22.95 63.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.731 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -108.11 -13.75 14.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.633 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 16.8 t -130.47 134.74 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.23 116.2 42.19 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.13 -6.0 12.15 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.204 2.603 . . . . 0.0 116.381 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.0 tp -81.7 -45.06 16.24 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.769 -176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.6 t -112.77 8.72 18.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 133' ' ' ILE . 2.0 pp -68.75 136.95 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.804 170.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER -130.38 166.27 20.8 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -136.41 141.35 43.62 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 118.899 0.772 . . . . 0.0 111.809 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.9 t -131.67 140.83 49.44 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.79 137.73 53.25 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.909 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 t -100.12 161.63 13.49 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.0 m -67.89 -21.01 65.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.28 7.72 36.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.826 0.822 . . . . 0.0 110.83 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.37 33.49 11.65 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.501 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.1 112.46 32.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -108.68 129.43 55.35 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -175.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.2 p -117.64 129.0 55.47 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 134' ' ' THR . 62.1 t -103.18 122.42 55.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.403 ' OD1' ' HB ' ' A' ' 134' ' ' THR . 24.1 p-10 -126.79 148.27 49.94 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.31 -118.3 0.9 Allowed Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.566 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -85.84 170.61 8.62 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 124.186 3.257 . . . . 0.0 114.19 -172.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.445 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 61.8 ttt180 -141.44 151.2 43.2 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 88.9 tttt . . . . . 0 C--N 1.294 -1.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.083 0.468 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -113.16 149.86 33.03 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 9.4 t80 -134.78 158.91 42.96 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.819 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 14.7 t -132.26 133.79 44.52 Favored 'General case' 0 N--CA 1.399 -3.015 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.0 137.65 47.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -109.82 135.24 51.04 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' B' ' 122' ' ' TYR . 1.7 mt -120.22 128.92 53.81 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -107.56 135.38 49.11 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 121.664 0.745 . . . . 0.0 111.802 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.93 -179.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.444 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 54.0 mtpt -99.76 -163.3 1.02 Allowed 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 120.301 1.409 . . . . 0.0 110.746 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -77.63 125.8 29.9 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 117.712 -1.595 . . . . 0.0 112.188 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' B' ' 118' ' ' PHE . 47.3 m-85 -142.06 146.51 35.56 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.701 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 14.6 m -66.53 129.61 94.13 Favored Pre-proline 0 N--CA 1.412 -2.342 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.411 ' HB3' HD22 ' B' ' 137' ' ' LEU . 69.9 Cg_exo -48.56 -31.98 19.87 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 124.517 3.478 . . . . 0.0 115.094 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -88.27 -4.68 58.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . 0.525 ' HB3' ' O ' ' B' ' 103' ' ' LYS . 11.3 mm-40 -100.47 -0.02 38.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.433 0.635 . . . . 0.0 110.606 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.07 147.7 45.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -133.41 125.92 30.13 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.152 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.79 122.45 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.964 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -118.91 136.39 54.09 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 120.952 0.406 . . . . 0.0 110.737 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.402 HG11 HD12 ' B' ' 98' ' ' ILE . 86.8 t -123.27 116.08 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.77 94.2 4.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.73 -112.62 4.55 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.067 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.38 11.11 35.96 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.075 0.55 . . . . 0.0 111.257 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -117.98 135.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.407 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 27.5 mm -121.8 120.65 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -136.53 137.11 39.94 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 118.71 0.686 . . . . 0.0 112.799 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 119' ' ' HIS . 46.7 t -107.33 117.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -113.68 119.11 36.31 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -123.74 135.65 9.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' B' ' 88' ' ' GLU . 25.5 ttpp -120.02 133.48 55.53 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -134.71 129.02 34.09 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.01 120.83 35.89 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -74.55 -65.69 0.83 Allowed 'General case' 0 CA--C 1.478 -1.798 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.083 -168.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 -140.3 124.27 17.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.141 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 112.41 21.11 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' B' ' 112' ' ' GLY . 5.2 t70 -113.87 -163.05 0.84 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.285 -163.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -73.62 -76.1 0.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 123.315 0.646 . . . . 0.0 111.215 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -110.6 -17.51 13.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' B' ' 109' ' ' ASP . . . -129.33 114.39 1.72 Allowed Glycine 0 C--O 1.2 -2.026 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.974 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -94.22 137.3 33.55 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 120' ' ' ARG . 3.1 tt -125.11 137.26 58.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 15.8 m -132.76 162.7 30.79 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.514 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -127.54 149.65 50.04 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.638 1.175 . . . . 0.0 108.164 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 37.1 tt0 -135.84 141.09 44.62 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' B' ' 82' ' ' LYS . 9.2 m-85 -126.72 124.95 40.95 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 2.0 p80 -133.1 125.75 30.25 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.914 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 24.7 ttt85 -112.66 137.02 51.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.417 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.9 mtmm -130.03 130.26 44.72 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.772 -173.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' TYR . . . . . 0.639 ' CE1' HD22 ' B' ' 79' ' ' LEU . 45.2 m-85 -121.35 131.97 54.5 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 123.704 0.628 . . . . 0.0 110.111 176.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -118.0 98.92 6.57 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 165.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 8.9 pt -135.37 105.5 10.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.055 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -92.59 -33.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.511 2.141 . . . . 0.0 111.386 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' B' ' 150' ' ' LYS . . . -69.29 -23.45 63.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.096 0.558 . . . . 0.0 111.628 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -107.47 -14.3 14.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 16.6 t -129.87 134.53 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -172.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -114.74 116.25 43.32 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.16 -5.49 11.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.056 2.504 . . . . 0.0 116.249 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.91 -45.29 15.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.614 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 8.8 t -113.02 9.05 18.62 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . 0.484 ' O ' HD12 ' B' ' 133' ' ' ILE . 2.0 pp -68.77 136.73 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.774 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 0.2 OUTLIER -130.6 166.15 21.26 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 16.5 m -136.43 141.38 43.59 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 118.853 0.751 . . . . 0.0 111.746 -176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 29.6 t -132.1 139.73 48.57 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -125.58 138.2 53.93 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.063 -177.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.24 161.68 13.45 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 13.2 m -67.56 -20.51 65.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -170.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.32 8.19 37.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.791 0.805 . . . . 0.0 110.558 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.27 33.27 12.04 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.713 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.94 112.78 33.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 0.8 OUTLIER -108.87 129.52 55.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -175.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 7.2 p -117.76 128.76 55.19 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 134' ' ' THR . 61.7 t -102.89 122.53 55.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -126.7 148.67 49.84 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.04 -118.5 0.92 Allowed Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 119.775 -1.202 . . . . 0.0 112.761 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -85.47 170.65 9.08 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.391 3.394 . . . . 0.0 114.288 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ARG . . . . . 0.442 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 61.2 ttt180 -141.77 151.1 42.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 88.2 tttt . . . . . 0 C--N 1.294 -1.807 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 2.8 m-20 . . . . . 0 CA--C 1.505 -0.76 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -118.14 131.52 56.4 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.58 160.28 40.93 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.476 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -137.25 133.41 35.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.492 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 46.4 t -116.02 148.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.83 152.71 27.59 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.668 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 71.0 mt -120.17 142.14 49.25 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.403 ' CG ' HH12 ' B' ' 107' ' ' ARG . 13.5 t70 -105.59 120.17 40.98 Favored 'General case' 0 CA--C 1.493 -1.235 0 O-C-N 123.526 0.516 . . . . 0.0 111.898 -166.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 83' ' ' HIS . 20.9 t -140.78 96.85 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 170.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.02 9.7 1.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.445 ' O ' HG12 ' A' ' 81' ' ' VAL . 4.1 m80 -150.19 173.07 14.33 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 33.9 p90 -103.94 119.02 38.05 Favored 'General case' 0 C--N 1.282 -2.37 0 C-N-CA 117.851 -1.539 . . . . 0.0 113.797 -166.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.504 ' OG ' ' HB2' ' A' ' 104' ' ' HIS . 50.8 m -119.56 65.16 8.74 Favored Pre-proline 0 N--CA 1.422 -1.841 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.826 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 84' ' ' PHE . 35.6 Cg_exo -58.06 -40.37 77.82 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.118 1.879 . . . . 0.0 112.074 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.6 -37.72 16.57 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.266 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 28.3 mt-10 -93.02 28.39 2.14 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -169.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 85' ' ' SER . 3.1 pp -128.66 153.67 47.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.519 174.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.69 129.47 34.83 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.46 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.3 t -107.24 132.82 53.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.11 131.36 47.24 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.399 0.618 . . . . 0.0 111.623 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.57 117.62 55.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -129.12 91.02 3.12 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.18 -113.94 5.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.934 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.27 11.09 39.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 108.971 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.13 137.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.305 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.5 mm -125.08 121.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 30.0 mt-10 -134.36 147.92 50.61 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.884 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 8.5 p -124.75 134.76 66.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -124.14 118.2 26.36 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.2 135.43 6.66 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -133.43 130.53 38.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.504 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 69.7 t60 -139.25 135.95 34.43 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.749 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.8 pt-20 -81.85 120.46 25.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -134.35 -5.29 2.63 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -124.33 124.02 41.48 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -112.99 136.05 53.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.262 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -120.44 -170.1 1.92 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -55.55 -74.66 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -120.34 24.74 10.23 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.46 127.65 4.39 Favored Glycine 0 N--CA 1.402 -3.573 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.37 150.6 29.53 Favored 'General case' 0 C--N 1.261 -3.239 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.429 HG12 ' HG2' ' B' ' 120' ' ' ARG . 3.0 mt -123.78 137.24 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 17.0 m -120.52 150.35 40.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.821 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 35.9 tt0 -137.34 142.37 41.81 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.46 128.25 53.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 12.7 t-80 -131.61 125.97 33.55 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.42 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 79' ' ' LEU . 64.5 mtt-85 -111.22 146.25 37.26 Favored 'General case' 0 CA--C 1.465 -2.302 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 25.0 ttmm -125.82 128.81 48.24 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -128.6 133.04 48.21 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.192 0.597 . . . . 0.0 110.827 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -122.76 98.46 5.92 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.529 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.0 pt -135.59 105.08 9.97 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.146 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.442 ' O ' ' HE2' ' A' ' 150' ' ' LYS . 10.3 Cg_exo -80.45 -39.91 0.23 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.347 2.031 . . . . 0.0 110.237 174.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . -67.44 -17.56 64.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.964 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.13 -17.9 12.28 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.006 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 55.3 t -131.34 126.12 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.32 126.66 26.15 Favored Pre-proline 0 N--CA 1.428 -1.569 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 165.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.6 -24.41 53.83 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 123.931 3.087 . . . . 0.0 115.172 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.3 -24.31 37.29 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.453 ' OG1' ' HD2' ' A' ' 148' ' ' PRO . 11.1 t -116.94 -17.22 10.45 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.88 -1.128 . . . . 0.0 113.197 -172.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.7 mm -81.3 125.22 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.947 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 11.2 p -122.01 167.19 13.39 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.904 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -126.99 133.76 50.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.917 0.389 . . . . 0.0 111.347 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 p -121.24 145.38 47.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.378 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 65.8 tp -123.88 131.52 53.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -96.76 162.91 13.22 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.1 t -67.43 -13.45 62.04 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -98.45 0.29 44.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.588 0.709 . . . . 0.0 110.465 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.54 4.51 52.54 Favored Glycine 0 C--N 1.316 -0.58 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.171 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.18 113.38 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.3 tm? -107.61 132.23 53.52 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.75 124.75 44.95 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.594 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.492 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 26.8 m -99.19 122.31 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -128.12 142.69 51.12 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.65 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.18 176.79 28.71 Favored Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.584 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 50.4 Cg_exo -62.72 141.13 84.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.902 3.068 . . . . 0.0 113.724 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 56.8 mtp180 -80.0 163.32 24.32 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 125' ' ' PRO . 36.4 ttpt . . . . . 0 C--N 1.298 -1.671 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.422 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 2.4 m-20 . . . . . 0 CA--C 1.506 -0.725 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -120.23 130.73 54.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.32 160.31 40.75 Favored 'General case' 0 N--CA 1.42 -1.942 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.513 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -137.29 132.67 34.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.954 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.49 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 46.5 t -115.95 148.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -111.58 152.58 27.42 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.686 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' B' ' 143' ' ' LEU . 70.7 mt -120.22 142.23 49.2 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.54 119.82 40.07 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -166.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.447 HG12 ' O ' ' B' ' 83' ' ' HIS . 20.5 t -139.79 97.94 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 102.465 -3.161 . . . . 0.0 102.465 169.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -75.77 9.75 2.16 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . 0.447 ' O ' HG12 ' B' ' 81' ' ' VAL . 3.7 m80 -150.13 173.28 14.08 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.431 ' C ' ' HD3' ' B' ' 86' ' ' PRO . 34.8 p90 -104.0 118.99 37.99 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 117.804 -1.558 . . . . 0.0 113.787 -166.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.509 ' OG ' ' HB2' ' B' ' 104' ' ' HIS . 49.3 m -119.44 65.26 8.42 Favored Pre-proline 0 N--CA 1.421 -1.895 0 CA-C-N 113.492 -1.686 . . . . 0.0 108.879 170.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.431 ' HD3' ' C ' ' B' ' 84' ' ' PHE . 48.8 Cg_exo -57.45 -40.81 78.25 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.159 1.906 . . . . 0.0 112.07 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -88.01 -38.12 15.76 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' B' ' 85' ' ' SER . 27.8 mt-10 -91.79 27.56 2.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -170.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 85' ' ' SER . 3.1 pp -128.31 154.17 46.22 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.56 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.48 130.01 34.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.289 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.25 132.61 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -128.96 131.38 47.48 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.647 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.59 117.37 54.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tt -129.37 90.67 3.05 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.6 -114.23 5.53 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.98 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -100.65 11.2 40.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.842 0.83 . . . . 0.0 108.968 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.3 137.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.222 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 36.4 mm -125.08 120.94 59.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 29.7 mt-10 -134.41 147.89 50.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.923 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . 0.4 ' HB ' HD13 ' B' ' 79' ' ' LEU . 9.1 p -124.62 134.72 66.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -123.84 118.39 27.02 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.35 135.37 6.58 Favored Glycine 0 CA--C 1.491 -1.419 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -133.41 130.29 38.5 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' HIS . . . . . 0.509 ' HB2' ' OG ' ' B' ' 85' ' ' SER . 70.0 t60 -139.03 135.94 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.852 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.7 pt-20 -81.68 120.34 24.98 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.57 -5.28 2.55 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.403 HH12 ' CG ' ' A' ' 80' ' ' ASP . 66.6 mtp180 -124.61 123.99 41.25 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -112.98 136.16 52.96 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.284 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.408 ' CG ' HH12 ' A' ' 120' ' ' ARG . 4.1 m-20 -120.86 -168.34 1.64 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.44 -74.29 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.521 0.729 . . . . 0.0 112.344 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -118.95 24.2 10.97 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -134.1 128.09 4.79 Favored Glycine 0 N--CA 1.402 -3.61 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -111.56 150.6 29.77 Favored 'General case' 0 C--N 1.263 -3.164 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.449 HG12 ' HG2' ' A' ' 120' ' ' ARG . 3.1 mt -123.9 137.07 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 15.6 m -120.42 150.3 41.01 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.689 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -127.29 148.56 50.23 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 36.0 tt0 -137.47 142.35 41.54 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.42 128.34 53.94 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -131.52 125.82 33.36 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.423 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' B' ' 79' ' ' LEU . 62.4 mtt-85 -111.04 146.29 36.99 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 24.8 ttmm -126.15 128.89 48.0 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.93 132.33 47.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 123.203 0.601 . . . . 0.0 110.833 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -121.87 98.49 5.97 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 168.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.526 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.9 pt -135.39 104.96 10.14 Favored Pre-proline 0 C--N 1.293 -1.886 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.152 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.449 ' O ' ' HE2' ' B' ' 150' ' ' LYS . 7.9 Cg_exo -80.09 -39.74 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.278 1.985 . . . . 0.0 110.321 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' B' ' 149' ' ' ARG . . . -67.26 -17.98 65.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.861 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -113.17 -17.99 12.23 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.109 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 55.4 t -131.35 125.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -169.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -122.35 126.43 26.22 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 165.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.69 -24.06 52.7 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.937 3.091 . . . . 0.0 115.152 -171.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 82.3 mt -81.25 -23.94 37.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' THR . . . . . 0.428 ' OG1' ' HD2' ' B' ' 148' ' ' PRO . 8.3 t -117.43 -17.81 9.98 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.779 -1.168 . . . . 0.0 113.102 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.6 mm -81.07 125.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.06 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 14.6 p -122.09 167.6 12.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.649 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -126.95 134.05 50.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 7.0 p -121.16 146.09 47.14 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.858 0.863 . . . . 0.0 109.139 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 66.3 tp -124.98 130.5 52.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.673 0.273 . . . . 0.0 111.387 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 7.4 m -95.89 163.12 13.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -67.66 -14.32 62.84 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -96.63 -0.69 48.17 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.541 0.686 . . . . 0.0 110.628 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.63 5.16 51.79 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.713 -1.232 . . . . 0.0 112.008 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 46.9 t -73.31 113.66 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.3 tm? -107.8 132.0 53.87 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.7 124.79 45.09 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.576 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . 0.49 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 26.9 m -99.15 122.39 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.858 -171.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.03 177.47 29.26 Favored Glycine 0 N--CA 1.415 -2.749 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.638 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 52.2 Cg_exo -62.98 140.74 80.81 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.892 3.061 . . . . 0.0 113.793 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 56.4 mtp180 -79.81 163.25 24.57 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.039 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' B' ' 125' ' ' PRO . 35.9 ttpt . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.618 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.417 ' HB2' ' CD ' ' A' ' 149' ' ' ARG . 2.8 m-20 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -130.65 126.59 36.97 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -105.92 132.93 51.43 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.962 0.887 . . . . 0.0 112.078 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m -114.38 131.07 56.69 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.61 131.44 66.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -110.4 130.53 55.53 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.647 HD22 ' CZ ' ' A' ' 122' ' ' TYR . 11.9 mt -120.24 128.3 53.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -103.01 128.26 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.002 0.906 . . . . 0.0 113.01 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.43 HG22 HH12 ' A' ' 120' ' ' ARG . 38.9 t -122.28 142.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -64.31 -56.7 12.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.597 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.749 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 18.2 t60 -153.96 125.84 7.74 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.261 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.48 172.17 12.19 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.257 0.48 . . . . 0.0 111.167 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 20.9 m -93.16 121.92 64.45 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.93 -28.64 78.79 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.957 2.438 . . . . 0.0 113.483 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.98 -38.64 19.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.632 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.433 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 35.8 mt-10 -85.42 40.08 0.82 Allowed 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.585 0.707 . . . . 0.0 109.519 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.438 HD13 ' N ' ' A' ' 90' ' ' LYS . 1.1 tm? -120.51 145.81 46.92 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -174.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.438 ' N ' HD13 ' A' ' 89' ' ' LEU . 25.9 tptp -144.0 125.88 15.27 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 138.68 40.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 99' ' ' GLU . 13.1 ptmm? -144.34 135.51 25.36 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.601 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.41 116.12 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.437 ' O ' HG22 ' A' ' 97' ' ' VAL . 62.3 tp -120.04 90.86 3.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.99 -111.96 4.56 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.849 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -90.01 4.2 50.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.941 0.896 . . . . 0.0 112.106 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 94' ' ' LEU . 35.4 m -117.48 137.75 50.38 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.349 -0.94 . . . . 0.0 113.195 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 37.2 mm -112.85 119.89 61.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 92' ' ' LYS . 14.8 mp0 -122.33 136.95 54.99 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.171 0.51 . . . . 0.0 109.867 174.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.6 126.95 61.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.88 42.69 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.01 140.74 12.58 Favored Glycine 0 CA--C 1.477 -2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.433 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 13.9 ptmm? -143.19 144.69 32.28 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 117.214 0.507 . . . . 0.0 109.733 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -136.74 128.82 29.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.56 120.95 25.19 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.401 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 21.9 mt-10 -83.95 -74.18 0.39 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.757 -167.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.401 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 18.2 ptt-85 -148.57 151.34 34.91 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.103 -173.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -111.48 119.73 39.77 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 -44.29 77.96 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 168.83 -75.34 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -94.23 -12.58 27.92 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.545 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -101.48 137.19 13.15 Favored Glycine 0 N--CA 1.411 -3.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.243 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.2 137.69 52.19 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.33 134.02 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.4 p -134.31 155.23 50.59 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -128.19 148.06 50.6 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -135.05 153.52 52.02 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.039 0.447 . . . . 0.0 109.997 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -122.62 125.99 46.76 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.51 122.11 43.75 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.43 HH12 HG22 ' A' ' 81' ' ' VAL . 41.3 ttp180 -133.11 138.0 46.52 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.878 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.47 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 33.1 mttm -139.87 130.46 25.69 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.099 0.875 . . . . 0.0 112.157 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CZ ' HD22 ' A' ' 79' ' ' LEU . 44.0 m-85 -126.15 136.95 53.48 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -117.32 98.63 6.53 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.566 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.8 pt -136.41 106.16 9.29 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.267 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -88.79 -45.88 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.193 1.929 . . . . 0.0 112.873 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.92 -13.03 62.19 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.488 0.661 . . . . 0.0 112.596 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -112.1 -17.65 12.78 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 2.9 t -132.6 117.67 31.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.57 123.27 26.43 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.15 -1.57 3.05 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.633 2.888 . . . . 0.0 116.339 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.4 tp -59.78 -44.43 93.92 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.45 ' HB ' ' HD3' ' A' ' 148' ' ' PRO . 39.6 m -110.84 -12.8 14.23 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 55.4 mt -67.99 126.08 27.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -165.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 p -122.11 163.61 19.17 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.385 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 144' ' ' THR . 26.7 t -138.0 135.68 36.19 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.217 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.8 p -127.75 156.27 42.71 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.41 144.07 44.3 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.195 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.414 ' HB3' ' HB ' ' A' ' 142' ' ' VAL . 17.8 t -100.49 162.74 12.74 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.7 m -61.55 -28.01 69.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.749 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 37.5 t70 -90.18 -12.3 38.55 Favored 'General case' 0 C--O 1.205 -1.265 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.343 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 120.75 8.91 7.91 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 117.978 -2.058 . . . . 0.0 113.237 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 138' ' ' SER . 51.4 t -78.89 118.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.8 tm? -115.23 133.75 55.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 135' ' ' SER . 27.5 m -121.56 130.13 53.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.841 -0.537 . . . . 0.0 111.078 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.3 m -121.03 125.53 74.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 7.9 p30 -137.27 137.52 39.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.048 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.471 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . -158.78 -143.27 3.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.29 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.45 ' HD3' ' HB ' ' A' ' 132' ' ' THR . 93.7 Cg_endo -102.73 169.64 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.022 3.148 . . . . 0.0 112.589 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.417 ' CD ' ' HB2' ' A' ' 73' ' ' ASP . 61.4 ttt180 -96.36 138.03 34.56 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.435 -1.175 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.578 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . 0.407 ' HB2' ' CD ' ' B' ' 149' ' ' ARG . 2.5 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -131.01 126.65 36.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -105.91 132.94 51.4 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.132 0.968 . . . . 0.0 111.976 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -113.76 131.19 56.3 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.79 131.35 67.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -110.47 130.51 55.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' LEU . . . . . 0.639 HD21 ' CZ ' ' B' ' 122' ' ' TYR . 11.4 mt -120.34 128.47 53.28 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.52 127.92 49.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.955 0.883 . . . . 0.0 113.108 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.431 HG22 HH12 ' B' ' 120' ' ' ARG . 39.0 t -122.32 141.9 40.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.24 -56.51 14.13 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.718 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . 0.763 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 18.2 t60 -153.97 125.74 7.69 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.255 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.42 172.06 12.29 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.267 0.485 . . . . 0.0 111.108 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 22.9 m -93.17 122.25 63.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.19 -28.3 78.68 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.938 2.425 . . . . 0.0 113.553 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -85.51 -38.52 18.46 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.787 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . 0.427 ' HB3' ' HG3' ' B' ' 103' ' ' LYS . 35.5 mt-10 -85.22 40.17 0.81 Allowed 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.479 0.656 . . . . 0.0 109.4 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.448 HD13 ' N ' ' B' ' 90' ' ' LYS . 1.1 tm? -120.59 145.83 46.97 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.448 ' N ' HD13 ' B' ' 89' ' ' LEU . 26.1 tptp -144.18 125.74 14.97 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.07 139.09 38.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.435 ' CG ' ' HB2' ' B' ' 99' ' ' GLU . 13.5 ptmm? -144.45 135.82 25.5 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.14 116.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.482 ' O ' HG22 ' B' ' 97' ' ' VAL . 62.4 tp -119.92 90.56 3.35 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.67 -111.96 4.58 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.625 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -90.08 4.17 51.1 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 123.933 0.893 . . . . 0.0 112.192 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.482 HG22 ' O ' ' B' ' 94' ' ' LEU . 29.2 m -117.25 137.74 50.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.315 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 37.6 mm -112.81 120.03 61.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.435 ' HB2' ' CG ' ' B' ' 92' ' ' LYS . 15.2 mp0 -122.46 137.04 55.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 121.199 0.523 . . . . 0.0 109.842 174.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.69 127.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.64 41.86 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.78 140.88 12.76 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.427 ' HG3' ' HB3' ' B' ' 88' ' ' GLU . 13.7 ptmm? -143.33 144.75 32.22 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 117.25 0.525 . . . . 0.0 109.78 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -136.75 128.65 29.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -80.19 121.08 25.15 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.17 -73.8 0.41 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.825 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -148.58 151.3 34.82 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.326 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -111.75 119.14 37.63 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.01 -44.51 80.15 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 169.04 -74.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -94.79 -12.79 26.42 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.576 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -101.45 137.2 13.16 Favored Glycine 0 N--CA 1.411 -3.02 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.245 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.18 137.54 52.27 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 134.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 36.7 p -134.31 155.13 50.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -128.21 148.15 50.61 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -135.19 153.43 51.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.988 0.423 . . . . 0.0 109.894 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.66 125.91 46.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.5 122.19 44.01 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.431 HH12 HG22 ' B' ' 81' ' ' VAL . 41.4 ttp180 -133.27 137.82 46.2 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.757 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 32.9 mttm -139.57 130.37 26.06 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 124.293 0.995 . . . . 0.0 112.11 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' TYR . . . . . 0.639 ' CZ ' HD21 ' B' ' 79' ' ' LEU . 46.4 m-85 -126.32 136.44 52.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -117.1 98.79 6.65 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.57 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -136.43 106.43 9.27 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.331 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -88.99 -45.39 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.207 1.938 . . . . 0.0 112.869 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.8 -13.97 62.74 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.468 0.651 . . . . 0.0 112.61 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -112.36 -17.22 12.77 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.311 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 2.9 t -132.56 117.47 31.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -123.41 123.48 26.5 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.24 -1.53 3.07 Favored 'Trans proline' 0 CA--C 1.551 1.361 0 C-N-CA 123.587 2.858 . . . . 0.0 116.223 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.44 -44.44 92.94 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' THR . . . . . 0.439 ' HB ' ' HD3' ' B' ' 148' ' ' PRO . 48.3 m -111.23 -11.65 14.19 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 55.0 mt -68.35 126.17 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -122.63 163.04 20.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.01 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.2 t -137.51 136.58 37.81 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 121.249 0.547 . . . . 0.0 111.243 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 10.1 p -128.5 156.64 42.94 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.74 143.67 43.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.125 0.488 . . . . 0.0 111.265 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' B' ' 142' ' ' VAL . 14.4 t -100.72 162.64 12.78 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.5 m -61.61 -27.39 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -168.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . 0.763 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 36.8 t70 -90.59 -12.61 36.47 Favored 'General case' 0 C--O 1.203 -1.349 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.329 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.17 9.06 7.52 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 118.095 -2.002 . . . . 0.0 113.222 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' B' ' 138' ' ' SER . 56.8 t -78.84 118.49 26.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . 0.416 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.9 tm? -115.15 133.8 55.72 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' B' ' 135' ' ' SER . 31.1 m -121.57 129.97 53.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.834 -0.541 . . . . 0.0 110.974 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 19.1 m -120.92 125.16 73.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 7.8 p30 -136.95 137.6 39.69 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.225 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.475 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . -158.79 -143.51 3.68 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.121 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.439 ' HD3' ' HB ' ' B' ' 132' ' ' THR . 96.9 Cg_endo -102.7 169.69 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.938 3.092 . . . . 0.0 112.586 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ARG . . . . . 0.407 ' CD ' ' HB2' ' B' ' 73' ' ' ASP . 62.9 ttt180 -96.28 138.25 34.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.715 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.928 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 . . . . . 0 N--CA 1.421 -1.913 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -94.92 119.67 33.85 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -126.86 154.42 44.4 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.932 -172.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.9 p -136.86 144.84 43.79 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 42.4 t -115.3 132.49 64.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -110.79 138.4 47.24 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.444 ' HG ' ' CE1' ' A' ' 122' ' ' TYR . 5.8 mp -118.26 126.12 51.51 Favored 'General case' 0 N--CA 1.386 -3.655 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -116.32 139.26 50.58 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.22 1.008 . . . . 0.0 110.551 -175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.533 ' HB ' ' NH1' ' A' ' 120' ' ' ARG . 8.4 p -155.06 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.464 ' H ' HG22 ' A' ' 81' ' ' VAL . 72.9 mmtt -85.68 -163.39 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 119.139 0.881 . . . . 0.0 110.806 176.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.571 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 74.7 m80 -78.54 124.44 28.16 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.612 0.72 . . . . 0.0 111.693 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -149.89 150.43 31.9 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 p -80.89 119.1 75.13 Favored Pre-proline 0 C--N 1.287 -2.123 0 C-N-CA 123.351 0.66 . . . . 0.0 112.432 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.06 -28.54 14.05 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 124.789 3.66 . . . . 0.0 115.122 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.55 -27.59 51.59 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 122.095 -0.378 . . . . 0.0 111.629 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.34 8.27 28.35 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.52 150.43 40.85 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.065 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -130.25 131.81 45.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.32 138.11 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 78.3 mttt -114.25 130.82 56.64 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.7 111.07 21.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.4 95.66 3.12 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.15 -111.53 3.54 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.598 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -99.45 4.14 45.99 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.105 0.962 . . . . 0.0 111.221 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -113.5 137.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.983 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 26.3 mt -130.31 120.48 48.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 43.7 mt-10 -136.74 149.69 47.98 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.675 0.274 . . . . 0.0 110.368 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.32 114.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -115.22 131.01 57.06 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.09 147.97 19.5 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -143.28 131.8 22.34 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 122.393 0.277 . . . . 0.0 110.784 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -136.66 128.88 29.81 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.21 -0.307 . . . . 0.0 110.274 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -80.82 121.36 25.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -79.99 -52.14 8.2 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.779 0.323 . . . . 0.0 110.886 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.421 ' O ' HG12 ' A' ' 114' ' ' ILE . 11.2 ptt180 -148.56 147.11 28.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.96 136.94 50.64 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.804 0.812 . . . . 0.0 111.63 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -90.77 -166.29 1.55 Allowed 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.09 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -47.63 -65.65 0.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.254 1.422 . . . . 0.0 111.41 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -141.78 39.22 1.66 Allowed 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -137.3 144.44 15.94 Favored Glycine 2 N--CA 1.382 -4.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 108.198 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.83 149.89 45.19 Favored 'General case' 0 C--N 1.245 -3.966 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 107' ' ' ARG . 5.5 pt -122.87 134.74 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.4 m -135.03 162.33 32.76 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.374 0.607 . . . . 0.0 110.688 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.72 147.56 49.95 Favored 'General case' 0 N--CA 1.39 -3.447 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 56.2 mt-10 -136.92 151.64 49.28 Favored 'General case' 0 C--N 1.261 -3.241 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -126.07 126.65 44.56 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -129.75 121.91 27.81 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.533 ' NH1' ' HB ' ' A' ' 81' ' ' VAL . 37.7 ttp180 -125.51 136.77 53.69 Favored 'General case' 0 C--N 1.263 -3.182 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.446 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 45.9 mtmt -138.49 129.82 27.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 123.399 0.437 . . . . 0.0 110.827 -169.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.483 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 73.2 m-85 -131.7 143.45 50.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.165 0.586 . . . . 0.0 111.171 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -128.2 98.59 5.14 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 167.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.428 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.5 pt -137.06 105.54 8.75 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.998 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.69 -40.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.383 2.055 . . . . 0.0 113.26 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.41 -33.87 73.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.954 0.407 . . . . 0.0 111.454 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -88.77 -17.1 30.53 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.655 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 78.8 t -127.36 120.49 55.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.354 0.597 . . . . 0.0 111.894 -175.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -115.7 119.62 37.3 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.446 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 97.7 Cg_endo -74.28 19.46 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.024 2.483 . . . . 0.0 116.305 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.96 -47.87 12.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.219 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.438 HG21 ' HG3' ' A' ' 148' ' ' PRO 0.362 8.9 t -121.82 10.88 10.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.466 HG22 ' HD2' ' A' ' 148' ' ' PRO . 1.2 pp -67.7 135.21 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.1 p -125.83 166.56 16.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.421 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 144' ' ' THR . 17.4 m -127.54 133.82 49.79 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.03 0.443 . . . . 0.0 110.175 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.3 m -116.67 133.48 55.96 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.26 128.2 53.8 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.6 m -97.56 162.02 13.49 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.1 m -68.33 -15.25 63.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.468 1.107 . . . . 0.0 113.491 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 10.2 t70 -90.6 -12.72 36.12 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.06 -2.04 35.4 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.65 137.13 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.0 134.43 50.35 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 135' ' ' SER . 58.1 m -115.54 120.5 39.68 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.534 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.0 m -101.57 121.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 13.0 p30 -133.89 137.43 44.95 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.833 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.43 -133.65 2.87 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 133' ' ' ILE . 60.8 Cg_endo -98.59 160.2 0.72 Allowed 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.976 2.45 . . . . 0.0 113.474 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 57.9 ttt-85 -110.0 163.41 13.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 4.0 ttmp? . . . . . 0 C--N 1.311 -1.09 0 CA-C-O 118.801 -0.619 . . . . 0.0 109.846 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -94.71 119.58 33.56 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -126.75 154.68 43.88 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.972 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 20.1 p -137.04 144.82 43.41 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.537 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 42.7 t -115.29 132.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.28 138.61 46.43 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' LEU . . . . . 0.448 ' HG ' ' CE1' ' B' ' 122' ' ' TYR . 5.8 mp -118.1 126.13 51.65 Favored 'General case' 0 N--CA 1.383 -3.798 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -116.25 139.24 50.58 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 124.239 1.016 . . . . 0.0 110.572 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.532 ' HB ' ' NH1' ' B' ' 120' ' ' ARG . 8.4 p -154.89 -174.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.471 ' H ' HG22 ' B' ' 81' ' ' VAL . 73.1 mmtt -85.74 -163.49 0.87 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 119.159 0.89 . . . . 0.0 110.991 175.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 74.9 m80 -78.4 124.43 28.11 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 121.631 0.729 . . . . 0.0 111.664 -172.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -150.25 150.1 31.07 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 1.6 p -80.7 119.0 74.94 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 123.27 0.628 . . . . 0.0 112.522 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.1 -28.88 14.9 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 124.685 3.59 . . . . 0.0 115.148 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.3 -26.94 52.78 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 122.138 -0.351 . . . . 0.0 111.729 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.86 8.25 30.14 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.957 -0.464 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.51 150.47 40.78 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.98 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 31.8 m -104.4 138.56 28.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.525 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' B' ' 98' ' ' ILE . 78.0 mttt -114.6 130.77 56.82 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 50.2 t -129.88 111.0 20.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -137.45 95.97 3.17 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.92 -111.54 3.56 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.468 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.84 4.24 45.08 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.846 0.858 . . . . 0.0 111.263 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.25 136.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.969 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' B' ' 92' ' ' LYS . 25.8 mt -130.18 120.54 49.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 43.9 mt-10 -136.84 149.7 47.85 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.795 0.331 . . . . 0.0 110.379 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 61.4 t -126.27 114.09 36.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -114.87 130.72 56.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.27 148.14 19.77 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -143.41 132.4 22.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 122.412 0.285 . . . . 0.0 110.822 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -136.97 129.48 30.1 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -81.12 121.21 25.81 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.56 -52.09 8.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.914 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.429 ' O ' HG12 ' B' ' 114' ' ' ILE . 11.6 ptt180 -149.05 146.71 27.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.57 137.22 49.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.793 0.806 . . . . 0.0 111.739 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -91.19 -166.22 1.53 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.127 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -46.59 -66.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.394 1.478 . . . . 0.0 111.302 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -141.69 39.83 1.69 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.483 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -138.47 144.24 15.31 Favored Glycine 2 N--CA 1.384 -4.779 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.101 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.81 150.24 44.74 Favored 'General case' 1 C--N 1.243 -4.028 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.429 HG12 ' O ' ' B' ' 107' ' ' ARG . 5.5 pt -123.11 134.85 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m -135.01 162.16 33.25 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-O 121.368 0.604 . . . . 0.0 110.619 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.87 147.39 50.06 Favored 'General case' 0 N--CA 1.392 -3.355 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 55.9 mt-10 -136.88 151.24 48.86 Favored 'General case' 0 C--N 1.26 -3.317 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -125.61 127.05 45.72 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -130.14 121.79 26.97 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.532 ' NH1' ' HB ' ' B' ' 81' ' ' VAL . 37.7 ttp180 -125.43 136.73 53.71 Favored 'General case' 0 C--N 1.26 -3.286 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.437 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 45.6 mtmt -138.41 129.84 27.55 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.344 0.403 . . . . 0.0 110.825 -169.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' TYR . . . . . 0.448 ' CE1' ' HG ' ' B' ' 79' ' ' LEU . 74.6 m-85 -131.57 143.8 50.62 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.681 0.613 . . . . 0.0 111.147 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -128.42 98.59 5.1 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 167.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.6 pt -137.18 105.42 8.66 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.01 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -90.7 -40.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.377 2.052 . . . . 0.0 113.143 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.06 74.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.867 0.365 . . . . 0.0 111.451 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.63 -17.04 30.92 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.61 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 80.8 t -127.16 120.24 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.531 0.681 . . . . 0.0 111.901 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.38 119.24 38.55 Favored Pre-proline 0 C--N 1.287 -2.131 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.446 ' HA ' ' CG1' ' B' ' 133' ' ' ILE . 82.8 Cg_endo -74.21 19.72 0.43 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.005 2.47 . . . . 0.0 116.277 -171.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.99 -47.83 12.2 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.989 -1.084 . . . . 0.0 112.267 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' THR . . . . . 0.421 HG22 ' HG3' ' B' ' 148' ' ' PRO 0.368 8.9 t -121.99 10.97 10.21 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . 0.464 HG22 ' HD2' ' B' ' 148' ' ' PRO . 1.2 pp -67.76 134.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 2.7 p -125.36 166.87 15.78 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.474 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' B' ' 144' ' ' THR . 17.9 m -127.48 133.61 49.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 15.1 m -116.65 133.09 56.43 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 5.8 mp -105.92 128.25 53.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -97.02 161.76 13.68 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.9 m -68.17 -14.04 62.68 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.426 1.09 . . . . 0.0 113.468 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 9.3 t70 -91.46 -12.74 33.79 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.71 -2.09 36.32 Favored Glycine 0 C--O 1.261 1.825 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.74 137.26 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.21 134.52 50.1 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' B' ' 135' ' ' SER . 57.9 m -115.63 120.68 40.21 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . 0.537 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 5.8 m -101.8 121.89 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 13.0 p30 -133.65 137.17 45.23 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.722 -174.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.01 -133.46 2.78 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' B' ' 133' ' ' ILE . 92.8 Cg_endo -98.04 160.33 0.84 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.28 2.653 . . . . 0.0 113.6 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -110.64 163.19 13.99 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' B' ' 150' ' ' LYS . 4.1 ttmp? . . . . . 0 C--N 1.308 -1.229 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.291 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.474 0.654 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -105.52 131.32 53.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 22.7 t80 -110.07 134.8 51.78 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.415 -171.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.9 m -113.13 129.71 56.42 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.0 t -114.97 130.76 68.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.73 155.91 24.75 Favored 'General case' 0 C--N 1.264 -3.152 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' A' ' 143' ' ' LEU . 31.5 tp -118.2 127.56 53.87 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.89 136.17 52.84 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -177.07 168.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -87.37 -175.14 5.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.623 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -77.73 125.61 29.61 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.993 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.05 160.65 38.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.613 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 14.3 m -66.56 107.9 1.96 Allowed Pre-proline 0 CA--C 1.554 1.102 0 O-C-N 124.523 1.14 . . . . 0.0 112.89 -170.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 54.4 Cg_exo -57.26 -28.3 79.01 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.314 3.343 . . . . 0.0 113.968 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -86.75 -9.44 55.87 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.777 0.323 . . . . 0.0 111.063 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 24.8 mm-40 -113.47 19.75 16.64 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.351 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 3.9 pp -120.82 153.8 36.61 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.318 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.73 125.86 45.5 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.723 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -109.35 122.18 63.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -125.73 131.37 52.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.529 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.01 113.03 35.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.37 91.23 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.65 -111.92 4.5 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.11 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.51 9.26 39.21 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.248 1.019 . . . . 0.0 111.612 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.12 136.03 61.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.536 -0.727 . . . . 0.0 109.535 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.6 mt -130.37 121.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -132.24 148.35 52.45 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.635 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.51 127.43 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.203 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -136.37 120.01 17.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.26 162.01 27.24 Favored Glycine 0 CA--C 1.482 -2.015 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.93 143.83 51.02 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -120.77 135.19 55.22 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.48 129.11 34.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.48 ' OE2' ' HB2' ' A' ' 116' ' ' ARG . 42.5 mt-10 -105.0 -76.08 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.414 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 48.7 mtm-85 -141.15 141.82 34.1 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -112.0 136.52 51.24 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.202 0.525 . . . . 0.0 110.922 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -97.12 -155.46 0.49 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.46 -57.18 3.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' B' ' 123' ' ' ARG . 57.3 m80 -100.52 -11.0 20.49 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.482 -176.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -112.3 139.71 15.79 Favored Glycine 1 N--CA 1.395 -4.085 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.428 -176.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -130.14 140.0 50.83 Favored 'General case' 0 C--N 1.256 -3.487 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.1 mt -123.73 132.94 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -136.43 158.28 44.81 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.48 ' HB2' ' OE2' ' A' ' 106' ' ' GLU . 22.8 ttm180 -127.04 148.44 50.12 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.3 mt-10 -125.0 150.78 46.35 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.08 124.75 37.78 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -131.79 132.34 43.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.876 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.426 HH21 ' CG ' ' B' ' 109' ' ' ASP . 44.4 ttt180 -130.35 137.88 50.13 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.466 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 27.7 mtpp -122.86 127.14 48.62 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.303 1.2 p90 -134.36 115.61 14.25 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' B' ' 111' ' ' HIS . 68.8 ttt180 -102.5 99.69 9.74 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.356 0.598 . . . . 0.0 109.764 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.0 pt -124.08 105.54 31.68 Favored Pre-proline 0 C--N 1.288 -2.107 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.458 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -90.13 -52.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.144 2.562 . . . . 0.0 113.163 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.9 64.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.351 0.596 . . . . 0.0 111.364 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.09 -18.14 17.88 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.321 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 57.4 t -132.15 113.48 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -100.16 128.39 30.79 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.04 16.71 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.664 2.243 . . . . 0.0 116.442 -171.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 tp -82.02 -46.97 13.22 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.257 14.3 t -120.36 9.99 11.12 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -68.44 130.3 33.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.8 t -137.75 163.0 32.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 p -128.0 133.0 49.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.8 t -125.89 129.56 49.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.06 135.06 48.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.453 0.644 . . . . 0.0 111.855 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.1 m -100.82 163.45 12.31 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.025 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.4 m -60.29 -21.85 62.44 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.21 7.37 41.05 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 121.383 0.611 . . . . 0.0 111.385 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.15 -6.12 61.57 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.534 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -73.95 112.76 11.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 144' ' ' THR . 1.9 tp -122.34 134.67 54.64 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.266 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.568 ' N ' HD12 ' A' ' 143' ' ' LEU . 17.8 m -117.75 117.92 30.65 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 134' ' ' THR . 31.8 t -101.65 121.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 8.9 p30 -135.38 144.07 46.4 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.396 -0.815 . . . . 0.0 111.164 -174.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.01 -136.45 2.17 Favored Glycine 0 N--CA 1.425 -2.087 0 O-C-N 123.806 0.691 . . . . 0.0 111.552 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -96.73 142.77 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.149 2.566 . . . . 0.0 113.632 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.425 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 67.8 ttt180 -92.84 133.41 36.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 C--N 1.291 -1.967 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.314 -172.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 121.542 0.686 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -105.74 130.02 53.83 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.435 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 21.4 t80 -108.91 132.29 54.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.205 0.526 . . . . 0.0 110.915 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 26.9 m -110.45 129.58 55.74 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.008 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.89 130.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -113.41 155.83 24.56 Favored 'General case' 0 C--N 1.261 -3.268 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' B' ' 143' ' ' LEU . 31.3 tp -118.11 127.64 53.97 Favored 'General case' 0 N--CA 1.387 -3.598 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -113.2 136.03 53.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -177.38 168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -86.49 -175.34 5.42 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.718 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -77.63 125.66 29.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.124 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.23 160.97 37.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.436 -1.257 . . . . 0.0 107.624 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 15.8 m -66.36 107.38 1.56 Allowed Pre-proline 0 C--N 1.311 -1.095 0 O-C-N 124.536 1.148 . . . . 0.0 112.972 -170.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.15 -28.37 78.81 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.071 3.181 . . . . 0.0 114.024 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.96 -9.64 55.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 85' ' ' SER . 22.1 mm-40 -112.7 19.45 17.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.402 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -120.87 153.34 37.3 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.323 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -123.09 126.02 46.28 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.935 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.76 122.32 64.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.99 131.62 52.2 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.475 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.15 112.95 34.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 84.5 mt -127.16 91.17 3.27 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.421 ' HA2' ' HG3' ' B' ' 130' ' ' PRO . . . 67.0 -112.1 4.62 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.874 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.52 9.09 39.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 124.371 1.068 . . . . 0.0 111.701 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.96 136.12 60.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.639 -0.663 . . . . 0.0 109.359 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 46.2 mt -130.72 121.38 50.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.26 148.44 52.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.095 0.474 . . . . 0.0 111.592 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.43 127.53 62.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.144 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -136.59 120.05 17.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 161.86 27.27 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.424 ' HB3' ' HG2' ' B' ' 117' ' ' GLU . 0.0 OUTLIER -130.45 143.95 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -120.71 135.37 55.15 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.81 128.01 33.17 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.478 ' OE2' ' HB2' ' B' ' 116' ' ' ARG . 42.9 mt-10 -103.7 -77.4 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 -139.86 142.56 36.57 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -112.19 136.14 51.97 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.634 0.73 . . . . 0.0 111.265 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.426 ' CG ' HH21 ' A' ' 120' ' ' ARG . 37.1 m-20 -96.83 -155.79 0.5 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 172.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.8 -57.31 3.03 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 122.037 0.922 . . . . 0.0 108.617 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . 0.449 ' HB3' ' O ' ' A' ' 123' ' ' ARG . 54.0 m80 -101.66 -11.13 19.42 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.178 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -111.12 139.57 15.62 Favored Glycine 0 N--CA 1.396 -3.981 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.591 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.22 139.68 50.79 Favored 'General case' 0 C--N 1.257 -3.437 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.16 133.18 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 46.8 m -136.44 158.18 45.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.478 ' HB2' ' OE2' ' B' ' 106' ' ' GLU . 22.4 ttm180 -127.19 148.25 50.19 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 36.9 mt-10 -125.02 150.85 46.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -128.16 124.89 37.97 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -131.87 132.09 43.34 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -130.19 137.91 50.32 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.502 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.6 mtpp -122.65 127.11 48.91 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' TYR . . . . . . . . . . . . 0.3 1.3 p90 -134.39 115.27 13.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 111' ' ' HIS . 71.0 ttt180 -101.95 99.73 9.94 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.394 0.616 . . . . 0.0 109.948 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.0 pt -123.99 105.52 31.92 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.538 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -90.01 -53.14 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 123.013 2.475 . . . . 0.0 113.136 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 -18.9 65.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.58 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -99.57 -18.1 17.53 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.265 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 60.0 t -132.21 113.8 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.81 128.31 30.12 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.421 ' HG3' ' HA2' ' B' ' 95' ' ' GLY . 72.1 Cg_endo -71.09 16.39 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.837 2.358 . . . . 0.0 116.415 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.76 -46.66 13.91 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 13.9 t -120.97 10.23 10.77 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.0 OUTLIER -68.36 130.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 11.9 t -137.84 162.99 32.54 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 15.0 p -127.79 133.14 49.44 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.257 0.551 . . . . 0.0 112.148 -174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -126.45 129.36 48.54 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.41 134.73 48.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.098 0.475 . . . . 0.0 111.68 -174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 20.1 m -100.72 163.36 12.36 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.138 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -60.47 -21.18 62.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -91.95 8.01 39.49 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.515 0.674 . . . . 0.0 111.171 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.87 -5.85 61.99 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.496 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 67.1 t -74.16 112.98 11.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.264 0.554 . . . . 0.0 109.506 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . 0.562 HD13 ' N ' ' B' ' 144' ' ' THR . 1.8 tp -122.67 134.43 54.48 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.123 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.562 ' N ' HD13 ' B' ' 143' ' ' LEU . 16.6 m -117.22 118.24 31.77 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' B' ' 134' ' ' THR . 35.5 t -102.24 121.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.4 p30 -134.97 144.17 47.26 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.305 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.88 -136.61 2.2 Favored Glycine 0 N--CA 1.423 -2.202 0 O-C-N 123.654 0.596 . . . . 0.0 111.738 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -96.72 142.63 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.265 2.644 . . . . 0.0 113.505 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 71.0 ttt180 -92.9 133.86 35.67 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 84.3 tttt . . . . . 0 C--N 1.29 -1.998 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.243 -172.422 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 . . . . . 0 N--CA 1.438 -1.041 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.6 tp 56.72 51.19 11.32 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 24.0 mm-40 42.37 110.04 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 111.848 -2.433 . . . . 0.0 116.772 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -86.95 106.32 17.72 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.669 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 31.3 t70 -177.61 138.11 0.21 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -94.37 117.57 30.32 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' ASN . 51.0 t80 -110.7 142.65 42.33 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.6 m -137.58 131.57 31.85 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.382 0.61 . . . . 0.0 111.641 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.627 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 47.6 t -118.9 141.68 37.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -111.78 143.82 42.09 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.974 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 3.1 mm? -119.99 127.6 52.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.468 ' CG ' HH12 ' B' ' 107' ' ' ARG . 0.6 OUTLIER -117.2 127.26 53.93 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.597 -175.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.85 116.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 103.344 -2.836 . . . . 0.0 103.344 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.4 -54.34 41.97 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.316 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -150.43 121.97 7.97 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.41 171.65 18.69 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 126.943 2.097 . . . . 0.0 106.983 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 m -112.87 141.13 24.95 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.89 -28.31 13.0 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 125.131 3.887 . . . . 0.0 116.361 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -73.98 -19.78 60.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.042 0.449 . . . . 0.0 111.227 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -98.25 18.1 17.11 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.921 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.18 147.96 44.26 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.499 0.666 . . . . 0.0 111.166 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -138.24 124.7 20.66 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 p -109.83 129.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -129.96 130.67 45.36 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 121.384 0.611 . . . . 0.0 111.244 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.8 117.81 52.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.64 90.94 2.71 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.312 0.577 . . . . 0.0 109.727 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 -111.82 4.44 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.855 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.87 -4.91 59.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.77 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.03 137.61 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.423 HG21 ' HB2' ' A' ' 122' ' ' TYR . 4.0 tp -124.72 119.94 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -138.18 149.71 46.09 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.357 -173.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.5 m -124.33 134.23 67.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -123.92 124.71 43.22 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.901 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.25 142.65 14.26 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -143.04 126.56 16.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -136.32 141.01 43.76 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.531 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.21 120.81 26.28 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -82.22 -62.47 1.61 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 123.562 0.745 . . . . 0.0 111.289 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' B' ' 80' ' ' ASP . 39.3 mtm180 -141.67 125.13 16.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.867 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 131.24 49.54 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.47 171.96 13.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 119.255 -0.403 . . . . 0.0 110.378 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 13.59 -83.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 127.652 2.381 . . . . 0.0 114.468 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.24 30.06 1.05 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -131.86 131.05 6.15 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.448 -1.705 . . . . 0.0 109.32 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -121.35 149.47 42.91 Favored 'General case' 1 C--N 1.238 -4.265 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.441 HG12 ' CD ' ' B' ' 120' ' ' ARG . 16.5 mt -123.3 132.97 70.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.1 m -129.23 158.42 39.1 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.109 0.481 . . . . 0.0 110.33 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -133.97 148.52 51.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -132.49 150.24 52.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.78 125.06 42.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -132.16 122.12 24.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.741 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.428 ' HG3' HG12 ' B' ' 114' ' ' ILE . 70.1 ttt180 -112.27 137.4 50.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.454 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 24.7 pttm -129.51 129.94 45.18 Favored 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.76 0.662 . . . . 0.0 110.76 -172.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.423 ' HB2' HG21 ' A' ' 98' ' ' ILE . 5.6 m-85 -128.63 145.1 51.25 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -128.05 98.91 5.28 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.537 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.9 pt -136.26 105.13 9.41 Favored Pre-proline 0 C--N 1.285 -2.219 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.259 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.82 -40.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.462 2.108 . . . . 0.0 112.021 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.07 -19.52 64.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -108.45 -17.3 14.02 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 64.6 t -128.31 121.11 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 150' ' ' LYS . 12.1 t70 -122.23 121.17 27.93 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 168.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.93 -15.53 39.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 114.777 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.34 -25.28 36.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.974 0.416 . . . . 0.0 111.384 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 129' ' ' ASP . 8.1 t -119.19 -21.31 7.63 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.3 126.91 42.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 34.4 p -122.47 168.04 12.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.644 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 m -126.27 133.72 51.36 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.152 0.501 . . . . 0.0 111.164 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.447 ' O ' HD21 ' A' ' 143' ' ' LEU . 24.1 p -118.7 150.51 39.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.8 142.34 42.93 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.783 0.72 . . . . 0.0 112.477 -174.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.4 t -100.38 161.59 13.5 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -68.85 -20.12 64.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.834 0.853 . . . . 0.0 112.9 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -85.79 -10.67 55.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 112.06 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.28 1.11 23.59 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.532 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.5 t -77.2 124.23 35.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 136' ' ' SER . 2.7 tm? -119.5 132.25 55.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.1 m -121.34 127.42 51.25 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 121.639 -0.663 . . . . 0.0 110.749 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.627 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 19.2 m -102.01 122.64 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 3.9 p-10 -138.58 155.48 48.31 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.782 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.11 171.69 17.32 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 41.5 Cg_exo -51.1 142.59 34.6 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.759 2.306 . . . . 0.0 111.995 171.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.573 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 11.2 ptm180 -90.66 165.97 13.42 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.37 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 76.6 tttt . . . . . 0 C--O 1.271 2.226 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 . . . . . 0 N--CA 1.434 -1.256 0 CA-C-O 119.533 -0.27 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 45.4 tp 57.06 51.53 10.33 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' B' ' 149' ' ' ARG . 21.0 mm-40 41.74 110.09 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 127.608 2.363 . . . . 0.0 116.932 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -86.98 105.74 17.34 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.657 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 31.0 t70 -176.54 138.99 0.31 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -95.02 117.35 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' B' ' 146' ' ' ASN . 50.7 t80 -110.62 142.92 41.82 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 35.1 m -137.82 131.2 30.78 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.243 0.544 . . . . 0.0 111.641 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 52.7 t -118.72 141.77 36.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.5 144.27 41.0 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.164 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' B' ' 143' ' ' LEU . 3.1 mm? -120.02 127.52 52.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 107' ' ' ARG . 0.6 OUTLIER -117.15 127.77 54.45 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.419 -1.312 . . . . 0.0 112.717 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -118.83 117.15 53.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 167.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.72 -54.21 44.92 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.265 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -150.44 121.7 7.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.57 171.87 18.18 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.796 2.038 . . . . 0.0 107.103 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.1 m -113.2 141.21 25.32 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.15 -28.09 13.71 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 125.044 3.83 . . . . 0.0 116.362 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.53 -20.34 60.68 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.353 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -98.37 18.43 16.5 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.723 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.34 147.75 44.62 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.829 0.823 . . . . 0.0 111.273 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -138.05 124.53 20.72 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -109.63 129.58 64.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -130.36 130.72 44.76 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.417 0.627 . . . . 0.0 111.091 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.91 118.16 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.5 tp -135.48 91.18 2.69 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-O 121.17 0.51 . . . . 0.0 109.716 -173.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.05 -111.92 4.53 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.022 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -86.56 -4.79 59.23 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.227 1.011 . . . . 0.0 112.022 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.84 137.74 47.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.535 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . 0.431 HG21 ' HB2' ' B' ' 122' ' ' TYR . 4.0 tp -124.87 120.03 57.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 174.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.16 149.72 46.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.151 0.501 . . . . 0.0 110.323 -173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 20.1 m -124.22 134.34 66.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -123.95 124.66 43.08 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.04 142.87 14.5 Favored Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -143.08 126.36 16.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -136.23 140.6 43.61 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.548 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -82.48 120.73 25.85 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -81.9 -63.76 1.32 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 123.512 0.725 . . . . 0.0 111.008 -173.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.468 HH12 ' CG ' ' A' ' 80' ' ' ASP . 39.8 mtm180 -140.9 125.42 17.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.961 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -103.24 130.4 50.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -139.16 172.47 12.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.39 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 12.86 -84.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 127.673 2.389 . . . . 0.0 114.27 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -145.85 30.19 1.08 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -132.1 130.18 5.83 Favored Glycine 0 N--CA 1.403 -3.53 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.403 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -120.43 149.86 41.7 Favored 'General case' 1 C--N 1.24 -4.156 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.428 HG12 ' HG3' ' A' ' 120' ' ' ARG . 16.9 mt -123.61 133.34 69.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.8 m -129.98 159.14 37.57 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.049 0.452 . . . . 0.0 110.174 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -134.17 148.55 50.94 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -126.03 125.03 41.97 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -132.06 122.22 25.1 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.785 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.441 ' CD ' HG12 ' A' ' 114' ' ' ILE . 70.0 ttt180 -112.3 137.36 50.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.459 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 24.1 pttm -129.37 129.83 45.27 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.717 0.635 . . . . 0.0 110.72 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' TYR . . . . . 0.431 ' HB2' HG21 ' B' ' 98' ' ' ILE . 6.1 m-85 -128.25 145.57 51.0 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.489 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -128.19 98.86 5.24 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.537 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 3.9 pt -136.38 105.2 9.3 Favored Pre-proline 0 C--N 1.284 -2.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.193 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.49 -40.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.542 2.161 . . . . 0.0 112.081 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.01 -19.86 64.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 111.513 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -108.36 -17.18 14.06 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.444 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 63.6 t -128.46 121.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . 0.485 ' HB2' ' HD2' ' B' ' 150' ' ' LYS . 12.2 t70 -122.35 121.32 27.78 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 168.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.17 -15.2 38.31 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.466 2.777 . . . . 0.0 114.632 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 tp -81.47 -25.87 35.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.461 . . . . 0.0 111.157 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' THR . . . . . 0.435 HG22 ' HB3' ' B' ' 129' ' ' ASP . 9.7 t -119.05 -21.14 7.79 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.14 127.12 42.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 33.4 p -122.5 167.72 13.0 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.839 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.7 m -126.28 133.96 51.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.436 ' O ' HD23 ' B' ' 143' ' ' LEU . 14.8 p -119.13 149.61 41.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 142.66 44.24 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.465 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.62 161.6 13.49 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -68.81 -19.59 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.603 0.761 . . . . 0.0 112.953 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.68 -10.14 54.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.041 0.448 . . . . 0.0 111.734 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.3 0.75 23.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.43 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.62 124.11 34.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.436 HD23 ' O ' ' B' ' 136' ' ' SER . 2.7 tm? -119.59 132.27 55.68 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 35.3 m -121.46 126.99 50.61 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.6 -0.688 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . 0.633 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 19.0 m -101.71 122.65 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' B' ' 75' ' ' PHE . 4.0 p-10 -138.51 154.97 48.8 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.775 -173.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.13 18.22 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 50.3 Cg_exo -50.8 142.3 33.12 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 122.745 2.297 . . . . 0.0 111.973 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 11.0 ptm180 -90.18 165.8 13.74 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.413 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' B' ' 129' ' ' ASP . 76.2 tttt . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 123.194 1.474 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tt -143.24 94.23 2.59 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.26 137.14 46.56 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.112 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -111.79 116.54 30.86 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.901 0.858 . . . . 0.0 110.296 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' OD2' ' HD3' ' A' ' 149' ' ' ARG . 31.5 t70 -147.7 140.54 24.84 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -128.72 145.28 51.21 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.793 -170.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 t -116.67 130.44 56.73 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.446 ' HB ' HG23 ' A' ' 145' ' ' VAL . 23.7 t -114.46 131.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.15 147.05 35.75 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.455 ' O ' HG22 ' A' ' 81' ' ' VAL . 6.7 mp -118.5 129.06 55.15 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -74.22 125.27 28.03 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.542 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 82' ' ' LYS . 32.9 t -138.97 142.67 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.65 ' O ' HG12 ' A' ' 81' ' ' VAL . 16.7 tptm -98.33 -177.34 3.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 7.8 t60 -77.63 124.98 28.64 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.841 -1.543 . . . . 0.0 113.412 -167.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.511 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 0.0 OUTLIER -132.67 172.45 12.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.148 172.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -77.57 117.82 68.03 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -53.09 -27.76 38.11 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 124.024 3.149 . . . . 0.0 114.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -87.14 -35.31 18.7 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.343 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -91.35 58.91 3.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.296 0.57 . . . . 0.0 110.593 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 pp -143.21 160.43 40.48 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.09 0.471 . . . . 0.0 111.175 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -135.63 124.61 24.22 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.18 122.87 58.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -129.07 133.29 47.63 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.416 0.626 . . . . 0.0 111.948 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.73 122.1 59.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.96 91.71 3.09 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.29 -112.12 4.17 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.751 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -93.2 -0.25 56.92 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.689 1.196 . . . . 0.0 110.96 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.7 136.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.574 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 16.6 mt -125.1 120.66 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.81 149.22 49.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.2 0.524 . . . . 0.0 110.84 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -129.8 120.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -113.56 120.06 39.67 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.43 ' HA3' ' CD2' ' A' ' 84' ' ' PHE . . . -136.98 154.79 22.4 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -138.56 143.28 39.35 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 117.454 0.627 . . . . 0.0 111.05 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 84' ' ' PHE . 81.1 t60 -137.97 127.86 25.52 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 170.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 114' ' ' ILE . 32.1 mt-10 -86.01 121.33 28.48 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.437 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 23.7 mt-10 -55.06 -80.82 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -166.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.437 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 51.5 mtm-85 -147.63 153.82 39.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -83.01 128.19 34.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -94.39 -172.32 2.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -39.87 -66.16 0.33 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.361 1.464 . . . . 0.0 112.634 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -142.74 28.06 1.62 Allowed 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.463 ' HA3' ' CE1' ' B' ' 122' ' ' TYR . . . -132.95 153.53 20.75 Favored Glycine 1 N--CA 1.369 -5.788 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.39 149.05 30.8 Favored 'General case' 1 C--N 1.243 -4.025 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.455 ' O ' ' HB3' ' A' ' 105' ' ' GLU . 35.5 mm -124.25 135.48 63.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.987 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.0 m -128.18 140.97 51.62 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -128.65 147.04 50.71 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.13 150.73 51.14 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.058 0.456 . . . . 0.0 110.105 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 84' ' ' PHE . 73.2 m-85 -124.96 133.67 52.93 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -127.1 121.94 32.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.607 ' CZ ' ' HA ' ' A' ' 81' ' ' VAL . 67.2 mtt-85 -117.02 136.88 52.62 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.4 tttp -134.82 128.38 32.65 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.756 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 98' ' ' ILE . 13.3 m-85 -131.42 135.2 46.96 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.867 0.867 . . . . 0.0 110.543 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -128.23 98.7 5.18 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.629 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 5.0 pt -135.94 106.43 9.67 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.73 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -87.67 -39.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.027 1.818 . . . . 0.0 112.508 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.42 72.26 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 121.451 0.643 . . . . 0.0 111.76 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' A' ' 149' ' ' ARG . 9.3 m-20 -91.99 -16.25 26.78 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.709 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 12.6 t -131.38 120.42 46.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -171.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.68 111.73 35.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.63 13.46 0.46 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.403 2.735 . . . . 0.0 116.215 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.79 -45.23 75.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.5 t -120.45 9.49 10.95 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 121.609 -0.682 . . . . 0.0 112.564 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.547 ' CD1' HG12 ' A' ' 128' ' ' VAL . 50.2 mt -67.8 132.51 32.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.418 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.8 p -121.58 165.89 15.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.901 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 144' ' ' THR . 15.1 m -130.09 134.06 47.1 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 120.971 0.415 . . . . 0.0 111.14 -177.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.5 m -116.52 145.44 43.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.7 tp -121.74 137.17 54.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.505 0.193 . . . . 0.0 110.756 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -96.62 164.24 12.68 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.528 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.4 t -60.21 -33.97 72.99 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.523 1.056 . . . . 0.0 113.055 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 19.7 t70 -81.25 -11.09 59.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.542 0.687 . . . . 0.0 110.331 -177.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 8.13 24.07 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.68 132.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.33 134.39 55.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -168.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 135' ' ' SER . 20.3 m -121.51 128.1 51.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.446 HG23 ' HB ' ' A' ' 77' ' ' VAL . 15.7 m -114.86 125.4 72.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.6 p-10 -132.25 138.62 47.97 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.444 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.77 -144.8 6.45 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.529 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -91.66 139.03 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.069 2.513 . . . . 0.0 114.392 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 127' ' ' ASP . 73.9 ttt180 -103.76 137.41 41.82 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--N 1.297 -1.702 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -175.493 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 123.108 1.432 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 tt -142.71 95.12 2.73 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.88 137.42 45.63 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.277 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -112.17 114.14 26.79 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 121.704 0.764 . . . . 0.0 110.528 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -145.14 141.22 28.58 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -96.08 125.74 40.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.4 ' CB ' ' HB2' ' B' ' 149' ' ' ARG . 53.0 t80 -128.88 145.81 51.11 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.738 -170.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.4 t -117.6 130.06 56.15 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.453 ' HB ' HG21 ' B' ' 145' ' ' VAL . 23.2 t -114.32 131.03 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -111.09 147.15 35.46 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' LEU . . . . . 0.469 ' O ' HG22 ' B' ' 81' ' ' VAL . 6.7 mp -118.5 128.83 54.96 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -73.67 125.32 27.78 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.402 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.648 HG11 ' O ' ' B' ' 82' ' ' LYS . 31.6 t -139.23 142.18 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 O-C-N 123.911 0.757 . . . . 0.0 109.107 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.648 ' O ' HG11 ' B' ' 81' ' ' VAL . 16.9 tptm -97.72 -177.42 3.77 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 7.6 t60 -77.7 124.76 28.37 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 117.89 -1.524 . . . . 0.0 113.4 -167.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.514 ' HB3' ' CE1' ' B' ' 118' ' ' PHE . 0.0 OUTLIER -132.55 172.5 12.43 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.174 172.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -77.54 118.05 69.49 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.2 -27.69 38.79 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 124.045 3.163 . . . . 0.0 114.036 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -87.22 -35.18 18.68 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.461 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -92.04 58.51 3.37 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.543 0.687 . . . . 0.0 110.42 -174.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.51 160.34 40.47 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.153 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -135.67 124.56 24.08 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.78 122.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -129.04 134.3 48.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.279 0.562 . . . . 0.0 111.744 -174.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 p -128.45 120.86 53.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.0 tp -129.93 91.78 3.19 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.63 -111.99 4.19 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.944 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -93.17 0.06 57.06 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 124.45 1.1 . . . . 0.0 111.003 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 97.6 t -110.06 136.33 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.526 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' B' ' 122' ' ' TYR . 17.1 mt -125.07 120.53 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.55 149.09 49.34 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.23 0.538 . . . . 0.0 110.759 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 94.0 t -129.54 120.93 51.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -113.52 120.14 39.96 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.425 ' HA3' ' CD2' ' B' ' 84' ' ' PHE . . . -137.07 154.59 22.35 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.33 143.26 39.83 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.508 0.67 . . . . 0.0 110.998 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' B' ' 84' ' ' PHE . 82.0 t60 -137.92 127.72 25.4 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 170.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' B' ' 114' ' ' ILE . 34.7 mt-10 -85.5 121.14 27.77 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.406 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 23.3 mt-10 -54.88 -80.7 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -166.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.406 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 51.6 mtm-85 -148.0 153.72 39.35 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -83.31 129.09 34.98 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -94.71 -172.53 2.76 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -39.5 -66.4 0.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.131 1.372 . . . . 0.0 112.958 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -142.69 27.95 1.64 Allowed 'General case' 0 CA--C 1.461 -2.472 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.45 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -132.81 153.57 20.74 Favored Glycine 1 N--CA 1.37 -5.761 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -177.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -110.41 149.04 30.83 Favored 'General case' 1 C--N 1.244 -4.018 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.458 ' O ' ' HB3' ' B' ' 105' ' ' GLU . 34.8 mm -124.21 135.53 63.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.127 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.6 m -128.18 141.09 51.57 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -128.64 147.17 50.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.3 150.44 50.98 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.128 0.489 . . . . 0.0 110.139 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' B' ' 84' ' ' PHE . 72.5 m-85 -124.77 133.92 52.98 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -127.38 121.88 32.14 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.595 ' CZ ' ' HA ' ' B' ' 81' ' ' VAL . 67.6 mtt-85 -117.18 137.02 52.62 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -135.16 128.3 31.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.774 -1.17 . . . . 0.0 110.697 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' B' ' 98' ' ' ILE . 13.5 m-85 -131.46 134.99 46.75 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.973 0.909 . . . . 0.0 110.672 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -127.78 98.67 5.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.631 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 5.0 pt -135.72 106.59 9.85 Favored Pre-proline 0 C--N 1.29 -1.979 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.739 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -40.32 0.06 OUTLIER 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.26 1.973 . . . . 0.0 112.544 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.69 -32.05 71.58 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.612 0.72 . . . . 0.0 111.794 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -92.15 -16.08 26.78 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.927 -0.483 . . . . 0.0 110.783 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 13.0 t -131.45 119.88 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -170.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.05 111.68 36.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.82 15.29 0.38 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 123.456 2.771 . . . . 0.0 115.887 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.06 -45.13 71.14 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.101 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 12.8 t -120.61 9.88 10.93 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . 0.542 ' CD1' HG13 ' B' ' 128' ' ' VAL . 50.0 mt -68.11 132.92 32.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.393 -170.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.7 p -121.98 166.18 14.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.733 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' B' ' 144' ' ' THR . 14.5 m -130.97 134.05 46.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.97 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 19.7 m -116.35 145.32 43.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -121.97 137.0 54.96 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 25.3 m -96.39 164.41 12.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.435 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -60.44 -34.07 73.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.448 1.022 . . . . 0.0 113.077 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 19.9 t70 -81.39 -10.73 59.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.43 0.633 . . . . 0.0 110.342 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.09 8.33 23.88 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.349 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 46.2 t -71.85 132.75 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.66 134.37 55.11 Favored 'General case' 0 C--O 1.209 -1.066 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.178 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' B' ' 135' ' ' SER . 20.1 m -121.4 127.87 51.62 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . 0.453 HG21 ' HB ' ' B' ' 77' ' ' VAL . 15.7 m -114.88 125.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 21.8 p-10 -132.47 138.14 47.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.465 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 179.69 -144.52 6.09 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -91.64 139.15 2.22 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.145 2.563 . . . . 0.0 114.383 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' B' ' 75' ' ' PHE . 71.5 ttt180 -103.8 137.89 41.18 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.492 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.15 -172.1 3.77 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.02 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 68.6 28.37 5.81 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.948 1.699 . . . . 0.0 108.097 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -127.47 150.45 49.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -170.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 t70 67.93 178.1 0.24 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.325 1.45 . . . . 0.0 111.198 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -113.09 120.17 40.37 Favored 'General case' 0 CA--C 1.471 -2.063 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.34 150.64 25.02 Favored 'General case' 0 N--CA 1.393 -3.323 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.595 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 p -137.13 144.34 42.96 Favored 'General case' 0 N--CA 1.402 -2.851 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.087 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.444 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 32.8 t -116.05 132.55 65.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -110.97 136.89 49.3 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HG ' ' OH ' ' A' ' 122' ' ' TYR . 6.0 mp -119.67 128.08 53.49 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.78 138.73 50.85 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 122.727 0.411 . . . . 0.0 109.911 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.42 165.99 5.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.72 -164.75 0.09 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.483 0.583 . . . . 0.0 110.441 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -77.41 123.94 27.21 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.003 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.58 143.11 15.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 m -74.02 124.73 90.33 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 123.477 0.485 . . . . 0.0 110.983 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.43 -30.96 75.75 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.865 3.043 . . . . 0.0 114.046 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -74.59 -26.58 60.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.861 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.81 0.84 51.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.291 0.567 . . . . 0.0 111.398 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.22 147.67 44.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -126.21 126.26 43.76 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.38 126.69 52.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -129.57 138.37 51.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.438 0.637 . . . . 0.0 109.417 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.16 90.44 3.34 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.91 -112.17 4.73 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.148 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.4 -0.55 57.31 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.355 1.062 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.69 135.74 42.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.44 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 59.0 mt -122.0 119.53 58.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 39.1 mt-10 -136.38 137.02 40.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.61 0.719 . . . . 0.0 111.705 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 60.6 t -119.05 124.78 73.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -127.76 128.74 45.86 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.84 156.66 27.11 Favored Glycine 0 C--N 1.283 -2.384 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -143.37 134.16 25.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 124.056 0.504 . . . . 0.0 109.921 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.403 ' CD2' ' HG2' ' A' ' 106' ' ' GLU . 62.4 t60 -136.77 127.72 27.59 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.55 0.34 . . . . 0.0 110.327 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 12.5 pt-20 -87.03 137.05 32.68 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.403 ' HG2' ' CD2' ' A' ' 104' ' ' HIS . 28.3 mt-10 -106.78 -53.98 2.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.331 -173.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -148.34 152.92 37.88 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 47.7 tt0 -111.76 122.24 47.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.453 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -75.2 -67.35 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -179.22 106.19 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' B' ' 122' ' ' TYR . 37.6 m80 60.1 25.29 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.027 0.918 . . . . 0.0 109.208 -175.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.642 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -156.4 119.13 0.89 Allowed Glycine 1 N--CA 1.39 -4.392 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -175.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 108' ' ' GLN . 11.7 p90 -119.28 153.54 34.88 Favored 'General case' 1 C--N 1.243 -4.033 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 pt -121.04 140.87 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 15.5 m -134.44 157.09 47.34 Favored 'General case' 0 N--CA 1.404 -2.749 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.974 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.9 ttp85 -126.65 146.46 50.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.7 mt-10 -136.87 153.69 50.69 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -128.54 133.6 48.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 26.6 t-80 -131.56 122.48 26.16 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.483 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.427 HH21 HG13 ' A' ' 100' ' ' VAL . 30.8 mtm180 -115.72 138.4 51.15 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.612 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 51.0 tttp -136.03 128.04 29.61 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.684 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 30.3 m-85 -132.17 142.32 49.42 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.104 0.878 . . . . 0.0 109.024 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -128.48 98.57 5.08 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.7 pt -137.33 106.21 8.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.328 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.49 -45.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.886 0 C-N-CA 122.642 2.228 . . . . 0.0 113.366 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 150' ' ' LYS . . . -67.54 -28.19 67.59 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -91.16 -18.0 25.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 77.8 t -132.81 127.6 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.574 ' H ' ' HB3' ' A' ' 148' ' ' PRO . 5.6 m-20 -121.62 109.6 34.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.233 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.505 ' HA ' ' CG2' ' A' ' 133' ' ' ILE . 20.8 Cg_endo -59.92 -12.26 18.08 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 124.239 3.293 . . . . 0.0 114.744 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.55 -40.34 96.74 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.177 0.513 . . . . 0.0 111.237 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.1 t -118.42 9.16 12.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.663 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.505 ' CG2' ' HA ' ' A' ' 130' ' ' PRO . 10.4 tt -77.26 141.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.992 0.425 . . . . 0.0 110.065 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 4.9 p -138.79 154.77 48.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 144' ' ' THR . 22.9 t -131.02 133.21 45.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.169 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 p -119.64 130.33 55.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.401 ' H ' HD21 ' A' ' 137' ' ' LEU . 1.4 pt? -130.13 137.23 50.04 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.01 0.434 . . . . 0.0 112.099 -169.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.3 p -99.91 168.0 10.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.358 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.4 m -67.13 -10.97 55.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.38 1.472 . . . . 0.0 112.308 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.38 20.07 19.42 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-O 121.789 0.804 . . . . 0.0 110.516 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.21 -5.34 63.51 Favored Glycine 0 C--O 1.261 1.791 0 CA-C-N 115.568 -0.742 . . . . 0.0 114.813 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.8 119.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.9 pp -129.94 135.55 48.45 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 135' ' ' SER . 13.5 p -107.31 133.08 52.38 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.483 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 134' ' ' THR . 12.5 m -111.82 121.52 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -137.38 164.75 27.88 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.361 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.494 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . 128.1 -49.06 0.94 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.41 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.574 ' HB3' ' H ' ' A' ' 129' ' ' ASP . 55.5 Cg_endo -62.29 169.72 7.55 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 123.241 2.628 . . . . 0.0 114.989 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -106.26 154.88 20.1 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 126' ' ' ALA . 81.5 tttt . . . . . 0 C--N 1.285 -2.207 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.117 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 . . . . . 0 N--CA 1.425 -1.707 0 CA-C-O 121.506 0.669 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.7 -171.48 3.62 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.781 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 68.03 28.9 6.61 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.742 1.617 . . . . 0.0 108.163 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -128.08 150.13 50.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -170.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 t70 68.49 177.98 0.25 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.412 1.485 . . . . 0.0 111.139 172.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -112.87 120.04 40.06 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.43 150.7 25.04 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.57 -172.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.7 p -137.36 144.24 42.41 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.186 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.456 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 33.3 t -116.0 132.91 64.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.35 136.72 50.06 Favored 'General case' 0 C--N 1.269 -2.928 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' LEU . . . . . 0.457 ' HG ' ' OH ' ' B' ' 122' ' ' TYR . 6.0 mp -119.53 128.16 53.68 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.76 138.63 50.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.48 165.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.37 -164.46 0.08 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.444 0.565 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -77.67 124.22 27.66 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.807 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.77 142.62 15.29 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.5 m -73.5 124.49 90.45 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 123.349 0.405 . . . . 0.0 111.057 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.4 -31.2 76.54 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.725 2.95 . . . . 0.0 113.993 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.77 -26.42 60.64 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.47 0.91 53.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.133 0.492 . . . . 0.0 111.398 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.29 147.52 44.89 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -125.98 125.89 43.43 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -98.5 127.14 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.808 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -129.88 140.01 51.06 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 117.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.95 90.19 3.28 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.34 -112.31 4.87 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.65 -0.19 56.53 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 124.417 1.087 . . . . 0.0 111.946 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 65.3 t -106.22 135.91 42.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.591 -0.693 . . . . 0.0 110.314 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 59.3 mt -122.18 119.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 39.1 mt-10 -136.23 136.91 40.29 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.661 0.743 . . . . 0.0 111.637 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 119' ' ' HIS . 61.1 t -118.99 124.41 73.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -127.25 128.73 46.5 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.15 156.62 27.07 Favored Glycine 0 C--N 1.286 -2.242 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -143.31 134.0 25.14 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 122.648 0.379 . . . . 0.0 110.024 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' HIS . . . . . 0.401 ' CD2' ' HG2' ' B' ' 106' ' ' GLU . 61.2 t60 -136.63 127.68 27.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 122.561 0.344 . . . . 0.0 110.311 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 12.0 pt-20 -86.72 137.05 32.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.401 ' HG2' ' CD2' ' B' ' 104' ' ' HIS . 27.8 mt-10 -106.74 -54.33 2.49 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.254 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -148.13 153.11 38.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -111.7 122.64 48.34 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.593 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.98 -67.99 0.59 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.769 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -178.7 106.16 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 39.1 m80 60.61 24.17 13.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.937 0.875 . . . . 0.0 109.158 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.684 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -154.99 120.26 1.0 Allowed Glycine 2 N--CA 1.389 -4.485 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -177.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -119.34 153.6 34.87 Favored 'General case' 1 C--N 1.241 -4.146 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 pt -121.06 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 14.5 m -134.4 157.08 47.32 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.108 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -126.42 146.49 50.05 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 37.1 mt-10 -136.83 153.59 50.75 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -172.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -128.63 133.43 48.27 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 121.186 0.517 . . . . 0.0 110.669 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 28.2 t-80 -131.49 122.43 26.18 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.469 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.429 HH21 HG11 ' B' ' 100' ' ' VAL . 30.1 mtm180 -115.81 138.43 51.15 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.609 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 50.3 tttp -136.13 128.06 29.44 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.312 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' TYR . . . . . 0.642 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 29.9 m-85 -132.22 142.56 49.47 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 124.013 0.821 . . . . 0.0 108.92 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -128.41 98.57 5.1 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.508 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -137.26 106.19 8.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.499 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -89.46 -44.53 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.638 2.225 . . . . 0.0 113.403 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' B' ' 150' ' ' LYS . . . -68.12 -27.74 66.73 Favored 'General case' 0 C--O 1.198 -1.639 0 O-C-N 122.049 -0.407 . . . . 0.0 111.959 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.66 -18.17 24.39 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 76.7 t -132.75 127.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . 0.59 ' H ' ' HB3' ' B' ' 148' ' ' PRO . 7.1 m-20 -121.34 110.42 34.22 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.164 168.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.49 ' HA ' ' CG2' ' B' ' 133' ' ' ILE . 20.7 Cg_endo -60.66 -12.02 19.71 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 124.026 3.151 . . . . 0.0 114.737 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.93 -40.14 95.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.093 0.473 . . . . 0.0 111.078 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 6.9 t -118.14 9.02 12.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . 0.49 ' CG2' ' HA ' ' B' ' 130' ' ' PRO . 10.9 tt -76.84 141.9 15.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.6 p -138.92 154.43 48.35 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.629 0.772 . . . . 0.0 109.2 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.0 t -130.82 132.9 45.5 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.19 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 2.6 p -119.74 130.09 54.82 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . 0.404 ' H ' HD21 ' B' ' 137' ' ' LEU . 1.4 pt? -130.06 136.97 49.95 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -169.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 76.8 p -99.55 168.14 10.15 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.487 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 6.9 m -67.62 -11.15 57.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.397 1.479 . . . . 0.0 112.092 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.22 20.04 19.53 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.677 0.751 . . . . 0.0 110.424 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.12 -4.72 65.53 Favored Glycine 0 C--O 1.26 1.725 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.28 119.79 33.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -130.12 135.77 48.57 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.828 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' B' ' 135' ' ' SER . 11.6 p -107.49 133.29 52.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.271 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' B' ' 134' ' ' THR . 12.4 m -111.85 121.56 64.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -137.56 164.82 27.82 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 122.179 -0.326 . . . . 0.0 110.163 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' B' ' 148' ' ' PRO . . . 127.93 -49.03 0.94 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.785 -1.197 . . . . 0.0 114.311 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.59 ' HB3' ' H ' ' B' ' 129' ' ' ASP . 55.6 Cg_endo -62.88 169.48 8.78 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.953 2.435 . . . . 0.0 115.05 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -105.22 155.51 18.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 79.9 tttt . . . . . 0 C--N 1.285 -2.217 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.19 105.96 16.25 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -89.89 141.77 28.33 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -87.16 105.65 17.34 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 118.878 -1.129 . . . . 0.0 108.752 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -159.96 141.91 13.03 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -95.5 139.76 31.31 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 128' ' ' VAL . 20.2 t80 -106.62 140.02 40.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.727 -170.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 t -137.91 129.14 27.6 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.71 130.79 72.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.44 155.95 22.39 Favored 'General case' 0 C--N 1.257 -3.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 16.6 tp -118.67 127.86 53.97 Favored 'General case' 0 N--CA 1.381 -3.916 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -104.32 130.27 52.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 p -156.56 162.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.494 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -93.42 -162.89 0.98 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.367 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.705 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 62.3 t-80 -76.58 123.78 26.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 117.334 -1.746 . . . . 0.0 112.296 -169.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.37 133.72 19.59 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -73.6 149.14 88.28 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -47.74 -34.79 22.13 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.921 2.414 . . . . 0.0 115.513 -171.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.31 -17.99 53.48 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.61 -20.06 44.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -120.95 151.12 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.426 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.481 ' HB2' ' HZ3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -138.19 136.2 36.38 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.03 139.97 37.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.588 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -132.55 139.51 47.89 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.241 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 98' ' ' ILE . 2.4 p -129.94 112.96 25.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.77 101.78 5.04 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.97 -111.74 4.0 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.002 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 125' ' ' PRO . 8.4 p-10 -93.94 -5.92 46.7 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 124.731 1.212 . . . . 0.0 111.431 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.92 135.57 54.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.071 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.446 ' HB ' ' CE2' ' A' ' 122' ' ' TYR . 3.0 mp -131.81 120.05 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.8 mt-10 -133.43 147.87 51.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 120.992 0.425 . . . . 0.0 111.686 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.65 129.44 71.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -136.0 133.37 37.42 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.95 147.0 17.92 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.02 134.52 45.66 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -130.53 131.14 44.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.3 pt-20 -87.18 120.85 28.88 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.598 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 30.5 mm-40 -67.6 -70.68 0.24 Allowed 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.308 -173.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.598 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 0.8 OUTLIER -144.17 154.89 43.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -111.26 128.59 55.98 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -93.88 -168.44 1.88 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 3.6 mp0 -57.6 -68.72 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.967 1.307 . . . . 0.0 109.539 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -122.18 14.84 10.59 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' B' ' 122' ' ' TYR . . . -115.54 142.32 17.51 Favored Glycine 1 N--CA 1.384 -4.773 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.393 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.75 139.57 53.85 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 107' ' ' ARG . 5.6 mt -123.7 131.98 72.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 23.3 t -137.16 157.46 46.61 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.093 0.473 . . . . 0.0 110.545 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -134.1 147.72 50.9 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 171.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -130.94 154.35 48.21 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 122.19 0.196 . . . . 0.0 110.483 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -122.1 128.28 51.13 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -131.25 122.04 25.82 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -126.63 137.86 53.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.496 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 23.6 mtpp -134.57 127.11 30.61 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.173 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.468 ' HB3' ' CA ' ' B' ' 112' ' ' GLY 0.305 1.3 p90 -134.7 133.72 40.31 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 173.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -109.9 101.68 10.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.448 0.642 . . . . 0.0 110.557 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.4 pt -135.52 106.91 10.01 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.463 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 59.2 Cg_endo -108.95 -37.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 122.7 2.267 . . . . 0.0 116.154 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.41 ' H ' ' HD2' ' A' ' 125' ' ' PRO . . . -68.03 -29.76 68.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.763 -0.585 . . . . 0.0 112.382 -172.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.06 8.18 20.01 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.525 0.679 . . . . 0.0 109.37 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.46 HG23 ' CE2' ' A' ' 75' ' ' PHE . 56.3 t -131.16 127.43 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.644 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.68 103.36 40.74 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.21 8.85 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 123.684 2.923 . . . . 0.0 116.167 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.91 -39.81 95.67 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.6 t -119.36 9.29 11.59 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.388 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 42.9 mt -68.36 122.46 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.703 0.763 . . . . 0.0 112.296 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.76 167.27 18.33 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.034 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 143' ' ' LEU . 19.0 p -127.2 135.64 50.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -116.46 129.54 56.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -129.29 127.95 42.2 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 123.16 0.288 . . . . 0.0 111.111 -171.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.8 m -99.84 163.98 12.22 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.643 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.0 m -55.14 -30.64 60.23 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.705 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 25.3 t70 -88.33 -11.79 45.32 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.841 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.35 62.01 0.81 Allowed Glycine 0 N--CA 1.409 -3.127 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.23 122.28 67.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 79' ' ' LEU . 15.9 tp -127.2 134.93 50.06 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -173.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.43 ' N ' HD11 ' A' ' 143' ' ' LEU . 41.3 m -121.43 118.93 30.64 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.368 171.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.451 HG11 ' CG2' ' A' ' 133' ' ' ILE . 13.6 t -106.72 120.39 57.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 9.4 p30 -139.47 159.69 41.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.9 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.47 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.69 -136.66 2.97 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -104.28 149.74 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.449 2.766 . . . . 0.0 113.72 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -101.11 153.94 19.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.66 106.23 16.64 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.06 141.03 29.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -87.04 105.6 17.27 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 118.417 -1.313 . . . . 0.0 108.782 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -158.77 142.32 15.05 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -95.31 140.14 30.63 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' B' ' 128' ' ' VAL . 19.7 t80 -107.19 139.95 40.83 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.686 -170.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -137.92 129.3 27.81 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.12 130.92 72.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.39 155.98 22.3 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' B' ' 143' ' ' LEU . 16.6 tp -118.66 127.68 53.8 Favored 'General case' 1 N--CA 1.379 -4.002 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.76 130.47 51.28 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.08 162.04 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.254 -3.548 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.96 -162.81 0.97 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.157 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . 0.73 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 61.4 t-80 -76.59 123.73 26.53 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 117.65 -1.62 . . . . 0.0 112.417 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -147.48 134.06 19.84 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -73.81 148.74 87.51 Favored Pre-proline 0 C--N 1.283 -2.314 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.69 -34.69 21.55 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.91 2.406 . . . . 0.0 115.556 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.22 -17.86 54.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 120.843 0.354 . . . . 0.0 111.624 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.89 -20.08 42.98 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -121.01 150.45 41.12 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.545 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.493 ' HZ2' ' HB2' ' B' ' 90' ' ' LYS . 0.1 OUTLIER -137.4 135.88 37.35 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 p -113.56 139.94 36.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.714 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.456 ' HZ2' ' HB3' ' B' ' 92' ' ' LYS . 0.2 OUTLIER -132.62 139.88 47.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.269 178.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.426 HG22 HG13 ' B' ' 98' ' ' ILE . 2.4 p -129.98 112.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.533 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.67 102.77 5.4 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.324 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.66 -111.55 4.04 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.009 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' B' ' 125' ' ' PRO . 8.6 p-10 -94.12 -5.9 46.19 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 124.499 1.12 . . . . 0.0 111.519 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.74 135.53 54.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.026 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . 0.433 ' HB ' ' CE2' ' B' ' 122' ' ' TYR . 3.0 mp -131.64 120.01 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.485 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 37.1 mt-10 -133.47 147.42 51.67 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.665 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.02 129.58 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -136.1 133.34 37.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.82 147.56 18.82 Favored Glycine 0 C--N 1.286 -2.228 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.96 134.3 45.47 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -130.16 132.06 45.9 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.5 pt-20 -88.34 120.51 29.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.598 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 31.7 mm-40 -67.09 -71.14 0.21 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 112.683 -2.053 . . . . 0.0 110.281 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.598 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 0.7 OUTLIER -143.71 154.99 44.05 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.19 128.68 55.99 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -94.13 -169.09 1.99 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' B' ' 110' ' ' GLU . 3.5 mp0 -56.95 -68.4 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.117 1.367 . . . . 0.0 109.635 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -122.33 14.93 10.47 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 122' ' ' TYR . . . -115.51 142.59 17.69 Favored Glycine 1 N--CA 1.385 -4.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.328 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.3 139.27 54.07 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' B' ' 107' ' ' ARG . 5.6 mt -123.7 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 22.8 t -137.03 157.56 46.45 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.265 0.555 . . . . 0.0 110.611 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -134.18 147.75 50.8 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 171.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -131.01 154.26 48.37 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -121.77 128.13 51.39 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -131.11 121.7 25.38 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -126.07 138.04 53.68 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.485 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 23.7 mtpp -134.68 127.07 30.35 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.226 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' TYR . . . . . 0.442 ' HB3' ' CA ' ' A' ' 112' ' ' GLY 0.312 1.3 p90 -134.72 134.05 40.62 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 174.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -110.53 101.51 10.18 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.452 0.644 . . . . 0.0 110.299 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 2.4 pt -135.58 106.9 9.96 Favored Pre-proline 0 C--N 1.292 -1.915 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.494 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.457 ' HB3' ' HB3' ' B' ' 96' ' ' ASP . 59.1 Cg_endo -109.03 -37.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.691 2.261 . . . . 0.0 116.455 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.404 ' H ' ' HD2' ' B' ' 125' ' ' PRO . . . -68.24 -29.44 68.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.98 8.24 20.16 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.731 0.777 . . . . 0.0 109.409 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.463 HG23 ' CE2' ' B' ' 75' ' ' PHE . 53.3 t -131.44 127.19 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.716 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -121.7 103.33 40.74 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.14 8.46 1.41 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.775 2.983 . . . . 0.0 116.166 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.56 -39.43 93.65 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 14.7 t -119.57 9.17 11.42 Favored 'General case' 0 C--O 1.252 1.189 0 O-C-N 121.229 -0.919 . . . . 0.0 111.233 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 42.7 mt -68.4 121.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.886 0.85 . . . . 0.0 112.342 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.74 167.13 17.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.52 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.411 ' HB2' HD13 ' B' ' 143' ' ' LEU . 21.9 p -126.99 135.71 51.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t -116.72 129.91 56.41 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 60.6 tp -130.19 127.02 38.83 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.682 0.277 . . . . 0.0 111.07 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 13.7 m -98.64 163.95 12.44 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.676 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.2 m -55.17 -30.49 59.97 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -169.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . 0.73 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 22.8 t70 -88.92 -11.67 43.84 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.554 0.692 . . . . 0.0 110.713 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.57 61.82 0.8 Allowed Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -172.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.72 121.94 66.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' B' ' 79' ' ' LEU . 16.1 tp -126.85 135.03 50.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.441 ' N ' HD12 ' B' ' 143' ' ' LEU . 42.4 m -121.66 118.21 28.59 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.352 171.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . 0.446 HG11 ' CG2' ' B' ' 133' ' ' ILE . 13.1 t -106.09 120.53 57.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.1 p30 -139.54 160.09 40.67 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.839 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.457 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 178.2 -136.91 3.12 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -104.06 150.29 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.443 2.762 . . . . 0.0 113.644 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -101.74 154.25 19.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt . . . . . 0 C--N 1.292 -1.896 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.831 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.0 tp -90.83 84.27 5.8 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 59.39 50.37 7.74 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.234 0.959 . . . . 0.0 109.833 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -86.06 107.45 17.81 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.953 -173.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -138.43 159.36 42.27 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 113.462 -1.699 . . . . 0.0 106.921 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 65.5 mtp180 -94.42 119.17 32.74 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -124.85 155.38 39.55 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.659 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.3 p -129.44 140.28 51.36 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.191 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.461 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 45.4 t -115.37 136.26 52.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -111.14 139.49 46.47 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.444 ' HG ' ' CZ ' ' A' ' 122' ' ' TYR . 6.1 mp -119.93 128.55 53.71 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.38 119.43 25.09 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 141' ' ' GLY . 40.4 t -133.67 141.08 45.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 174.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -83.33 -171.15 3.41 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.538 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -76.13 125.04 28.4 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -158.16 166.63 31.94 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -74.97 113.41 24.54 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 123.719 0.637 . . . . 0.0 110.294 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.94 -29.81 83.68 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.787 2.991 . . . . 0.0 115.055 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.39 -7.98 57.11 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.999 -0.438 . . . . 0.0 111.392 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.411 ' HA ' ' OE1' ' A' ' 88' ' ' GLU . 5.5 mm-40 -93.18 2.74 56.54 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.679 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.58 147.25 45.44 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -124.26 126.61 46.36 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.89 122.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.17 131.12 54.89 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.143 0.497 . . . . 0.0 111.07 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.13 125.03 72.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.98 91.73 2.72 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.569 0.7 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.76 -112.4 4.73 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.742 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -95.26 11.48 32.35 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.743 0.817 . . . . 0.0 111.515 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.34 137.21 55.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.821 -0.549 . . . . 0.0 110.314 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.51 HG22 ' HB2' ' A' ' 122' ' ' TYR . 2.3 tp -125.99 120.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.3 mt-10 -132.2 150.04 52.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.138 0.494 . . . . 0.0 110.453 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.7 t -126.84 124.2 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -128.36 133.19 48.6 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.63 150.94 23.24 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 128.07 17.69 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -138.27 134.16 34.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 111.216 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -80.89 120.45 24.73 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.17 -55.94 5.0 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.024 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HG2' HD12 ' A' ' 114' ' ' ILE . 30.7 ptt180 -148.59 155.38 41.02 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -82.24 113.58 20.16 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -93.98 -148.86 0.27 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.891 -164.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -72.85 83.62 1.21 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.496 0.589 . . . . 0.0 109.786 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 74.53 -52.65 0.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.076 1.75 . . . . 0.0 110.321 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.36 173.22 54.27 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.189 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.91 149.27 41.86 Favored 'General case' 0 C--N 1.255 -3.517 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.51 HD11 ' NH2' ' B' ' 120' ' ' ARG . 38.1 pt -122.88 137.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.195 -175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -134.47 154.24 51.51 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.22 0.533 . . . . 0.0 111.244 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.402 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 6.8 ttp180 -127.3 147.05 50.24 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -134.13 153.45 51.82 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.509 ' HD2' ' NH1' ' A' ' 120' ' ' ARG . 50.1 m-85 -128.26 126.41 40.82 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.494 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.75 122.52 27.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' NH2' HD12 ' B' ' 114' ' ' ILE . 26.3 mtt85 -126.94 138.21 53.25 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -138.66 128.88 25.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.908 0.755 . . . . 0.0 111.541 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 98' ' ' ILE . 3.7 m-85 -133.1 123.67 26.15 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.084 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -107.56 99.42 8.92 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.481 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 4.3 pt -135.93 105.8 9.68 Favored Pre-proline 0 C--N 1.303 -1.452 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.774 -177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.53 -38.67 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.91 2.407 . . . . 0.0 112.122 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 150' ' ' LYS . . . -68.63 -32.32 72.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.292 0.567 . . . . 0.0 111.338 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.99 -18.27 22.06 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.727 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 70.3 t -131.71 114.38 24.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.42 127.04 27.91 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 168.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.32 16.01 0.48 Allowed 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 122.665 2.244 . . . . 0.0 116.402 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.1 tp -81.84 -48.18 11.88 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.277 3.0 t -122.27 10.74 9.99 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.2 pp -67.28 129.28 31.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.1 p -132.56 166.38 22.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 52.9 p -127.87 134.12 49.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 121.03 0.443 . . . . 0.0 110.912 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -125.09 129.96 51.29 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.8 148.46 44.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.5 m -100.37 163.86 12.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.9 m -64.32 -21.57 66.65 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.767 0.827 . . . . 0.0 112.384 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.83 5.15 22.62 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 121.274 0.559 . . . . 0.0 110.467 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.617 ' O ' ' HB ' ' A' ' 81' ' ' VAL . . . 96.64 -20.54 50.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.868 173.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.85 123.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.766 0.793 . . . . 0.0 110.454 -175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.65 136.26 49.51 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.583 -175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.0 t -109.72 135.68 50.26 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.461 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 31.1 m -105.9 122.16 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 3.6 p-10 -132.89 143.48 49.53 Favored 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.171 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 74' ' ' ARG . . . 174.34 -138.09 4.27 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -91.76 147.08 3.25 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.379 2.053 . . . . 0.0 112.813 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -100.57 151.47 21.56 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 126' ' ' ALA . 87.1 tttt . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 43.1 tp -90.6 83.28 5.8 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.11 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 59.8 50.81 6.64 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.31 1.006 . . . . 0.0 109.643 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -86.2 107.39 17.88 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 122.532 1.158 . . . . 0.0 109.843 -173.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -137.89 159.32 42.32 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.32 -1.764 . . . . 0.0 106.954 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' B' ' 147' ' ' GLY . 66.3 mtp180 -94.3 119.08 32.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -124.99 154.87 40.55 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.697 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.3 p -128.56 140.34 51.84 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.428 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.464 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 44.6 t -115.24 136.57 51.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -111.14 139.65 46.35 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' LEU . . . . . 0.435 ' HG ' ' CZ ' ' B' ' 122' ' ' TYR . 6.1 mp -120.12 128.63 53.62 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -84.5 119.24 24.93 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.63 ' HB ' ' O ' ' B' ' 141' ' ' GLY . 41.0 t -134.1 140.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 103.01 -2.959 . . . . 0.0 103.01 174.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -82.87 -170.93 3.26 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.671 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -75.9 125.11 28.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -158.24 166.62 31.92 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -74.82 113.29 23.05 Favored Pre-proline 0 N--CA 1.435 -1.211 0 O-C-N 123.777 0.673 . . . . 0.0 110.253 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.93 -30.07 84.65 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.806 3.004 . . . . 0.0 114.969 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.25 -7.15 58.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.023 0.44 . . . . 0.0 111.476 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' B' ' 88' ' ' GLU . 5.4 mm-40 -94.26 2.82 55.84 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.14 0.495 . . . . 0.0 111.53 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.35 147.01 45.58 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.84 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -124.57 125.71 44.62 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -96.27 122.05 47.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -120.34 130.96 54.65 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.67 125.14 71.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -135.84 91.87 2.75 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.0 -112.26 4.6 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.898 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.64 11.43 33.32 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.548 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.51 137.21 55.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.452 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' B' ' 122' ' ' TYR . 2.3 tp -125.99 120.25 56.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 174.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 38.2 mt-10 -132.33 149.93 52.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.11 0.481 . . . . 0.0 110.467 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 88.0 t -126.64 124.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -128.17 132.97 48.86 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.0 151.0 23.35 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 128.09 17.65 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -138.29 134.12 33.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.405 -0.809 . . . . 0.0 111.208 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.73 120.58 24.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -77.21 -55.98 4.95 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.061 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.462 ' HG2' HD13 ' B' ' 114' ' ' ILE . 30.2 ptt180 -148.65 155.46 41.08 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -82.06 113.6 20.05 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.09 -148.53 0.27 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.928 -163.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.55 82.57 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.602 0.637 . . . . 0.0 110.021 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 75.41 -51.46 0.65 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.245 1.818 . . . . 0.0 110.078 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.408 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -77.53 173.2 55.08 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.142 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -118.65 149.59 41.14 Favored 'General case' 0 C--N 1.255 -3.52 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.522 HD12 ' NH2' ' A' ' 120' ' ' ARG . 37.7 pt -122.92 137.03 57.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.315 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -134.59 153.92 51.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.404 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 6.3 ttp180 -127.11 147.05 50.18 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.05 153.35 51.85 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.515 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.5 ' HD2' ' NH1' ' B' ' 120' ' ' ARG . 49.9 m-85 -128.23 126.75 41.54 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.356 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -131.03 122.62 27.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.51 ' NH2' HD11 ' A' ' 114' ' ' ILE . 25.8 mtt85 -126.96 138.1 53.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -138.36 128.88 26.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 124.023 0.827 . . . . 0.0 111.474 -177.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' TYR . . . . . 0.508 ' HB2' HG22 ' B' ' 98' ' ' ILE . 4.1 m-85 -133.11 124.7 28.03 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.027 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -108.79 99.27 8.64 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 4.1 pt -136.06 106.0 9.58 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.772 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -84.9 -38.83 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 111.92 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' B' ' 150' ' ' LYS . . . -67.84 -32.32 72.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.73 -18.14 21.55 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.582 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 70.7 t -131.87 114.31 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -174.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -109.3 127.56 27.01 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.55 15.96 0.52 Allowed 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 122.759 2.306 . . . . 0.0 116.374 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -81.9 -48.39 11.58 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' THR . . . . . . . . . . . . 0.272 4.4 t -122.14 10.55 10.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.2 pp -67.46 128.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -175.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 12.1 p -130.6 166.7 20.08 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.653 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 55.9 p -127.67 134.69 49.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.065 0.46 . . . . 0.0 110.859 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 18.4 m -125.37 129.81 50.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 pp -122.3 148.32 45.16 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 16.3 m -100.07 163.73 12.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 18.6 m -64.1 -21.87 66.71 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 112.439 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.43 4.19 25.16 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 123.182 0.593 . . . . 0.0 110.484 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . 0.63 ' O ' ' HB ' ' B' ' 81' ' ' VAL . . . 97.3 -20.34 51.14 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.755 173.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.79 123.64 26.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.757 0.789 . . . . 0.0 110.432 -175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.71 136.12 49.3 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.475 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -109.29 135.65 50.03 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . 0.464 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 31.5 m -105.74 122.24 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 3.6 p-10 -133.02 142.73 48.97 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.941 0.401 . . . . 0.0 111.349 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' B' ' 74' ' ' ARG . . . 174.76 -138.02 4.17 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -91.65 146.9 3.31 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.474 2.116 . . . . 0.0 112.887 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -100.62 151.41 21.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' B' ' 126' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.66 125.5 24.16 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.964 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 149' ' ' ARG . 12.6 pt-20 -145.95 53.1 1.15 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.511 -174.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -88.15 114.01 24.35 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.739 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 77.88 168.21 0.22 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.462 1.505 . . . . 0.0 110.39 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -112.43 149.6 32.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 9.3 t80 -134.22 158.66 43.15 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.908 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.3 t -131.85 133.81 45.06 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.95 137.77 47.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -110.2 135.27 51.24 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.631 HD23 ' CE1' ' A' ' 122' ' ' TYR . 1.8 mt -120.46 128.86 53.54 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -107.45 134.88 49.84 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.878 0.847 . . . . 0.0 111.82 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.23 -179.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 172.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 54.9 mtpt -100.08 -163.21 1.01 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 120.325 1.421 . . . . 0.0 110.666 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -77.78 125.9 30.04 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.156 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 47.9 m-85 -142.47 146.75 35.1 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.876 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 m -66.54 129.41 94.13 Favored Pre-proline 0 N--CA 1.407 -2.599 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.87 -31.96 21.38 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.229 3.286 . . . . 0.0 115.094 -173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.37 -4.45 58.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.526 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.4 mm-40 -100.11 -0.14 39.57 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.56 147.53 45.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.34 126.03 30.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.49 122.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.02 137.5 53.49 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.079 0.466 . . . . 0.0 110.831 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.51 115.5 44.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.934 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.67 95.01 4.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.67 -112.81 4.86 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.045 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -95.92 11.23 34.6 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 123.186 0.594 . . . . 0.0 111.394 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.42 135.79 57.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.297 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 27.1 mm -121.68 120.57 62.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.46 136.9 39.87 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.701 0.682 . . . . 0.0 112.753 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 46.8 t -107.25 117.17 52.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -113.67 119.05 36.1 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -123.83 135.64 9.87 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 25.4 ttpp -120.21 133.41 55.49 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -134.6 128.67 33.66 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.59 120.92 35.58 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -75.1 -66.26 0.78 Allowed 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.873 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -139.51 124.38 18.61 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.192 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.89 112.62 21.31 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 103.02 -2.956 . . . . 0.0 103.02 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 112' ' ' GLY . 5.4 t70 -114.35 -163.06 0.84 Allowed 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.138 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -74.24 -76.58 0.13 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.051 0.54 . . . . 0.0 111.237 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -109.87 -15.54 14.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 109' ' ' ASP . . . -130.58 113.58 1.45 Allowed Glycine 0 C--O 1.2 -1.995 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.659 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -94.07 137.22 33.51 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' B' ' 120' ' ' ARG . 3.0 tt -125.24 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -131.56 162.76 29.55 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.485 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -127.58 149.61 50.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.631 1.172 . . . . 0.0 108.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 36.6 tt0 -135.83 141.18 44.65 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.448 ' CZ ' ' HD3' ' A' ' 82' ' ' LYS . 9.2 m-85 -126.73 124.96 40.97 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.0 p80 -133.05 125.58 29.96 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.063 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' B' ' 114' ' ' ILE . 24.8 ttt85 -112.63 136.91 51.64 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.425 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 28.1 mtmm -130.05 130.45 44.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.78 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.631 ' CE1' HD23 ' A' ' 79' ' ' LEU . 45.4 m-85 -121.55 131.6 54.23 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 123.418 0.687 . . . . 0.0 110.089 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -117.82 99.07 6.69 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 9.0 pt -135.48 105.51 10.05 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.099 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.67 -33.54 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.443 2.096 . . . . 0.0 111.341 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 150' ' ' LYS . . . -69.23 -22.95 63.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.731 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -108.11 -13.75 14.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.633 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 16.8 t -130.47 134.74 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.23 116.2 42.19 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.13 -6.0 12.15 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.204 2.603 . . . . 0.0 116.381 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.0 tp -81.7 -45.06 16.24 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.769 -176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.6 t -112.77 8.72 18.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 133' ' ' ILE . 2.0 pp -68.75 136.95 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.804 170.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER -130.38 166.27 20.8 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -136.41 141.35 43.62 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 118.899 0.772 . . . . 0.0 111.809 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.9 t -131.67 140.83 49.44 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.79 137.73 53.25 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.909 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 t -100.12 161.63 13.49 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.0 m -67.89 -21.01 65.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.28 7.72 36.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.826 0.822 . . . . 0.0 110.83 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.37 33.49 11.65 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.501 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.1 112.46 32.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -108.68 129.43 55.35 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -175.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.2 p -117.64 129.0 55.47 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 134' ' ' THR . 62.1 t -103.18 122.42 55.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.403 ' OD1' ' HB ' ' A' ' 134' ' ' THR . 24.1 p-10 -126.79 148.27 49.94 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.31 -118.3 0.9 Allowed Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.566 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -85.84 170.61 8.62 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 124.186 3.257 . . . . 0.0 114.19 -172.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 61.8 ttt180 -141.44 151.2 43.2 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 88.9 tttt . . . . . 0 C--N 1.294 -1.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 . . . . . 0 N--CA 1.432 -1.366 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 59.6 tp -63.1 125.72 24.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.902 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' B' ' 149' ' ' ARG . 12.8 pt-20 -146.37 52.98 1.12 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.445 -174.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -87.97 113.75 23.92 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.736 -1.186 . . . . 0.0 110.676 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 78.67 168.23 0.2 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.99 1.316 . . . . 0.0 110.301 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -113.16 149.86 33.03 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 9.4 t80 -134.78 158.91 42.96 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.819 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 14.7 t -132.26 133.79 44.52 Favored 'General case' 0 N--CA 1.399 -3.015 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.0 137.65 47.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -109.82 135.24 51.04 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' B' ' 122' ' ' TYR . 1.7 mt -120.22 128.92 53.81 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -107.56 135.38 49.11 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 121.664 0.745 . . . . 0.0 111.802 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.93 -179.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.444 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 54.0 mtpt -99.76 -163.3 1.02 Allowed 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 120.301 1.409 . . . . 0.0 110.746 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -77.63 125.8 29.9 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 117.712 -1.595 . . . . 0.0 112.188 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' B' ' 118' ' ' PHE . 47.3 m-85 -142.06 146.51 35.56 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.701 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 14.6 m -66.53 129.61 94.13 Favored Pre-proline 0 N--CA 1.412 -2.342 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.411 ' HB3' HD22 ' B' ' 137' ' ' LEU . 69.9 Cg_exo -48.56 -31.98 19.87 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 124.517 3.478 . . . . 0.0 115.094 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -88.27 -4.68 58.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.525 ' HB3' ' O ' ' B' ' 103' ' ' LYS . 11.3 mm-40 -100.47 -0.02 38.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.433 0.635 . . . . 0.0 110.606 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.07 147.7 45.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -133.41 125.92 30.13 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.152 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.79 122.45 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.964 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -118.91 136.39 54.09 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 120.952 0.406 . . . . 0.0 110.737 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.402 HG11 HD12 ' B' ' 98' ' ' ILE . 86.8 t -123.27 116.08 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.77 94.2 4.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.73 -112.62 4.55 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.067 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.38 11.11 35.96 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.075 0.55 . . . . 0.0 111.257 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -117.98 135.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.407 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 27.5 mm -121.8 120.65 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -136.53 137.11 39.94 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 118.71 0.686 . . . . 0.0 112.799 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 119' ' ' HIS . 46.7 t -107.33 117.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -113.68 119.11 36.31 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -123.74 135.65 9.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' B' ' 88' ' ' GLU . 25.5 ttpp -120.02 133.48 55.53 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -134.71 129.02 34.09 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.01 120.83 35.89 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -74.55 -65.69 0.83 Allowed 'General case' 0 CA--C 1.478 -1.798 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.083 -168.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 -140.3 124.27 17.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.141 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 112.41 21.11 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' B' ' 112' ' ' GLY . 5.2 t70 -113.87 -163.05 0.84 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.285 -163.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -73.62 -76.1 0.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 123.315 0.646 . . . . 0.0 111.215 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -110.6 -17.51 13.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' B' ' 109' ' ' ASP . . . -129.33 114.39 1.72 Allowed Glycine 0 C--O 1.2 -2.026 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.974 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -94.22 137.3 33.55 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 120' ' ' ARG . 3.1 tt -125.11 137.26 58.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 15.8 m -132.76 162.7 30.79 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.514 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -127.54 149.65 50.04 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.638 1.175 . . . . 0.0 108.164 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 37.1 tt0 -135.84 141.09 44.62 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' B' ' 82' ' ' LYS . 9.2 m-85 -126.72 124.95 40.95 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 2.0 p80 -133.1 125.75 30.25 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.914 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 24.7 ttt85 -112.66 137.02 51.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.417 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.9 mtmm -130.03 130.26 44.72 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.772 -173.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' TYR . . . . . 0.639 ' CE1' HD22 ' B' ' 79' ' ' LEU . 45.2 m-85 -121.35 131.97 54.5 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 123.704 0.628 . . . . 0.0 110.111 176.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -118.0 98.92 6.57 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 165.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 8.9 pt -135.37 105.5 10.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.055 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -92.59 -33.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.511 2.141 . . . . 0.0 111.386 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' B' ' 150' ' ' LYS . . . -69.29 -23.45 63.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.096 0.558 . . . . 0.0 111.628 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -107.47 -14.3 14.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 16.6 t -129.87 134.53 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -172.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -114.74 116.25 43.32 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.16 -5.49 11.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.056 2.504 . . . . 0.0 116.249 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.91 -45.29 15.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.614 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 8.8 t -113.02 9.05 18.62 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . 0.484 ' O ' HD12 ' B' ' 133' ' ' ILE . 2.0 pp -68.77 136.73 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.774 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 0.2 OUTLIER -130.6 166.15 21.26 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 16.5 m -136.43 141.38 43.59 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 118.853 0.751 . . . . 0.0 111.746 -176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 29.6 t -132.1 139.73 48.57 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -125.58 138.2 53.93 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.063 -177.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.24 161.68 13.45 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 13.2 m -67.56 -20.51 65.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -170.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.32 8.19 37.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.791 0.805 . . . . 0.0 110.558 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.27 33.27 12.04 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.713 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.94 112.78 33.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 0.8 OUTLIER -108.87 129.52 55.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -175.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 7.2 p -117.76 128.76 55.19 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 134' ' ' THR . 61.7 t -102.89 122.53 55.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -126.7 148.67 49.84 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.04 -118.5 0.92 Allowed Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 119.775 -1.202 . . . . 0.0 112.761 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -85.47 170.65 9.08 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.391 3.394 . . . . 0.0 114.288 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 61.2 ttt180 -141.77 151.1 42.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 88.2 tttt . . . . . 0 C--N 1.294 -1.807 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 45.1 mt 63.15 -166.88 0.22 Allowed 'General case' 0 C--O 1.242 0.659 0 O-C-N 124.318 1.012 . . . . 0.0 108.975 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -64.08 -68.82 0.32 Allowed 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.248 171.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -140.62 146.37 37.87 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.806 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 2.8 m-20 -54.29 -73.15 0.05 Allowed 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -118.14 131.52 56.4 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.58 160.28 40.93 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.476 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -137.25 133.41 35.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.492 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 46.4 t -116.02 148.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.83 152.71 27.59 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.668 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 71.0 mt -120.17 142.14 49.25 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' CG ' HH12 ' B' ' 107' ' ' ARG . 13.5 t70 -105.59 120.17 40.98 Favored 'General case' 0 CA--C 1.493 -1.235 0 O-C-N 123.526 0.516 . . . . 0.0 111.898 -166.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 83' ' ' HIS . 20.9 t -140.78 96.85 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 170.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.02 9.7 1.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.445 ' O ' HG12 ' A' ' 81' ' ' VAL . 4.1 m80 -150.19 173.07 14.33 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 33.9 p90 -103.94 119.02 38.05 Favored 'General case' 0 C--N 1.282 -2.37 0 C-N-CA 117.851 -1.539 . . . . 0.0 113.797 -166.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.504 ' OG ' ' HB2' ' A' ' 104' ' ' HIS . 50.8 m -119.56 65.16 8.74 Favored Pre-proline 0 N--CA 1.422 -1.841 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.826 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 84' ' ' PHE . 35.6 Cg_exo -58.06 -40.37 77.82 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.118 1.879 . . . . 0.0 112.074 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.6 -37.72 16.57 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.266 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 28.3 mt-10 -93.02 28.39 2.14 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -169.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 85' ' ' SER . 3.1 pp -128.66 153.67 47.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.519 174.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.69 129.47 34.83 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.46 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.3 t -107.24 132.82 53.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.11 131.36 47.24 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.399 0.618 . . . . 0.0 111.623 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.57 117.62 55.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -129.12 91.02 3.12 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.18 -113.94 5.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.934 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.27 11.09 39.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 108.971 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.13 137.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.305 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.5 mm -125.08 121.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 30.0 mt-10 -134.36 147.92 50.61 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.884 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 8.5 p -124.75 134.76 66.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -124.14 118.2 26.36 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.2 135.43 6.66 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -133.43 130.53 38.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.504 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 69.7 t60 -139.25 135.95 34.43 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.749 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.8 pt-20 -81.85 120.46 25.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -134.35 -5.29 2.63 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -124.33 124.02 41.48 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -112.99 136.05 53.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.262 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -120.44 -170.1 1.92 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -55.55 -74.66 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -120.34 24.74 10.23 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.46 127.65 4.39 Favored Glycine 0 N--CA 1.402 -3.573 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.37 150.6 29.53 Favored 'General case' 0 C--N 1.261 -3.239 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.429 HG12 ' HG2' ' B' ' 120' ' ' ARG . 3.0 mt -123.78 137.24 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 17.0 m -120.52 150.35 40.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.821 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 35.9 tt0 -137.34 142.37 41.81 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.46 128.25 53.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 12.7 t-80 -131.61 125.97 33.55 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.42 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 79' ' ' LEU . 64.5 mtt-85 -111.22 146.25 37.26 Favored 'General case' 0 CA--C 1.465 -2.302 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 25.0 ttmm -125.82 128.81 48.24 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -128.6 133.04 48.21 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.192 0.597 . . . . 0.0 110.827 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -122.76 98.46 5.92 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.529 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.0 pt -135.59 105.08 9.97 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.146 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.442 ' O ' ' HE2' ' A' ' 150' ' ' LYS . 10.3 Cg_exo -80.45 -39.91 0.23 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.347 2.031 . . . . 0.0 110.237 174.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . -67.44 -17.56 64.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.964 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.13 -17.9 12.28 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.006 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 55.3 t -131.34 126.12 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.32 126.66 26.15 Favored Pre-proline 0 N--CA 1.428 -1.569 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 165.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.6 -24.41 53.83 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 123.931 3.087 . . . . 0.0 115.172 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.3 -24.31 37.29 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.453 ' OG1' ' HD2' ' A' ' 148' ' ' PRO . 11.1 t -116.94 -17.22 10.45 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.88 -1.128 . . . . 0.0 113.197 -172.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.7 mm -81.3 125.22 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.947 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 11.2 p -122.01 167.19 13.39 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.904 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -126.99 133.76 50.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.917 0.389 . . . . 0.0 111.347 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 p -121.24 145.38 47.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.378 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 65.8 tp -123.88 131.52 53.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -96.76 162.91 13.22 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.1 t -67.43 -13.45 62.04 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -98.45 0.29 44.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.588 0.709 . . . . 0.0 110.465 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.54 4.51 52.54 Favored Glycine 0 C--N 1.316 -0.58 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.171 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.18 113.38 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.3 tm? -107.61 132.23 53.52 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.75 124.75 44.95 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.594 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.492 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 26.8 m -99.19 122.31 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -128.12 142.69 51.12 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.65 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.18 176.79 28.71 Favored Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.584 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 50.4 Cg_exo -62.72 141.13 84.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.902 3.068 . . . . 0.0 113.724 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 56.8 mtp180 -80.0 163.32 24.32 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 125' ' ' PRO . 36.4 ttpt . . . . . 0 C--N 1.298 -1.671 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.422 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 . . . . . 0 C--O 1.25 1.128 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 47.1 mt 63.61 -166.67 0.22 Allowed 'General case' 0 C--O 1.254 1.303 0 O-C-N 124.186 0.929 . . . . 0.0 108.896 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -63.69 -69.65 0.26 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.28 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.34 146.08 38.0 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.662 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 2.4 m-20 -53.58 -71.5 0.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -120.23 130.73 54.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.32 160.31 40.75 Favored 'General case' 0 N--CA 1.42 -1.942 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.513 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -137.29 132.67 34.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.954 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.49 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 46.5 t -115.95 148.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -111.58 152.58 27.42 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.686 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' B' ' 143' ' ' LEU . 70.7 mt -120.22 142.23 49.2 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.54 119.82 40.07 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -166.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.447 HG12 ' O ' ' B' ' 83' ' ' HIS . 20.5 t -139.79 97.94 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 102.465 -3.161 . . . . 0.0 102.465 169.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -75.77 9.75 2.16 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . 0.447 ' O ' HG12 ' B' ' 81' ' ' VAL . 3.7 m80 -150.13 173.28 14.08 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.431 ' C ' ' HD3' ' B' ' 86' ' ' PRO . 34.8 p90 -104.0 118.99 37.99 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 117.804 -1.558 . . . . 0.0 113.787 -166.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.509 ' OG ' ' HB2' ' B' ' 104' ' ' HIS . 49.3 m -119.44 65.26 8.42 Favored Pre-proline 0 N--CA 1.421 -1.895 0 CA-C-N 113.492 -1.686 . . . . 0.0 108.879 170.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.431 ' HD3' ' C ' ' B' ' 84' ' ' PHE . 48.8 Cg_exo -57.45 -40.81 78.25 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.159 1.906 . . . . 0.0 112.07 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -88.01 -38.12 15.76 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' B' ' 85' ' ' SER . 27.8 mt-10 -91.79 27.56 2.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -170.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 85' ' ' SER . 3.1 pp -128.31 154.17 46.22 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.56 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.48 130.01 34.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.289 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.25 132.61 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -128.96 131.38 47.48 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.647 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.59 117.37 54.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tt -129.37 90.67 3.05 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.6 -114.23 5.53 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.98 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -100.65 11.2 40.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.842 0.83 . . . . 0.0 108.968 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.3 137.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.222 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 36.4 mm -125.08 120.94 59.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 29.7 mt-10 -134.41 147.89 50.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.923 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . 0.4 ' HB ' HD13 ' B' ' 79' ' ' LEU . 9.1 p -124.62 134.72 66.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -123.84 118.39 27.02 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.35 135.37 6.58 Favored Glycine 0 CA--C 1.491 -1.419 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -133.41 130.29 38.5 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' HIS . . . . . 0.509 ' HB2' ' OG ' ' B' ' 85' ' ' SER . 70.0 t60 -139.03 135.94 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.852 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.7 pt-20 -81.68 120.34 24.98 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.57 -5.28 2.55 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.403 HH12 ' CG ' ' A' ' 80' ' ' ASP . 66.6 mtp180 -124.61 123.99 41.25 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -112.98 136.16 52.96 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.284 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.408 ' CG ' HH12 ' A' ' 120' ' ' ARG . 4.1 m-20 -120.86 -168.34 1.64 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.44 -74.29 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.521 0.729 . . . . 0.0 112.344 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -118.95 24.2 10.97 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -134.1 128.09 4.79 Favored Glycine 0 N--CA 1.402 -3.61 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -111.56 150.6 29.77 Favored 'General case' 0 C--N 1.263 -3.164 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.449 HG12 ' HG2' ' A' ' 120' ' ' ARG . 3.1 mt -123.9 137.07 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 15.6 m -120.42 150.3 41.01 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.689 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -127.29 148.56 50.23 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 36.0 tt0 -137.47 142.35 41.54 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.42 128.34 53.94 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -131.52 125.82 33.36 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.423 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' B' ' 79' ' ' LEU . 62.4 mtt-85 -111.04 146.29 36.99 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 24.8 ttmm -126.15 128.89 48.0 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.93 132.33 47.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 123.203 0.601 . . . . 0.0 110.833 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -121.87 98.49 5.97 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 168.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.526 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.9 pt -135.39 104.96 10.14 Favored Pre-proline 0 C--N 1.293 -1.886 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.152 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.449 ' O ' ' HE2' ' B' ' 150' ' ' LYS . 7.9 Cg_exo -80.09 -39.74 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.278 1.985 . . . . 0.0 110.321 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' B' ' 149' ' ' ARG . . . -67.26 -17.98 65.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.861 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -113.17 -17.99 12.23 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.109 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 55.4 t -131.35 125.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -169.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -122.35 126.43 26.22 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 165.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.69 -24.06 52.7 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.937 3.091 . . . . 0.0 115.152 -171.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 82.3 mt -81.25 -23.94 37.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' THR . . . . . 0.428 ' OG1' ' HD2' ' B' ' 148' ' ' PRO . 8.3 t -117.43 -17.81 9.98 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.779 -1.168 . . . . 0.0 113.102 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.6 mm -81.07 125.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.06 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 14.6 p -122.09 167.6 12.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.649 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -126.95 134.05 50.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 7.0 p -121.16 146.09 47.14 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.858 0.863 . . . . 0.0 109.139 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 66.3 tp -124.98 130.5 52.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.673 0.273 . . . . 0.0 111.387 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 7.4 m -95.89 163.12 13.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -67.66 -14.32 62.84 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -96.63 -0.69 48.17 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.541 0.686 . . . . 0.0 110.628 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.63 5.16 51.79 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.713 -1.232 . . . . 0.0 112.008 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 46.9 t -73.31 113.66 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.3 tm? -107.8 132.0 53.87 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.7 124.79 45.09 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.576 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . 0.49 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 26.9 m -99.15 122.39 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.858 -171.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.03 177.47 29.26 Favored Glycine 0 N--CA 1.415 -2.749 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.638 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 52.2 Cg_exo -62.98 140.74 80.81 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.892 3.061 . . . . 0.0 113.793 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 56.4 mtp180 -79.81 163.25 24.57 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.039 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' B' ' 125' ' ' PRO . 35.9 ttpt . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.618 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.455 0.645 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.5 tp -72.09 -51.96 19.05 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 32.5 mm-40 -150.0 170.21 19.39 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 126.182 1.793 . . . . 0.0 106.254 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -91.54 104.93 17.37 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.349 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.417 ' HB2' ' CD ' ' A' ' 149' ' ' ARG . 2.8 m-20 143.16 159.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 129.262 3.025 . . . . 0.0 108.095 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -130.65 126.59 36.97 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -105.92 132.93 51.43 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.962 0.887 . . . . 0.0 112.078 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m -114.38 131.07 56.69 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.61 131.44 66.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -110.4 130.53 55.53 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.647 HD22 ' CZ ' ' A' ' 122' ' ' TYR . 11.9 mt -120.24 128.3 53.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -103.01 128.26 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.002 0.906 . . . . 0.0 113.01 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.43 HG22 HH12 ' A' ' 120' ' ' ARG . 38.9 t -122.28 142.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -64.31 -56.7 12.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.597 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.749 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 18.2 t60 -153.96 125.84 7.74 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.261 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.48 172.17 12.19 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.257 0.48 . . . . 0.0 111.167 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 20.9 m -93.16 121.92 64.45 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.93 -28.64 78.79 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.957 2.438 . . . . 0.0 113.483 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.98 -38.64 19.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.632 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.433 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 35.8 mt-10 -85.42 40.08 0.82 Allowed 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.585 0.707 . . . . 0.0 109.519 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.438 HD13 ' N ' ' A' ' 90' ' ' LYS . 1.1 tm? -120.51 145.81 46.92 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -174.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.438 ' N ' HD13 ' A' ' 89' ' ' LEU . 25.9 tptp -144.0 125.88 15.27 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 138.68 40.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 99' ' ' GLU . 13.1 ptmm? -144.34 135.51 25.36 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.601 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.41 116.12 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.437 ' O ' HG22 ' A' ' 97' ' ' VAL . 62.3 tp -120.04 90.86 3.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.99 -111.96 4.56 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.849 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -90.01 4.2 50.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.941 0.896 . . . . 0.0 112.106 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 94' ' ' LEU . 35.4 m -117.48 137.75 50.38 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.349 -0.94 . . . . 0.0 113.195 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 37.2 mm -112.85 119.89 61.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 92' ' ' LYS . 14.8 mp0 -122.33 136.95 54.99 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.171 0.51 . . . . 0.0 109.867 174.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.6 126.95 61.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.88 42.69 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.01 140.74 12.58 Favored Glycine 0 CA--C 1.477 -2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.433 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 13.9 ptmm? -143.19 144.69 32.28 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 117.214 0.507 . . . . 0.0 109.733 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -136.74 128.82 29.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.56 120.95 25.19 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.401 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 21.9 mt-10 -83.95 -74.18 0.39 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.757 -167.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.401 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 18.2 ptt-85 -148.57 151.34 34.91 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.103 -173.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -111.48 119.73 39.77 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 -44.29 77.96 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 168.83 -75.34 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -94.23 -12.58 27.92 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.545 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -101.48 137.19 13.15 Favored Glycine 0 N--CA 1.411 -3.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.243 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.2 137.69 52.19 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.33 134.02 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.4 p -134.31 155.23 50.59 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -128.19 148.06 50.6 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -135.05 153.52 52.02 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.039 0.447 . . . . 0.0 109.997 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -122.62 125.99 46.76 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.51 122.11 43.75 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.43 HH12 HG22 ' A' ' 81' ' ' VAL . 41.3 ttp180 -133.11 138.0 46.52 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.878 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.47 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 33.1 mttm -139.87 130.46 25.69 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.099 0.875 . . . . 0.0 112.157 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CZ ' HD22 ' A' ' 79' ' ' LEU . 44.0 m-85 -126.15 136.95 53.48 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -117.32 98.63 6.53 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.566 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.8 pt -136.41 106.16 9.29 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.267 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -88.79 -45.88 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.193 1.929 . . . . 0.0 112.873 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.92 -13.03 62.19 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.488 0.661 . . . . 0.0 112.596 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -112.1 -17.65 12.78 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 2.9 t -132.6 117.67 31.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.57 123.27 26.43 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.15 -1.57 3.05 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.633 2.888 . . . . 0.0 116.339 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.4 tp -59.78 -44.43 93.92 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.45 ' HB ' ' HD3' ' A' ' 148' ' ' PRO . 39.6 m -110.84 -12.8 14.23 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 55.4 mt -67.99 126.08 27.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -165.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 p -122.11 163.61 19.17 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.385 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 144' ' ' THR . 26.7 t -138.0 135.68 36.19 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.217 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.8 p -127.75 156.27 42.71 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.41 144.07 44.3 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.195 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.414 ' HB3' ' HB ' ' A' ' 142' ' ' VAL . 17.8 t -100.49 162.74 12.74 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.7 m -61.55 -28.01 69.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.749 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 37.5 t70 -90.18 -12.3 38.55 Favored 'General case' 0 C--O 1.205 -1.265 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.343 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 120.75 8.91 7.91 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 117.978 -2.058 . . . . 0.0 113.237 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 138' ' ' SER . 51.4 t -78.89 118.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.8 tm? -115.23 133.75 55.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 135' ' ' SER . 27.5 m -121.56 130.13 53.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.841 -0.537 . . . . 0.0 111.078 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.3 m -121.03 125.53 74.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 7.9 p30 -137.27 137.52 39.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.048 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.471 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . -158.78 -143.27 3.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.29 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.45 ' HD3' ' HB ' ' A' ' 132' ' ' THR . 93.7 Cg_endo -102.73 169.64 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.022 3.148 . . . . 0.0 112.589 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.59 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 61.4 ttt180 -96.36 138.03 34.56 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.435 -1.175 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.578 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.523 0.678 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.12 -52.01 21.77 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.58 ' HB2' ' O ' ' B' ' 149' ' ' ARG . 28.4 mm-40 -149.83 170.93 17.61 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -92.4 105.25 17.47 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.407 ' HB2' ' CD ' ' B' ' 149' ' ' ARG . 2.5 m-20 142.48 159.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 129.084 2.954 . . . . 0.0 107.828 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -131.01 126.65 36.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -105.91 132.94 51.4 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.132 0.968 . . . . 0.0 111.976 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -113.76 131.19 56.3 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.79 131.35 67.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -110.47 130.51 55.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' LEU . . . . . 0.639 HD21 ' CZ ' ' B' ' 122' ' ' TYR . 11.4 mt -120.34 128.47 53.28 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.52 127.92 49.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.955 0.883 . . . . 0.0 113.108 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.431 HG22 HH12 ' B' ' 120' ' ' ARG . 39.0 t -122.32 141.9 40.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.24 -56.51 14.13 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.718 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . 0.763 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 18.2 t60 -153.97 125.74 7.69 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.255 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.42 172.06 12.29 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.267 0.485 . . . . 0.0 111.108 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 22.9 m -93.17 122.25 63.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.19 -28.3 78.68 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.938 2.425 . . . . 0.0 113.553 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -85.51 -38.52 18.46 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.787 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.427 ' HB3' ' HG3' ' B' ' 103' ' ' LYS . 35.5 mt-10 -85.22 40.17 0.81 Allowed 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.479 0.656 . . . . 0.0 109.4 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.448 HD13 ' N ' ' B' ' 90' ' ' LYS . 1.1 tm? -120.59 145.83 46.97 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.448 ' N ' HD13 ' B' ' 89' ' ' LEU . 26.1 tptp -144.18 125.74 14.97 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.07 139.09 38.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.435 ' CG ' ' HB2' ' B' ' 99' ' ' GLU . 13.5 ptmm? -144.45 135.82 25.5 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.14 116.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.482 ' O ' HG22 ' B' ' 97' ' ' VAL . 62.4 tp -119.92 90.56 3.35 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.67 -111.96 4.58 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.625 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -90.08 4.17 51.1 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 123.933 0.893 . . . . 0.0 112.192 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.482 HG22 ' O ' ' B' ' 94' ' ' LEU . 29.2 m -117.25 137.74 50.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.315 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 37.6 mm -112.81 120.03 61.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.435 ' HB2' ' CG ' ' B' ' 92' ' ' LYS . 15.2 mp0 -122.46 137.04 55.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 121.199 0.523 . . . . 0.0 109.842 174.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.69 127.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.64 41.86 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.78 140.88 12.76 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.427 ' HG3' ' HB3' ' B' ' 88' ' ' GLU . 13.7 ptmm? -143.33 144.75 32.22 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 117.25 0.525 . . . . 0.0 109.78 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -136.75 128.65 29.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -80.19 121.08 25.15 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.17 -73.8 0.41 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.825 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -148.58 151.3 34.82 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.326 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -111.75 119.14 37.63 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.01 -44.51 80.15 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 169.04 -74.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -94.79 -12.79 26.42 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.576 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -101.45 137.2 13.16 Favored Glycine 0 N--CA 1.411 -3.02 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.245 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.18 137.54 52.27 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 134.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 36.7 p -134.31 155.13 50.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -128.21 148.15 50.61 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -135.19 153.43 51.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.988 0.423 . . . . 0.0 109.894 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.66 125.91 46.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.5 122.19 44.01 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.431 HH12 HG22 ' B' ' 81' ' ' VAL . 41.4 ttp180 -133.27 137.82 46.2 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.757 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 32.9 mttm -139.57 130.37 26.06 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 124.293 0.995 . . . . 0.0 112.11 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' TYR . . . . . 0.639 ' CZ ' HD21 ' B' ' 79' ' ' LEU . 46.4 m-85 -126.32 136.44 52.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -117.1 98.79 6.65 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.57 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -136.43 106.43 9.27 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.331 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -88.99 -45.39 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.207 1.938 . . . . 0.0 112.869 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.8 -13.97 62.74 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.468 0.651 . . . . 0.0 112.61 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -112.36 -17.22 12.77 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.311 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 2.9 t -132.56 117.47 31.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -123.41 123.48 26.5 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.24 -1.53 3.07 Favored 'Trans proline' 0 CA--C 1.551 1.361 0 C-N-CA 123.587 2.858 . . . . 0.0 116.223 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.44 -44.44 92.94 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' THR . . . . . 0.439 ' HB ' ' HD3' ' B' ' 148' ' ' PRO . 48.3 m -111.23 -11.65 14.19 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 55.0 mt -68.35 126.17 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -122.63 163.04 20.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.01 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.2 t -137.51 136.58 37.81 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 121.249 0.547 . . . . 0.0 111.243 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 10.1 p -128.5 156.64 42.94 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.74 143.67 43.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.125 0.488 . . . . 0.0 111.265 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' B' ' 142' ' ' VAL . 14.4 t -100.72 162.64 12.78 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.5 m -61.61 -27.39 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -168.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . 0.763 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 36.8 t70 -90.59 -12.61 36.47 Favored 'General case' 0 C--O 1.203 -1.349 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.329 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.17 9.06 7.52 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 118.095 -2.002 . . . . 0.0 113.222 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' B' ' 138' ' ' SER . 56.8 t -78.84 118.49 26.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.416 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.9 tm? -115.15 133.8 55.72 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' B' ' 135' ' ' SER . 31.1 m -121.57 129.97 53.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.834 -0.541 . . . . 0.0 110.974 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 19.1 m -120.92 125.16 73.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 7.8 p30 -136.95 137.6 39.69 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.225 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.475 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . -158.79 -143.51 3.68 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.121 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.439 ' HD3' ' HB ' ' B' ' 132' ' ' THR . 96.9 Cg_endo -102.7 169.69 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.938 3.092 . . . . 0.0 112.586 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ARG . . . . . 0.58 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 62.9 ttt180 -96.28 138.25 34.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.715 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.928 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 . . . . . 0 N--CA 1.427 -1.588 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.75 131.52 35.26 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -82.87 104.67 13.27 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -85.35 106.89 17.06 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 122.555 1.169 . . . . 0.0 112.11 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -136.41 149.17 48.15 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -94.92 119.67 33.85 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -126.86 154.42 44.4 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.932 -172.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.9 p -136.86 144.84 43.79 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 42.4 t -115.3 132.49 64.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -110.79 138.4 47.24 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.444 ' HG ' ' CE1' ' A' ' 122' ' ' TYR . 5.8 mp -118.26 126.12 51.51 Favored 'General case' 0 N--CA 1.386 -3.655 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -116.32 139.26 50.58 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.22 1.008 . . . . 0.0 110.551 -175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.533 ' HB ' ' NH1' ' A' ' 120' ' ' ARG . 8.4 p -155.06 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.464 ' H ' HG22 ' A' ' 81' ' ' VAL . 72.9 mmtt -85.68 -163.39 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 119.139 0.881 . . . . 0.0 110.806 176.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.571 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 74.7 m80 -78.54 124.44 28.16 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.612 0.72 . . . . 0.0 111.693 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -149.89 150.43 31.9 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 p -80.89 119.1 75.13 Favored Pre-proline 0 C--N 1.287 -2.123 0 C-N-CA 123.351 0.66 . . . . 0.0 112.432 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.06 -28.54 14.05 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 124.789 3.66 . . . . 0.0 115.122 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.55 -27.59 51.59 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 122.095 -0.378 . . . . 0.0 111.629 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.34 8.27 28.35 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.52 150.43 40.85 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.065 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -130.25 131.81 45.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.32 138.11 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 78.3 mttt -114.25 130.82 56.64 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.7 111.07 21.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.4 95.66 3.12 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.15 -111.53 3.54 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.598 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -99.45 4.14 45.99 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.105 0.962 . . . . 0.0 111.221 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -113.5 137.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.983 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 26.3 mt -130.31 120.48 48.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 43.7 mt-10 -136.74 149.69 47.98 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.675 0.274 . . . . 0.0 110.368 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.32 114.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -115.22 131.01 57.06 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.09 147.97 19.5 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -143.28 131.8 22.34 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 122.393 0.277 . . . . 0.0 110.784 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -136.66 128.88 29.81 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.21 -0.307 . . . . 0.0 110.274 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -80.82 121.36 25.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -79.99 -52.14 8.2 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.779 0.323 . . . . 0.0 110.886 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.421 ' O ' HG12 ' A' ' 114' ' ' ILE . 11.2 ptt180 -148.56 147.11 28.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.96 136.94 50.64 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.804 0.812 . . . . 0.0 111.63 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -90.77 -166.29 1.55 Allowed 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.09 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -47.63 -65.65 0.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.254 1.422 . . . . 0.0 111.41 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -141.78 39.22 1.66 Allowed 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -137.3 144.44 15.94 Favored Glycine 2 N--CA 1.382 -4.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 108.198 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.83 149.89 45.19 Favored 'General case' 0 C--N 1.245 -3.966 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 107' ' ' ARG . 5.5 pt -122.87 134.74 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.4 m -135.03 162.33 32.76 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.374 0.607 . . . . 0.0 110.688 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.72 147.56 49.95 Favored 'General case' 0 N--CA 1.39 -3.447 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 56.2 mt-10 -136.92 151.64 49.28 Favored 'General case' 0 C--N 1.261 -3.241 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -126.07 126.65 44.56 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -129.75 121.91 27.81 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.533 ' NH1' ' HB ' ' A' ' 81' ' ' VAL . 37.7 ttp180 -125.51 136.77 53.69 Favored 'General case' 0 C--N 1.263 -3.182 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.446 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 45.9 mtmt -138.49 129.82 27.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 123.399 0.437 . . . . 0.0 110.827 -169.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.483 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 73.2 m-85 -131.7 143.45 50.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.165 0.586 . . . . 0.0 111.171 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -128.2 98.59 5.14 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 167.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.428 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.5 pt -137.06 105.54 8.75 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.998 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.69 -40.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.383 2.055 . . . . 0.0 113.26 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.41 -33.87 73.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.954 0.407 . . . . 0.0 111.454 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -88.77 -17.1 30.53 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.655 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 78.8 t -127.36 120.49 55.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.354 0.597 . . . . 0.0 111.894 -175.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -115.7 119.62 37.3 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.446 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 97.7 Cg_endo -74.28 19.46 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.024 2.483 . . . . 0.0 116.305 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.96 -47.87 12.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.219 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.438 HG21 ' HG3' ' A' ' 148' ' ' PRO 0.362 8.9 t -121.82 10.88 10.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.466 HG22 ' HD2' ' A' ' 148' ' ' PRO . 1.2 pp -67.7 135.21 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.1 p -125.83 166.56 16.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.421 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 144' ' ' THR . 17.4 m -127.54 133.82 49.79 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.03 0.443 . . . . 0.0 110.175 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.3 m -116.67 133.48 55.96 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.26 128.2 53.8 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.6 m -97.56 162.02 13.49 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.1 m -68.33 -15.25 63.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.468 1.107 . . . . 0.0 113.491 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 10.2 t70 -90.6 -12.72 36.12 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.06 -2.04 35.4 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.65 137.13 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.0 134.43 50.35 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 135' ' ' SER . 58.1 m -115.54 120.5 39.68 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.534 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.0 m -101.57 121.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 13.0 p30 -133.89 137.43 44.95 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.833 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.43 -133.65 2.87 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 133' ' ' ILE . 60.8 Cg_endo -98.59 160.2 0.72 Allowed 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.976 2.45 . . . . 0.0 113.474 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 57.9 ttt-85 -110.0 163.41 13.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 4.0 ttmp? . . . . . 0 C--N 1.311 -1.09 0 CA-C-O 118.801 -0.619 . . . . 0.0 109.846 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 . . . . . 0 N--CA 1.428 -1.557 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.6 131.92 35.56 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -83.35 105.28 14.18 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -85.71 107.18 17.47 Favored 'General case' 0 N--CA 1.412 -2.354 0 CA-C-O 122.373 1.082 . . . . 0.0 112.17 -167.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -136.95 148.98 47.28 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -94.71 119.58 33.56 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -126.75 154.68 43.88 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.972 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 20.1 p -137.04 144.82 43.41 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.537 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 42.7 t -115.29 132.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.28 138.61 46.43 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' LEU . . . . . 0.448 ' HG ' ' CE1' ' B' ' 122' ' ' TYR . 5.8 mp -118.1 126.13 51.65 Favored 'General case' 0 N--CA 1.383 -3.798 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -116.25 139.24 50.58 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 124.239 1.016 . . . . 0.0 110.572 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.532 ' HB ' ' NH1' ' B' ' 120' ' ' ARG . 8.4 p -154.89 -174.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.471 ' H ' HG22 ' B' ' 81' ' ' VAL . 73.1 mmtt -85.74 -163.49 0.87 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 119.159 0.89 . . . . 0.0 110.991 175.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 74.9 m80 -78.4 124.43 28.11 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 121.631 0.729 . . . . 0.0 111.664 -172.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -150.25 150.1 31.07 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 1.6 p -80.7 119.0 74.94 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 123.27 0.628 . . . . 0.0 112.522 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.1 -28.88 14.9 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 124.685 3.59 . . . . 0.0 115.148 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.3 -26.94 52.78 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 122.138 -0.351 . . . . 0.0 111.729 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.86 8.25 30.14 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.957 -0.464 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.51 150.47 40.78 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.98 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 31.8 m -104.4 138.56 28.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.525 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' B' ' 98' ' ' ILE . 78.0 mttt -114.6 130.77 56.82 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 50.2 t -129.88 111.0 20.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -137.45 95.97 3.17 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.92 -111.54 3.56 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.468 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.84 4.24 45.08 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.846 0.858 . . . . 0.0 111.263 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.25 136.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.969 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' B' ' 92' ' ' LYS . 25.8 mt -130.18 120.54 49.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 43.9 mt-10 -136.84 149.7 47.85 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.795 0.331 . . . . 0.0 110.379 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 61.4 t -126.27 114.09 36.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -114.87 130.72 56.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.27 148.14 19.77 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -143.41 132.4 22.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 122.412 0.285 . . . . 0.0 110.822 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -136.97 129.48 30.1 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -81.12 121.21 25.81 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.56 -52.09 8.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.914 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.429 ' O ' HG12 ' B' ' 114' ' ' ILE . 11.6 ptt180 -149.05 146.71 27.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.57 137.22 49.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.793 0.806 . . . . 0.0 111.739 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -91.19 -166.22 1.53 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.127 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -46.59 -66.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.394 1.478 . . . . 0.0 111.302 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -141.69 39.83 1.69 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.483 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -138.47 144.24 15.31 Favored Glycine 2 N--CA 1.384 -4.779 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.101 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.81 150.24 44.74 Favored 'General case' 1 C--N 1.243 -4.028 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.429 HG12 ' O ' ' B' ' 107' ' ' ARG . 5.5 pt -123.11 134.85 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m -135.01 162.16 33.25 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-O 121.368 0.604 . . . . 0.0 110.619 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.87 147.39 50.06 Favored 'General case' 0 N--CA 1.392 -3.355 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 55.9 mt-10 -136.88 151.24 48.86 Favored 'General case' 0 C--N 1.26 -3.317 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -125.61 127.05 45.72 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -130.14 121.79 26.97 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.532 ' NH1' ' HB ' ' B' ' 81' ' ' VAL . 37.7 ttp180 -125.43 136.73 53.71 Favored 'General case' 0 C--N 1.26 -3.286 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.437 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 45.6 mtmt -138.41 129.84 27.55 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.344 0.403 . . . . 0.0 110.825 -169.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' TYR . . . . . 0.448 ' CE1' ' HG ' ' B' ' 79' ' ' LEU . 74.6 m-85 -131.57 143.8 50.62 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.681 0.613 . . . . 0.0 111.147 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -128.42 98.59 5.1 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 167.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.6 pt -137.18 105.42 8.66 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.01 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -90.7 -40.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.377 2.052 . . . . 0.0 113.143 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.06 74.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.867 0.365 . . . . 0.0 111.451 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.63 -17.04 30.92 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.61 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 80.8 t -127.16 120.24 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.531 0.681 . . . . 0.0 111.901 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.38 119.24 38.55 Favored Pre-proline 0 C--N 1.287 -2.131 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.446 ' HA ' ' CG1' ' B' ' 133' ' ' ILE . 82.8 Cg_endo -74.21 19.72 0.43 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.005 2.47 . . . . 0.0 116.277 -171.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.99 -47.83 12.2 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.989 -1.084 . . . . 0.0 112.267 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' THR . . . . . 0.421 HG22 ' HG3' ' B' ' 148' ' ' PRO 0.368 8.9 t -121.99 10.97 10.21 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . 0.464 HG22 ' HD2' ' B' ' 148' ' ' PRO . 1.2 pp -67.76 134.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 2.7 p -125.36 166.87 15.78 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.474 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' B' ' 144' ' ' THR . 17.9 m -127.48 133.61 49.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 15.1 m -116.65 133.09 56.43 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 5.8 mp -105.92 128.25 53.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -97.02 161.76 13.68 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.9 m -68.17 -14.04 62.68 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.426 1.09 . . . . 0.0 113.468 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 9.3 t70 -91.46 -12.74 33.79 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.71 -2.09 36.32 Favored Glycine 0 C--O 1.261 1.825 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.74 137.26 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.21 134.52 50.1 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' B' ' 135' ' ' SER . 57.9 m -115.63 120.68 40.21 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . 0.537 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 5.8 m -101.8 121.89 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 13.0 p30 -133.65 137.17 45.23 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.722 -174.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.01 -133.46 2.78 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' B' ' 133' ' ' ILE . 92.8 Cg_endo -98.04 160.33 0.84 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.28 2.653 . . . . 0.0 113.6 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -110.64 163.19 13.99 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' B' ' 150' ' ' LYS . 4.1 ttmp? . . . . . 0 C--N 1.308 -1.229 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.291 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 C--O 1.215 -0.739 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.8 mt -168.63 112.24 0.57 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 126.564 1.946 . . . . 0.0 107.675 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 149' ' ' ARG . 36.1 tt0 -149.43 72.28 1.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 149' ' ' ARG . 58.6 mtpt -99.3 106.16 18.24 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 77.96 157.38 0.17 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.993 1.717 . . . . 0.0 109.983 -174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -105.52 131.32 53.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 22.7 t80 -110.07 134.8 51.78 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.415 -171.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.9 m -113.13 129.71 56.42 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.0 t -114.97 130.76 68.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.73 155.91 24.75 Favored 'General case' 0 C--N 1.264 -3.152 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' A' ' 143' ' ' LEU . 31.5 tp -118.2 127.56 53.87 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.89 136.17 52.84 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -177.07 168.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -87.37 -175.14 5.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.623 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -77.73 125.61 29.61 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.993 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.05 160.65 38.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.613 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 14.3 m -66.56 107.9 1.96 Allowed Pre-proline 0 CA--C 1.554 1.102 0 O-C-N 124.523 1.14 . . . . 0.0 112.89 -170.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 54.4 Cg_exo -57.26 -28.3 79.01 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.314 3.343 . . . . 0.0 113.968 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -86.75 -9.44 55.87 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.777 0.323 . . . . 0.0 111.063 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 24.8 mm-40 -113.47 19.75 16.64 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.351 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 3.9 pp -120.82 153.8 36.61 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.318 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.73 125.86 45.5 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.723 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -109.35 122.18 63.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -125.73 131.37 52.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.529 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.01 113.03 35.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.37 91.23 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.65 -111.92 4.5 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.11 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.51 9.26 39.21 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.248 1.019 . . . . 0.0 111.612 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.12 136.03 61.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.536 -0.727 . . . . 0.0 109.535 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.6 mt -130.37 121.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -132.24 148.35 52.45 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.635 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.51 127.43 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.203 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -136.37 120.01 17.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.26 162.01 27.24 Favored Glycine 0 CA--C 1.482 -2.015 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.93 143.83 51.02 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -120.77 135.19 55.22 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.48 129.11 34.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.48 ' OE2' ' HB2' ' A' ' 116' ' ' ARG . 42.5 mt-10 -105.0 -76.08 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.414 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 48.7 mtm-85 -141.15 141.82 34.1 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -112.0 136.52 51.24 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.202 0.525 . . . . 0.0 110.922 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -97.12 -155.46 0.49 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.46 -57.18 3.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' B' ' 123' ' ' ARG . 57.3 m80 -100.52 -11.0 20.49 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.482 -176.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -112.3 139.71 15.79 Favored Glycine 1 N--CA 1.395 -4.085 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.428 -176.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -130.14 140.0 50.83 Favored 'General case' 0 C--N 1.256 -3.487 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.1 mt -123.73 132.94 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -136.43 158.28 44.81 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.48 ' HB2' ' OE2' ' A' ' 106' ' ' GLU . 22.8 ttm180 -127.04 148.44 50.12 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.3 mt-10 -125.0 150.78 46.35 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.08 124.75 37.78 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -131.79 132.34 43.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.876 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.426 HH21 ' CG ' ' B' ' 109' ' ' ASP . 44.4 ttt180 -130.35 137.88 50.13 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.466 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 27.7 mtpp -122.86 127.14 48.62 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.303 1.2 p90 -134.36 115.61 14.25 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' B' ' 111' ' ' HIS . 68.8 ttt180 -102.5 99.69 9.74 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.356 0.598 . . . . 0.0 109.764 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.0 pt -124.08 105.54 31.68 Favored Pre-proline 0 C--N 1.288 -2.107 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.458 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -90.13 -52.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.144 2.562 . . . . 0.0 113.163 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.9 64.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.351 0.596 . . . . 0.0 111.364 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.09 -18.14 17.88 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.321 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 57.4 t -132.15 113.48 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -100.16 128.39 30.79 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.04 16.71 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.664 2.243 . . . . 0.0 116.442 -171.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 tp -82.02 -46.97 13.22 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.257 14.3 t -120.36 9.99 11.12 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -68.44 130.3 33.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.8 t -137.75 163.0 32.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 p -128.0 133.0 49.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.8 t -125.89 129.56 49.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.06 135.06 48.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.453 0.644 . . . . 0.0 111.855 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.1 m -100.82 163.45 12.31 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.025 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.4 m -60.29 -21.85 62.44 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.21 7.37 41.05 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 121.383 0.611 . . . . 0.0 111.385 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.15 -6.12 61.57 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.534 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -73.95 112.76 11.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 144' ' ' THR . 1.9 tp -122.34 134.67 54.64 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.266 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.568 ' N ' HD12 ' A' ' 143' ' ' LEU . 17.8 m -117.75 117.92 30.65 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 134' ' ' THR . 31.8 t -101.65 121.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 8.9 p30 -135.38 144.07 46.4 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.396 -0.815 . . . . 0.0 111.164 -174.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.01 -136.45 2.17 Favored Glycine 0 N--CA 1.425 -2.087 0 O-C-N 123.806 0.691 . . . . 0.0 111.552 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -96.73 142.77 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.149 2.566 . . . . 0.0 113.632 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 72' ' ' LYS . 67.8 ttt180 -92.84 133.41 36.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 C--N 1.291 -1.967 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.314 -172.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 . . . . . 0 C--O 1.218 -0.563 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 23.9 mt -168.95 111.68 0.52 Allowed 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.529 1.932 . . . . 0.0 107.768 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' B' ' 149' ' ' ARG . 34.3 tt0 -149.23 72.38 1.16 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' B' ' 149' ' ' ARG . 58.0 mtpt -99.21 106.18 18.31 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 78.44 157.16 0.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.711 1.604 . . . . 0.0 109.83 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -105.74 130.02 53.83 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.435 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 21.4 t80 -108.91 132.29 54.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.205 0.526 . . . . 0.0 110.915 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 26.9 m -110.45 129.58 55.74 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.008 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.89 130.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -113.41 155.83 24.56 Favored 'General case' 0 C--N 1.261 -3.268 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' B' ' 143' ' ' LEU . 31.3 tp -118.11 127.64 53.97 Favored 'General case' 0 N--CA 1.387 -3.598 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -113.2 136.03 53.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -177.38 168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -86.49 -175.34 5.42 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.718 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -77.63 125.66 29.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.124 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.23 160.97 37.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.436 -1.257 . . . . 0.0 107.624 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 15.8 m -66.36 107.38 1.56 Allowed Pre-proline 0 C--N 1.311 -1.095 0 O-C-N 124.536 1.148 . . . . 0.0 112.972 -170.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.15 -28.37 78.81 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.071 3.181 . . . . 0.0 114.024 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.96 -9.64 55.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 85' ' ' SER . 22.1 mm-40 -112.7 19.45 17.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.402 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -120.87 153.34 37.3 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.323 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -123.09 126.02 46.28 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.935 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.76 122.32 64.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.99 131.62 52.2 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.475 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.15 112.95 34.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 84.5 mt -127.16 91.17 3.27 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.421 ' HA2' ' HG3' ' B' ' 130' ' ' PRO . . . 67.0 -112.1 4.62 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.874 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.52 9.09 39.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 124.371 1.068 . . . . 0.0 111.701 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.96 136.12 60.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.639 -0.663 . . . . 0.0 109.359 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 46.2 mt -130.72 121.38 50.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.26 148.44 52.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.095 0.474 . . . . 0.0 111.592 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.43 127.53 62.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.144 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -136.59 120.05 17.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 161.86 27.27 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.424 ' HB3' ' HG2' ' B' ' 117' ' ' GLU . 0.0 OUTLIER -130.45 143.95 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -120.71 135.37 55.15 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.81 128.01 33.17 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.478 ' OE2' ' HB2' ' B' ' 116' ' ' ARG . 42.9 mt-10 -103.7 -77.4 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 -139.86 142.56 36.57 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -112.19 136.14 51.97 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.634 0.73 . . . . 0.0 111.265 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.426 ' CG ' HH21 ' A' ' 120' ' ' ARG . 37.1 m-20 -96.83 -155.79 0.5 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 172.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.8 -57.31 3.03 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 122.037 0.922 . . . . 0.0 108.617 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . 0.449 ' HB3' ' O ' ' A' ' 123' ' ' ARG . 54.0 m80 -101.66 -11.13 19.42 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.178 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -111.12 139.57 15.62 Favored Glycine 0 N--CA 1.396 -3.981 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.591 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.22 139.68 50.79 Favored 'General case' 0 C--N 1.257 -3.437 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.16 133.18 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 46.8 m -136.44 158.18 45.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.478 ' HB2' ' OE2' ' B' ' 106' ' ' GLU . 22.4 ttm180 -127.19 148.25 50.19 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 36.9 mt-10 -125.02 150.85 46.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -128.16 124.89 37.97 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -131.87 132.09 43.34 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -130.19 137.91 50.32 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.502 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.6 mtpp -122.65 127.11 48.91 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' TYR . . . . . . . . . . . . 0.3 1.3 p90 -134.39 115.27 13.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 111' ' ' HIS . 71.0 ttt180 -101.95 99.73 9.94 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.394 0.616 . . . . 0.0 109.948 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.0 pt -123.99 105.52 31.92 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.538 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -90.01 -53.14 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 123.013 2.475 . . . . 0.0 113.136 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 -18.9 65.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.58 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -99.57 -18.1 17.53 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.265 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 60.0 t -132.21 113.8 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.81 128.31 30.12 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.421 ' HG3' ' HA2' ' B' ' 95' ' ' GLY . 72.1 Cg_endo -71.09 16.39 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.837 2.358 . . . . 0.0 116.415 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.76 -46.66 13.91 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 13.9 t -120.97 10.23 10.77 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.0 OUTLIER -68.36 130.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 11.9 t -137.84 162.99 32.54 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 15.0 p -127.79 133.14 49.44 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.257 0.551 . . . . 0.0 112.148 -174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -126.45 129.36 48.54 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.41 134.73 48.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.098 0.475 . . . . 0.0 111.68 -174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 20.1 m -100.72 163.36 12.36 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.138 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -60.47 -21.18 62.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -91.95 8.01 39.49 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.515 0.674 . . . . 0.0 111.171 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.87 -5.85 61.99 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.496 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 67.1 t -74.16 112.98 11.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.264 0.554 . . . . 0.0 109.506 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.562 HD13 ' N ' ' B' ' 144' ' ' THR . 1.8 tp -122.67 134.43 54.48 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.123 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.562 ' N ' HD13 ' B' ' 143' ' ' LEU . 16.6 m -117.22 118.24 31.77 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' B' ' 134' ' ' THR . 35.5 t -102.24 121.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.4 p30 -134.97 144.17 47.26 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.305 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.88 -136.61 2.2 Favored Glycine 0 N--CA 1.423 -2.202 0 O-C-N 123.654 0.596 . . . . 0.0 111.738 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -96.72 142.63 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.265 2.644 . . . . 0.0 113.505 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' B' ' 72' ' ' LYS . 71.0 ttt180 -92.9 133.86 35.67 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 84.3 tttt . . . . . 0 C--N 1.29 -1.998 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.243 -172.422 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 31.3 t70 . . . . . 0 CA--C 1.484 -1.563 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -94.37 117.57 30.32 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' ASN . 51.0 t80 -110.7 142.65 42.33 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.6 m -137.58 131.57 31.85 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.382 0.61 . . . . 0.0 111.641 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.644 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 47.6 t -118.9 141.68 37.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -111.78 143.82 42.09 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.974 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 3.1 mm? -119.99 127.6 52.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' B' ' 107' ' ' ARG . 0.6 OUTLIER -117.2 127.26 53.93 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.597 -175.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.85 116.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 103.344 -2.836 . . . . 0.0 103.344 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.4 -54.34 41.97 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.316 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -150.43 121.97 7.97 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.41 171.65 18.69 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 126.943 2.097 . . . . 0.0 106.983 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 20.3 m -112.87 141.13 24.95 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 85' ' ' SER . 80.6 Cg_exo -48.89 -28.31 13.0 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 125.131 3.887 . . . . 0.0 116.361 -172.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -73.98 -19.78 60.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.042 0.449 . . . . 0.0 111.227 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 3.0 mp0 -98.25 18.1 17.11 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.921 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.18 147.96 44.26 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.499 0.666 . . . . 0.0 111.166 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -138.24 124.7 20.66 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 p -109.83 129.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' HG3' ' HB2' ' A' ' 99' ' ' GLU . 17.5 ptmt -129.96 130.67 45.36 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 121.384 0.611 . . . . 0.0 111.244 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.8 117.81 52.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.64 90.94 2.71 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.312 0.577 . . . . 0.0 109.727 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 -111.82 4.44 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.855 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.87 -4.91 59.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.77 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.03 137.61 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 122' ' ' TYR . 4.0 tp -124.72 119.94 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 35.5 mt-10 -138.18 149.71 46.09 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.357 -173.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.415 HG22 ' HB3' ' A' ' 120' ' ' ARG . 19.5 m -124.33 134.23 67.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -123.92 124.71 43.22 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.901 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 88' ' ' GLU . . . -124.25 142.65 14.26 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -143.04 126.56 16.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -136.32 141.01 43.76 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.531 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.21 120.81 26.28 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -82.22 -62.47 1.61 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 123.562 0.745 . . . . 0.0 111.289 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.514 ' HB2' HD12 ' A' ' 114' ' ' ILE . 39.3 mtm180 -141.67 125.13 16.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.867 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 131.24 49.54 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.47 171.96 13.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 119.255 -0.403 . . . . 0.0 110.378 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 13.59 -83.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 127.652 2.381 . . . . 0.0 114.468 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.24 30.06 1.05 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -131.86 131.05 6.15 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.448 -1.705 . . . . 0.0 109.32 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -121.35 149.47 42.91 Favored 'General case' 1 C--N 1.238 -4.265 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 107' ' ' ARG . 16.5 mt -123.3 132.97 70.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.1 m -129.23 158.42 39.1 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.109 0.481 . . . . 0.0 110.33 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -133.97 148.52 51.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 49.2 mt-10 -132.49 150.24 52.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.78 125.06 42.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -132.16 122.12 24.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.741 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.472 ' HG3' HG12 ' B' ' 114' ' ' ILE . 70.1 ttt180 -112.27 137.4 50.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 24.7 pttm -129.51 129.94 45.18 Favored 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.76 0.662 . . . . 0.0 110.76 -172.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.543 ' HB2' HG23 ' A' ' 98' ' ' ILE . 5.6 m-85 -128.63 145.1 51.25 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -128.05 98.91 5.28 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.9 pt -136.26 105.13 9.41 Favored Pre-proline 0 C--N 1.285 -2.219 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.259 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.82 -40.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.462 2.108 . . . . 0.0 112.021 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.07 -19.52 64.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.4 ' HB3' ' CE2' ' A' ' 75' ' ' PHE . 16.2 m-20 -108.45 -17.3 14.02 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 64.6 t -128.31 121.11 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' HB2' ' HD2' ' A' ' 150' ' ' LYS . 12.1 t70 -122.23 121.17 27.93 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 168.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.93 -15.53 39.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 114.777 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.34 -25.28 36.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.974 0.416 . . . . 0.0 111.384 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.458 HG22 ' HB3' ' A' ' 129' ' ' ASP . 8.1 t -119.19 -21.31 7.63 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.3 126.91 42.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 34.4 p -122.47 168.04 12.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.644 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 m -126.27 133.72 51.36 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.152 0.501 . . . . 0.0 111.164 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.457 ' O ' HD22 ' A' ' 143' ' ' LEU . 24.1 p -118.7 150.51 39.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.8 142.34 42.93 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.783 0.72 . . . . 0.0 112.477 -174.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.4 t -100.38 161.59 13.5 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -68.85 -20.12 64.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.834 0.853 . . . . 0.0 112.9 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -85.79 -10.67 55.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 112.06 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.28 1.11 23.59 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.532 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.5 t -77.2 124.23 35.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 2.7 tm? -119.5 132.25 55.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.1 m -121.34 127.42 51.25 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 121.639 -0.663 . . . . 0.0 110.749 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.644 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 19.2 m -102.01 122.64 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 3.9 p-10 -138.58 155.48 48.31 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.782 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.11 171.69 17.32 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 41.5 Cg_exo -51.1 142.59 34.6 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.759 2.306 . . . . 0.0 111.995 171.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 11.2 ptm180 -90.66 165.97 13.42 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.37 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.527 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 76.6 tttt . . . . . 0 C--O 1.271 2.226 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.669 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 31.0 t70 . . . . . 0 CA--C 1.482 -1.644 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -95.02 117.35 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' B' ' 146' ' ' ASN . 50.7 t80 -110.62 142.92 41.82 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' B' ' 145' ' ' VAL . 35.1 m -137.82 131.2 30.78 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.243 0.544 . . . . 0.0 111.641 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.653 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 52.7 t -118.72 141.77 36.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.5 144.27 41.0 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.164 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' B' ' 143' ' ' LEU . 3.1 mm? -120.02 127.52 52.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 107' ' ' ARG . 0.6 OUTLIER -117.15 127.77 54.45 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.419 -1.312 . . . . 0.0 112.717 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -118.83 117.15 53.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 167.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.72 -54.21 44.92 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.265 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -150.44 121.7 7.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.57 171.87 18.18 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.796 2.038 . . . . 0.0 107.103 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.1 m -113.2 141.21 25.32 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.15 -28.09 13.71 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 125.044 3.83 . . . . 0.0 116.362 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.53 -20.34 60.68 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.353 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLU . . . . . 0.408 ' O ' ' HA2' ' B' ' 102' ' ' GLY . 2.9 mp0 -98.37 18.43 16.5 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.723 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.34 147.75 44.62 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.829 0.823 . . . . 0.0 111.273 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -138.05 124.53 20.72 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -109.63 129.58 64.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' B' ' 99' ' ' GLU . 17.8 ptmt -130.36 130.72 44.76 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.417 0.627 . . . . 0.0 111.091 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.91 118.16 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.5 tp -135.48 91.18 2.69 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-O 121.17 0.51 . . . . 0.0 109.716 -173.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.05 -111.92 4.53 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.022 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -86.56 -4.79 59.23 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.227 1.011 . . . . 0.0 112.022 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.84 137.74 47.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.535 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 122' ' ' TYR . 4.0 tp -124.87 120.03 57.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 174.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.413 ' HB2' ' HG3' ' B' ' 92' ' ' LYS . 35.4 mt-10 -138.16 149.72 46.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.151 0.501 . . . . 0.0 110.323 -173.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' B' ' 120' ' ' ARG . 20.1 m -124.22 134.34 66.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -123.95 124.66 43.08 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 88' ' ' GLU . . . -124.04 142.87 14.5 Favored Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 173.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -143.08 126.36 16.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -136.23 140.6 43.61 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.548 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -82.48 120.73 25.85 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -81.9 -63.76 1.32 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 123.512 0.725 . . . . 0.0 111.008 -173.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.485 ' HB2' HD12 ' B' ' 114' ' ' ILE . 39.8 mtm180 -140.9 125.42 17.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.961 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -103.24 130.4 50.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -139.16 172.47 12.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.39 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 12.86 -84.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 127.673 2.389 . . . . 0.0 114.27 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -145.85 30.19 1.08 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -132.1 130.18 5.83 Favored Glycine 0 N--CA 1.403 -3.53 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.403 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -120.43 149.86 41.7 Favored 'General case' 1 C--N 1.24 -4.156 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' B' ' 107' ' ' ARG . 16.9 mt -123.61 133.34 69.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.8 m -129.98 159.14 37.57 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.049 0.452 . . . . 0.0 110.174 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -134.17 148.55 50.94 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 48.8 mt-10 -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -126.03 125.03 41.97 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -132.06 122.22 25.1 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.785 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' HG12 ' A' ' 114' ' ' ILE . 70.0 ttt180 -112.3 137.36 50.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 24.1 pttm -129.37 129.83 45.27 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.717 0.635 . . . . 0.0 110.72 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' TYR . . . . . 0.552 ' HB2' HG23 ' B' ' 98' ' ' ILE . 6.1 m-85 -128.25 145.57 51.0 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.489 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -128.19 98.86 5.24 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 3.9 pt -136.38 105.2 9.3 Favored Pre-proline 0 C--N 1.284 -2.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.193 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.49 -40.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.542 2.161 . . . . 0.0 112.081 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.01 -19.86 64.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 111.513 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' B' ' 75' ' ' PHE . 15.0 m-20 -108.36 -17.18 14.06 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.444 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 63.6 t -128.46 121.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ASP . . . . . 0.528 ' HB2' ' HD2' ' B' ' 150' ' ' LYS . 12.2 t70 -122.35 121.32 27.78 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 168.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.17 -15.2 38.31 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.466 2.777 . . . . 0.0 114.632 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 tp -81.47 -25.87 35.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.461 . . . . 0.0 111.157 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' THR . . . . . 0.471 HG22 ' HB3' ' B' ' 129' ' ' ASP . 9.7 t -119.05 -21.14 7.79 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.14 127.12 42.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 33.4 p -122.5 167.72 13.0 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.839 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.7 m -126.28 133.96 51.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.446 ' O ' HD22 ' B' ' 143' ' ' LEU . 14.8 p -119.13 149.61 41.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 142.66 44.24 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.465 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.62 161.6 13.49 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -68.81 -19.59 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.603 0.761 . . . . 0.0 112.953 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.68 -10.14 54.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.041 0.448 . . . . 0.0 111.734 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.3 0.75 23.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.43 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.62 124.11 34.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 2.7 tm? -119.59 132.27 55.68 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 35.3 m -121.46 126.99 50.61 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.6 -0.688 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' VAL . . . . . 0.653 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 19.0 m -101.71 122.65 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 146' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' B' ' 75' ' ' PHE . 4.0 p-10 -138.51 154.97 48.8 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.775 -173.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.13 18.22 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 50.3 Cg_exo -50.8 142.3 33.12 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 122.745 2.297 . . . . 0.0 111.973 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' B' ' 75' ' ' PHE . 11.0 ptm180 -90.18 165.8 13.74 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.413 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' LYS . . . . . 0.528 ' HD2' ' HB2' ' B' ' 129' ' ' ASP . 76.2 tttt . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.414 ' OD2' ' HD3' ' A' ' 149' ' ' ARG . 31.5 t70 . . . . . 0 CA--C 1.492 -1.258 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 52.7 t80 -128.72 145.28 51.21 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.793 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 t -116.67 130.44 56.73 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.566 ' HB ' HG23 ' A' ' 145' ' ' VAL . 23.7 t -114.46 131.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.15 147.05 35.75 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 81' ' ' VAL . 6.7 mp -118.5 129.06 55.15 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -74.22 125.27 28.03 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.542 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 82' ' ' LYS . 32.9 t -138.97 142.67 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.66 ' O ' HG12 ' A' ' 81' ' ' VAL . 16.7 tptm -98.33 -177.34 3.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.567 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 7.8 t60 -77.63 124.98 28.64 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.841 -1.543 . . . . 0.0 113.412 -167.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -132.67 172.45 12.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.148 172.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 15.1 m -77.57 117.82 68.03 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -53.09 -27.76 38.11 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 124.024 3.149 . . . . 0.0 114.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -87.14 -35.31 18.7 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.343 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 18.5 mm-40 -91.35 58.91 3.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.296 0.57 . . . . 0.0 110.593 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 pp -143.21 160.43 40.48 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.09 0.471 . . . . 0.0 111.175 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -135.63 124.61 24.22 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.18 122.87 58.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -129.07 133.29 47.63 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.416 0.626 . . . . 0.0 111.948 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.73 122.1 59.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.96 91.71 3.09 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.29 -112.12 4.17 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.751 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -93.2 -0.25 56.92 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.689 1.196 . . . . 0.0 110.96 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.7 136.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.574 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 145' ' ' VAL . 16.6 mt -125.1 120.66 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.81 149.22 49.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.2 0.524 . . . . 0.0 110.84 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -129.8 120.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -113.56 120.06 39.67 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.428 ' HA3' ' CD2' ' A' ' 84' ' ' PHE . . . -136.98 154.79 22.4 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -138.56 143.28 39.35 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 117.454 0.627 . . . . 0.0 111.05 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 84' ' ' PHE . 81.1 t60 -137.97 127.86 25.52 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 170.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 32.1 mt-10 -86.01 121.33 28.48 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 23.7 mt-10 -55.06 -80.82 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -166.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 51.5 mtm-85 -147.63 153.82 39.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -83.01 128.19 34.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -94.39 -172.32 2.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -39.87 -66.16 0.33 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.361 1.464 . . . . 0.0 112.634 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -142.74 28.06 1.62 Allowed 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' B' ' 122' ' ' TYR . . . -132.95 153.53 20.75 Favored Glycine 1 N--CA 1.369 -5.788 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.39 149.05 30.8 Favored 'General case' 1 C--N 1.243 -4.025 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.482 HG23 ' HG2' ' B' ' 120' ' ' ARG . 35.5 mm -124.25 135.48 63.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.987 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 12.0 m -128.18 140.97 51.62 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -128.65 147.04 50.71 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.13 150.73 51.14 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.058 0.456 . . . . 0.0 110.105 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 84' ' ' PHE . 73.2 m-85 -124.96 133.67 52.93 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -127.1 121.94 32.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.61 ' CZ ' ' HA ' ' A' ' 81' ' ' VAL . 67.2 mtt-85 -117.02 136.88 52.62 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.4 tttp -134.82 128.38 32.65 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.756 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.458 ' CD1' ' HA3' ' B' ' 112' ' ' GLY . 13.3 m-85 -131.42 135.2 46.96 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.867 0.867 . . . . 0.0 110.543 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -128.23 98.7 5.18 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.637 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 5.0 pt -135.94 106.43 9.67 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.73 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -87.67 -39.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.027 1.818 . . . . 0.0 112.508 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.42 72.26 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 121.451 0.643 . . . . 0.0 111.76 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 149' ' ' ARG . 9.3 m-20 -91.99 -16.25 26.78 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.709 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.637 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 12.6 t -131.38 120.42 46.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -171.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.68 111.73 35.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.63 13.46 0.46 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.403 2.735 . . . . 0.0 116.215 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.79 -45.23 75.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.403 HG22 ' HD3' ' A' ' 148' ' ' PRO . 10.5 t -120.45 9.49 10.95 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 121.609 -0.682 . . . . 0.0 112.564 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' A' ' 128' ' ' VAL . 50.2 mt -67.8 132.51 32.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.418 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.8 p -121.58 165.89 15.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.901 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 144' ' ' THR . 15.1 m -130.09 134.06 47.1 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 120.971 0.415 . . . . 0.0 111.14 -177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.5 m -116.52 145.44 43.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.7 tp -121.74 137.17 54.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.505 0.193 . . . . 0.0 110.756 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -96.62 164.24 12.68 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.528 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.4 t -60.21 -33.97 72.99 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.523 1.056 . . . . 0.0 113.055 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 19.7 t70 -81.25 -11.09 59.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.542 0.687 . . . . 0.0 110.331 -177.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 8.13 24.07 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.437 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 43.7 t -71.68 132.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.33 134.39 55.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -168.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 135' ' ' SER . 20.3 m -121.51 128.1 51.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 77' ' ' VAL . 15.7 m -114.86 125.4 72.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.6 p-10 -132.25 138.62 47.97 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.505 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.77 -144.8 6.45 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.529 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 132' ' ' THR . 10.6 Cg_endo -91.66 139.03 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.069 2.513 . . . . 0.0 114.392 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.464 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 73.9 ttt180 -103.76 137.41 41.82 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--N 1.297 -1.702 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -175.493 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 CA--C 1.497 -1.063 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -96.08 125.74 40.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 53.0 t80 -128.88 145.81 51.11 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.738 -170.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.4 t -117.6 130.06 56.15 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.543 ' HB ' HG23 ' B' ' 145' ' ' VAL . 23.2 t -114.32 131.03 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -111.09 147.15 35.46 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' LEU . . . . . 0.478 ' O ' HG23 ' B' ' 81' ' ' VAL . 6.7 mp -118.5 128.83 54.96 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -73.67 125.32 27.78 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.402 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.656 HG12 ' O ' ' B' ' 82' ' ' LYS . 31.6 t -139.23 142.18 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 O-C-N 123.911 0.757 . . . . 0.0 109.107 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.656 ' O ' HG12 ' B' ' 81' ' ' VAL . 16.9 tptm -97.72 -177.42 3.77 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 7.6 t60 -77.7 124.76 28.37 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 117.89 -1.524 . . . . 0.0 113.4 -167.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.622 ' HA ' ' HB2' ' B' ' 104' ' ' HIS . 0.0 OUTLIER -132.55 172.5 12.43 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.174 172.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 15.3 m -77.54 118.05 69.49 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.2 -27.69 38.79 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 124.045 3.163 . . . . 0.0 114.036 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -87.22 -35.18 18.68 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.461 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' B' ' 85' ' ' SER . 16.1 mm-40 -92.04 58.51 3.37 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.543 0.687 . . . . 0.0 110.42 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.51 160.34 40.47 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.153 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -135.67 124.56 24.08 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.78 122.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -129.04 134.3 48.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.279 0.562 . . . . 0.0 111.744 -174.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 p -128.45 120.86 53.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.0 tp -129.93 91.78 3.19 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.63 -111.99 4.19 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.944 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -93.17 0.06 57.06 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 124.45 1.1 . . . . 0.0 111.003 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 97.6 t -110.06 136.33 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.526 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ILE . . . . . 0.499 HD13 HG21 ' B' ' 145' ' ' VAL . 17.1 mt -125.07 120.53 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.55 149.09 49.34 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.23 0.538 . . . . 0.0 110.759 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 94.0 t -129.54 120.93 51.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -113.52 120.14 39.96 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' B' ' 84' ' ' PHE . . . -137.07 154.59 22.35 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.33 143.26 39.83 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.508 0.67 . . . . 0.0 110.998 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' B' ' 84' ' ' PHE . 82.0 t60 -137.92 127.72 25.4 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 170.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 34.7 mt-10 -85.5 121.14 27.77 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.415 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 23.3 mt-10 -54.88 -80.7 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -166.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 51.6 mtm-85 -148.0 153.72 39.35 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -83.31 129.09 34.98 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -94.71 -172.53 2.76 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -39.5 -66.4 0.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.131 1.372 . . . . 0.0 112.958 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -142.69 27.95 1.64 Allowed 'General case' 0 CA--C 1.461 -2.472 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 122' ' ' TYR . . . -132.81 153.57 20.74 Favored Glycine 1 N--CA 1.37 -5.761 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -177.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -110.41 149.04 30.83 Favored 'General case' 1 C--N 1.244 -4.018 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' B' ' 105' ' ' GLU . 34.8 mm -124.21 135.53 63.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.127 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 9.6 m -128.18 141.09 51.57 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -128.64 147.17 50.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.3 150.44 50.98 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.128 0.489 . . . . 0.0 110.139 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' B' ' 84' ' ' PHE . 72.5 m-85 -124.77 133.92 52.98 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -127.38 121.88 32.14 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.593 ' CZ ' ' HA ' ' B' ' 81' ' ' VAL . 67.6 mtt-85 -117.18 137.02 52.62 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -135.16 128.3 31.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.774 -1.17 . . . . 0.0 110.697 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' TYR . . . . . 0.47 ' CE1' ' HA3' ' A' ' 112' ' ' GLY . 13.5 m-85 -131.46 134.99 46.75 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.973 0.909 . . . . 0.0 110.672 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -127.78 98.67 5.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.643 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 5.0 pt -135.72 106.59 9.85 Favored Pre-proline 0 C--N 1.29 -1.979 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.739 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -40.32 0.06 OUTLIER 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.26 1.973 . . . . 0.0 112.544 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.69 -32.05 71.58 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.612 0.72 . . . . 0.0 111.794 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ASP . . . . . 0.428 ' HA ' ' HG3' ' B' ' 149' ' ' ARG . 9.9 m-20 -92.15 -16.08 26.78 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.927 -0.483 . . . . 0.0 110.783 -176.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 13.0 t -131.45 119.88 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -170.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.05 111.68 36.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.82 15.29 0.38 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 123.456 2.771 . . . . 0.0 115.887 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.06 -45.13 71.14 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.101 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' THR . . . . . 0.406 HG22 ' HG3' ' B' ' 148' ' ' PRO . 12.8 t -120.61 9.88 10.93 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' B' ' 128' ' ' VAL . 50.0 mt -68.11 132.92 32.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.393 -170.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.7 p -121.98 166.18 14.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.733 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' B' ' 144' ' ' THR . 14.5 m -130.97 134.05 46.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.97 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 19.7 m -116.35 145.32 43.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -121.97 137.0 54.96 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 25.3 m -96.39 164.41 12.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.435 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -60.44 -34.07 73.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.448 1.022 . . . . 0.0 113.077 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 19.9 t70 -81.39 -10.73 59.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.43 0.633 . . . . 0.0 110.342 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.09 8.33 23.88 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.349 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.439 ' HA ' ' HB ' ' B' ' 81' ' ' VAL . 46.2 t -71.85 132.75 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.66 134.37 55.11 Favored 'General case' 0 C--O 1.209 -1.066 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.178 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' B' ' 135' ' ' SER . 20.1 m -121.4 127.87 51.62 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' VAL . . . . . 0.543 HG23 ' HB ' ' B' ' 77' ' ' VAL . 15.7 m -114.88 125.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 146' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 21.8 p-10 -132.47 138.14 47.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.522 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 179.69 -144.52 6.09 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.406 ' HG3' HG22 ' B' ' 132' ' ' THR . 9.8 Cg_endo -91.64 139.15 2.22 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.145 2.563 . . . . 0.0 114.383 -177.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 71.5 ttt180 -103.8 137.89 41.18 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.492 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.866 0.365 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -113.09 120.17 40.37 Favored 'General case' 0 CA--C 1.471 -2.063 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.34 150.64 25.02 Favored 'General case' 0 N--CA 1.393 -3.323 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.595 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 p -137.13 144.34 42.96 Favored 'General case' 0 N--CA 1.402 -2.851 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.087 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 32.8 t -116.05 132.55 65.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -110.97 136.89 49.3 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.465 HD22 HD11 ' A' ' 143' ' ' LEU . 6.0 mp -119.67 128.08 53.49 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.78 138.73 50.85 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 122.727 0.411 . . . . 0.0 109.911 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.42 165.99 5.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.72 -164.75 0.09 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.483 0.583 . . . . 0.0 110.441 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -77.41 123.94 27.21 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.003 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.58 143.11 15.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 m -74.02 124.73 90.33 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 123.477 0.485 . . . . 0.0 110.983 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 139' ' ' SER . 10.3 Cg_endo -55.43 -30.96 75.75 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.865 3.043 . . . . 0.0 114.046 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -74.59 -26.58 60.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.861 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.81 0.84 51.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.291 0.567 . . . . 0.0 111.398 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.22 147.67 44.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -126.21 126.26 43.76 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.38 126.69 52.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -129.57 138.37 51.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.438 0.637 . . . . 0.0 109.417 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.16 90.44 3.34 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.91 -112.17 4.73 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.148 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.4 -0.55 57.31 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.355 1.062 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.407 HG12 ' HG3' ' A' ' 99' ' ' GLU . 65.3 t -105.69 135.74 42.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.44 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 59.0 mt -122.0 119.53 58.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 39.1 mt-10 -136.38 137.02 40.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.61 0.719 . . . . 0.0 111.705 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.468 HG11 HH21 ' A' ' 120' ' ' ARG . 60.6 t -119.05 124.78 73.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -127.76 128.74 45.86 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.84 156.66 27.11 Favored Glycine 0 C--N 1.283 -2.384 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -143.37 134.16 25.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 124.056 0.504 . . . . 0.0 109.921 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.437 ' CD2' ' HG2' ' A' ' 106' ' ' GLU . 62.4 t60 -136.77 127.72 27.59 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.55 0.34 . . . . 0.0 110.327 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 12.5 pt-20 -87.03 137.05 32.68 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.437 ' HG2' ' CD2' ' A' ' 104' ' ' HIS . 28.3 mt-10 -106.78 -53.98 2.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.331 -173.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -148.34 152.92 37.88 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 47.7 tt0 -111.76 122.24 47.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.453 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -75.2 -67.35 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -179.22 106.19 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 37.6 m80 60.1 25.29 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.027 0.918 . . . . 0.0 109.208 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.66 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -156.4 119.13 0.89 Allowed Glycine 1 N--CA 1.39 -4.392 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -175.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' GLN . 11.7 p90 -119.28 153.54 34.88 Favored 'General case' 1 C--N 1.243 -4.033 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.416 HG22 ' HG2' ' B' ' 120' ' ' ARG . 1.9 pt -121.04 140.87 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 15.5 m -134.44 157.09 47.34 Favored 'General case' 0 N--CA 1.404 -2.749 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.974 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.9 ttp85 -126.65 146.46 50.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.7 mt-10 -136.87 153.69 50.69 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -128.54 133.6 48.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 26.6 t-80 -131.56 122.48 26.16 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.483 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.468 HH21 HG11 ' A' ' 100' ' ' VAL . 30.8 mtm180 -115.72 138.4 51.15 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.627 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 51.0 tttp -136.03 128.04 29.61 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.702 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 30.3 m-85 -132.17 142.32 49.42 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.104 0.878 . . . . 0.0 109.024 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -128.48 98.57 5.08 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.7 pt -137.33 106.21 8.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.328 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.49 -45.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.886 0 C-N-CA 122.642 2.228 . . . . 0.0 113.366 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 150' ' ' LYS . . . -67.54 -28.19 67.59 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -91.16 -18.0 25.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 77.8 t -132.81 127.6 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.77 ' H ' ' HB3' ' A' ' 148' ' ' PRO . 5.6 m-20 -121.62 109.6 34.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.233 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.55 ' HA ' ' CG2' ' A' ' 133' ' ' ILE . 20.8 Cg_endo -59.92 -12.26 18.08 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 124.239 3.293 . . . . 0.0 114.744 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.55 -40.34 96.74 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.177 0.513 . . . . 0.0 111.237 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.1 t -118.42 9.16 12.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.663 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.55 ' CG2' ' HA ' ' A' ' 130' ' ' PRO . 10.4 tt -77.26 141.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.992 0.425 . . . . 0.0 110.065 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 4.9 p -138.79 154.77 48.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 144' ' ' THR . 22.9 t -131.02 133.21 45.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.169 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 p -119.64 130.33 55.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 137' ' ' LEU . 1.4 pt? -130.13 137.23 50.04 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.01 0.434 . . . . 0.0 112.099 -169.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.3 p -99.91 168.0 10.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.358 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 11.4 m -67.13 -10.97 55.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.38 1.472 . . . . 0.0 112.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.38 20.07 19.42 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-O 121.789 0.804 . . . . 0.0 110.516 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.21 -5.34 63.51 Favored Glycine 0 C--O 1.261 1.791 0 CA-C-N 115.568 -0.742 . . . . 0.0 114.813 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.8 119.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.465 HD11 HD22 ' A' ' 79' ' ' LEU . 3.9 pp -129.94 135.55 48.45 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 135' ' ' SER . 13.5 p -107.31 133.08 52.38 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.483 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 134' ' ' THR . 12.5 m -111.82 121.52 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -137.38 164.75 27.88 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.361 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.505 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . 128.1 -49.06 0.94 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.41 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.77 ' HB3' ' H ' ' A' ' 129' ' ' ASP . 55.5 Cg_endo -62.29 169.72 7.55 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 123.241 2.628 . . . . 0.0 114.989 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -106.26 154.88 20.1 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 126' ' ' ALA . 81.5 tttt . . . . . 0 C--N 1.285 -2.207 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.117 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' B' ' 149' ' ' ARG . 4.2 t70 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.038 0.447 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -112.87 120.04 40.06 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.43 150.7 25.04 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.57 -172.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.7 p -137.36 144.24 42.41 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.186 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 33.3 t -116.0 132.91 64.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.35 136.72 50.06 Favored 'General case' 0 C--N 1.269 -2.928 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' LEU . . . . . 0.47 ' HG ' ' OH ' ' B' ' 122' ' ' TYR . 6.0 mp -119.53 128.16 53.68 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.76 138.63 50.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.48 165.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.37 -164.46 0.08 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.444 0.565 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -77.67 124.22 27.66 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.807 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.77 142.62 15.29 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.5 m -73.5 124.49 90.45 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 123.349 0.405 . . . . 0.0 111.057 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 139' ' ' SER . 9.3 Cg_endo -55.4 -31.2 76.54 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.725 2.95 . . . . 0.0 113.993 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.77 -26.42 60.64 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.47 0.91 53.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.133 0.492 . . . . 0.0 111.398 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.29 147.52 44.89 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -125.98 125.89 43.43 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -98.5 127.14 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.808 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -129.88 140.01 51.06 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 117.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.95 90.19 3.28 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.34 -112.31 4.87 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.65 -0.19 56.53 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 124.417 1.087 . . . . 0.0 111.946 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' B' ' 99' ' ' GLU . 65.3 t -106.22 135.91 42.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.591 -0.693 . . . . 0.0 110.314 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 59.3 mt -122.18 119.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 39.1 mt-10 -136.23 136.91 40.29 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.661 0.743 . . . . 0.0 111.637 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.464 HG11 HH21 ' B' ' 120' ' ' ARG . 61.1 t -118.99 124.41 73.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -127.25 128.73 46.5 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.15 156.62 27.07 Favored Glycine 0 C--N 1.286 -2.242 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -143.31 134.0 25.14 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 122.648 0.379 . . . . 0.0 110.024 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' HIS . . . . . 0.43 ' CD2' ' HG2' ' B' ' 106' ' ' GLU . 61.2 t60 -136.63 127.68 27.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 122.561 0.344 . . . . 0.0 110.311 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 12.0 pt-20 -86.72 137.05 32.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.43 ' HG2' ' CD2' ' B' ' 104' ' ' HIS . 27.8 mt-10 -106.74 -54.33 2.49 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.254 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -148.13 153.11 38.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' B' ' 113' ' ' PHE . 46.9 tt0 -111.7 122.64 48.34 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.593 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.98 -67.99 0.59 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.769 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -178.7 106.16 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 39.1 m80 60.61 24.17 13.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.937 0.875 . . . . 0.0 109.158 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.702 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -154.99 120.26 1.0 Allowed Glycine 2 N--CA 1.389 -4.485 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -177.141 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 113' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 108' ' ' GLN . 11.8 p90 -119.34 153.6 34.87 Favored 'General case' 1 C--N 1.241 -4.146 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.049 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.403 HG22 ' HG2' ' A' ' 120' ' ' ARG . 1.8 pt -121.06 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 14.5 m -134.4 157.08 47.32 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.108 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -126.42 146.49 50.05 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 37.1 mt-10 -136.83 153.59 50.75 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -172.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -128.63 133.43 48.27 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 121.186 0.517 . . . . 0.0 110.669 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 28.2 t-80 -131.49 122.43 26.18 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.469 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.464 HH21 HG11 ' B' ' 100' ' ' VAL . 30.1 mtm180 -115.81 138.43 51.15 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.628 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 50.3 tttp -136.13 128.06 29.44 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.312 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' TYR . . . . . 0.66 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 29.9 m-85 -132.22 142.56 49.47 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 124.013 0.821 . . . . 0.0 108.92 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -128.41 98.57 5.1 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -137.26 106.19 8.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.499 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -89.46 -44.53 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.638 2.225 . . . . 0.0 113.403 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' B' ' 150' ' ' LYS . . . -68.12 -27.74 66.73 Favored 'General case' 0 C--O 1.198 -1.639 0 O-C-N 122.049 -0.407 . . . . 0.0 111.959 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.66 -18.17 24.39 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 76.7 t -132.75 127.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ASP . . . . . 0.766 ' H ' ' HB3' ' B' ' 148' ' ' PRO . 7.1 m-20 -121.34 110.42 34.22 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.164 168.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.534 ' HA ' ' CG2' ' B' ' 133' ' ' ILE . 20.7 Cg_endo -60.66 -12.02 19.71 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 124.026 3.151 . . . . 0.0 114.737 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.93 -40.14 95.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.093 0.473 . . . . 0.0 111.078 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 6.9 t -118.14 9.02 12.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ILE . . . . . 0.534 ' CG2' ' HA ' ' B' ' 130' ' ' PRO . 10.9 tt -76.84 141.9 15.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.6 p -138.92 154.43 48.35 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.629 0.772 . . . . 0.0 109.2 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.0 t -130.82 132.9 45.5 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.19 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 2.6 p -119.74 130.09 54.82 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' LEU . . . . . 0.498 HD23 ' H ' ' B' ' 137' ' ' LEU . 1.4 pt? -130.06 136.97 49.95 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -169.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 76.8 p -99.55 168.14 10.15 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.487 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' B' ' 86' ' ' PRO . 6.9 m -67.62 -11.15 57.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.397 1.479 . . . . 0.0 112.092 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.22 20.04 19.53 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.677 0.751 . . . . 0.0 110.424 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.12 -4.72 65.53 Favored Glycine 0 C--O 1.26 1.725 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.28 119.79 33.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.458 HD11 HD22 ' B' ' 79' ' ' LEU . 4.0 pp -130.12 135.77 48.57 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.828 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' B' ' 135' ' ' SER . 11.6 p -107.49 133.29 52.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.271 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' B' ' 134' ' ' THR . 12.4 m -111.85 121.56 64.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -137.56 164.82 27.82 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 122.179 -0.326 . . . . 0.0 110.163 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.496 ' N ' ' HD2' ' B' ' 148' ' ' PRO . . . 127.93 -49.03 0.94 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.785 -1.197 . . . . 0.0 114.311 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.766 ' HB3' ' H ' ' B' ' 129' ' ' ASP . 55.6 Cg_endo -62.88 169.48 8.78 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.953 2.435 . . . . 0.0 115.05 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 36.0 ptt180 -105.22 155.51 18.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 150' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 79.9 tttt . . . . . 0 C--N 1.285 -2.217 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 74' ' ' ARG . 25.5 mtm180 -95.5 139.76 31.31 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.472 ' CE2' HG22 ' A' ' 128' ' ' VAL . 20.2 t80 -106.62 140.02 40.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.727 -170.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 t -137.91 129.14 27.6 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.71 130.79 72.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.44 155.95 22.39 Favored 'General case' 0 C--N 1.257 -3.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 16.6 tp -118.67 127.86 53.97 Favored 'General case' 0 N--CA 1.381 -3.916 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -104.32 130.27 52.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 p -156.56 162.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.494 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -93.42 -162.89 0.98 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.367 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.714 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 34.9 t60 -76.58 123.78 26.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 117.334 -1.746 . . . . 0.0 112.296 -169.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.37 133.72 19.59 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -73.6 149.14 88.28 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HA ' HD21 ' A' ' 137' ' ' LEU . 93.4 Cg_exo -47.74 -34.79 22.13 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.921 2.414 . . . . 0.0 115.513 -171.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.31 -17.99 53.48 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.61 -20.06 44.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 89' ' ' LEU . 2.5 pt? -120.95 151.12 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.426 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.19 136.2 36.38 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.03 139.97 37.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.588 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.55 139.51 47.89 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.241 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 98' ' ' ILE . 2.4 p -129.94 112.96 25.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.77 101.78 5.04 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.97 -111.74 4.0 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.002 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 125' ' ' PRO . 8.4 p-10 -93.94 -5.92 46.7 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 124.731 1.212 . . . . 0.0 111.431 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.92 135.57 54.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.071 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 93' ' ' VAL . 3.0 mp -131.81 120.05 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.8 mt-10 -133.43 147.87 51.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 120.992 0.425 . . . . 0.0 111.686 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 79' ' ' LEU . 39.9 t -126.65 129.44 71.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -136.0 133.37 37.42 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.95 147.0 17.92 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.02 134.52 45.66 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -130.53 131.14 44.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.3 pt-20 -87.18 120.85 28.88 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.604 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 30.5 mm-40 -67.6 -70.68 0.24 Allowed 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.308 -173.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.604 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 0.8 OUTLIER -144.17 154.89 43.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -111.26 128.59 55.98 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 110' ' ' GLU . 61.2 m-20 -93.88 -168.44 1.88 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 3.6 mp0 -57.6 -68.72 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.967 1.307 . . . . 0.0 109.539 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -122.18 14.84 10.59 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' B' ' 122' ' ' TYR . . . -115.54 142.32 17.51 Favored Glycine 1 N--CA 1.384 -4.773 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.393 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.75 139.57 53.85 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 107' ' ' ARG . 5.6 mt -123.7 131.98 72.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 23.3 t -137.16 157.46 46.61 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.093 0.473 . . . . 0.0 110.545 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -134.1 147.72 50.9 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 171.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -130.94 154.35 48.21 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 122.19 0.196 . . . . 0.0 110.483 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -122.1 128.28 51.13 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -131.25 122.04 25.82 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -126.63 137.86 53.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.514 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 23.6 mtpp -134.57 127.11 30.61 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.173 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.48 ' HB3' ' CA ' ' B' ' 112' ' ' GLY 0.305 1.3 p90 -134.7 133.72 40.31 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 173.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -109.9 101.68 10.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.448 0.642 . . . . 0.0 110.557 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.46 HG13 HD13 ' A' ' 98' ' ' ILE . 2.4 pt -135.52 106.91 10.01 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.463 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 59.2 Cg_endo -108.95 -37.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 122.7 2.267 . . . . 0.0 116.154 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.402 ' H ' ' HD2' ' A' ' 125' ' ' PRO . . . -68.03 -29.76 68.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.763 -0.585 . . . . 0.0 112.382 -172.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.06 8.18 20.01 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.525 0.679 . . . . 0.0 109.37 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 75' ' ' PHE . 56.3 t -131.16 127.43 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.644 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.68 103.36 40.74 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.21 8.85 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 123.684 2.923 . . . . 0.0 116.167 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.91 -39.81 95.67 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 148' ' ' PRO . 14.6 t -119.36 9.29 11.59 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.388 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.539 HG12 ' HA3' ' A' ' 147' ' ' GLY . 42.9 mt -68.36 122.46 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.703 0.763 . . . . 0.0 112.296 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.76 167.27 18.33 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.034 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 143' ' ' LEU . 19.0 p -127.2 135.64 50.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -116.46 129.54 56.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 86' ' ' PRO . 60.1 tp -129.29 127.95 42.2 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 123.16 0.288 . . . . 0.0 111.111 -171.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 14.8 m -99.84 163.98 12.22 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.643 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.0 m -55.14 -30.64 60.23 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.714 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 25.3 t70 -88.33 -11.79 45.32 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.841 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.35 62.01 0.81 Allowed Glycine 0 N--CA 1.409 -3.127 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 46.8 t -121.23 122.28 67.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 174.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 135' ' ' SER . 15.9 tp -127.2 134.93 50.06 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -173.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.451 ' N ' HD12 ' A' ' 143' ' ' LEU . 41.3 m -121.43 118.93 30.64 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.368 171.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.463 HG12 ' CG2' ' A' ' 133' ' ' ILE . 13.6 t -106.72 120.39 57.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 9.4 p30 -139.47 159.69 41.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.9 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.539 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.69 -136.66 2.97 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 132' ' ' THR . 61.1 Cg_endo -104.28 149.74 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.449 2.766 . . . . 0.0 113.72 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -101.11 153.94 19.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 150' ' ' LYS . 36.3 ttmt . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 23.7 t0 . . . . . 0 N--CA 1.437 -1.106 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -95.31 140.14 30.63 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.482 ' CE2' HG22 ' B' ' 128' ' ' VAL . 19.7 t80 -107.19 139.95 40.83 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.686 -170.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -137.92 129.3 27.81 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.4 HG11 ' CE2' ' B' ' 122' ' ' TYR . 46.2 t -118.12 130.92 72.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.39 155.98 22.3 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' B' ' 143' ' ' LEU . 16.6 tp -118.66 127.68 53.8 Favored 'General case' 1 N--CA 1.379 -4.002 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.76 130.47 51.28 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.08 162.04 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.254 -3.548 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.96 -162.81 0.97 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.157 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' HIS . . . . . 0.732 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 40.6 t60 -76.59 123.73 26.53 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 117.65 -1.62 . . . . 0.0 112.417 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -147.48 134.06 19.84 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -73.81 148.74 87.51 Favored Pre-proline 0 C--N 1.283 -2.314 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.69 -34.69 21.55 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.91 2.406 . . . . 0.0 115.556 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.22 -17.86 54.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 120.843 0.354 . . . . 0.0 111.624 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.89 -20.08 42.98 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.448 HD23 ' H ' ' B' ' 89' ' ' LEU . 2.5 pt? -121.01 150.45 41.12 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.545 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.4 135.88 37.35 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 p -113.56 139.94 36.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.714 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.62 139.88 47.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.269 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.525 HG23 HG13 ' B' ' 98' ' ' ILE . 2.4 p -129.98 112.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.533 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.67 102.77 5.4 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.324 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.66 -111.55 4.04 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.009 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' B' ' 125' ' ' PRO . 8.6 p-10 -94.12 -5.9 46.19 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 124.499 1.12 . . . . 0.0 111.519 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.74 135.53 54.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.026 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ILE . . . . . 0.525 HG13 HG23 ' B' ' 93' ' ' VAL . 3.0 mp -131.64 120.01 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 37.1 mt-10 -133.47 147.42 51.67 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.665 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.413 HG11 ' CD2' ' B' ' 79' ' ' LEU . 40.0 t -126.02 129.58 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -136.1 133.34 37.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.82 147.56 18.82 Favored Glycine 0 C--N 1.286 -2.228 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.96 134.3 45.47 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -130.16 132.06 45.9 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.5 pt-20 -88.34 120.51 29.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.603 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 31.7 mm-40 -67.09 -71.14 0.21 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 112.683 -2.053 . . . . 0.0 110.281 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.603 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 0.7 OUTLIER -143.71 154.99 44.05 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.19 128.68 55.99 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' B' ' 110' ' ' GLU . 63.6 m-20 -94.13 -169.09 1.99 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' B' ' 110' ' ' GLU . 3.5 mp0 -56.95 -68.4 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.117 1.367 . . . . 0.0 109.635 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -122.33 14.93 10.47 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 122' ' ' TYR . . . -115.51 142.59 17.69 Favored Glycine 1 N--CA 1.385 -4.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.328 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.3 139.27 54.07 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' B' ' 107' ' ' ARG . 5.6 mt -123.7 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 22.8 t -137.03 157.56 46.45 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.265 0.555 . . . . 0.0 110.611 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -134.18 147.75 50.8 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 171.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -131.01 154.26 48.37 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -121.77 128.13 51.39 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -131.11 121.7 25.38 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -126.07 138.04 53.68 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.5 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 23.7 mtpp -134.68 127.07 30.35 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.226 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' TYR . . . . . 0.455 ' HB3' ' CA ' ' A' ' 112' ' ' GLY 0.312 1.3 p90 -134.72 134.05 40.62 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 174.026 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -110.53 101.51 10.18 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.452 0.644 . . . . 0.0 110.299 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.449 HG13 HD13 ' B' ' 98' ' ' ILE . 2.4 pt -135.58 106.9 9.96 Favored Pre-proline 0 C--N 1.292 -1.915 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.494 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.524 ' HB3' ' HB3' ' B' ' 96' ' ' ASP . 59.1 Cg_endo -109.03 -37.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.691 2.261 . . . . 0.0 116.455 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.401 ' H ' ' HD2' ' B' ' 125' ' ' PRO . . . -68.24 -29.44 68.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.98 8.24 20.16 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.731 0.777 . . . . 0.0 109.409 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.482 HG22 ' CE2' ' B' ' 75' ' ' PHE . 53.3 t -131.44 127.19 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.716 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -121.7 103.33 40.74 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.14 8.46 1.41 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.775 2.983 . . . . 0.0 116.166 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.56 -39.43 93.65 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' THR . . . . . 0.444 HG22 ' HD3' ' B' ' 148' ' ' PRO . 14.7 t -119.57 9.17 11.42 Favored 'General case' 0 C--O 1.252 1.189 0 O-C-N 121.229 -0.919 . . . . 0.0 111.233 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ILE . . . . . 0.524 HG12 ' HA3' ' B' ' 147' ' ' GLY . 42.7 mt -68.4 121.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.886 0.85 . . . . 0.0 112.342 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.74 167.13 17.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.52 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.543 ' HB2' HD11 ' B' ' 143' ' ' LEU . 21.9 p -126.99 135.71 51.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t -116.72 129.91 56.41 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 60.6 tp -130.19 127.02 38.83 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.682 0.277 . . . . 0.0 111.07 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 13.7 m -98.64 163.95 12.44 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.676 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.2 m -55.17 -30.49 59.97 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -169.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' ASP . . . . . 0.732 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 22.8 t70 -88.92 -11.67 43.84 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.554 0.692 . . . . 0.0 110.713 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.57 61.82 0.8 Allowed Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -172.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 46.7 t -120.72 121.94 66.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 174.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' B' ' 135' ' ' SER . 16.1 tp -126.85 135.03 50.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.448 ' N ' HD12 ' B' ' 143' ' ' LEU . 42.4 m -121.66 118.21 28.59 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.352 171.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 145' ' ' VAL . . . . . 0.459 HG12 ' CG2' ' B' ' 133' ' ' ILE . 13.1 t -106.09 120.53 57.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 146' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.1 p30 -139.54 160.09 40.67 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.839 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.524 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 178.2 -136.91 3.12 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' B' ' 132' ' ' THR . 64.5 Cg_endo -104.06 150.29 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.443 2.762 . . . . 0.0 113.644 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -101.74 154.25 19.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' B' ' 150' ' ' LYS . 36.2 ttmt . . . . . 0 C--N 1.292 -1.896 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 65.5 mtp180 -94.42 119.17 32.74 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -124.85 155.38 39.55 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.659 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.3 p -129.44 140.28 51.36 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.191 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.472 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 45.4 t -115.37 136.26 52.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -111.14 139.49 46.47 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 143' ' ' LEU . 6.1 mp -119.93 128.55 53.71 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.38 119.43 25.09 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 141' ' ' GLY . 40.4 t -133.67 141.08 45.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 174.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -83.33 -171.15 3.41 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.538 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -76.13 125.04 28.4 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -158.16 166.63 31.94 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -74.97 113.41 24.54 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 123.719 0.637 . . . . 0.0 110.294 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.94 -29.81 83.68 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.787 2.991 . . . . 0.0 115.055 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.39 -7.98 57.11 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.999 -0.438 . . . . 0.0 111.392 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 88' ' ' GLU . 5.5 mm-40 -93.18 2.74 56.54 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.679 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.58 147.25 45.44 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -124.26 126.61 46.36 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.89 122.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.17 131.12 54.89 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.143 0.497 . . . . 0.0 111.07 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.518 HG22 HD13 ' A' ' 98' ' ' ILE . 58.3 t -115.13 125.03 72.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.98 91.73 2.72 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.569 0.7 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.76 -112.4 4.73 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.742 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -95.26 11.48 32.35 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.743 0.817 . . . . 0.0 111.515 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.34 137.21 55.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.821 -0.549 . . . . 0.0 110.314 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 122' ' ' TYR . 2.3 tp -125.99 120.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.497 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.3 mt-10 -132.2 150.04 52.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.138 0.494 . . . . 0.0 110.453 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.7 t -126.84 124.2 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -128.36 133.19 48.6 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.63 150.94 23.24 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 128.07 17.69 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -138.27 134.16 34.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 111.216 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -80.89 120.45 24.73 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.17 -55.94 5.0 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.024 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.651 ' HG2' HD11 ' A' ' 114' ' ' ILE . 30.7 ptt180 -148.59 155.38 41.02 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -82.24 113.58 20.16 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 114' ' ' ILE . 13.1 t70 -93.98 -148.86 0.27 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.891 -164.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -72.85 83.62 1.21 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.496 0.589 . . . . 0.0 109.786 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 74.53 -52.65 0.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.076 1.75 . . . . 0.0 110.321 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.36 173.22 54.27 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.189 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.91 149.27 41.86 Favored 'General case' 0 C--N 1.255 -3.517 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.651 HD11 ' HG2' ' A' ' 107' ' ' ARG . 38.1 pt -122.88 137.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.195 -175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -134.47 154.24 51.51 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.22 0.533 . . . . 0.0 111.244 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.409 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 6.8 ttp180 -127.3 147.05 50.24 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -134.13 153.45 51.82 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.51 ' HD2' ' NH1' ' A' ' 120' ' ' ARG . 50.1 m-85 -128.26 126.41 40.82 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.494 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.75 122.52 27.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.534 ' NH2' HD12 ' B' ' 114' ' ' ILE . 26.3 mtt85 -126.94 138.21 53.25 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -138.66 128.88 25.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.908 0.755 . . . . 0.0 111.541 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.765 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.7 m-85 -133.1 123.67 26.15 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.084 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -107.56 99.42 8.92 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 4.3 pt -135.93 105.8 9.68 Favored Pre-proline 0 C--N 1.303 -1.452 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.774 -177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.53 -38.67 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.91 2.407 . . . . 0.0 112.122 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 150' ' ' LYS . . . -68.63 -32.32 72.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.292 0.567 . . . . 0.0 111.338 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.99 -18.27 22.06 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.727 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 70.3 t -131.71 114.38 24.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.42 127.04 27.91 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 168.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 79.9 Cg_endo -73.32 16.01 0.48 Allowed 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 122.665 2.244 . . . . 0.0 116.402 -172.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.1 tp -81.84 -48.18 11.88 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.277 3.0 t -122.27 10.74 9.99 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.2 pp -67.28 129.28 31.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.1 p -132.56 166.38 22.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.417 ' HB3' HG12 ' A' ' 145' ' ' VAL . 52.9 p -127.87 134.12 49.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 121.03 0.443 . . . . 0.0 110.912 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -125.09 129.96 51.29 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.8 148.46 44.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.5 m -100.37 163.86 12.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.9 m -64.32 -21.57 66.65 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.767 0.827 . . . . 0.0 112.384 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.83 5.15 22.62 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 121.274 0.559 . . . . 0.0 110.467 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 81' ' ' VAL . . . 96.64 -20.54 50.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.868 173.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.85 123.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.766 0.793 . . . . 0.0 110.454 -175.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 79' ' ' LEU . 4.1 pp -129.65 136.26 49.51 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.583 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.0 t -109.72 135.68 50.26 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.472 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 31.1 m -105.9 122.16 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 3.6 p-10 -132.89 143.48 49.53 Favored 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.171 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' ARG . . . 174.34 -138.09 4.27 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -91.76 147.08 3.25 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.379 2.053 . . . . 0.0 112.813 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -100.57 151.47 21.56 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 126' ' ' ALA . 87.1 tttt . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 N--CA 1.441 -0.908 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' B' ' 147' ' ' GLY . 66.3 mtp180 -94.3 119.08 32.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -124.99 154.87 40.55 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.697 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.3 p -128.56 140.34 51.84 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.428 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 44.6 t -115.24 136.57 51.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -111.14 139.65 46.35 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' LEU . . . . . 0.477 HD22 HD11 ' B' ' 143' ' ' LEU . 6.1 mp -120.12 128.63 53.62 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -84.5 119.24 24.93 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.641 ' HB ' ' O ' ' B' ' 141' ' ' GLY . 41.0 t -134.1 140.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 103.01 -2.959 . . . . 0.0 103.01 174.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -82.87 -170.93 3.26 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.671 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -75.9 125.11 28.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -158.24 166.62 31.92 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -74.82 113.29 23.05 Favored Pre-proline 0 N--CA 1.435 -1.211 0 O-C-N 123.777 0.673 . . . . 0.0 110.253 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.93 -30.07 84.65 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.806 3.004 . . . . 0.0 114.969 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.25 -7.15 58.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.023 0.44 . . . . 0.0 111.476 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' B' ' 88' ' ' GLU . 5.4 mm-40 -94.26 2.82 55.84 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.14 0.495 . . . . 0.0 111.53 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.35 147.01 45.58 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.84 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -124.57 125.71 44.62 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -96.27 122.05 47.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -120.34 130.96 54.65 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.505 HG22 HD13 ' B' ' 98' ' ' ILE . 58.0 t -114.67 125.14 71.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 172.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -135.84 91.87 2.75 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.0 -112.26 4.6 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.898 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.64 11.43 33.32 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.548 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.51 137.21 55.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.452 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ILE . . . . . 0.757 HG23 ' HB2' ' B' ' 122' ' ' TYR . 2.3 tp -125.99 120.25 56.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 174.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 38.2 mt-10 -132.33 149.93 52.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.11 0.481 . . . . 0.0 110.467 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 88.0 t -126.64 124.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -128.17 132.97 48.86 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.0 151.0 23.35 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.407 ' HD3' ' H ' ' B' ' 103' ' ' LYS . 0.0 OUTLIER -143.93 128.09 17.65 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -138.29 134.12 33.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.405 -0.809 . . . . 0.0 111.208 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.73 120.58 24.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -77.21 -55.98 4.95 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.061 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' B' ' 114' ' ' ILE . 30.2 ptt180 -148.65 155.46 41.08 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -82.06 113.6 20.05 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.413 ' HB2' HG23 ' B' ' 114' ' ' ILE . 13.8 t70 -94.09 -148.53 0.27 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.928 -163.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.55 82.57 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.602 0.637 . . . . 0.0 110.021 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 75.41 -51.46 0.65 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.245 1.818 . . . . 0.0 110.078 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.4 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -77.53 173.2 55.08 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.142 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -118.65 149.59 41.14 Favored 'General case' 0 C--N 1.255 -3.52 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.671 HD11 ' HG2' ' B' ' 107' ' ' ARG . 37.7 pt -122.92 137.03 57.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.315 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -134.59 153.92 51.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.411 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 6.3 ttp180 -127.11 147.05 50.18 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.05 153.35 51.85 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.515 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.5 ' HD2' ' NH1' ' B' ' 120' ' ' ARG . 49.9 m-85 -128.23 126.75 41.54 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.356 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -131.03 122.62 27.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.524 ' NH2' HD12 ' A' ' 114' ' ' ILE . 25.8 mtt85 -126.96 138.1 53.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -138.36 128.88 26.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 124.023 0.827 . . . . 0.0 111.474 -177.001 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 122' ' ' TYR . . . . . 0.757 ' HB2' HG23 ' B' ' 98' ' ' ILE . 4.1 m-85 -133.11 124.7 28.03 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.027 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -108.79 99.27 8.64 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.492 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 4.1 pt -136.06 106.0 9.58 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.772 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 124' ' ' ILE . 5.4 Cg_exo -84.9 -38.83 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 111.92 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' B' ' 150' ' ' LYS . . . -67.84 -32.32 72.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.73 -18.14 21.55 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.582 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 70.7 t -131.87 114.31 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -174.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -109.3 127.56 27.01 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.414 ' HA ' ' CG1' ' B' ' 133' ' ' ILE . 86.9 Cg_endo -73.55 15.96 0.52 Allowed 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 122.759 2.306 . . . . 0.0 116.374 -172.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -81.9 -48.39 11.58 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' THR . . . . . 0.4 HG22 ' HG3' ' B' ' 148' ' ' PRO 0.272 4.4 t -122.14 10.55 10.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.226 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.2 pp -67.46 128.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -175.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 12.1 p -130.6 166.7 20.08 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.653 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.42 ' HB3' HG12 ' B' ' 145' ' ' VAL . 55.9 p -127.67 134.69 49.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.065 0.46 . . . . 0.0 110.859 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 18.4 m -125.37 129.81 50.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' LEU . . . . . 0.41 ' HB3' ' HB3' ' B' ' 143' ' ' LEU . 3.8 pp -122.3 148.32 45.16 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 16.3 m -100.07 163.73 12.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 18.6 m -64.1 -21.87 66.71 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 112.439 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.43 4.19 25.16 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 123.182 0.593 . . . . 0.0 110.484 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.641 ' O ' ' HB ' ' B' ' 81' ' ' VAL . . . 97.3 -20.34 51.14 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.755 173.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.79 123.64 26.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.757 0.789 . . . . 0.0 110.432 -175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.477 HD11 HD22 ' B' ' 79' ' ' LEU . 4.1 pp -129.71 136.12 49.3 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.475 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -109.29 135.65 50.03 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' VAL . . . . . 0.475 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 31.5 m -105.74 122.24 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 146' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 3.6 p-10 -133.02 142.73 48.97 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.941 0.401 . . . . 0.0 111.349 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' B' ' 74' ' ' ARG . . . 174.76 -138.02 4.17 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.4 ' HG3' HG22 ' B' ' 132' ' ' THR . 21.7 Cg_endo -91.65 146.9 3.31 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.474 2.116 . . . . 0.0 112.887 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -100.62 151.41 21.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' B' ' 126' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.108 0.48 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -112.43 149.6 32.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 9.3 t80 -134.22 158.66 43.15 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.908 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.3 t -131.85 133.81 45.06 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.95 137.77 47.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -110.2 135.27 51.24 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.647 HD22 ' CE1' ' A' ' 122' ' ' TYR . 1.8 mt -120.46 128.86 53.54 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -107.45 134.88 49.84 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.878 0.847 . . . . 0.0 111.82 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.23 -179.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 172.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 54.9 mtpt -100.08 -163.21 1.01 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 120.325 1.421 . . . . 0.0 110.666 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -77.78 125.9 30.04 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.156 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 47.9 m-85 -142.47 146.75 35.1 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.876 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 m -66.54 129.41 94.13 Favored Pre-proline 0 N--CA 1.407 -2.599 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.473 ' HB3' HD21 ' A' ' 137' ' ' LEU . 72.9 Cg_exo -48.87 -31.96 21.38 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.229 3.286 . . . . 0.0 115.094 -173.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.37 -4.45 58.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.4 mm-40 -100.11 -0.14 39.57 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.407 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 4.0 pp -121.56 147.53 45.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.34 126.03 30.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.49 122.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.02 137.5 53.49 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.079 0.466 . . . . 0.0 110.831 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 98' ' ' ILE . 85.6 t -124.51 115.5 44.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.934 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.67 95.01 4.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.67 -112.81 4.86 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.045 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -95.92 11.23 34.6 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 123.186 0.594 . . . . 0.0 111.394 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.42 135.79 57.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.297 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 27.1 mm -121.68 120.57 62.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 46.4 mt-10 -136.46 136.9 39.87 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.701 0.682 . . . . 0.0 112.753 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 46.8 t -107.25 117.17 52.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -113.67 119.05 36.1 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 89' ' ' LEU . . . -123.83 135.64 9.87 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 25.4 ttpp -120.21 133.41 55.49 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -134.6 128.67 33.66 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.59 120.92 35.58 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -75.1 -66.26 0.78 Allowed 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.873 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -139.51 124.38 18.61 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.192 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.89 112.62 21.31 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 103.02 -2.956 . . . . 0.0 103.02 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 112' ' ' GLY . 5.4 t70 -114.35 -163.06 0.84 Allowed 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.138 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -74.24 -76.58 0.13 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.051 0.54 . . . . 0.0 111.237 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -109.87 -15.54 14.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 109' ' ' ASP . . . -130.58 113.58 1.45 Allowed Glycine 0 C--O 1.2 -1.995 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.659 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -94.07 137.22 33.51 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 120' ' ' ARG . 3.0 tt -125.24 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -131.56 162.76 29.55 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.485 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -127.58 149.61 50.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.631 1.172 . . . . 0.0 108.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 36.6 tt0 -135.83 141.18 44.65 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.463 ' CZ ' ' HD3' ' A' ' 82' ' ' LYS . 9.2 m-85 -126.73 124.96 40.97 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.0 p80 -133.05 125.58 29.96 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.063 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' B' ' 114' ' ' ILE . 24.8 ttt85 -112.63 136.91 51.64 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.449 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 28.1 mtmm -130.05 130.45 44.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.78 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE1' HD22 ' A' ' 79' ' ' LEU . 45.4 m-85 -121.55 131.6 54.23 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 123.418 0.687 . . . . 0.0 110.089 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -117.82 99.07 6.69 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.567 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 9.0 pt -135.48 105.51 10.05 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.099 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.67 -33.54 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.443 2.096 . . . . 0.0 111.341 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 150' ' ' LYS . . . -69.23 -22.95 63.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.731 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -108.11 -13.75 14.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.633 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.575 HG11 HD11 ' A' ' 98' ' ' ILE . 16.8 t -130.47 134.74 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.23 116.2 42.19 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 38.2 Cg_endo -65.13 -6.0 12.15 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.204 2.603 . . . . 0.0 116.381 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.0 tp -81.7 -45.06 16.24 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.769 -176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.6 t -112.77 8.72 18.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.473 ' O ' HD12 ' A' ' 133' ' ' ILE . 2.0 pp -68.75 136.95 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.804 170.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER -130.38 166.27 20.8 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 144' ' ' THR . 14.8 m -136.41 141.35 43.62 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 118.899 0.772 . . . . 0.0 111.809 -176.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.9 t -131.67 140.83 49.44 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -126.79 137.73 53.25 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.909 -177.324 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 t -100.12 161.63 13.49 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.0 m -67.89 -21.01 65.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.28 7.72 36.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.826 0.822 . . . . 0.0 110.83 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.37 33.49 11.65 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.501 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.1 112.46 32.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -108.68 129.43 55.35 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -175.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 135' ' ' SER . 5.2 p -117.64 129.0 55.47 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 175.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 134' ' ' THR . 62.1 t -103.18 122.42 55.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 134' ' ' THR . 24.1 p-10 -126.79 148.27 49.94 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.31 -118.3 0.9 Allowed Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.566 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -85.84 170.61 8.62 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 124.186 3.257 . . . . 0.0 114.19 -172.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 61.8 ttt180 -141.44 151.2 43.2 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 88.9 tttt . . . . . 0 C--N 1.294 -1.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.083 0.468 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -113.16 149.86 33.03 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.523 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 9.4 t80 -134.78 158.91 42.96 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.819 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 14.7 t -132.26 133.79 44.52 Favored 'General case' 0 N--CA 1.399 -3.015 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.0 137.65 47.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -109.82 135.24 51.04 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' LEU . . . . . 0.651 HD22 ' CE1' ' B' ' 122' ' ' TYR . 1.7 mt -120.22 128.92 53.81 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -107.56 135.38 49.11 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 121.664 0.745 . . . . 0.0 111.802 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.93 -179.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 54.0 mtpt -99.76 -163.3 1.02 Allowed 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 120.301 1.409 . . . . 0.0 110.746 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -77.63 125.8 29.9 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 117.712 -1.595 . . . . 0.0 112.188 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' B' ' 118' ' ' PHE . 47.3 m-85 -142.06 146.51 35.56 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.701 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 14.6 m -66.53 129.61 94.13 Favored Pre-proline 0 N--CA 1.412 -2.342 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.474 ' HB3' HD21 ' B' ' 137' ' ' LEU . 69.9 Cg_exo -48.56 -31.98 19.87 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 124.517 3.478 . . . . 0.0 115.094 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -88.27 -4.68 58.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' B' ' 103' ' ' LYS . 11.3 mm-40 -100.47 -0.02 38.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.433 0.635 . . . . 0.0 110.606 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.402 ' HA ' ' HA2' ' B' ' 102' ' ' GLY . 4.0 pp -121.07 147.7 45.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -133.41 125.92 30.13 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.152 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.79 122.45 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.964 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -118.91 136.39 54.09 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 120.952 0.406 . . . . 0.0 110.737 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.478 HG13 HD13 ' B' ' 98' ' ' ILE . 86.8 t -123.27 116.08 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.77 94.2 4.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.417 ' HA2' ' HG3' ' B' ' 130' ' ' PRO . . . 69.73 -112.62 4.55 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.067 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.38 11.11 35.96 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.075 0.55 . . . . 0.0 111.257 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -117.98 135.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.407 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ILE . . . . . 0.593 HD11 HG11 ' B' ' 128' ' ' VAL . 27.5 mm -121.8 120.65 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 46.7 mt-10 -136.53 137.11 39.94 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 118.71 0.686 . . . . 0.0 112.799 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' B' ' 119' ' ' HIS . 46.7 t -107.33 117.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -113.68 119.11 36.31 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 89' ' ' LEU . . . -123.74 135.65 9.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' B' ' 88' ' ' GLU . 25.5 ttpp -120.02 133.48 55.53 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -134.71 129.02 34.09 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.01 120.83 35.89 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -74.55 -65.69 0.83 Allowed 'General case' 0 CA--C 1.478 -1.798 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.083 -168.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 -140.3 124.27 17.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.141 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 112.41 21.11 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' B' ' 112' ' ' GLY . 5.2 t70 -113.87 -163.05 0.84 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.285 -163.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -73.62 -76.1 0.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 123.315 0.646 . . . . 0.0 111.215 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -110.6 -17.51 13.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' B' ' 109' ' ' ASP . . . -129.33 114.39 1.72 Allowed Glycine 0 C--O 1.2 -2.026 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.974 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -94.22 137.3 33.55 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' ARG . 3.1 tt -125.11 137.26 58.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 15.8 m -132.76 162.7 30.79 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.514 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -127.54 149.65 50.04 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.638 1.175 . . . . 0.0 108.164 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 37.1 tt0 -135.84 141.09 44.62 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.462 ' CZ ' ' HD3' ' B' ' 82' ' ' LYS . 9.2 m-85 -126.72 124.95 40.95 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 2.0 p80 -133.1 125.75 30.25 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.914 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 24.7 ttt85 -112.66 137.02 51.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.443 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.9 mtmm -130.03 130.26 44.72 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.772 -173.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' TYR . . . . . 0.651 ' CE1' HD22 ' B' ' 79' ' ' LEU . 45.2 m-85 -121.35 131.97 54.5 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 123.704 0.628 . . . . 0.0 110.111 176.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -118.0 98.92 6.57 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 165.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 8.9 pt -135.37 105.5 10.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.055 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -92.59 -33.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.511 2.141 . . . . 0.0 111.386 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' B' ' 150' ' ' LYS . . . -69.29 -23.45 63.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.096 0.558 . . . . 0.0 111.628 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -107.47 -14.3 14.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.593 HG11 HD11 ' B' ' 98' ' ' ILE . 16.6 t -129.87 134.53 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -172.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -114.74 116.25 43.32 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.417 ' HG3' ' HA2' ' B' ' 95' ' ' GLY . 34.9 Cg_endo -65.16 -5.49 11.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.056 2.504 . . . . 0.0 116.249 -174.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.91 -45.29 15.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.614 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 8.8 t -113.02 9.05 18.62 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ILE . . . . . 0.478 ' O ' HD12 ' B' ' 133' ' ' ILE . 2.0 pp -68.77 136.73 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.774 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 0.2 OUTLIER -130.6 166.15 21.26 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 144' ' ' THR . 16.5 m -136.43 141.38 43.59 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 118.853 0.751 . . . . 0.0 111.746 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 29.6 t -132.1 139.73 48.57 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -125.58 138.2 53.93 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.063 -177.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.24 161.68 13.45 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 13.2 m -67.56 -20.51 65.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -170.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.32 8.19 37.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.791 0.805 . . . . 0.0 110.558 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.27 33.27 12.04 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.713 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.94 112.78 33.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 0.8 OUTLIER -108.87 129.52 55.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -175.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 135' ' ' SER . 7.2 p -117.76 128.76 55.19 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 145' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' B' ' 134' ' ' THR . 61.7 t -102.89 122.53 55.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -126.7 148.67 49.84 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.04 -118.5 0.92 Allowed Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 119.775 -1.202 . . . . 0.0 112.761 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -85.47 170.65 9.08 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.391 3.394 . . . . 0.0 114.288 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ARG . . . . . 0.523 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 61.2 ttt180 -141.77 151.1 42.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 150' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 88.2 tttt . . . . . 0 C--N 1.294 -1.807 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 2.8 m-20 . . . . . 0 CA--C 1.505 -0.76 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -118.14 131.52 56.4 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.58 160.28 40.93 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.476 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -137.25 133.41 35.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.507 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 46.4 t -116.02 148.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.83 152.71 27.59 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.668 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.663 ' HA ' ' HD2' ' A' ' 120' ' ' ARG . 71.0 mt -120.17 142.14 49.25 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' B' ' 107' ' ' ARG . 13.5 t70 -105.59 120.17 40.98 Favored 'General case' 0 CA--C 1.493 -1.235 0 O-C-N 123.526 0.516 . . . . 0.0 111.898 -166.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 83' ' ' HIS . 20.9 t -140.78 96.85 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 170.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.02 9.7 1.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.456 ' O ' HG12 ' A' ' 81' ' ' VAL . 4.1 m80 -150.19 173.07 14.33 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.445 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 33.9 p90 -103.94 119.02 38.05 Favored 'General case' 0 C--N 1.282 -2.37 0 C-N-CA 117.851 -1.539 . . . . 0.0 113.797 -166.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 104' ' ' HIS . 50.8 m -119.56 65.16 8.74 Favored Pre-proline 0 N--CA 1.422 -1.841 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.826 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 84' ' ' PHE . 35.6 Cg_exo -58.06 -40.37 77.82 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.118 1.879 . . . . 0.0 112.074 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.6 -37.72 16.57 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.266 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 28.3 mt-10 -93.02 28.39 2.14 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -169.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 85' ' ' SER . 3.1 pp -128.66 153.67 47.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.519 174.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.69 129.47 34.83 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.46 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.46 HG21 HD21 ' A' ' 143' ' ' LEU . 19.3 t -107.24 132.82 53.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.11 131.36 47.24 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.399 0.618 . . . . 0.0 111.623 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.57 117.62 55.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -129.12 91.02 3.12 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.18 -113.94 5.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.934 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.27 11.09 39.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 108.971 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.13 137.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.305 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.434 HG13 HG21 ' A' ' 128' ' ' VAL . 36.5 mm -125.08 121.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 30.0 mt-10 -134.36 147.92 50.61 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.884 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.633 ' HB ' HD13 ' A' ' 79' ' ' LEU . 8.5 p -124.75 134.76 66.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -124.14 118.2 26.36 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.2 135.43 6.66 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -133.43 130.53 38.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.518 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 69.7 t60 -139.25 135.95 34.43 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.749 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.8 pt-20 -81.85 120.46 25.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -134.35 -5.29 2.63 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -124.33 124.02 41.48 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -112.99 136.05 53.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.262 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.425 ' CG ' HH12 ' B' ' 120' ' ' ARG . 3.6 m-20 -120.44 -170.1 1.92 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -55.55 -74.66 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -120.34 24.74 10.23 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.46 127.65 4.39 Favored Glycine 0 N--CA 1.402 -3.573 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.37 150.6 29.53 Favored 'General case' 0 C--N 1.261 -3.239 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' B' ' 120' ' ' ARG . 3.0 mt -123.78 137.24 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 17.0 m -120.52 150.35 40.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.821 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 35.9 tt0 -137.34 142.37 41.81 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.46 128.25 53.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 12.7 t-80 -131.61 125.97 33.55 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.42 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.663 ' HD2' ' HA ' ' A' ' 79' ' ' LEU . 64.5 mtt-85 -111.22 146.25 37.26 Favored 'General case' 0 CA--C 1.465 -2.302 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 25.0 ttmm -125.82 128.81 48.24 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -128.6 133.04 48.21 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.192 0.597 . . . . 0.0 110.827 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -122.76 98.46 5.92 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.536 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.0 pt -135.59 105.08 9.97 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.146 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.461 ' O ' ' HE2' ' A' ' 150' ' ' LYS . 10.3 Cg_exo -80.45 -39.91 0.23 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.347 2.031 . . . . 0.0 110.237 174.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . -67.44 -17.56 64.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.964 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.41 ' HB2' HD12 ' A' ' 124' ' ' ILE . 3.9 m-20 -113.13 -17.9 12.28 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.006 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.536 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 55.3 t -131.34 126.12 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.32 126.66 26.15 Favored Pre-proline 0 N--CA 1.428 -1.569 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 165.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.6 -24.41 53.83 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 123.931 3.087 . . . . 0.0 115.172 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.3 -24.31 37.29 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 148' ' ' PRO . 11.1 t -116.94 -17.22 10.45 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.88 -1.128 . . . . 0.0 113.197 -172.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.7 mm -81.3 125.22 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.947 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 11.2 p -122.01 167.19 13.39 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.904 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -126.99 133.76 50.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.917 0.389 . . . . 0.0 111.347 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 p -121.24 145.38 47.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.378 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 65.8 tp -123.88 131.52 53.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.431 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 11.7 m -96.76 162.91 13.22 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.1 t -67.43 -13.45 62.04 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -98.45 0.29 44.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.588 0.709 . . . . 0.0 110.465 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.54 4.51 52.54 Favored Glycine 0 C--N 1.316 -0.58 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.171 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 47.5 t -73.18 113.38 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.3 tm? -107.61 132.23 53.52 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.75 124.75 44.95 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.594 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.507 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 26.8 m -99.19 122.31 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -128.12 142.69 51.12 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.65 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.18 176.79 28.71 Favored Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.584 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 50.4 Cg_exo -62.72 141.13 84.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.902 3.068 . . . . 0.0 113.724 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 56.8 mtp180 -80.0 163.32 24.32 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 125' ' ' PRO . 36.4 ttpt . . . . . 0 C--N 1.298 -1.671 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.422 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 2.4 m-20 . . . . . 0 CA--C 1.506 -0.725 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -120.23 130.73 54.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.32 160.31 40.75 Favored 'General case' 0 N--CA 1.42 -1.942 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.513 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -137.29 132.67 34.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.954 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.505 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 46.5 t -115.95 148.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -111.58 152.58 27.42 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.686 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' LEU . . . . . 0.644 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 70.7 mt -120.22 142.23 49.2 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.54 119.82 40.07 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -166.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 83' ' ' HIS . 20.5 t -139.79 97.94 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 102.465 -3.161 . . . . 0.0 102.465 169.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -75.77 9.75 2.16 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' HIS . . . . . 0.453 ' O ' HG12 ' B' ' 81' ' ' VAL . 3.7 m80 -150.13 173.28 14.08 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' B' ' 86' ' ' PRO . 34.8 p90 -104.0 118.99 37.99 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 117.804 -1.558 . . . . 0.0 113.787 -166.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.52 ' OG ' ' HB2' ' B' ' 104' ' ' HIS . 49.3 m -119.44 65.26 8.42 Favored Pre-proline 0 N--CA 1.421 -1.895 0 CA-C-N 113.492 -1.686 . . . . 0.0 108.879 170.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' B' ' 84' ' ' PHE . 48.8 Cg_exo -57.45 -40.81 78.25 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.159 1.906 . . . . 0.0 112.07 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -88.01 -38.12 15.76 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 85' ' ' SER . 27.8 mt-10 -91.79 27.56 2.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -170.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' B' ' 85' ' ' SER . 3.1 pp -128.31 154.17 46.22 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.56 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.48 130.01 34.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.289 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.452 HG21 HD21 ' B' ' 143' ' ' LEU . 20.3 t -108.25 132.61 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -128.96 131.38 47.48 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.647 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.59 117.37 54.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tt -129.37 90.67 3.05 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.6 -114.23 5.53 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.98 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -100.65 11.2 40.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.842 0.83 . . . . 0.0 108.968 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.3 137.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.222 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ILE . . . . . 0.432 HG13 HG21 ' B' ' 128' ' ' VAL . 36.4 mm -125.08 120.94 59.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 29.7 mt-10 -134.41 147.89 50.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.923 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.625 ' HB ' HD13 ' B' ' 79' ' ' LEU . 9.1 p -124.62 134.72 66.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -123.84 118.39 27.02 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.35 135.37 6.58 Favored Glycine 0 CA--C 1.491 -1.419 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -133.41 130.29 38.5 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' HIS . . . . . 0.52 ' HB2' ' OG ' ' B' ' 85' ' ' SER . 70.0 t60 -139.03 135.94 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.852 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.7 pt-20 -81.68 120.34 24.98 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.57 -5.28 2.55 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 80' ' ' ASP . 66.6 mtp180 -124.61 123.99 41.25 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -112.98 136.16 52.96 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.284 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.414 ' CG ' HH12 ' A' ' 120' ' ' ARG . 4.1 m-20 -120.86 -168.34 1.64 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.44 -74.29 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.521 0.729 . . . . 0.0 112.344 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -118.95 24.2 10.97 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -134.1 128.09 4.79 Favored Glycine 0 N--CA 1.402 -3.61 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -111.56 150.6 29.77 Favored 'General case' 0 C--N 1.263 -3.164 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.495 HG12 ' HG2' ' A' ' 120' ' ' ARG . 3.1 mt -123.9 137.07 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 15.6 m -120.42 150.3 41.01 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.689 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -127.29 148.56 50.23 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 36.0 tt0 -137.47 142.35 41.54 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.42 128.34 53.94 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 12.9 t-80 -131.52 125.82 33.36 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.423 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.644 ' HD2' ' HA ' ' B' ' 79' ' ' LEU . 62.4 mtt-85 -111.04 146.29 36.99 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.451 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 24.8 ttmm -126.15 128.89 48.0 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.93 132.33 47.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 123.203 0.601 . . . . 0.0 110.833 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -121.87 98.49 5.97 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 168.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.9 pt -135.39 104.96 10.14 Favored Pre-proline 0 C--N 1.293 -1.886 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.152 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.469 ' O ' ' HE2' ' B' ' 150' ' ' LYS . 7.9 Cg_exo -80.09 -39.74 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.278 1.985 . . . . 0.0 110.321 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' B' ' 149' ' ' ARG . . . -67.26 -17.98 65.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.861 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ASP . . . . . 0.409 ' HB2' HD12 ' B' ' 124' ' ' ILE . 4.0 m-20 -113.17 -17.99 12.23 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.109 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 55.4 t -131.35 125.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -169.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -122.35 126.43 26.22 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 165.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.69 -24.06 52.7 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.937 3.091 . . . . 0.0 115.152 -171.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 82.3 mt -81.25 -23.94 37.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' THR . . . . . 0.442 ' OG1' ' HD2' ' B' ' 148' ' ' PRO . 8.3 t -117.43 -17.81 9.98 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.779 -1.168 . . . . 0.0 113.102 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.6 mm -81.07 125.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.06 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 14.6 p -122.09 167.6 12.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.649 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -126.95 134.05 50.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 7.0 p -121.16 146.09 47.14 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.858 0.863 . . . . 0.0 109.139 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 66.3 tp -124.98 130.5 52.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.673 0.273 . . . . 0.0 111.387 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 7.4 m -95.89 163.12 13.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -67.66 -14.32 62.84 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -96.63 -0.69 48.17 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.541 0.686 . . . . 0.0 110.628 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.63 5.16 51.79 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.713 -1.232 . . . . 0.0 112.008 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 46.9 t -73.31 113.66 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.3 tm? -107.8 132.0 53.87 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.7 124.79 45.09 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.576 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' VAL . . . . . 0.505 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 26.9 m -99.15 122.39 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.858 -171.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.03 177.47 29.26 Favored Glycine 0 N--CA 1.415 -2.749 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.638 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 52.2 Cg_exo -62.98 140.74 80.81 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.892 3.061 . . . . 0.0 113.793 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 56.4 mtp180 -79.81 163.25 24.57 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.039 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 150' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' B' ' 125' ' ' PRO . 35.9 ttpt . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.618 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' A' ' 149' ' ' ARG . 2.8 m-20 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -130.65 126.59 36.97 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -105.92 132.93 51.43 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.962 0.887 . . . . 0.0 112.078 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 146' ' ' ASN . 15.7 m -114.38 131.07 56.69 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.61 131.44 66.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -110.4 130.53 55.53 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.657 HD22 ' CZ ' ' A' ' 122' ' ' TYR . 11.9 mt -120.24 128.3 53.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -103.01 128.26 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.002 0.906 . . . . 0.0 113.01 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.516 HG23 HH12 ' A' ' 120' ' ' ARG . 38.9 t -122.28 142.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -64.31 -56.7 12.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.597 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 18.2 t60 -153.96 125.84 7.74 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.261 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.403 ' CE2' ' HA2' ' A' ' 141' ' ' GLY . 0.3 OUTLIER -130.48 172.17 12.19 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.257 0.48 . . . . 0.0 111.167 177.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 20.9 m -93.16 121.92 64.45 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.93 -28.64 78.79 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.957 2.438 . . . . 0.0 113.483 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.98 -38.64 19.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.632 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.564 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 35.8 mt-10 -85.42 40.08 0.82 Allowed 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.585 0.707 . . . . 0.0 109.519 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 90' ' ' LYS . 1.1 tm? -120.51 145.81 46.92 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -174.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.447 ' N ' HD13 ' A' ' 89' ' ' LEU . 25.9 tptp -144.0 125.88 15.27 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 138.68 40.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.492 ' HG3' ' HB2' ' A' ' 99' ' ' GLU . 13.1 ptmm? -144.34 135.51 25.36 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.601 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.41 116.12 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 97' ' ' VAL . 62.3 tp -120.04 90.86 3.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.99 -111.96 4.56 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.849 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -90.01 4.2 50.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.941 0.896 . . . . 0.0 112.106 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 94' ' ' LEU . 35.4 m -117.48 137.75 50.38 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.349 -0.94 . . . . 0.0 113.195 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 37.2 mm -112.85 119.89 61.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 14.8 mp0 -122.33 136.95 54.99 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.171 0.51 . . . . 0.0 109.867 174.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.6 126.95 61.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.88 42.69 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.01 140.74 12.58 Favored Glycine 0 CA--C 1.477 -2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.564 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 13.9 ptmm? -143.19 144.69 32.28 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 117.214 0.507 . . . . 0.0 109.733 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -136.74 128.82 29.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.56 120.95 25.19 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 21.9 mt-10 -83.95 -74.18 0.39 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.757 -167.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 18.2 ptt-85 -148.57 151.34 34.91 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.103 -173.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -111.48 119.73 39.77 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 -44.29 77.96 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 168.83 -75.34 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -94.23 -12.58 27.92 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.559 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -101.48 137.19 13.15 Favored Glycine 0 N--CA 1.411 -3.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.243 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.2 137.69 52.19 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.33 134.02 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.4 p -134.31 155.23 50.59 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -128.19 148.06 50.6 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -135.05 153.52 52.02 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.039 0.447 . . . . 0.0 109.997 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -122.62 125.99 46.76 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.51 122.11 43.75 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.516 HH12 HG23 ' A' ' 81' ' ' VAL . 41.3 ttp180 -133.11 138.0 46.52 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.878 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.492 ' HG2' ' HG3' ' A' ' 99' ' ' GLU . 33.1 mttm -139.87 130.46 25.69 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.099 0.875 . . . . 0.0 112.157 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CZ ' HD22 ' A' ' 79' ' ' LEU . 44.0 m-85 -126.15 136.95 53.48 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -117.32 98.63 6.53 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.598 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.8 pt -136.41 106.16 9.29 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.267 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -88.79 -45.88 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.193 1.929 . . . . 0.0 112.873 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.92 -13.03 62.19 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.488 0.661 . . . . 0.0 112.596 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -112.1 -17.65 12.78 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 2.9 t -132.6 117.67 31.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.57 123.27 26.43 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.15 -1.57 3.05 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.633 2.888 . . . . 0.0 116.339 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.4 tp -59.78 -44.43 93.92 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.475 ' HB ' ' HD3' ' A' ' 148' ' ' PRO . 39.6 m -110.84 -12.8 14.23 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.642 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 55.4 mt -67.99 126.08 27.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -165.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 p -122.11 163.61 19.17 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.385 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 144' ' ' THR . 26.7 t -138.0 135.68 36.19 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.217 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.8 p -127.75 156.27 42.71 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.41 144.07 44.3 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.195 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.488 ' HB3' ' HB ' ' A' ' 142' ' ' VAL . 17.8 t -100.49 162.74 12.74 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.7 m -61.55 -28.01 69.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.761 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 37.5 t70 -90.18 -12.3 38.55 Favored 'General case' 0 C--O 1.205 -1.265 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.343 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.403 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . 120.75 8.91 7.91 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 117.978 -2.058 . . . . 0.0 113.237 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 138' ' ' SER . 51.4 t -78.89 118.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.8 tm? -115.23 133.75 55.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 135' ' ' SER . 27.5 m -121.56 130.13 53.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.841 -0.537 . . . . 0.0 111.078 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.3 m -121.03 125.53 74.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.642 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 7.9 p30 -137.27 137.52 39.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.048 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . -158.78 -143.27 3.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.29 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 132' ' ' THR . 93.7 Cg_endo -102.73 169.64 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.022 3.148 . . . . 0.0 112.589 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.439 ' CD ' ' HB2' ' A' ' 73' ' ' ASP . 61.4 ttt180 -96.36 138.03 34.56 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.435 -1.175 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.578 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' B' ' 149' ' ' ARG . 2.5 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -131.01 126.65 36.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -105.91 132.94 51.4 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.132 0.968 . . . . 0.0 111.976 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -113.76 131.19 56.3 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.79 131.35 67.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -110.47 130.51 55.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' LEU . . . . . 0.648 HD22 ' CZ ' ' B' ' 122' ' ' TYR . 11.4 mt -120.34 128.47 53.28 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.52 127.92 49.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.955 0.883 . . . . 0.0 113.108 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.524 HG23 HH12 ' B' ' 120' ' ' ARG . 39.0 t -122.32 141.9 40.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.24 -56.51 14.13 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.718 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' HIS . . . . . 0.777 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 18.2 t60 -153.97 125.74 7.69 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.255 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.42 172.06 12.29 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.267 0.485 . . . . 0.0 111.108 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 22.9 m -93.17 122.25 63.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.19 -28.3 78.68 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.938 2.425 . . . . 0.0 113.553 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -85.51 -38.52 18.46 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.787 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' B' ' 103' ' ' LYS . 35.5 mt-10 -85.22 40.17 0.81 Allowed 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.479 0.656 . . . . 0.0 109.4 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.45 HD13 ' N ' ' B' ' 90' ' ' LYS . 1.1 tm? -120.59 145.83 46.97 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.45 ' N ' HD13 ' B' ' 89' ' ' LEU . 26.1 tptp -144.18 125.74 14.97 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.07 139.09 38.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' B' ' 99' ' ' GLU . 13.5 ptmm? -144.45 135.82 25.5 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.14 116.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.447 ' O ' HG22 ' B' ' 97' ' ' VAL . 62.4 tp -119.92 90.56 3.35 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.67 -111.96 4.58 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.625 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -90.08 4.17 51.1 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 123.933 0.893 . . . . 0.0 112.192 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 94' ' ' LEU . 29.2 m -117.25 137.74 50.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.315 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 37.6 mm -112.81 120.03 61.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' B' ' 92' ' ' LYS . 15.2 mp0 -122.46 137.04 55.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 121.199 0.523 . . . . 0.0 109.842 174.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.41 HG21 HD12 ' B' ' 79' ' ' LEU . 92.4 t -130.69 127.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.64 41.86 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.78 140.88 12.76 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.551 ' HG3' ' HB3' ' B' ' 88' ' ' GLU . 13.7 ptmm? -143.33 144.75 32.22 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 117.25 0.525 . . . . 0.0 109.78 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -136.75 128.65 29.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -80.19 121.08 25.15 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.17 -73.8 0.41 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.825 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -148.58 151.3 34.82 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.326 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -111.75 119.14 37.63 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.01 -44.51 80.15 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 169.04 -74.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -94.79 -12.79 26.42 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.589 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -101.45 137.2 13.16 Favored Glycine 0 N--CA 1.411 -3.02 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.245 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.18 137.54 52.27 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 134.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 36.7 p -134.31 155.13 50.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -128.21 148.15 50.61 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -135.19 153.43 51.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.988 0.423 . . . . 0.0 109.894 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.66 125.91 46.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.5 122.19 44.01 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.524 HH12 HG23 ' B' ' 81' ' ' VAL . 41.4 ttp180 -133.27 137.82 46.2 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.757 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.48 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 32.9 mttm -139.57 130.37 26.06 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 124.293 0.995 . . . . 0.0 112.11 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' TYR . . . . . 0.648 ' CZ ' HD22 ' B' ' 79' ' ' LEU . 46.4 m-85 -126.32 136.44 52.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -117.1 98.79 6.65 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.591 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -136.43 106.43 9.27 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.331 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -88.99 -45.39 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.207 1.938 . . . . 0.0 112.869 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.8 -13.97 62.74 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.468 0.651 . . . . 0.0 112.61 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -112.36 -17.22 12.77 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.311 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 2.9 t -132.56 117.47 31.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -123.41 123.48 26.5 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.24 -1.53 3.07 Favored 'Trans proline' 0 CA--C 1.551 1.361 0 C-N-CA 123.587 2.858 . . . . 0.0 116.223 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.44 -44.44 92.94 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' B' ' 148' ' ' PRO . 48.3 m -111.23 -11.65 14.19 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 55.0 mt -68.35 126.17 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -122.63 163.04 20.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.01 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.2 t -137.51 136.58 37.81 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 121.249 0.547 . . . . 0.0 111.243 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 10.1 p -128.5 156.64 42.94 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.74 143.67 43.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.125 0.488 . . . . 0.0 111.265 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' B' ' 142' ' ' VAL . 14.4 t -100.72 162.64 12.78 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.5 m -61.61 -27.39 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -168.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' ASP . . . . . 0.777 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 36.8 t70 -90.59 -12.61 36.47 Favored 'General case' 0 C--O 1.203 -1.349 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.329 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.17 9.06 7.52 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 118.095 -2.002 . . . . 0.0 113.222 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 138' ' ' SER . 56.8 t -78.84 118.49 26.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.9 tm? -115.15 133.8 55.72 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' B' ' 135' ' ' SER . 31.1 m -121.57 129.97 53.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.834 -0.541 . . . . 0.0 110.974 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 19.1 m -120.92 125.16 73.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' ASN . . . . . 0.649 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 7.8 p30 -136.95 137.6 39.69 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.225 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.577 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . -158.79 -143.51 3.68 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.121 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' B' ' 132' ' ' THR . 96.9 Cg_endo -102.7 169.69 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.938 3.092 . . . . 0.0 112.586 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ARG . . . . . 0.428 ' CD ' ' HB2' ' B' ' 73' ' ' ASP . 62.9 ttt180 -96.28 138.25 34.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.715 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.928 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 . . . . . 0 N--CA 1.421 -1.913 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -94.92 119.67 33.85 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -126.86 154.42 44.4 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.932 -172.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.9 p -136.86 144.84 43.79 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.553 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 42.4 t -115.3 132.49 64.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -110.79 138.4 47.24 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' A' ' 122' ' ' TYR . 5.8 mp -118.26 126.12 51.51 Favored 'General case' 0 N--CA 1.386 -3.655 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -116.32 139.26 50.58 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.22 1.008 . . . . 0.0 110.551 -175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' HB ' ' NH1' ' A' ' 120' ' ' ARG . 8.4 p -155.06 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.464 ' H ' HG22 ' A' ' 81' ' ' VAL . 72.9 mmtt -85.68 -163.39 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 119.139 0.881 . . . . 0.0 110.806 176.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.588 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 74.7 m80 -78.54 124.44 28.16 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.612 0.72 . . . . 0.0 111.693 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -149.89 150.43 31.9 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 p -80.89 119.1 75.13 Favored Pre-proline 0 C--N 1.287 -2.123 0 C-N-CA 123.351 0.66 . . . . 0.0 112.432 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.06 -28.54 14.05 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 124.789 3.66 . . . . 0.0 115.122 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.55 -27.59 51.59 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 122.095 -0.378 . . . . 0.0 111.629 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.34 8.27 28.35 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.52 150.43 40.85 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.065 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -130.25 131.81 45.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 100' ' ' VAL . 32.6 m -103.32 138.11 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 -176.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 78.3 mttt -114.25 130.82 56.64 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.7 111.07 21.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.4 95.66 3.12 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.15 -111.53 3.54 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.598 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -99.45 4.14 45.99 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.105 0.962 . . . . 0.0 111.221 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -113.5 137.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.983 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 145' ' ' VAL . 26.3 mt -130.31 120.48 48.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 43.7 mt-10 -136.74 149.69 47.98 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.675 0.274 . . . . 0.0 110.368 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 91' ' ' VAL . 61.8 t -126.32 114.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -115.22 131.01 57.06 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.09 147.97 19.5 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -143.28 131.8 22.34 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 122.393 0.277 . . . . 0.0 110.784 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -136.66 128.88 29.81 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.21 -0.307 . . . . 0.0 110.274 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -80.82 121.36 25.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -79.99 -52.14 8.2 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.779 0.323 . . . . 0.0 110.886 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 114' ' ' ILE . 11.2 ptt180 -148.56 147.11 28.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.96 136.94 50.64 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.804 0.812 . . . . 0.0 111.63 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -90.77 -166.29 1.55 Allowed 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.09 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -47.63 -65.65 0.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.254 1.422 . . . . 0.0 111.41 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -141.78 39.22 1.66 Allowed 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.46 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -137.3 144.44 15.94 Favored Glycine 2 N--CA 1.382 -4.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 108.198 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.83 149.89 45.19 Favored 'General case' 0 C--N 1.245 -3.966 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 107' ' ' ARG . 5.5 pt -122.87 134.74 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.4 m -135.03 162.33 32.76 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.374 0.607 . . . . 0.0 110.688 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.72 147.56 49.95 Favored 'General case' 0 N--CA 1.39 -3.447 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 56.2 mt-10 -136.92 151.64 49.28 Favored 'General case' 0 C--N 1.261 -3.241 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -126.07 126.65 44.56 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -129.75 121.91 27.81 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' NH1' ' HB ' ' A' ' 81' ' ' VAL . 37.7 ttp180 -125.51 136.77 53.69 Favored 'General case' 0 C--N 1.263 -3.182 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.461 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 45.9 mtmt -138.49 129.82 27.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 123.399 0.437 . . . . 0.0 110.827 -169.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.508 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 73.2 m-85 -131.7 143.45 50.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.165 0.586 . . . . 0.0 111.171 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -128.2 98.59 5.14 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 167.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.5 pt -137.06 105.54 8.75 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.998 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.69 -40.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.383 2.055 . . . . 0.0 113.26 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 149' ' ' ARG . . . -69.41 -33.87 73.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.954 0.407 . . . . 0.0 111.454 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -88.77 -17.1 30.53 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.655 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 78.8 t -127.36 120.49 55.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.354 0.597 . . . . 0.0 111.894 -175.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -115.7 119.62 37.3 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.512 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 97.7 Cg_endo -74.28 19.46 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.024 2.483 . . . . 0.0 116.305 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.96 -47.87 12.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.219 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 148' ' ' PRO 0.362 8.9 t -121.82 10.88 10.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.554 HG23 ' HD2' ' A' ' 148' ' ' PRO . 1.2 pp -67.7 135.21 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.1 p -125.83 166.56 16.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.421 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 144' ' ' THR . 17.4 m -127.54 133.82 49.79 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.03 0.443 . . . . 0.0 110.175 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.3 m -116.67 133.48 55.96 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.26 128.2 53.8 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.6 m -97.56 162.02 13.49 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.1 m -68.33 -15.25 63.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.468 1.107 . . . . 0.0 113.491 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 10.2 t70 -90.6 -12.72 36.12 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.06 -2.04 35.4 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.65 137.13 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.401 ' CD1' HG13 ' A' ' 145' ' ' VAL . 3.3 tm? -127.0 134.43 50.35 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -173.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 135' ' ' SER . 58.1 m -115.54 120.5 39.68 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.0 m -101.57 121.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 13.0 p30 -133.89 137.43 44.95 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.833 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.43 -133.65 2.87 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 133' ' ' ILE . 60.8 Cg_endo -98.59 160.2 0.72 Allowed 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.976 2.45 . . . . 0.0 113.474 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 126' ' ' ALA . 57.9 ttt-85 -110.0 163.41 13.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 4.0 ttmp? . . . . . 0 C--N 1.311 -1.09 0 CA-C-O 118.801 -0.619 . . . . 0.0 109.846 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -94.71 119.58 33.56 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -126.75 154.68 43.88 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.972 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 20.1 p -137.04 144.82 43.41 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.554 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 42.7 t -115.29 132.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.28 138.61 46.43 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' B' ' 122' ' ' TYR . 5.8 mp -118.1 126.13 51.65 Favored 'General case' 0 N--CA 1.383 -3.798 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -116.25 139.24 50.58 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 124.239 1.016 . . . . 0.0 110.572 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.52 ' HB ' ' NH1' ' B' ' 120' ' ' ARG . 8.4 p -154.89 -174.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.474 ' H ' HG22 ' B' ' 81' ' ' VAL . 73.1 mmtt -85.74 -163.49 0.87 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 119.159 0.89 . . . . 0.0 110.991 175.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 74.9 m80 -78.4 124.43 28.11 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 121.631 0.729 . . . . 0.0 111.664 -172.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -150.25 150.1 31.07 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 1.6 p -80.7 119.0 74.94 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 123.27 0.628 . . . . 0.0 112.522 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.1 -28.88 14.9 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 124.685 3.59 . . . . 0.0 115.148 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.3 -26.94 52.78 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 122.138 -0.351 . . . . 0.0 111.729 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.86 8.25 30.14 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.957 -0.464 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.51 150.47 40.78 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.98 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.468 HG12 HG22 ' B' ' 100' ' ' VAL . 31.8 m -104.4 138.56 28.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.525 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' B' ' 98' ' ' ILE . 78.0 mttt -114.6 130.77 56.82 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 50.2 t -129.88 111.0 20.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -137.45 95.97 3.17 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.92 -111.54 3.56 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.468 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.84 4.24 45.08 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.846 0.858 . . . . 0.0 111.263 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.25 136.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.969 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ILE . . . . . 0.455 HD13 HG21 ' B' ' 145' ' ' VAL . 25.8 mt -130.18 120.54 49.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 43.9 mt-10 -136.84 149.7 47.85 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.795 0.331 . . . . 0.0 110.379 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG12 ' B' ' 91' ' ' VAL . 61.4 t -126.27 114.09 36.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -114.87 130.72 56.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.27 148.14 19.77 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' B' ' 103' ' ' LYS . 11.7 ptmt -143.41 132.4 22.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 122.412 0.285 . . . . 0.0 110.822 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -136.97 129.48 30.1 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -81.12 121.21 25.81 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.56 -52.09 8.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.914 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.45 ' HG2' HD11 ' B' ' 114' ' ' ILE . 11.6 ptt180 -149.05 146.71 27.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.57 137.22 49.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.793 0.806 . . . . 0.0 111.739 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -91.19 -166.22 1.53 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.127 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -46.59 -66.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.394 1.478 . . . . 0.0 111.302 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -141.69 39.83 1.69 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.508 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -138.47 144.24 15.31 Favored Glycine 2 N--CA 1.384 -4.779 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.101 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.81 150.24 44.74 Favored 'General case' 1 C--N 1.243 -4.028 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.45 HD11 ' HG2' ' B' ' 107' ' ' ARG . 5.5 pt -123.11 134.85 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m -135.01 162.16 33.25 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-O 121.368 0.604 . . . . 0.0 110.619 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.87 147.39 50.06 Favored 'General case' 0 N--CA 1.392 -3.355 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 55.9 mt-10 -136.88 151.24 48.86 Favored 'General case' 0 C--N 1.26 -3.317 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -125.61 127.05 45.72 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -130.14 121.79 26.97 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.52 ' NH1' ' HB ' ' B' ' 81' ' ' VAL . 37.7 ttp180 -125.43 136.73 53.71 Favored 'General case' 0 C--N 1.26 -3.286 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.455 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 45.6 mtmt -138.41 129.84 27.55 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.344 0.403 . . . . 0.0 110.825 -169.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' TYR . . . . . 0.46 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 74.6 m-85 -131.57 143.8 50.62 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.681 0.613 . . . . 0.0 111.147 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -128.42 98.59 5.1 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 167.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.6 pt -137.18 105.42 8.66 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.01 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -90.7 -40.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.377 2.052 . . . . 0.0 113.143 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.06 74.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.867 0.365 . . . . 0.0 111.451 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.63 -17.04 30.92 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.61 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 80.8 t -127.16 120.24 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.531 0.681 . . . . 0.0 111.901 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.38 119.24 38.55 Favored Pre-proline 0 C--N 1.287 -2.131 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.506 ' HA ' ' CG1' ' B' ' 133' ' ' ILE . 82.8 Cg_endo -74.21 19.72 0.43 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.005 2.47 . . . . 0.0 116.277 -171.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.99 -47.83 12.2 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.989 -1.084 . . . . 0.0 112.267 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' THR . . . . . 0.537 HG22 ' HG3' ' B' ' 148' ' ' PRO 0.368 8.9 t -121.99 10.97 10.21 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ILE . . . . . 0.548 HG23 ' HD2' ' B' ' 148' ' ' PRO . 1.2 pp -67.76 134.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 2.7 p -125.36 166.87 15.78 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.474 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' B' ' 144' ' ' THR . 17.9 m -127.48 133.61 49.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 15.1 m -116.65 133.09 56.43 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 5.8 mp -105.92 128.25 53.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 17.0 m -97.02 161.76 13.68 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.9 m -68.17 -14.04 62.68 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.426 1.09 . . . . 0.0 113.468 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 9.3 t70 -91.46 -12.74 33.79 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.71 -2.09 36.32 Favored Glycine 0 C--O 1.261 1.825 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 89.3 t -73.74 137.26 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.404 ' CD1' HG13 ' B' ' 145' ' ' VAL . 3.3 tm? -127.21 134.52 50.1 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 135' ' ' SER . 57.9 m -115.63 120.68 40.21 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 145' ' ' VAL . . . . . 0.554 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 5.8 m -101.8 121.89 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -133.65 137.17 45.23 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.722 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.01 -133.46 2.78 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' B' ' 133' ' ' ILE . 92.8 Cg_endo -98.04 160.33 0.84 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.28 2.653 . . . . 0.0 113.6 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -110.64 163.19 13.99 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' B' ' 150' ' ' LYS . 4.1 ttmp? . . . . . 0 C--N 1.308 -1.229 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.291 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.474 0.654 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -105.52 131.32 53.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 22.7 t80 -110.07 134.8 51.78 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.415 -171.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.9 m -113.13 129.71 56.42 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.0 t -114.97 130.76 68.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.73 155.91 24.75 Favored 'General case' 0 C--N 1.264 -3.152 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 143' ' ' LEU . 31.5 tp -118.2 127.56 53.87 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.89 136.17 52.84 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -177.07 168.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -87.37 -175.14 5.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.623 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -77.73 125.61 29.61 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.993 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.05 160.65 38.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.613 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 14.3 m -66.56 107.9 1.96 Allowed Pre-proline 0 CA--C 1.554 1.102 0 O-C-N 124.523 1.14 . . . . 0.0 112.89 -170.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 54.4 Cg_exo -57.26 -28.3 79.01 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.314 3.343 . . . . 0.0 113.968 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -86.75 -9.44 55.87 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.777 0.323 . . . . 0.0 111.063 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 24.8 mm-40 -113.47 19.75 16.64 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.351 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 3.9 pp -120.82 153.8 36.61 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.318 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.73 125.86 45.5 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.723 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -109.35 122.18 63.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -125.73 131.37 52.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.529 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.46 HG23 HG12 ' A' ' 98' ' ' ILE . 3.4 p -124.01 113.03 35.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.37 91.23 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA2' ' HG3' ' A' ' 130' ' ' PRO . . . 66.65 -111.92 4.5 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.11 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.51 9.26 39.21 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.248 1.019 . . . . 0.0 111.612 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.12 136.03 61.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.536 -0.727 . . . . 0.0 109.535 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 93' ' ' VAL . 44.6 mt -130.37 121.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 47.4 mt-10 -132.24 148.35 52.45 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.635 -178.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.51 127.43 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.203 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -136.37 120.01 17.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.26 162.01 27.24 Favored Glycine 0 CA--C 1.482 -2.015 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.93 143.83 51.02 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -120.77 135.19 55.22 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.48 129.11 34.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 116' ' ' ARG . 42.5 mt-10 -105.0 -76.08 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.414 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 48.7 mtm-85 -141.15 141.82 34.1 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -112.0 136.52 51.24 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.202 0.525 . . . . 0.0 110.922 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 112' ' ' GLY . 33.4 m-20 -97.12 -155.46 0.49 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 173.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.46 -57.18 3.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' B' ' 123' ' ' ARG . 57.3 m80 -100.52 -11.0 20.49 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.482 -176.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -112.3 139.71 15.79 Favored Glycine 1 N--CA 1.395 -4.085 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.428 -176.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -130.14 140.0 50.83 Favored 'General case' 0 C--N 1.256 -3.487 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.411 HG12 ' HG3' ' B' ' 120' ' ' ARG . 3.1 mt -123.73 132.94 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -136.43 158.28 44.81 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.491 ' HB2' ' OE2' ' A' ' 106' ' ' GLU . 22.8 ttm180 -127.04 148.44 50.12 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.3 mt-10 -125.0 150.78 46.35 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.08 124.75 37.78 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -131.79 132.34 43.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.876 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.423 HH21 ' CG ' ' B' ' 109' ' ' ASP . 44.4 ttt180 -130.35 137.88 50.13 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 27.7 mtpp -122.86 127.14 48.62 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.303 1.2 p90 -134.36 115.61 14.25 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' B' ' 111' ' ' HIS . 68.8 ttt180 -102.5 99.69 9.74 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.356 0.598 . . . . 0.0 109.764 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.0 pt -124.08 105.54 31.68 Favored Pre-proline 0 C--N 1.288 -2.107 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.458 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -90.13 -52.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.144 2.562 . . . . 0.0 113.163 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.9 64.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.351 0.596 . . . . 0.0 111.364 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.09 -18.14 17.88 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.321 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 57.4 t -132.15 113.48 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 17.2 t70 -100.16 128.39 30.79 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.428 ' HG3' ' HA2' ' A' ' 95' ' ' GLY . 72.3 Cg_endo -71.04 16.71 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.664 2.243 . . . . 0.0 116.442 -171.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 tp -82.02 -46.97 13.22 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.257 14.3 t -120.36 9.99 11.12 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -68.44 130.3 33.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.8 t -137.75 163.0 32.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.454 ' HB2' HD11 ' A' ' 143' ' ' LEU . 16.8 p -128.0 133.0 49.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.8 t -125.89 129.56 49.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.06 135.06 48.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.453 0.644 . . . . 0.0 111.855 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.1 m -100.82 163.45 12.31 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.025 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.4 m -60.29 -21.85 62.44 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.21 7.37 41.05 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 121.383 0.611 . . . . 0.0 111.385 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.15 -6.12 61.57 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.534 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -73.95 112.76 11.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 144' ' ' THR . 1.9 tp -122.34 134.67 54.64 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.266 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.566 ' N ' HD12 ' A' ' 143' ' ' LEU . 17.8 m -117.75 117.92 30.65 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 134' ' ' THR . 31.8 t -101.65 121.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 8.9 p30 -135.38 144.07 46.4 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.396 -0.815 . . . . 0.0 111.164 -174.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.01 -136.45 2.17 Favored Glycine 0 N--CA 1.425 -2.087 0 O-C-N 123.806 0.691 . . . . 0.0 111.552 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.402 ' HG2' ' HB3' ' A' ' 129' ' ' ASP . 94.4 Cg_endo -96.73 142.77 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.149 2.566 . . . . 0.0 113.632 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.502 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 67.8 ttt180 -92.84 133.41 36.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 C--N 1.291 -1.967 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.314 -172.816 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 121.542 0.686 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -105.74 130.02 53.83 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 21.4 t80 -108.91 132.29 54.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.205 0.526 . . . . 0.0 110.915 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 26.9 m -110.45 129.58 55.74 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.008 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.89 130.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -113.41 155.83 24.56 Favored 'General case' 0 C--N 1.261 -3.268 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' B' ' 143' ' ' LEU . 31.3 tp -118.11 127.64 53.97 Favored 'General case' 0 N--CA 1.387 -3.598 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -113.2 136.03 53.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -177.38 168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -86.49 -175.34 5.42 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.718 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -77.63 125.66 29.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.124 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.23 160.97 37.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.436 -1.257 . . . . 0.0 107.624 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 15.8 m -66.36 107.38 1.56 Allowed Pre-proline 0 C--N 1.311 -1.095 0 O-C-N 124.536 1.148 . . . . 0.0 112.972 -170.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.443 ' HA ' ' CD2' ' B' ' 89' ' ' LEU . 50.8 Cg_exo -57.15 -28.37 78.81 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.071 3.181 . . . . 0.0 114.024 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.96 -9.64 55.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' B' ' 85' ' ' SER . 22.1 mm-40 -112.7 19.45 17.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.402 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.443 ' CD2' ' HA ' ' B' ' 86' ' ' PRO . 3.9 pp -120.87 153.34 37.3 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.323 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -123.09 126.02 46.28 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.935 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.76 122.32 64.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.99 131.62 52.2 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.475 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.471 HG23 HG12 ' B' ' 98' ' ' ILE . 3.4 p -124.15 112.95 34.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 84.5 mt -127.16 91.17 3.27 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.443 ' HA2' ' HG3' ' B' ' 130' ' ' PRO . . . 67.0 -112.1 4.62 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.874 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.52 9.09 39.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 124.371 1.068 . . . . 0.0 111.701 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.96 136.12 60.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.639 -0.663 . . . . 0.0 109.359 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ILE . . . . . 0.471 HG12 HG23 ' B' ' 93' ' ' VAL . 46.2 mt -130.72 121.38 50.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 46.6 mt-10 -132.26 148.44 52.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.095 0.474 . . . . 0.0 111.592 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.43 127.53 62.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.144 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -136.59 120.05 17.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 161.86 27.27 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.477 ' HB3' ' HG2' ' B' ' 117' ' ' GLU . 0.0 OUTLIER -130.45 143.95 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -120.71 135.37 55.15 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.81 128.01 33.17 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.487 ' OE2' ' HB2' ' B' ' 116' ' ' ARG . 42.9 mt-10 -103.7 -77.4 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 -139.86 142.56 36.57 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -112.19 136.14 51.97 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.634 0.73 . . . . 0.0 111.265 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' B' ' 112' ' ' GLY . 37.1 m-20 -96.83 -155.79 0.5 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 172.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.8 -57.31 3.03 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 122.037 0.922 . . . . 0.0 108.617 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' A' ' 123' ' ' ARG . 54.0 m80 -101.66 -11.13 19.42 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.178 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -111.12 139.57 15.62 Favored Glycine 0 N--CA 1.396 -3.981 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.591 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.22 139.68 50.79 Favored 'General case' 0 C--N 1.257 -3.437 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.16 133.18 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 46.8 m -136.44 158.18 45.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.487 ' HB2' ' OE2' ' B' ' 106' ' ' GLU . 22.4 ttm180 -127.19 148.25 50.19 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 36.9 mt-10 -125.02 150.85 46.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -128.16 124.89 37.97 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -131.87 132.09 43.34 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.411 ' HG3' HG12 ' A' ' 114' ' ' ILE . 43.9 ttt180 -130.19 137.91 50.32 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.515 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.6 mtpp -122.65 127.11 48.91 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' TYR . . . . . . . . . . . . 0.3 1.3 p90 -134.39 115.27 13.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 111' ' ' HIS . 71.0 ttt180 -101.95 99.73 9.94 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.394 0.616 . . . . 0.0 109.948 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.0 pt -123.99 105.52 31.92 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.538 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -90.01 -53.14 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 123.013 2.475 . . . . 0.0 113.136 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 -18.9 65.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.58 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -99.57 -18.1 17.53 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.265 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 60.0 t -132.21 113.8 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ASP . . . . . 0.408 ' HB3' ' HG2' ' B' ' 148' ' ' PRO . 17.5 t70 -100.81 128.31 30.12 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.443 ' HG3' ' HA2' ' B' ' 95' ' ' GLY . 72.1 Cg_endo -71.09 16.39 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.837 2.358 . . . . 0.0 116.415 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.76 -46.66 13.91 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' THR . . . . . 0.416 HG22 ' HG3' ' B' ' 148' ' ' PRO . 13.9 t -120.97 10.23 10.77 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.0 OUTLIER -68.36 130.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 134' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 11.9 t -137.84 162.99 32.54 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.449 ' HB2' HD11 ' B' ' 143' ' ' LEU . 15.0 p -127.79 133.14 49.44 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.257 0.551 . . . . 0.0 112.148 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -126.45 129.36 48.54 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.41 134.73 48.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.098 0.475 . . . . 0.0 111.68 -174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 20.1 m -100.72 163.36 12.36 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.138 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -60.47 -21.18 62.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -91.95 8.01 39.49 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.515 0.674 . . . . 0.0 111.171 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.87 -5.85 61.99 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.496 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 67.1 t -74.16 112.98 11.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.264 0.554 . . . . 0.0 109.506 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.57 HD12 ' N ' ' B' ' 144' ' ' THR . 1.8 tp -122.67 134.43 54.48 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.123 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.57 ' N ' HD12 ' B' ' 143' ' ' LEU . 16.6 m -117.22 118.24 31.77 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 134' ' ' THR . 35.5 t -102.24 121.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.4 p30 -134.97 144.17 47.26 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.305 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.88 -136.61 2.2 Favored Glycine 0 N--CA 1.423 -2.202 0 O-C-N 123.654 0.596 . . . . 0.0 111.738 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.416 ' HG3' HG22 ' B' ' 132' ' ' THR . 93.1 Cg_endo -96.72 142.63 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.265 2.644 . . . . 0.0 113.505 -176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 71.0 ttt180 -92.9 133.86 35.67 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 84.3 tttt . . . . . 0 C--N 1.29 -1.998 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.243 -172.422 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 . . . . . 0 N--CA 1.438 -1.041 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.6 tp 56.72 51.19 11.32 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 24.0 mm-40 42.37 110.04 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 111.848 -2.433 . . . . 0.0 116.772 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -86.95 106.32 17.72 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 31.3 t70 -177.61 138.11 0.21 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -94.37 117.57 30.32 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' ASN . 51.0 t80 -110.7 142.65 42.33 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.6 m -137.58 131.57 31.85 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.382 0.61 . . . . 0.0 111.641 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.644 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 47.6 t -118.9 141.68 37.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -111.78 143.82 42.09 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.974 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 3.1 mm? -119.99 127.6 52.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' B' ' 107' ' ' ARG . 0.6 OUTLIER -117.2 127.26 53.93 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.597 -175.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.85 116.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 103.344 -2.836 . . . . 0.0 103.344 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.4 -54.34 41.97 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.316 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -150.43 121.97 7.97 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.41 171.65 18.69 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 126.943 2.097 . . . . 0.0 106.983 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 20.3 m -112.87 141.13 24.95 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 85' ' ' SER . 80.6 Cg_exo -48.89 -28.31 13.0 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 125.131 3.887 . . . . 0.0 116.361 -172.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -73.98 -19.78 60.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.042 0.449 . . . . 0.0 111.227 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 3.0 mp0 -98.25 18.1 17.11 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.921 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.18 147.96 44.26 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.499 0.666 . . . . 0.0 111.166 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -138.24 124.7 20.66 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 p -109.83 129.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' HG3' ' HB2' ' A' ' 99' ' ' GLU . 17.5 ptmt -129.96 130.67 45.36 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 121.384 0.611 . . . . 0.0 111.244 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.8 117.81 52.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.64 90.94 2.71 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.312 0.577 . . . . 0.0 109.727 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 -111.82 4.44 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.855 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.87 -4.91 59.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.77 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.03 137.61 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 122' ' ' TYR . 4.0 tp -124.72 119.94 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 35.5 mt-10 -138.18 149.71 46.09 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.357 -173.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.415 HG22 ' HB3' ' A' ' 120' ' ' ARG . 19.5 m -124.33 134.23 67.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -123.92 124.71 43.22 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.901 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 88' ' ' GLU . . . -124.25 142.65 14.26 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -143.04 126.56 16.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -136.32 141.01 43.76 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.531 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.21 120.81 26.28 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -82.22 -62.47 1.61 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 123.562 0.745 . . . . 0.0 111.289 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.514 ' HB2' HD12 ' A' ' 114' ' ' ILE . 39.3 mtm180 -141.67 125.13 16.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.867 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 131.24 49.54 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.47 171.96 13.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 119.255 -0.403 . . . . 0.0 110.378 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 13.59 -83.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 127.652 2.381 . . . . 0.0 114.468 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.24 30.06 1.05 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -131.86 131.05 6.15 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.448 -1.705 . . . . 0.0 109.32 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -121.35 149.47 42.91 Favored 'General case' 1 C--N 1.238 -4.265 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 107' ' ' ARG . 16.5 mt -123.3 132.97 70.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.1 m -129.23 158.42 39.1 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.109 0.481 . . . . 0.0 110.33 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -133.97 148.52 51.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 49.2 mt-10 -132.49 150.24 52.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.78 125.06 42.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -132.16 122.12 24.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.741 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.472 ' HG3' HG12 ' B' ' 114' ' ' ILE . 70.1 ttt180 -112.27 137.4 50.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 24.7 pttm -129.51 129.94 45.18 Favored 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.76 0.662 . . . . 0.0 110.76 -172.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.543 ' HB2' HG23 ' A' ' 98' ' ' ILE . 5.6 m-85 -128.63 145.1 51.25 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -128.05 98.91 5.28 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.9 pt -136.26 105.13 9.41 Favored Pre-proline 0 C--N 1.285 -2.219 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.259 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.82 -40.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.462 2.108 . . . . 0.0 112.021 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.07 -19.52 64.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.4 ' HB3' ' CE2' ' A' ' 75' ' ' PHE . 16.2 m-20 -108.45 -17.3 14.02 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 64.6 t -128.31 121.11 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' HB2' ' HD2' ' A' ' 150' ' ' LYS . 12.1 t70 -122.23 121.17 27.93 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 168.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.93 -15.53 39.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 114.777 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.34 -25.28 36.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.974 0.416 . . . . 0.0 111.384 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.458 HG22 ' HB3' ' A' ' 129' ' ' ASP . 8.1 t -119.19 -21.31 7.63 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.3 126.91 42.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 34.4 p -122.47 168.04 12.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.644 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 m -126.27 133.72 51.36 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.152 0.501 . . . . 0.0 111.164 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.457 ' O ' HD22 ' A' ' 143' ' ' LEU . 24.1 p -118.7 150.51 39.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.8 142.34 42.93 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.783 0.72 . . . . 0.0 112.477 -174.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.4 t -100.38 161.59 13.5 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -68.85 -20.12 64.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.834 0.853 . . . . 0.0 112.9 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -85.79 -10.67 55.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 112.06 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.28 1.11 23.59 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.532 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.5 t -77.2 124.23 35.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 2.7 tm? -119.5 132.25 55.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.1 m -121.34 127.42 51.25 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 121.639 -0.663 . . . . 0.0 110.749 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.644 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 19.2 m -102.01 122.64 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 3.9 p-10 -138.58 155.48 48.31 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.782 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.11 171.69 17.32 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 41.5 Cg_exo -51.1 142.59 34.6 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.759 2.306 . . . . 0.0 111.995 171.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 11.2 ptm180 -90.66 165.97 13.42 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.37 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.527 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 76.6 tttt . . . . . 0 C--O 1.271 2.226 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 . . . . . 0 N--CA 1.434 -1.256 0 CA-C-O 119.533 -0.27 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 45.4 tp 57.06 51.53 10.33 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.584 ' HB2' ' O ' ' B' ' 149' ' ' ARG . 21.0 mm-40 41.74 110.09 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 127.608 2.363 . . . . 0.0 116.932 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -86.98 105.74 17.34 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.669 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 31.0 t70 -176.54 138.99 0.31 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -95.02 117.35 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' B' ' 146' ' ' ASN . 50.7 t80 -110.62 142.92 41.82 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' B' ' 145' ' ' VAL . 35.1 m -137.82 131.2 30.78 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.243 0.544 . . . . 0.0 111.641 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.653 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 52.7 t -118.72 141.77 36.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.5 144.27 41.0 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.164 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' B' ' 143' ' ' LEU . 3.1 mm? -120.02 127.52 52.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 107' ' ' ARG . 0.6 OUTLIER -117.15 127.77 54.45 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.419 -1.312 . . . . 0.0 112.717 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -118.83 117.15 53.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 167.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.72 -54.21 44.92 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.265 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -150.44 121.7 7.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.57 171.87 18.18 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.796 2.038 . . . . 0.0 107.103 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.1 m -113.2 141.21 25.32 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.15 -28.09 13.71 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 125.044 3.83 . . . . 0.0 116.362 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.53 -20.34 60.68 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.353 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLU . . . . . 0.408 ' O ' ' HA2' ' B' ' 102' ' ' GLY . 2.9 mp0 -98.37 18.43 16.5 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.723 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.34 147.75 44.62 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.829 0.823 . . . . 0.0 111.273 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -138.05 124.53 20.72 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -109.63 129.58 64.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' B' ' 99' ' ' GLU . 17.8 ptmt -130.36 130.72 44.76 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.417 0.627 . . . . 0.0 111.091 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.91 118.16 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.5 tp -135.48 91.18 2.69 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-O 121.17 0.51 . . . . 0.0 109.716 -173.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.05 -111.92 4.53 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.022 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -86.56 -4.79 59.23 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.227 1.011 . . . . 0.0 112.022 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.84 137.74 47.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.535 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 122' ' ' TYR . 4.0 tp -124.87 120.03 57.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 174.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.413 ' HB2' ' HG3' ' B' ' 92' ' ' LYS . 35.4 mt-10 -138.16 149.72 46.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.151 0.501 . . . . 0.0 110.323 -173.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' B' ' 120' ' ' ARG . 20.1 m -124.22 134.34 66.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -123.95 124.66 43.08 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 88' ' ' GLU . . . -124.04 142.87 14.5 Favored Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 173.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -143.08 126.36 16.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -136.23 140.6 43.61 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.548 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -82.48 120.73 25.85 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -81.9 -63.76 1.32 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 123.512 0.725 . . . . 0.0 111.008 -173.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.485 ' HB2' HD12 ' B' ' 114' ' ' ILE . 39.8 mtm180 -140.9 125.42 17.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.961 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -103.24 130.4 50.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -139.16 172.47 12.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.39 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 12.86 -84.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 127.673 2.389 . . . . 0.0 114.27 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -145.85 30.19 1.08 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -132.1 130.18 5.83 Favored Glycine 0 N--CA 1.403 -3.53 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.403 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -120.43 149.86 41.7 Favored 'General case' 1 C--N 1.24 -4.156 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' B' ' 107' ' ' ARG . 16.9 mt -123.61 133.34 69.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.8 m -129.98 159.14 37.57 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.049 0.452 . . . . 0.0 110.174 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -134.17 148.55 50.94 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 48.8 mt-10 -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -126.03 125.03 41.97 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -132.06 122.22 25.1 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.785 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' HG12 ' A' ' 114' ' ' ILE . 70.0 ttt180 -112.3 137.36 50.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 24.1 pttm -129.37 129.83 45.27 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.717 0.635 . . . . 0.0 110.72 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' TYR . . . . . 0.552 ' HB2' HG23 ' B' ' 98' ' ' ILE . 6.1 m-85 -128.25 145.57 51.0 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.489 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -128.19 98.86 5.24 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 3.9 pt -136.38 105.2 9.3 Favored Pre-proline 0 C--N 1.284 -2.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.193 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.49 -40.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.542 2.161 . . . . 0.0 112.081 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.01 -19.86 64.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 111.513 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' B' ' 75' ' ' PHE . 15.0 m-20 -108.36 -17.18 14.06 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.444 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 63.6 t -128.46 121.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ASP . . . . . 0.528 ' HB2' ' HD2' ' B' ' 150' ' ' LYS . 12.2 t70 -122.35 121.32 27.78 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 168.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.17 -15.2 38.31 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.466 2.777 . . . . 0.0 114.632 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 tp -81.47 -25.87 35.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.461 . . . . 0.0 111.157 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' THR . . . . . 0.471 HG22 ' HB3' ' B' ' 129' ' ' ASP . 9.7 t -119.05 -21.14 7.79 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.14 127.12 42.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 33.4 p -122.5 167.72 13.0 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.839 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.7 m -126.28 133.96 51.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.446 ' O ' HD22 ' B' ' 143' ' ' LEU . 14.8 p -119.13 149.61 41.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 142.66 44.24 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.465 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.62 161.6 13.49 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -68.81 -19.59 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.603 0.761 . . . . 0.0 112.953 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.68 -10.14 54.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.041 0.448 . . . . 0.0 111.734 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.3 0.75 23.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.43 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.62 124.11 34.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 2.7 tm? -119.59 132.27 55.68 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 35.3 m -121.46 126.99 50.61 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.6 -0.688 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' VAL . . . . . 0.653 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 19.0 m -101.71 122.65 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' B' ' 75' ' ' PHE . 4.0 p-10 -138.51 154.97 48.8 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.775 -173.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.13 18.22 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 50.3 Cg_exo -50.8 142.3 33.12 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 122.745 2.297 . . . . 0.0 111.973 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 11.0 ptm180 -90.18 165.8 13.74 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.413 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' LYS . . . . . 0.528 ' HD2' ' HB2' ' B' ' 129' ' ' ASP . 76.2 tttt . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 123.194 1.474 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tt -143.24 94.23 2.59 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.26 137.14 46.56 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.112 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -111.79 116.54 30.86 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.901 0.858 . . . . 0.0 110.296 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.414 ' OD2' ' HD3' ' A' ' 149' ' ' ARG . 31.5 t70 -147.7 140.54 24.84 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 52.7 t80 -128.72 145.28 51.21 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.793 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 t -116.67 130.44 56.73 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.566 ' HB ' HG23 ' A' ' 145' ' ' VAL . 23.7 t -114.46 131.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.15 147.05 35.75 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 81' ' ' VAL . 6.7 mp -118.5 129.06 55.15 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -74.22 125.27 28.03 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.542 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 82' ' ' LYS . 32.9 t -138.97 142.67 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.66 ' O ' HG12 ' A' ' 81' ' ' VAL . 16.7 tptm -98.33 -177.34 3.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.567 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 7.8 t60 -77.63 124.98 28.64 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.841 -1.543 . . . . 0.0 113.412 -167.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -132.67 172.45 12.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.148 172.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 15.1 m -77.57 117.82 68.03 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -53.09 -27.76 38.11 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 124.024 3.149 . . . . 0.0 114.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -87.14 -35.31 18.7 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.343 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 18.5 mm-40 -91.35 58.91 3.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.296 0.57 . . . . 0.0 110.593 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 pp -143.21 160.43 40.48 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.09 0.471 . . . . 0.0 111.175 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -135.63 124.61 24.22 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.18 122.87 58.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -129.07 133.29 47.63 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.416 0.626 . . . . 0.0 111.948 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.73 122.1 59.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.96 91.71 3.09 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.29 -112.12 4.17 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.751 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -93.2 -0.25 56.92 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.689 1.196 . . . . 0.0 110.96 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.7 136.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.574 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 145' ' ' VAL . 16.6 mt -125.1 120.66 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.81 149.22 49.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.2 0.524 . . . . 0.0 110.84 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -129.8 120.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -113.56 120.06 39.67 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.428 ' HA3' ' CD2' ' A' ' 84' ' ' PHE . . . -136.98 154.79 22.4 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -138.56 143.28 39.35 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 117.454 0.627 . . . . 0.0 111.05 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 84' ' ' PHE . 81.1 t60 -137.97 127.86 25.52 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 170.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 32.1 mt-10 -86.01 121.33 28.48 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 23.7 mt-10 -55.06 -80.82 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -166.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 51.5 mtm-85 -147.63 153.82 39.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -83.01 128.19 34.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -94.39 -172.32 2.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -39.87 -66.16 0.33 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.361 1.464 . . . . 0.0 112.634 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -142.74 28.06 1.62 Allowed 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' B' ' 122' ' ' TYR . . . -132.95 153.53 20.75 Favored Glycine 1 N--CA 1.369 -5.788 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.39 149.05 30.8 Favored 'General case' 1 C--N 1.243 -4.025 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.482 HG23 ' HG2' ' B' ' 120' ' ' ARG . 35.5 mm -124.25 135.48 63.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.987 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 12.0 m -128.18 140.97 51.62 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -128.65 147.04 50.71 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.13 150.73 51.14 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.058 0.456 . . . . 0.0 110.105 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 84' ' ' PHE . 73.2 m-85 -124.96 133.67 52.93 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -127.1 121.94 32.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.61 ' CZ ' ' HA ' ' A' ' 81' ' ' VAL . 67.2 mtt-85 -117.02 136.88 52.62 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.4 tttp -134.82 128.38 32.65 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.756 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.458 ' CD1' ' HA3' ' B' ' 112' ' ' GLY . 13.3 m-85 -131.42 135.2 46.96 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.867 0.867 . . . . 0.0 110.543 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -128.23 98.7 5.18 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.637 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 5.0 pt -135.94 106.43 9.67 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.73 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -87.67 -39.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.027 1.818 . . . . 0.0 112.508 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.42 72.26 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 121.451 0.643 . . . . 0.0 111.76 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 149' ' ' ARG . 9.3 m-20 -91.99 -16.25 26.78 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.709 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.637 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 12.6 t -131.38 120.42 46.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -171.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.68 111.73 35.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.63 13.46 0.46 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.403 2.735 . . . . 0.0 116.215 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.79 -45.23 75.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.403 HG22 ' HD3' ' A' ' 148' ' ' PRO . 10.5 t -120.45 9.49 10.95 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 121.609 -0.682 . . . . 0.0 112.564 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' A' ' 128' ' ' VAL . 50.2 mt -67.8 132.51 32.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.418 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.8 p -121.58 165.89 15.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.901 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 144' ' ' THR . 15.1 m -130.09 134.06 47.1 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 120.971 0.415 . . . . 0.0 111.14 -177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.5 m -116.52 145.44 43.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.7 tp -121.74 137.17 54.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.505 0.193 . . . . 0.0 110.756 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -96.62 164.24 12.68 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.528 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.4 t -60.21 -33.97 72.99 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.523 1.056 . . . . 0.0 113.055 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 19.7 t70 -81.25 -11.09 59.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.542 0.687 . . . . 0.0 110.331 -177.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 8.13 24.07 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.437 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 43.7 t -71.68 132.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.33 134.39 55.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -168.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 135' ' ' SER . 20.3 m -121.51 128.1 51.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 77' ' ' VAL . 15.7 m -114.86 125.4 72.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.6 p-10 -132.25 138.62 47.97 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.505 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.77 -144.8 6.45 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.529 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 132' ' ' THR . 10.6 Cg_endo -91.66 139.03 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.069 2.513 . . . . 0.0 114.392 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.464 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 73.9 ttt180 -103.76 137.41 41.82 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--N 1.297 -1.702 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -175.493 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 123.108 1.432 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 tt -142.71 95.12 2.73 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.88 137.42 45.63 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.277 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -112.17 114.14 26.79 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 121.704 0.764 . . . . 0.0 110.528 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -145.14 141.22 28.58 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -96.08 125.74 40.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 53.0 t80 -128.88 145.81 51.11 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.738 -170.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.4 t -117.6 130.06 56.15 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.543 ' HB ' HG23 ' B' ' 145' ' ' VAL . 23.2 t -114.32 131.03 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -111.09 147.15 35.46 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' LEU . . . . . 0.478 ' O ' HG23 ' B' ' 81' ' ' VAL . 6.7 mp -118.5 128.83 54.96 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -73.67 125.32 27.78 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.402 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.656 HG12 ' O ' ' B' ' 82' ' ' LYS . 31.6 t -139.23 142.18 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 O-C-N 123.911 0.757 . . . . 0.0 109.107 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.656 ' O ' HG12 ' B' ' 81' ' ' VAL . 16.9 tptm -97.72 -177.42 3.77 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 7.6 t60 -77.7 124.76 28.37 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 117.89 -1.524 . . . . 0.0 113.4 -167.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.622 ' HA ' ' HB2' ' B' ' 104' ' ' HIS . 0.0 OUTLIER -132.55 172.5 12.43 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.174 172.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 15.3 m -77.54 118.05 69.49 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.2 -27.69 38.79 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 124.045 3.163 . . . . 0.0 114.036 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -87.22 -35.18 18.68 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.461 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' B' ' 85' ' ' SER . 16.1 mm-40 -92.04 58.51 3.37 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.543 0.687 . . . . 0.0 110.42 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.51 160.34 40.47 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.153 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -135.67 124.56 24.08 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.78 122.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -129.04 134.3 48.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.279 0.562 . . . . 0.0 111.744 -174.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 p -128.45 120.86 53.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.0 tp -129.93 91.78 3.19 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.63 -111.99 4.19 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.944 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -93.17 0.06 57.06 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 124.45 1.1 . . . . 0.0 111.003 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 97.6 t -110.06 136.33 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.526 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.499 HD13 HG21 ' B' ' 145' ' ' VAL . 17.1 mt -125.07 120.53 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.55 149.09 49.34 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.23 0.538 . . . . 0.0 110.759 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 94.0 t -129.54 120.93 51.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -113.52 120.14 39.96 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' B' ' 84' ' ' PHE . . . -137.07 154.59 22.35 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.33 143.26 39.83 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.508 0.67 . . . . 0.0 110.998 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' B' ' 84' ' ' PHE . 82.0 t60 -137.92 127.72 25.4 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 170.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 34.7 mt-10 -85.5 121.14 27.77 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.415 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 23.3 mt-10 -54.88 -80.7 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -166.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 51.6 mtm-85 -148.0 153.72 39.35 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -83.31 129.09 34.98 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -94.71 -172.53 2.76 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -39.5 -66.4 0.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.131 1.372 . . . . 0.0 112.958 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -142.69 27.95 1.64 Allowed 'General case' 0 CA--C 1.461 -2.472 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 122' ' ' TYR . . . -132.81 153.57 20.74 Favored Glycine 1 N--CA 1.37 -5.761 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -177.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -110.41 149.04 30.83 Favored 'General case' 1 C--N 1.244 -4.018 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' B' ' 105' ' ' GLU . 34.8 mm -124.21 135.53 63.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.127 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 9.6 m -128.18 141.09 51.57 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -128.64 147.17 50.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.3 150.44 50.98 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.128 0.489 . . . . 0.0 110.139 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' B' ' 84' ' ' PHE . 72.5 m-85 -124.77 133.92 52.98 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -127.38 121.88 32.14 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.593 ' CZ ' ' HA ' ' B' ' 81' ' ' VAL . 67.6 mtt-85 -117.18 137.02 52.62 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -135.16 128.3 31.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.774 -1.17 . . . . 0.0 110.697 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' TYR . . . . . 0.47 ' CE1' ' HA3' ' A' ' 112' ' ' GLY . 13.5 m-85 -131.46 134.99 46.75 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.973 0.909 . . . . 0.0 110.672 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -127.78 98.67 5.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.643 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 5.0 pt -135.72 106.59 9.85 Favored Pre-proline 0 C--N 1.29 -1.979 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.739 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -40.32 0.06 OUTLIER 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.26 1.973 . . . . 0.0 112.544 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.69 -32.05 71.58 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.612 0.72 . . . . 0.0 111.794 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ASP . . . . . 0.428 ' HA ' ' HG3' ' B' ' 149' ' ' ARG . 9.9 m-20 -92.15 -16.08 26.78 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.927 -0.483 . . . . 0.0 110.783 -176.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 13.0 t -131.45 119.88 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -170.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.05 111.68 36.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.82 15.29 0.38 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 123.456 2.771 . . . . 0.0 115.887 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.06 -45.13 71.14 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.101 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' THR . . . . . 0.406 HG22 ' HG3' ' B' ' 148' ' ' PRO . 12.8 t -120.61 9.88 10.93 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' B' ' 128' ' ' VAL . 50.0 mt -68.11 132.92 32.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.393 -170.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.7 p -121.98 166.18 14.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.733 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' B' ' 144' ' ' THR . 14.5 m -130.97 134.05 46.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.97 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 19.7 m -116.35 145.32 43.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -121.97 137.0 54.96 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 25.3 m -96.39 164.41 12.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.435 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -60.44 -34.07 73.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.448 1.022 . . . . 0.0 113.077 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 19.9 t70 -81.39 -10.73 59.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.43 0.633 . . . . 0.0 110.342 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.09 8.33 23.88 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.349 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.439 ' HA ' ' HB ' ' B' ' 81' ' ' VAL . 46.2 t -71.85 132.75 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.66 134.37 55.11 Favored 'General case' 0 C--O 1.209 -1.066 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.178 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' B' ' 135' ' ' SER . 20.1 m -121.4 127.87 51.62 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' VAL . . . . . 0.543 HG23 ' HB ' ' B' ' 77' ' ' VAL . 15.7 m -114.88 125.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 21.8 p-10 -132.47 138.14 47.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.522 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 179.69 -144.52 6.09 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.406 ' HG3' HG22 ' B' ' 132' ' ' THR . 9.8 Cg_endo -91.64 139.15 2.22 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.145 2.563 . . . . 0.0 114.383 -177.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 71.5 ttt180 -103.8 137.89 41.18 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.492 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.15 -172.1 3.77 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.02 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 68.6 28.37 5.81 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.948 1.699 . . . . 0.0 108.097 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -127.47 150.45 49.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -170.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 t70 67.93 178.1 0.24 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.325 1.45 . . . . 0.0 111.198 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -113.09 120.17 40.37 Favored 'General case' 0 CA--C 1.471 -2.063 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.34 150.64 25.02 Favored 'General case' 0 N--CA 1.393 -3.323 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.595 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 p -137.13 144.34 42.96 Favored 'General case' 0 N--CA 1.402 -2.851 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.087 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 32.8 t -116.05 132.55 65.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -110.97 136.89 49.3 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.465 HD22 HD11 ' A' ' 143' ' ' LEU . 6.0 mp -119.67 128.08 53.49 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.78 138.73 50.85 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 122.727 0.411 . . . . 0.0 109.911 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.42 165.99 5.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.72 -164.75 0.09 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.483 0.583 . . . . 0.0 110.441 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -77.41 123.94 27.21 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.003 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.58 143.11 15.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 m -74.02 124.73 90.33 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 123.477 0.485 . . . . 0.0 110.983 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 139' ' ' SER . 10.3 Cg_endo -55.43 -30.96 75.75 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.865 3.043 . . . . 0.0 114.046 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -74.59 -26.58 60.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.861 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.81 0.84 51.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.291 0.567 . . . . 0.0 111.398 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.22 147.67 44.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -126.21 126.26 43.76 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.38 126.69 52.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -129.57 138.37 51.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.438 0.637 . . . . 0.0 109.417 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.16 90.44 3.34 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.91 -112.17 4.73 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.148 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.4 -0.55 57.31 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.355 1.062 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.407 HG12 ' HG3' ' A' ' 99' ' ' GLU . 65.3 t -105.69 135.74 42.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.44 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 59.0 mt -122.0 119.53 58.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 39.1 mt-10 -136.38 137.02 40.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.61 0.719 . . . . 0.0 111.705 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.468 HG11 HH21 ' A' ' 120' ' ' ARG . 60.6 t -119.05 124.78 73.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -127.76 128.74 45.86 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.84 156.66 27.11 Favored Glycine 0 C--N 1.283 -2.384 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -143.37 134.16 25.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 124.056 0.504 . . . . 0.0 109.921 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.437 ' CD2' ' HG2' ' A' ' 106' ' ' GLU . 62.4 t60 -136.77 127.72 27.59 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.55 0.34 . . . . 0.0 110.327 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 12.5 pt-20 -87.03 137.05 32.68 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.437 ' HG2' ' CD2' ' A' ' 104' ' ' HIS . 28.3 mt-10 -106.78 -53.98 2.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.331 -173.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -148.34 152.92 37.88 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 47.7 tt0 -111.76 122.24 47.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.453 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -75.2 -67.35 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -179.22 106.19 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 37.6 m80 60.1 25.29 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.027 0.918 . . . . 0.0 109.208 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.66 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -156.4 119.13 0.89 Allowed Glycine 1 N--CA 1.39 -4.392 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -175.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' GLN . 11.7 p90 -119.28 153.54 34.88 Favored 'General case' 1 C--N 1.243 -4.033 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.416 HG22 ' HG2' ' B' ' 120' ' ' ARG . 1.9 pt -121.04 140.87 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 15.5 m -134.44 157.09 47.34 Favored 'General case' 0 N--CA 1.404 -2.749 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.974 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.9 ttp85 -126.65 146.46 50.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.7 mt-10 -136.87 153.69 50.69 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -128.54 133.6 48.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 26.6 t-80 -131.56 122.48 26.16 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.483 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.468 HH21 HG11 ' A' ' 100' ' ' VAL . 30.8 mtm180 -115.72 138.4 51.15 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.627 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 51.0 tttp -136.03 128.04 29.61 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.702 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 30.3 m-85 -132.17 142.32 49.42 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.104 0.878 . . . . 0.0 109.024 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -128.48 98.57 5.08 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.7 pt -137.33 106.21 8.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.328 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.49 -45.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.886 0 C-N-CA 122.642 2.228 . . . . 0.0 113.366 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 150' ' ' LYS . . . -67.54 -28.19 67.59 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -91.16 -18.0 25.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 77.8 t -132.81 127.6 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.77 ' H ' ' HB3' ' A' ' 148' ' ' PRO . 5.6 m-20 -121.62 109.6 34.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.233 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.55 ' HA ' ' CG2' ' A' ' 133' ' ' ILE . 20.8 Cg_endo -59.92 -12.26 18.08 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 124.239 3.293 . . . . 0.0 114.744 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.55 -40.34 96.74 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.177 0.513 . . . . 0.0 111.237 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.1 t -118.42 9.16 12.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.663 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.55 ' CG2' ' HA ' ' A' ' 130' ' ' PRO . 10.4 tt -77.26 141.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.992 0.425 . . . . 0.0 110.065 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 4.9 p -138.79 154.77 48.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 144' ' ' THR . 22.9 t -131.02 133.21 45.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.169 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 p -119.64 130.33 55.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 137' ' ' LEU . 1.4 pt? -130.13 137.23 50.04 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.01 0.434 . . . . 0.0 112.099 -169.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.3 p -99.91 168.0 10.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.358 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 11.4 m -67.13 -10.97 55.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.38 1.472 . . . . 0.0 112.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.38 20.07 19.42 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-O 121.789 0.804 . . . . 0.0 110.516 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.21 -5.34 63.51 Favored Glycine 0 C--O 1.261 1.791 0 CA-C-N 115.568 -0.742 . . . . 0.0 114.813 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.8 119.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.465 HD11 HD22 ' A' ' 79' ' ' LEU . 3.9 pp -129.94 135.55 48.45 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 135' ' ' SER . 13.5 p -107.31 133.08 52.38 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.483 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 134' ' ' THR . 12.5 m -111.82 121.52 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -137.38 164.75 27.88 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.361 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.505 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . 128.1 -49.06 0.94 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.41 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.77 ' HB3' ' H ' ' A' ' 129' ' ' ASP . 55.5 Cg_endo -62.29 169.72 7.55 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 123.241 2.628 . . . . 0.0 114.989 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -106.26 154.88 20.1 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 126' ' ' ALA . 81.5 tttt . . . . . 0 C--N 1.285 -2.207 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.117 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 . . . . . 0 N--CA 1.425 -1.707 0 CA-C-O 121.506 0.669 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.7 -171.48 3.62 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.781 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 68.03 28.9 6.61 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.742 1.617 . . . . 0.0 108.163 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -128.08 150.13 50.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -170.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' B' ' 149' ' ' ARG . 4.2 t70 68.49 177.98 0.25 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.412 1.485 . . . . 0.0 111.139 172.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -112.87 120.04 40.06 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.43 150.7 25.04 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.57 -172.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.7 p -137.36 144.24 42.41 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.186 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 33.3 t -116.0 132.91 64.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.35 136.72 50.06 Favored 'General case' 0 C--N 1.269 -2.928 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' LEU . . . . . 0.47 ' HG ' ' OH ' ' B' ' 122' ' ' TYR . 6.0 mp -119.53 128.16 53.68 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.76 138.63 50.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.48 165.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.37 -164.46 0.08 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.444 0.565 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -77.67 124.22 27.66 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.807 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.77 142.62 15.29 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.5 m -73.5 124.49 90.45 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 123.349 0.405 . . . . 0.0 111.057 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 139' ' ' SER . 9.3 Cg_endo -55.4 -31.2 76.54 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.725 2.95 . . . . 0.0 113.993 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.77 -26.42 60.64 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.47 0.91 53.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.133 0.492 . . . . 0.0 111.398 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.29 147.52 44.89 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -125.98 125.89 43.43 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -98.5 127.14 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.808 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -129.88 140.01 51.06 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 117.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.95 90.19 3.28 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.34 -112.31 4.87 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.65 -0.19 56.53 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 124.417 1.087 . . . . 0.0 111.946 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' B' ' 99' ' ' GLU . 65.3 t -106.22 135.91 42.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.591 -0.693 . . . . 0.0 110.314 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 59.3 mt -122.18 119.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 39.1 mt-10 -136.23 136.91 40.29 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.661 0.743 . . . . 0.0 111.637 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.464 HG11 HH21 ' B' ' 120' ' ' ARG . 61.1 t -118.99 124.41 73.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -127.25 128.73 46.5 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.15 156.62 27.07 Favored Glycine 0 C--N 1.286 -2.242 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -143.31 134.0 25.14 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 122.648 0.379 . . . . 0.0 110.024 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' HIS . . . . . 0.43 ' CD2' ' HG2' ' B' ' 106' ' ' GLU . 61.2 t60 -136.63 127.68 27.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 122.561 0.344 . . . . 0.0 110.311 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 12.0 pt-20 -86.72 137.05 32.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.43 ' HG2' ' CD2' ' B' ' 104' ' ' HIS . 27.8 mt-10 -106.74 -54.33 2.49 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.254 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -148.13 153.11 38.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' B' ' 113' ' ' PHE . 46.9 tt0 -111.7 122.64 48.34 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.593 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.98 -67.99 0.59 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.769 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -178.7 106.16 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 39.1 m80 60.61 24.17 13.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.937 0.875 . . . . 0.0 109.158 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.702 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -154.99 120.26 1.0 Allowed Glycine 2 N--CA 1.389 -4.485 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -177.141 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 113' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 108' ' ' GLN . 11.8 p90 -119.34 153.6 34.87 Favored 'General case' 1 C--N 1.241 -4.146 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.049 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.403 HG22 ' HG2' ' A' ' 120' ' ' ARG . 1.8 pt -121.06 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 14.5 m -134.4 157.08 47.32 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.108 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -126.42 146.49 50.05 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 37.1 mt-10 -136.83 153.59 50.75 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -172.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -128.63 133.43 48.27 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 121.186 0.517 . . . . 0.0 110.669 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 28.2 t-80 -131.49 122.43 26.18 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.469 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.464 HH21 HG11 ' B' ' 100' ' ' VAL . 30.1 mtm180 -115.81 138.43 51.15 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.628 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 50.3 tttp -136.13 128.06 29.44 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.312 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' TYR . . . . . 0.66 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 29.9 m-85 -132.22 142.56 49.47 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 124.013 0.821 . . . . 0.0 108.92 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -128.41 98.57 5.1 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -137.26 106.19 8.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.499 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -89.46 -44.53 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.638 2.225 . . . . 0.0 113.403 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' B' ' 150' ' ' LYS . . . -68.12 -27.74 66.73 Favored 'General case' 0 C--O 1.198 -1.639 0 O-C-N 122.049 -0.407 . . . . 0.0 111.959 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.66 -18.17 24.39 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 76.7 t -132.75 127.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ASP . . . . . 0.766 ' H ' ' HB3' ' B' ' 148' ' ' PRO . 7.1 m-20 -121.34 110.42 34.22 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.164 168.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.534 ' HA ' ' CG2' ' B' ' 133' ' ' ILE . 20.7 Cg_endo -60.66 -12.02 19.71 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 124.026 3.151 . . . . 0.0 114.737 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.93 -40.14 95.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.093 0.473 . . . . 0.0 111.078 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 6.9 t -118.14 9.02 12.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ILE . . . . . 0.534 ' CG2' ' HA ' ' B' ' 130' ' ' PRO . 10.9 tt -76.84 141.9 15.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.6 p -138.92 154.43 48.35 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.629 0.772 . . . . 0.0 109.2 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.0 t -130.82 132.9 45.5 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.19 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 2.6 p -119.74 130.09 54.82 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' LEU . . . . . 0.498 HD23 ' H ' ' B' ' 137' ' ' LEU . 1.4 pt? -130.06 136.97 49.95 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -169.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 76.8 p -99.55 168.14 10.15 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.487 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' B' ' 86' ' ' PRO . 6.9 m -67.62 -11.15 57.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.397 1.479 . . . . 0.0 112.092 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.22 20.04 19.53 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.677 0.751 . . . . 0.0 110.424 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.12 -4.72 65.53 Favored Glycine 0 C--O 1.26 1.725 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.28 119.79 33.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.458 HD11 HD22 ' B' ' 79' ' ' LEU . 4.0 pp -130.12 135.77 48.57 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.828 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' B' ' 135' ' ' SER . 11.6 p -107.49 133.29 52.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.271 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' B' ' 134' ' ' THR . 12.4 m -111.85 121.56 64.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -137.56 164.82 27.82 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 122.179 -0.326 . . . . 0.0 110.163 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.496 ' N ' ' HD2' ' B' ' 148' ' ' PRO . . . 127.93 -49.03 0.94 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.785 -1.197 . . . . 0.0 114.311 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.766 ' HB3' ' H ' ' B' ' 129' ' ' ASP . 55.6 Cg_endo -62.88 169.48 8.78 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.953 2.435 . . . . 0.0 115.05 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 36.0 ptt180 -105.22 155.51 18.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 79.9 tttt . . . . . 0 C--N 1.285 -2.217 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HG ' ' HG3' ' A' ' 150' ' ' LYS . 5.4 mp -106.19 105.96 16.25 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -89.89 141.77 28.33 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -87.16 105.65 17.34 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 118.878 -1.129 . . . . 0.0 108.752 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -159.96 141.91 13.03 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 74' ' ' ARG . 25.5 mtm180 -95.5 139.76 31.31 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' CE2' HG22 ' A' ' 128' ' ' VAL . 20.2 t80 -106.62 140.02 40.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.727 -170.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 t -137.91 129.14 27.6 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.71 130.79 72.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.44 155.95 22.39 Favored 'General case' 0 C--N 1.257 -3.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 16.6 tp -118.67 127.86 53.97 Favored 'General case' 0 N--CA 1.381 -3.916 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -104.32 130.27 52.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 p -156.56 162.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.494 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -93.42 -162.89 0.98 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.367 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.714 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 34.9 t60 -76.58 123.78 26.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 117.334 -1.746 . . . . 0.0 112.296 -169.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.37 133.72 19.59 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -73.6 149.14 88.28 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HA ' HD21 ' A' ' 137' ' ' LEU . 93.4 Cg_exo -47.74 -34.79 22.13 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.921 2.414 . . . . 0.0 115.513 -171.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.31 -17.99 53.48 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.61 -20.06 44.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 89' ' ' LEU . 2.5 pt? -120.95 151.12 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.426 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.19 136.2 36.38 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.03 139.97 37.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.588 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.55 139.51 47.89 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.241 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 98' ' ' ILE . 2.4 p -129.94 112.96 25.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.77 101.78 5.04 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.97 -111.74 4.0 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.002 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 125' ' ' PRO . 8.4 p-10 -93.94 -5.92 46.7 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 124.731 1.212 . . . . 0.0 111.431 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.92 135.57 54.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.071 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 93' ' ' VAL . 3.0 mp -131.81 120.05 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.8 mt-10 -133.43 147.87 51.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 120.992 0.425 . . . . 0.0 111.686 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 79' ' ' LEU . 39.9 t -126.65 129.44 71.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -136.0 133.37 37.42 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.95 147.0 17.92 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.02 134.52 45.66 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -130.53 131.14 44.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.3 pt-20 -87.18 120.85 28.88 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.604 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 30.5 mm-40 -67.6 -70.68 0.24 Allowed 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.308 -173.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.604 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 0.8 OUTLIER -144.17 154.89 43.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -111.26 128.59 55.98 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 110' ' ' GLU . 61.2 m-20 -93.88 -168.44 1.88 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 3.6 mp0 -57.6 -68.72 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.967 1.307 . . . . 0.0 109.539 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -122.18 14.84 10.59 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' B' ' 122' ' ' TYR . . . -115.54 142.32 17.51 Favored Glycine 1 N--CA 1.384 -4.773 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.393 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.75 139.57 53.85 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 107' ' ' ARG . 5.6 mt -123.7 131.98 72.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 23.3 t -137.16 157.46 46.61 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.093 0.473 . . . . 0.0 110.545 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -134.1 147.72 50.9 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 171.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -130.94 154.35 48.21 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 122.19 0.196 . . . . 0.0 110.483 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -122.1 128.28 51.13 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -131.25 122.04 25.82 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -126.63 137.86 53.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.514 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 23.6 mtpp -134.57 127.11 30.61 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.173 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.48 ' HB3' ' CA ' ' B' ' 112' ' ' GLY 0.305 1.3 p90 -134.7 133.72 40.31 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 173.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -109.9 101.68 10.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.448 0.642 . . . . 0.0 110.557 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.46 HG13 HD13 ' A' ' 98' ' ' ILE . 2.4 pt -135.52 106.91 10.01 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.463 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 59.2 Cg_endo -108.95 -37.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 122.7 2.267 . . . . 0.0 116.154 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.402 ' H ' ' HD2' ' A' ' 125' ' ' PRO . . . -68.03 -29.76 68.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.763 -0.585 . . . . 0.0 112.382 -172.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.06 8.18 20.01 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.525 0.679 . . . . 0.0 109.37 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 75' ' ' PHE . 56.3 t -131.16 127.43 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.644 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.68 103.36 40.74 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.21 8.85 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 123.684 2.923 . . . . 0.0 116.167 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.91 -39.81 95.67 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 148' ' ' PRO . 14.6 t -119.36 9.29 11.59 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.388 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.539 HG12 ' HA3' ' A' ' 147' ' ' GLY . 42.9 mt -68.36 122.46 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.703 0.763 . . . . 0.0 112.296 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.76 167.27 18.33 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.034 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 143' ' ' LEU . 19.0 p -127.2 135.64 50.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -116.46 129.54 56.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 86' ' ' PRO . 60.1 tp -129.29 127.95 42.2 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 123.16 0.288 . . . . 0.0 111.111 -171.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 14.8 m -99.84 163.98 12.22 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.643 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.0 m -55.14 -30.64 60.23 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.714 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 25.3 t70 -88.33 -11.79 45.32 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.841 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.35 62.01 0.81 Allowed Glycine 0 N--CA 1.409 -3.127 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 46.8 t -121.23 122.28 67.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 174.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 135' ' ' SER . 15.9 tp -127.2 134.93 50.06 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -173.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.451 ' N ' HD12 ' A' ' 143' ' ' LEU . 41.3 m -121.43 118.93 30.64 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.368 171.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.463 HG12 ' CG2' ' A' ' 133' ' ' ILE . 13.6 t -106.72 120.39 57.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 9.4 p30 -139.47 159.69 41.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.9 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.539 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.69 -136.66 2.97 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 132' ' ' THR . 61.1 Cg_endo -104.28 149.74 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.449 2.766 . . . . 0.0 113.72 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -101.11 153.94 19.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.435 ' HG3' ' HG ' ' A' ' 70' ' ' LEU . 36.3 ttmt . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.438 ' HG ' ' HG3' ' B' ' 150' ' ' LYS . 5.3 mp -105.66 106.23 16.64 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.06 141.03 29.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -87.04 105.6 17.27 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 118.417 -1.313 . . . . 0.0 108.782 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -158.77 142.32 15.05 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -95.31 140.14 30.63 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.482 ' CE2' HG22 ' B' ' 128' ' ' VAL . 19.7 t80 -107.19 139.95 40.83 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.686 -170.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -137.92 129.3 27.81 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.4 HG11 ' CE2' ' B' ' 122' ' ' TYR . 46.2 t -118.12 130.92 72.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.39 155.98 22.3 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' B' ' 143' ' ' LEU . 16.6 tp -118.66 127.68 53.8 Favored 'General case' 1 N--CA 1.379 -4.002 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.76 130.47 51.28 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.08 162.04 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.254 -3.548 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.96 -162.81 0.97 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.157 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' HIS . . . . . 0.732 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 40.6 t60 -76.59 123.73 26.53 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 117.65 -1.62 . . . . 0.0 112.417 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -147.48 134.06 19.84 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -73.81 148.74 87.51 Favored Pre-proline 0 C--N 1.283 -2.314 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.69 -34.69 21.55 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.91 2.406 . . . . 0.0 115.556 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.22 -17.86 54.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 120.843 0.354 . . . . 0.0 111.624 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.89 -20.08 42.98 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.448 HD23 ' H ' ' B' ' 89' ' ' LEU . 2.5 pt? -121.01 150.45 41.12 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.545 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.4 135.88 37.35 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 p -113.56 139.94 36.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.714 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.62 139.88 47.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.269 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.525 HG23 HG13 ' B' ' 98' ' ' ILE . 2.4 p -129.98 112.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.533 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.67 102.77 5.4 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.324 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.66 -111.55 4.04 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.009 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' B' ' 125' ' ' PRO . 8.6 p-10 -94.12 -5.9 46.19 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 124.499 1.12 . . . . 0.0 111.519 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.74 135.53 54.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.026 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.525 HG13 HG23 ' B' ' 93' ' ' VAL . 3.0 mp -131.64 120.01 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 37.1 mt-10 -133.47 147.42 51.67 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.665 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.413 HG11 ' CD2' ' B' ' 79' ' ' LEU . 40.0 t -126.02 129.58 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -136.1 133.34 37.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.82 147.56 18.82 Favored Glycine 0 C--N 1.286 -2.228 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.96 134.3 45.47 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -130.16 132.06 45.9 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.5 pt-20 -88.34 120.51 29.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.603 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 31.7 mm-40 -67.09 -71.14 0.21 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 112.683 -2.053 . . . . 0.0 110.281 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.603 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 0.7 OUTLIER -143.71 154.99 44.05 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.19 128.68 55.99 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' B' ' 110' ' ' GLU . 63.6 m-20 -94.13 -169.09 1.99 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' B' ' 110' ' ' GLU . 3.5 mp0 -56.95 -68.4 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.117 1.367 . . . . 0.0 109.635 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -122.33 14.93 10.47 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 122' ' ' TYR . . . -115.51 142.59 17.69 Favored Glycine 1 N--CA 1.385 -4.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.328 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.3 139.27 54.07 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' B' ' 107' ' ' ARG . 5.6 mt -123.7 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 22.8 t -137.03 157.56 46.45 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.265 0.555 . . . . 0.0 110.611 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -134.18 147.75 50.8 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 171.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -131.01 154.26 48.37 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -121.77 128.13 51.39 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -131.11 121.7 25.38 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -126.07 138.04 53.68 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.5 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 23.7 mtpp -134.68 127.07 30.35 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.226 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' TYR . . . . . 0.455 ' HB3' ' CA ' ' A' ' 112' ' ' GLY 0.312 1.3 p90 -134.72 134.05 40.62 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 174.026 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -110.53 101.51 10.18 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.452 0.644 . . . . 0.0 110.299 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.449 HG13 HD13 ' B' ' 98' ' ' ILE . 2.4 pt -135.58 106.9 9.96 Favored Pre-proline 0 C--N 1.292 -1.915 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.494 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.524 ' HB3' ' HB3' ' B' ' 96' ' ' ASP . 59.1 Cg_endo -109.03 -37.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.691 2.261 . . . . 0.0 116.455 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.401 ' H ' ' HD2' ' B' ' 125' ' ' PRO . . . -68.24 -29.44 68.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.98 8.24 20.16 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.731 0.777 . . . . 0.0 109.409 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.482 HG22 ' CE2' ' B' ' 75' ' ' PHE . 53.3 t -131.44 127.19 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.716 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -121.7 103.33 40.74 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.14 8.46 1.41 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.775 2.983 . . . . 0.0 116.166 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.56 -39.43 93.65 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' THR . . . . . 0.444 HG22 ' HD3' ' B' ' 148' ' ' PRO . 14.7 t -119.57 9.17 11.42 Favored 'General case' 0 C--O 1.252 1.189 0 O-C-N 121.229 -0.919 . . . . 0.0 111.233 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ILE . . . . . 0.524 HG12 ' HA3' ' B' ' 147' ' ' GLY . 42.7 mt -68.4 121.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.886 0.85 . . . . 0.0 112.342 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.74 167.13 17.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.52 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.543 ' HB2' HD11 ' B' ' 143' ' ' LEU . 21.9 p -126.99 135.71 51.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t -116.72 129.91 56.41 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 60.6 tp -130.19 127.02 38.83 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.682 0.277 . . . . 0.0 111.07 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 13.7 m -98.64 163.95 12.44 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.676 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.2 m -55.17 -30.49 59.97 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -169.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' ASP . . . . . 0.732 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 22.8 t70 -88.92 -11.67 43.84 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.554 0.692 . . . . 0.0 110.713 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.57 61.82 0.8 Allowed Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -172.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 46.7 t -120.72 121.94 66.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 174.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' B' ' 135' ' ' SER . 16.1 tp -126.85 135.03 50.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.448 ' N ' HD12 ' B' ' 143' ' ' LEU . 42.4 m -121.66 118.21 28.59 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.352 171.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' VAL . . . . . 0.459 HG12 ' CG2' ' B' ' 133' ' ' ILE . 13.1 t -106.09 120.53 57.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.1 p30 -139.54 160.09 40.67 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.839 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.524 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 178.2 -136.91 3.12 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' B' ' 132' ' ' THR . 64.5 Cg_endo -104.06 150.29 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.443 2.762 . . . . 0.0 113.644 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -101.74 154.25 19.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' LYS . . . . . 0.438 ' HG3' ' HG ' ' B' ' 70' ' ' LEU . 36.2 ttmt . . . . . 0 C--N 1.292 -1.896 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.0 tp -90.83 84.27 5.8 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 59.39 50.37 7.74 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.234 0.959 . . . . 0.0 109.833 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -86.06 107.45 17.81 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.953 -173.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -138.43 159.36 42.27 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 113.462 -1.699 . . . . 0.0 106.921 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 65.5 mtp180 -94.42 119.17 32.74 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -124.85 155.38 39.55 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.659 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.3 p -129.44 140.28 51.36 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.191 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.472 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 45.4 t -115.37 136.26 52.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -111.14 139.49 46.47 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 143' ' ' LEU . 6.1 mp -119.93 128.55 53.71 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.38 119.43 25.09 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 141' ' ' GLY . 40.4 t -133.67 141.08 45.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 174.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -83.33 -171.15 3.41 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.538 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -76.13 125.04 28.4 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -158.16 166.63 31.94 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -74.97 113.41 24.54 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 123.719 0.637 . . . . 0.0 110.294 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.94 -29.81 83.68 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.787 2.991 . . . . 0.0 115.055 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.39 -7.98 57.11 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.999 -0.438 . . . . 0.0 111.392 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 88' ' ' GLU . 5.5 mm-40 -93.18 2.74 56.54 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.679 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.58 147.25 45.44 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -124.26 126.61 46.36 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.89 122.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.17 131.12 54.89 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.143 0.497 . . . . 0.0 111.07 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.518 HG22 HD13 ' A' ' 98' ' ' ILE . 58.3 t -115.13 125.03 72.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.98 91.73 2.72 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.569 0.7 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.76 -112.4 4.73 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.742 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -95.26 11.48 32.35 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.743 0.817 . . . . 0.0 111.515 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.34 137.21 55.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.821 -0.549 . . . . 0.0 110.314 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 122' ' ' TYR . 2.3 tp -125.99 120.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.497 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.3 mt-10 -132.2 150.04 52.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.138 0.494 . . . . 0.0 110.453 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.7 t -126.84 124.2 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -128.36 133.19 48.6 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.63 150.94 23.24 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 128.07 17.69 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -138.27 134.16 34.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 111.216 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -80.89 120.45 24.73 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.17 -55.94 5.0 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.024 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.651 ' HG2' HD11 ' A' ' 114' ' ' ILE . 30.7 ptt180 -148.59 155.38 41.02 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -82.24 113.58 20.16 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 114' ' ' ILE . 13.1 t70 -93.98 -148.86 0.27 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.891 -164.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -72.85 83.62 1.21 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.496 0.589 . . . . 0.0 109.786 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 74.53 -52.65 0.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.076 1.75 . . . . 0.0 110.321 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.36 173.22 54.27 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.189 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.91 149.27 41.86 Favored 'General case' 0 C--N 1.255 -3.517 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.651 HD11 ' HG2' ' A' ' 107' ' ' ARG . 38.1 pt -122.88 137.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.195 -175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -134.47 154.24 51.51 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.22 0.533 . . . . 0.0 111.244 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.409 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 6.8 ttp180 -127.3 147.05 50.24 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -134.13 153.45 51.82 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.51 ' HD2' ' NH1' ' A' ' 120' ' ' ARG . 50.1 m-85 -128.26 126.41 40.82 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.494 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.75 122.52 27.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.534 ' NH2' HD12 ' B' ' 114' ' ' ILE . 26.3 mtt85 -126.94 138.21 53.25 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -138.66 128.88 25.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.908 0.755 . . . . 0.0 111.541 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.765 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.7 m-85 -133.1 123.67 26.15 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.084 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -107.56 99.42 8.92 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 4.3 pt -135.93 105.8 9.68 Favored Pre-proline 0 C--N 1.303 -1.452 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.774 -177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.53 -38.67 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.91 2.407 . . . . 0.0 112.122 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 150' ' ' LYS . . . -68.63 -32.32 72.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.292 0.567 . . . . 0.0 111.338 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.99 -18.27 22.06 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.727 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 70.3 t -131.71 114.38 24.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.42 127.04 27.91 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 168.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 79.9 Cg_endo -73.32 16.01 0.48 Allowed 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 122.665 2.244 . . . . 0.0 116.402 -172.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.1 tp -81.84 -48.18 11.88 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.277 3.0 t -122.27 10.74 9.99 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.2 pp -67.28 129.28 31.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.1 p -132.56 166.38 22.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.417 ' HB3' HG12 ' A' ' 145' ' ' VAL . 52.9 p -127.87 134.12 49.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 121.03 0.443 . . . . 0.0 110.912 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -125.09 129.96 51.29 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.8 148.46 44.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.5 m -100.37 163.86 12.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.9 m -64.32 -21.57 66.65 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.767 0.827 . . . . 0.0 112.384 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.83 5.15 22.62 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 121.274 0.559 . . . . 0.0 110.467 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 81' ' ' VAL . . . 96.64 -20.54 50.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.868 173.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.85 123.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.766 0.793 . . . . 0.0 110.454 -175.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 79' ' ' LEU . 4.1 pp -129.65 136.26 49.51 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.583 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.0 t -109.72 135.68 50.26 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.472 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 31.1 m -105.9 122.16 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 3.6 p-10 -132.89 143.48 49.53 Favored 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.171 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' ARG . . . 174.34 -138.09 4.27 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -91.76 147.08 3.25 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.379 2.053 . . . . 0.0 112.813 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -100.57 151.47 21.56 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 126' ' ' ALA . 87.1 tttt . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 43.1 tp -90.6 83.28 5.8 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.11 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 59.8 50.81 6.64 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.31 1.006 . . . . 0.0 109.643 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -86.2 107.39 17.88 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 122.532 1.158 . . . . 0.0 109.843 -173.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -137.89 159.32 42.32 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.32 -1.764 . . . . 0.0 106.954 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' B' ' 147' ' ' GLY . 66.3 mtp180 -94.3 119.08 32.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -124.99 154.87 40.55 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.697 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.3 p -128.56 140.34 51.84 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.428 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 44.6 t -115.24 136.57 51.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -111.14 139.65 46.35 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' LEU . . . . . 0.477 HD22 HD11 ' B' ' 143' ' ' LEU . 6.1 mp -120.12 128.63 53.62 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -84.5 119.24 24.93 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.641 ' HB ' ' O ' ' B' ' 141' ' ' GLY . 41.0 t -134.1 140.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 103.01 -2.959 . . . . 0.0 103.01 174.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -82.87 -170.93 3.26 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.671 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -75.9 125.11 28.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -158.24 166.62 31.92 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -74.82 113.29 23.05 Favored Pre-proline 0 N--CA 1.435 -1.211 0 O-C-N 123.777 0.673 . . . . 0.0 110.253 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.93 -30.07 84.65 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.806 3.004 . . . . 0.0 114.969 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.25 -7.15 58.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.023 0.44 . . . . 0.0 111.476 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' B' ' 88' ' ' GLU . 5.4 mm-40 -94.26 2.82 55.84 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.14 0.495 . . . . 0.0 111.53 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.35 147.01 45.58 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.84 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -124.57 125.71 44.62 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -96.27 122.05 47.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -120.34 130.96 54.65 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.505 HG22 HD13 ' B' ' 98' ' ' ILE . 58.0 t -114.67 125.14 71.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 172.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -135.84 91.87 2.75 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.0 -112.26 4.6 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.898 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.64 11.43 33.32 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.548 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.51 137.21 55.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.452 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.757 HG23 ' HB2' ' B' ' 122' ' ' TYR . 2.3 tp -125.99 120.25 56.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 174.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 38.2 mt-10 -132.33 149.93 52.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.11 0.481 . . . . 0.0 110.467 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 88.0 t -126.64 124.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -128.17 132.97 48.86 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.0 151.0 23.35 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.407 ' HD3' ' H ' ' B' ' 103' ' ' LYS . 0.0 OUTLIER -143.93 128.09 17.65 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -138.29 134.12 33.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.405 -0.809 . . . . 0.0 111.208 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.73 120.58 24.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -77.21 -55.98 4.95 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.061 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' B' ' 114' ' ' ILE . 30.2 ptt180 -148.65 155.46 41.08 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -82.06 113.6 20.05 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.413 ' HB2' HG23 ' B' ' 114' ' ' ILE . 13.8 t70 -94.09 -148.53 0.27 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.928 -163.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.55 82.57 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.602 0.637 . . . . 0.0 110.021 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 75.41 -51.46 0.65 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.245 1.818 . . . . 0.0 110.078 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.4 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -77.53 173.2 55.08 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.142 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -118.65 149.59 41.14 Favored 'General case' 0 C--N 1.255 -3.52 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.671 HD11 ' HG2' ' B' ' 107' ' ' ARG . 37.7 pt -122.92 137.03 57.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.315 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -134.59 153.92 51.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.411 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 6.3 ttp180 -127.11 147.05 50.18 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.05 153.35 51.85 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.515 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.5 ' HD2' ' NH1' ' B' ' 120' ' ' ARG . 49.9 m-85 -128.23 126.75 41.54 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.356 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -131.03 122.62 27.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.524 ' NH2' HD12 ' A' ' 114' ' ' ILE . 25.8 mtt85 -126.96 138.1 53.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -138.36 128.88 26.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 124.023 0.827 . . . . 0.0 111.474 -177.001 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 122' ' ' TYR . . . . . 0.757 ' HB2' HG23 ' B' ' 98' ' ' ILE . 4.1 m-85 -133.11 124.7 28.03 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.027 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -108.79 99.27 8.64 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.492 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 4.1 pt -136.06 106.0 9.58 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.772 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 124' ' ' ILE . 5.4 Cg_exo -84.9 -38.83 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 111.92 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' B' ' 150' ' ' LYS . . . -67.84 -32.32 72.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.73 -18.14 21.55 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.582 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 70.7 t -131.87 114.31 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -174.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -109.3 127.56 27.01 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.414 ' HA ' ' CG1' ' B' ' 133' ' ' ILE . 86.9 Cg_endo -73.55 15.96 0.52 Allowed 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 122.759 2.306 . . . . 0.0 116.374 -172.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -81.9 -48.39 11.58 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' THR . . . . . 0.4 HG22 ' HG3' ' B' ' 148' ' ' PRO 0.272 4.4 t -122.14 10.55 10.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.226 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.2 pp -67.46 128.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -175.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 12.1 p -130.6 166.7 20.08 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.653 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.42 ' HB3' HG12 ' B' ' 145' ' ' VAL . 55.9 p -127.67 134.69 49.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.065 0.46 . . . . 0.0 110.859 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 18.4 m -125.37 129.81 50.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' LEU . . . . . 0.41 ' HB3' ' HB3' ' B' ' 143' ' ' LEU . 3.8 pp -122.3 148.32 45.16 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 16.3 m -100.07 163.73 12.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 18.6 m -64.1 -21.87 66.71 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 112.439 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.43 4.19 25.16 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 123.182 0.593 . . . . 0.0 110.484 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.641 ' O ' ' HB ' ' B' ' 81' ' ' VAL . . . 97.3 -20.34 51.14 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.755 173.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.79 123.64 26.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.757 0.789 . . . . 0.0 110.432 -175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.477 HD11 HD22 ' B' ' 79' ' ' LEU . 4.1 pp -129.71 136.12 49.3 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.475 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -109.29 135.65 50.03 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' VAL . . . . . 0.475 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 31.5 m -105.74 122.24 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 3.6 p-10 -133.02 142.73 48.97 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.941 0.401 . . . . 0.0 111.349 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' B' ' 74' ' ' ARG . . . 174.76 -138.02 4.17 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.4 ' HG3' HG22 ' B' ' 132' ' ' THR . 21.7 Cg_endo -91.65 146.9 3.31 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.474 2.116 . . . . 0.0 112.887 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -100.62 151.41 21.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' B' ' 126' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.66 125.5 24.16 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.964 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 149' ' ' ARG . 12.6 pt-20 -145.95 53.1 1.15 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.511 -174.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -88.15 114.01 24.35 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.739 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 77.88 168.21 0.22 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.462 1.505 . . . . 0.0 110.39 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -112.43 149.6 32.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 9.3 t80 -134.22 158.66 43.15 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.908 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.3 t -131.85 133.81 45.06 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.95 137.77 47.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -110.2 135.27 51.24 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.647 HD22 ' CE1' ' A' ' 122' ' ' TYR . 1.8 mt -120.46 128.86 53.54 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -107.45 134.88 49.84 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.878 0.847 . . . . 0.0 111.82 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.23 -179.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 172.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 54.9 mtpt -100.08 -163.21 1.01 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 120.325 1.421 . . . . 0.0 110.666 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -77.78 125.9 30.04 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.156 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 47.9 m-85 -142.47 146.75 35.1 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.876 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 m -66.54 129.41 94.13 Favored Pre-proline 0 N--CA 1.407 -2.599 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.473 ' HB3' HD21 ' A' ' 137' ' ' LEU . 72.9 Cg_exo -48.87 -31.96 21.38 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.229 3.286 . . . . 0.0 115.094 -173.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.37 -4.45 58.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.4 mm-40 -100.11 -0.14 39.57 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.407 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 4.0 pp -121.56 147.53 45.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.34 126.03 30.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.49 122.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.02 137.5 53.49 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.079 0.466 . . . . 0.0 110.831 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 98' ' ' ILE . 85.6 t -124.51 115.5 44.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.934 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.67 95.01 4.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.67 -112.81 4.86 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.045 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -95.92 11.23 34.6 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 123.186 0.594 . . . . 0.0 111.394 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.42 135.79 57.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.297 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 27.1 mm -121.68 120.57 62.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 46.4 mt-10 -136.46 136.9 39.87 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.701 0.682 . . . . 0.0 112.753 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 46.8 t -107.25 117.17 52.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -113.67 119.05 36.1 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 89' ' ' LEU . . . -123.83 135.64 9.87 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 25.4 ttpp -120.21 133.41 55.49 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -134.6 128.67 33.66 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.59 120.92 35.58 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -75.1 -66.26 0.78 Allowed 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.873 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -139.51 124.38 18.61 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.192 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.89 112.62 21.31 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 103.02 -2.956 . . . . 0.0 103.02 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 112' ' ' GLY . 5.4 t70 -114.35 -163.06 0.84 Allowed 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.138 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -74.24 -76.58 0.13 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.051 0.54 . . . . 0.0 111.237 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -109.87 -15.54 14.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 109' ' ' ASP . . . -130.58 113.58 1.45 Allowed Glycine 0 C--O 1.2 -1.995 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.659 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -94.07 137.22 33.51 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 120' ' ' ARG . 3.0 tt -125.24 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -131.56 162.76 29.55 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.485 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -127.58 149.61 50.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.631 1.172 . . . . 0.0 108.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 36.6 tt0 -135.83 141.18 44.65 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.463 ' CZ ' ' HD3' ' A' ' 82' ' ' LYS . 9.2 m-85 -126.73 124.96 40.97 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.0 p80 -133.05 125.58 29.96 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.063 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' B' ' 114' ' ' ILE . 24.8 ttt85 -112.63 136.91 51.64 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.449 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 28.1 mtmm -130.05 130.45 44.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.78 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE1' HD22 ' A' ' 79' ' ' LEU . 45.4 m-85 -121.55 131.6 54.23 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 123.418 0.687 . . . . 0.0 110.089 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -117.82 99.07 6.69 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.567 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 9.0 pt -135.48 105.51 10.05 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.099 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.67 -33.54 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.443 2.096 . . . . 0.0 111.341 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 150' ' ' LYS . . . -69.23 -22.95 63.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.731 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -108.11 -13.75 14.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.633 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.575 HG11 HD11 ' A' ' 98' ' ' ILE . 16.8 t -130.47 134.74 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.23 116.2 42.19 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 38.2 Cg_endo -65.13 -6.0 12.15 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.204 2.603 . . . . 0.0 116.381 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.0 tp -81.7 -45.06 16.24 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.769 -176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.6 t -112.77 8.72 18.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.473 ' O ' HD12 ' A' ' 133' ' ' ILE . 2.0 pp -68.75 136.95 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.804 170.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER -130.38 166.27 20.8 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 144' ' ' THR . 14.8 m -136.41 141.35 43.62 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 118.899 0.772 . . . . 0.0 111.809 -176.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.9 t -131.67 140.83 49.44 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -126.79 137.73 53.25 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.909 -177.324 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 t -100.12 161.63 13.49 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.0 m -67.89 -21.01 65.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.28 7.72 36.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.826 0.822 . . . . 0.0 110.83 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.37 33.49 11.65 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.501 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.1 112.46 32.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -108.68 129.43 55.35 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -175.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 135' ' ' SER . 5.2 p -117.64 129.0 55.47 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 175.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 134' ' ' THR . 62.1 t -103.18 122.42 55.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 134' ' ' THR . 24.1 p-10 -126.79 148.27 49.94 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.31 -118.3 0.9 Allowed Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.566 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -85.84 170.61 8.62 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 124.186 3.257 . . . . 0.0 114.19 -172.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 61.8 ttt180 -141.44 151.2 43.2 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 88.9 tttt . . . . . 0 C--N 1.294 -1.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 . . . . . 0 N--CA 1.432 -1.366 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.406 ' HB3' ' HG3' ' B' ' 150' ' ' LYS . 59.6 tp -63.1 125.72 24.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.902 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' B' ' 149' ' ' ARG . 12.8 pt-20 -146.37 52.98 1.12 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.445 -174.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -87.97 113.75 23.92 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.736 -1.186 . . . . 0.0 110.676 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 78.67 168.23 0.2 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.99 1.316 . . . . 0.0 110.301 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -113.16 149.86 33.03 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.523 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 9.4 t80 -134.78 158.91 42.96 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.819 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 14.7 t -132.26 133.79 44.52 Favored 'General case' 0 N--CA 1.399 -3.015 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.0 137.65 47.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -109.82 135.24 51.04 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' LEU . . . . . 0.651 HD22 ' CE1' ' B' ' 122' ' ' TYR . 1.7 mt -120.22 128.92 53.81 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -107.56 135.38 49.11 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 121.664 0.745 . . . . 0.0 111.802 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.93 -179.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 54.0 mtpt -99.76 -163.3 1.02 Allowed 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 120.301 1.409 . . . . 0.0 110.746 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -77.63 125.8 29.9 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 117.712 -1.595 . . . . 0.0 112.188 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' B' ' 118' ' ' PHE . 47.3 m-85 -142.06 146.51 35.56 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.701 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 14.6 m -66.53 129.61 94.13 Favored Pre-proline 0 N--CA 1.412 -2.342 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.474 ' HB3' HD21 ' B' ' 137' ' ' LEU . 69.9 Cg_exo -48.56 -31.98 19.87 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 124.517 3.478 . . . . 0.0 115.094 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -88.27 -4.68 58.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' B' ' 103' ' ' LYS . 11.3 mm-40 -100.47 -0.02 38.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.433 0.635 . . . . 0.0 110.606 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.402 ' HA ' ' HA2' ' B' ' 102' ' ' GLY . 4.0 pp -121.07 147.7 45.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -133.41 125.92 30.13 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.152 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.79 122.45 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.964 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -118.91 136.39 54.09 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 120.952 0.406 . . . . 0.0 110.737 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.478 HG13 HD13 ' B' ' 98' ' ' ILE . 86.8 t -123.27 116.08 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.77 94.2 4.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.417 ' HA2' ' HG3' ' B' ' 130' ' ' PRO . . . 69.73 -112.62 4.55 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.067 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.38 11.11 35.96 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.075 0.55 . . . . 0.0 111.257 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -117.98 135.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.407 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.593 HD11 HG11 ' B' ' 128' ' ' VAL . 27.5 mm -121.8 120.65 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 46.7 mt-10 -136.53 137.11 39.94 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 118.71 0.686 . . . . 0.0 112.799 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' B' ' 119' ' ' HIS . 46.7 t -107.33 117.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -113.68 119.11 36.31 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 89' ' ' LEU . . . -123.74 135.65 9.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' B' ' 88' ' ' GLU . 25.5 ttpp -120.02 133.48 55.53 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -134.71 129.02 34.09 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.01 120.83 35.89 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -74.55 -65.69 0.83 Allowed 'General case' 0 CA--C 1.478 -1.798 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.083 -168.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 -140.3 124.27 17.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.141 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 112.41 21.11 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' B' ' 112' ' ' GLY . 5.2 t70 -113.87 -163.05 0.84 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.285 -163.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -73.62 -76.1 0.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 123.315 0.646 . . . . 0.0 111.215 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -110.6 -17.51 13.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' B' ' 109' ' ' ASP . . . -129.33 114.39 1.72 Allowed Glycine 0 C--O 1.2 -2.026 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.974 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -94.22 137.3 33.55 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' ARG . 3.1 tt -125.11 137.26 58.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 15.8 m -132.76 162.7 30.79 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.514 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -127.54 149.65 50.04 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.638 1.175 . . . . 0.0 108.164 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 37.1 tt0 -135.84 141.09 44.62 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.462 ' CZ ' ' HD3' ' B' ' 82' ' ' LYS . 9.2 m-85 -126.72 124.95 40.95 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 2.0 p80 -133.1 125.75 30.25 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.914 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 24.7 ttt85 -112.66 137.02 51.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.443 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.9 mtmm -130.03 130.26 44.72 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.772 -173.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' TYR . . . . . 0.651 ' CE1' HD22 ' B' ' 79' ' ' LEU . 45.2 m-85 -121.35 131.97 54.5 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 123.704 0.628 . . . . 0.0 110.111 176.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -118.0 98.92 6.57 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 165.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 8.9 pt -135.37 105.5 10.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.055 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -92.59 -33.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.511 2.141 . . . . 0.0 111.386 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' B' ' 150' ' ' LYS . . . -69.29 -23.45 63.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.096 0.558 . . . . 0.0 111.628 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -107.47 -14.3 14.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.593 HG11 HD11 ' B' ' 98' ' ' ILE . 16.6 t -129.87 134.53 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -172.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -114.74 116.25 43.32 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.417 ' HG3' ' HA2' ' B' ' 95' ' ' GLY . 34.9 Cg_endo -65.16 -5.49 11.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.056 2.504 . . . . 0.0 116.249 -174.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.91 -45.29 15.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.614 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 8.8 t -113.02 9.05 18.62 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ILE . . . . . 0.478 ' O ' HD12 ' B' ' 133' ' ' ILE . 2.0 pp -68.77 136.73 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.774 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 0.2 OUTLIER -130.6 166.15 21.26 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 144' ' ' THR . 16.5 m -136.43 141.38 43.59 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 118.853 0.751 . . . . 0.0 111.746 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 29.6 t -132.1 139.73 48.57 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -125.58 138.2 53.93 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.063 -177.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.24 161.68 13.45 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 13.2 m -67.56 -20.51 65.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -170.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.32 8.19 37.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.791 0.805 . . . . 0.0 110.558 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.27 33.27 12.04 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.713 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.94 112.78 33.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 0.8 OUTLIER -108.87 129.52 55.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -175.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 135' ' ' SER . 7.2 p -117.76 128.76 55.19 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' B' ' 134' ' ' THR . 61.7 t -102.89 122.53 55.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -126.7 148.67 49.84 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.04 -118.5 0.92 Allowed Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 119.775 -1.202 . . . . 0.0 112.761 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -85.47 170.65 9.08 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.391 3.394 . . . . 0.0 114.288 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 61.2 ttt180 -141.77 151.1 42.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 88.2 tttt . . . . . 0 C--N 1.294 -1.807 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 45.1 mt 63.15 -166.88 0.22 Allowed 'General case' 0 C--O 1.242 0.659 0 O-C-N 124.318 1.012 . . . . 0.0 108.975 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -64.08 -68.82 0.32 Allowed 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.248 171.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -140.62 146.37 37.87 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.806 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 2.8 m-20 -54.29 -73.15 0.05 Allowed 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -118.14 131.52 56.4 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.58 160.28 40.93 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.476 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -137.25 133.41 35.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.507 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 46.4 t -116.02 148.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.83 152.71 27.59 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.668 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.663 ' HA ' ' HD2' ' A' ' 120' ' ' ARG . 71.0 mt -120.17 142.14 49.25 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' B' ' 107' ' ' ARG . 13.5 t70 -105.59 120.17 40.98 Favored 'General case' 0 CA--C 1.493 -1.235 0 O-C-N 123.526 0.516 . . . . 0.0 111.898 -166.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 83' ' ' HIS . 20.9 t -140.78 96.85 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 170.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.02 9.7 1.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.456 ' O ' HG12 ' A' ' 81' ' ' VAL . 4.1 m80 -150.19 173.07 14.33 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.445 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 33.9 p90 -103.94 119.02 38.05 Favored 'General case' 0 C--N 1.282 -2.37 0 C-N-CA 117.851 -1.539 . . . . 0.0 113.797 -166.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 104' ' ' HIS . 50.8 m -119.56 65.16 8.74 Favored Pre-proline 0 N--CA 1.422 -1.841 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.826 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 84' ' ' PHE . 35.6 Cg_exo -58.06 -40.37 77.82 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.118 1.879 . . . . 0.0 112.074 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.6 -37.72 16.57 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.266 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 28.3 mt-10 -93.02 28.39 2.14 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -169.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 85' ' ' SER . 3.1 pp -128.66 153.67 47.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.519 174.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.69 129.47 34.83 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.46 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.46 HG21 HD21 ' A' ' 143' ' ' LEU . 19.3 t -107.24 132.82 53.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.11 131.36 47.24 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.399 0.618 . . . . 0.0 111.623 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.57 117.62 55.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -129.12 91.02 3.12 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.18 -113.94 5.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.934 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.27 11.09 39.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 108.971 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.13 137.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.305 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.434 HG13 HG21 ' A' ' 128' ' ' VAL . 36.5 mm -125.08 121.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 30.0 mt-10 -134.36 147.92 50.61 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.884 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.633 ' HB ' HD13 ' A' ' 79' ' ' LEU . 8.5 p -124.75 134.76 66.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -124.14 118.2 26.36 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.2 135.43 6.66 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -133.43 130.53 38.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.518 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 69.7 t60 -139.25 135.95 34.43 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.749 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.8 pt-20 -81.85 120.46 25.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -134.35 -5.29 2.63 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -124.33 124.02 41.48 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -112.99 136.05 53.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.262 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' CG ' HH12 ' B' ' 120' ' ' ARG . 3.6 m-20 -120.44 -170.1 1.92 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -55.55 -74.66 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -120.34 24.74 10.23 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.46 127.65 4.39 Favored Glycine 0 N--CA 1.402 -3.573 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.37 150.6 29.53 Favored 'General case' 0 C--N 1.261 -3.239 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' B' ' 120' ' ' ARG . 3.0 mt -123.78 137.24 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 17.0 m -120.52 150.35 40.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.821 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 35.9 tt0 -137.34 142.37 41.81 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.46 128.25 53.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 12.7 t-80 -131.61 125.97 33.55 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.42 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.663 ' HD2' ' HA ' ' A' ' 79' ' ' LEU . 64.5 mtt-85 -111.22 146.25 37.26 Favored 'General case' 0 CA--C 1.465 -2.302 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 25.0 ttmm -125.82 128.81 48.24 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -128.6 133.04 48.21 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.192 0.597 . . . . 0.0 110.827 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -122.76 98.46 5.92 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.536 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.0 pt -135.59 105.08 9.97 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.146 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.461 ' O ' ' HE2' ' A' ' 150' ' ' LYS . 10.3 Cg_exo -80.45 -39.91 0.23 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.347 2.031 . . . . 0.0 110.237 174.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . -67.44 -17.56 64.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.964 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.41 ' HB2' HD12 ' A' ' 124' ' ' ILE . 3.9 m-20 -113.13 -17.9 12.28 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.006 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.536 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 55.3 t -131.34 126.12 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.32 126.66 26.15 Favored Pre-proline 0 N--CA 1.428 -1.569 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 165.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.6 -24.41 53.83 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 123.931 3.087 . . . . 0.0 115.172 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.3 -24.31 37.29 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 148' ' ' PRO . 11.1 t -116.94 -17.22 10.45 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.88 -1.128 . . . . 0.0 113.197 -172.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.7 mm -81.3 125.22 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.947 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 11.2 p -122.01 167.19 13.39 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.904 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -126.99 133.76 50.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.917 0.389 . . . . 0.0 111.347 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 p -121.24 145.38 47.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.378 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 65.8 tp -123.88 131.52 53.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.431 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 11.7 m -96.76 162.91 13.22 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.1 t -67.43 -13.45 62.04 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -98.45 0.29 44.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.588 0.709 . . . . 0.0 110.465 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.54 4.51 52.54 Favored Glycine 0 C--N 1.316 -0.58 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.171 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 47.5 t -73.18 113.38 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.3 tm? -107.61 132.23 53.52 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.75 124.75 44.95 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.594 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.507 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 26.8 m -99.19 122.31 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -128.12 142.69 51.12 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.65 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.18 176.79 28.71 Favored Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.584 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 50.4 Cg_exo -62.72 141.13 84.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.902 3.068 . . . . 0.0 113.724 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 56.8 mtp180 -80.0 163.32 24.32 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 125' ' ' PRO . 36.4 ttpt . . . . . 0 C--N 1.298 -1.671 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.422 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 . . . . . 0 C--O 1.25 1.128 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 47.1 mt 63.61 -166.67 0.22 Allowed 'General case' 0 C--O 1.254 1.303 0 O-C-N 124.186 0.929 . . . . 0.0 108.896 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -63.69 -69.65 0.26 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.28 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.34 146.08 38.0 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.662 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 2.4 m-20 -53.58 -71.5 0.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -120.23 130.73 54.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.32 160.31 40.75 Favored 'General case' 0 N--CA 1.42 -1.942 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.513 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -137.29 132.67 34.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.954 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.505 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 46.5 t -115.95 148.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -111.58 152.58 27.42 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.686 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' LEU . . . . . 0.644 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 70.7 mt -120.22 142.23 49.2 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.54 119.82 40.07 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -166.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 83' ' ' HIS . 20.5 t -139.79 97.94 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 102.465 -3.161 . . . . 0.0 102.465 169.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -75.77 9.75 2.16 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' HIS . . . . . 0.453 ' O ' HG12 ' B' ' 81' ' ' VAL . 3.7 m80 -150.13 173.28 14.08 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' B' ' 86' ' ' PRO . 34.8 p90 -104.0 118.99 37.99 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 117.804 -1.558 . . . . 0.0 113.787 -166.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.52 ' OG ' ' HB2' ' B' ' 104' ' ' HIS . 49.3 m -119.44 65.26 8.42 Favored Pre-proline 0 N--CA 1.421 -1.895 0 CA-C-N 113.492 -1.686 . . . . 0.0 108.879 170.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' B' ' 84' ' ' PHE . 48.8 Cg_exo -57.45 -40.81 78.25 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.159 1.906 . . . . 0.0 112.07 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -88.01 -38.12 15.76 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 85' ' ' SER . 27.8 mt-10 -91.79 27.56 2.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -170.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' B' ' 85' ' ' SER . 3.1 pp -128.31 154.17 46.22 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.56 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.48 130.01 34.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.289 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.452 HG21 HD21 ' B' ' 143' ' ' LEU . 20.3 t -108.25 132.61 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -128.96 131.38 47.48 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.647 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.59 117.37 54.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tt -129.37 90.67 3.05 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.6 -114.23 5.53 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.98 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -100.65 11.2 40.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.842 0.83 . . . . 0.0 108.968 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.3 137.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.222 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.432 HG13 HG21 ' B' ' 128' ' ' VAL . 36.4 mm -125.08 120.94 59.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 29.7 mt-10 -134.41 147.89 50.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.923 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.625 ' HB ' HD13 ' B' ' 79' ' ' LEU . 9.1 p -124.62 134.72 66.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -123.84 118.39 27.02 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.35 135.37 6.58 Favored Glycine 0 CA--C 1.491 -1.419 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -133.41 130.29 38.5 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' HIS . . . . . 0.52 ' HB2' ' OG ' ' B' ' 85' ' ' SER . 70.0 t60 -139.03 135.94 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.852 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.7 pt-20 -81.68 120.34 24.98 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.57 -5.28 2.55 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 80' ' ' ASP . 66.6 mtp180 -124.61 123.99 41.25 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -112.98 136.16 52.96 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.284 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.414 ' CG ' HH12 ' A' ' 120' ' ' ARG . 4.1 m-20 -120.86 -168.34 1.64 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.44 -74.29 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.521 0.729 . . . . 0.0 112.344 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -118.95 24.2 10.97 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -134.1 128.09 4.79 Favored Glycine 0 N--CA 1.402 -3.61 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -111.56 150.6 29.77 Favored 'General case' 0 C--N 1.263 -3.164 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.495 HG12 ' HG2' ' A' ' 120' ' ' ARG . 3.1 mt -123.9 137.07 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 15.6 m -120.42 150.3 41.01 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.689 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -127.29 148.56 50.23 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 36.0 tt0 -137.47 142.35 41.54 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.42 128.34 53.94 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 12.9 t-80 -131.52 125.82 33.36 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.423 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.644 ' HD2' ' HA ' ' B' ' 79' ' ' LEU . 62.4 mtt-85 -111.04 146.29 36.99 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.451 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 24.8 ttmm -126.15 128.89 48.0 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.93 132.33 47.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 123.203 0.601 . . . . 0.0 110.833 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -121.87 98.49 5.97 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 168.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.9 pt -135.39 104.96 10.14 Favored Pre-proline 0 C--N 1.293 -1.886 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.152 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.469 ' O ' ' HE2' ' B' ' 150' ' ' LYS . 7.9 Cg_exo -80.09 -39.74 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.278 1.985 . . . . 0.0 110.321 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' B' ' 149' ' ' ARG . . . -67.26 -17.98 65.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.861 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ASP . . . . . 0.409 ' HB2' HD12 ' B' ' 124' ' ' ILE . 4.0 m-20 -113.17 -17.99 12.23 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.109 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 55.4 t -131.35 125.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -169.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -122.35 126.43 26.22 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 165.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.69 -24.06 52.7 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.937 3.091 . . . . 0.0 115.152 -171.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 82.3 mt -81.25 -23.94 37.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' THR . . . . . 0.442 ' OG1' ' HD2' ' B' ' 148' ' ' PRO . 8.3 t -117.43 -17.81 9.98 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.779 -1.168 . . . . 0.0 113.102 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.6 mm -81.07 125.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.06 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 14.6 p -122.09 167.6 12.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.649 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -126.95 134.05 50.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 7.0 p -121.16 146.09 47.14 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.858 0.863 . . . . 0.0 109.139 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 66.3 tp -124.98 130.5 52.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.673 0.273 . . . . 0.0 111.387 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 7.4 m -95.89 163.12 13.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -67.66 -14.32 62.84 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -96.63 -0.69 48.17 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.541 0.686 . . . . 0.0 110.628 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.63 5.16 51.79 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.713 -1.232 . . . . 0.0 112.008 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 46.9 t -73.31 113.66 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.3 tm? -107.8 132.0 53.87 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.7 124.79 45.09 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.576 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' VAL . . . . . 0.505 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 26.9 m -99.15 122.39 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.858 -171.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.03 177.47 29.26 Favored Glycine 0 N--CA 1.415 -2.749 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.638 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 52.2 Cg_exo -62.98 140.74 80.81 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.892 3.061 . . . . 0.0 113.793 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 56.4 mtp180 -79.81 163.25 24.57 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.039 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' B' ' 125' ' ' PRO . 35.9 ttpt . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.618 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.455 0.645 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.5 tp -72.09 -51.96 19.05 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.596 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 32.5 mm-40 -150.0 170.21 19.39 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 126.182 1.793 . . . . 0.0 106.254 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -91.54 104.93 17.37 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.349 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' A' ' 149' ' ' ARG . 2.8 m-20 143.16 159.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 129.262 3.025 . . . . 0.0 108.095 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -130.65 126.59 36.97 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -105.92 132.93 51.43 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.962 0.887 . . . . 0.0 112.078 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 146' ' ' ASN . 15.7 m -114.38 131.07 56.69 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.61 131.44 66.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -110.4 130.53 55.53 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.657 HD22 ' CZ ' ' A' ' 122' ' ' TYR . 11.9 mt -120.24 128.3 53.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -103.01 128.26 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.002 0.906 . . . . 0.0 113.01 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.516 HG23 HH12 ' A' ' 120' ' ' ARG . 38.9 t -122.28 142.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -64.31 -56.7 12.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.597 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 18.2 t60 -153.96 125.84 7.74 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.261 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.403 ' CE2' ' HA2' ' A' ' 141' ' ' GLY . 0.3 OUTLIER -130.48 172.17 12.19 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.257 0.48 . . . . 0.0 111.167 177.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 20.9 m -93.16 121.92 64.45 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.93 -28.64 78.79 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.957 2.438 . . . . 0.0 113.483 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.98 -38.64 19.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.632 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.564 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 35.8 mt-10 -85.42 40.08 0.82 Allowed 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.585 0.707 . . . . 0.0 109.519 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 90' ' ' LYS . 1.1 tm? -120.51 145.81 46.92 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -174.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.447 ' N ' HD13 ' A' ' 89' ' ' LEU . 25.9 tptp -144.0 125.88 15.27 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 138.68 40.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.492 ' HG3' ' HB2' ' A' ' 99' ' ' GLU . 13.1 ptmm? -144.34 135.51 25.36 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.601 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.41 116.12 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 97' ' ' VAL . 62.3 tp -120.04 90.86 3.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.99 -111.96 4.56 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.849 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -90.01 4.2 50.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.941 0.896 . . . . 0.0 112.106 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 94' ' ' LEU . 35.4 m -117.48 137.75 50.38 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.349 -0.94 . . . . 0.0 113.195 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 37.2 mm -112.85 119.89 61.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 14.8 mp0 -122.33 136.95 54.99 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.171 0.51 . . . . 0.0 109.867 174.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.6 126.95 61.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.88 42.69 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.01 140.74 12.58 Favored Glycine 0 CA--C 1.477 -2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.564 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 13.9 ptmm? -143.19 144.69 32.28 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 117.214 0.507 . . . . 0.0 109.733 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -136.74 128.82 29.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.56 120.95 25.19 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 21.9 mt-10 -83.95 -74.18 0.39 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.757 -167.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 18.2 ptt-85 -148.57 151.34 34.91 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.103 -173.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -111.48 119.73 39.77 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 -44.29 77.96 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 168.83 -75.34 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -94.23 -12.58 27.92 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.559 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -101.48 137.19 13.15 Favored Glycine 0 N--CA 1.411 -3.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.243 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.2 137.69 52.19 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.33 134.02 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.4 p -134.31 155.23 50.59 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -128.19 148.06 50.6 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -135.05 153.52 52.02 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.039 0.447 . . . . 0.0 109.997 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -122.62 125.99 46.76 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.51 122.11 43.75 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.516 HH12 HG23 ' A' ' 81' ' ' VAL . 41.3 ttp180 -133.11 138.0 46.52 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.878 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.492 ' HG2' ' HG3' ' A' ' 99' ' ' GLU . 33.1 mttm -139.87 130.46 25.69 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.099 0.875 . . . . 0.0 112.157 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CZ ' HD22 ' A' ' 79' ' ' LEU . 44.0 m-85 -126.15 136.95 53.48 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -117.32 98.63 6.53 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.598 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.8 pt -136.41 106.16 9.29 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.267 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -88.79 -45.88 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.193 1.929 . . . . 0.0 112.873 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.92 -13.03 62.19 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.488 0.661 . . . . 0.0 112.596 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -112.1 -17.65 12.78 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 2.9 t -132.6 117.67 31.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.57 123.27 26.43 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.15 -1.57 3.05 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.633 2.888 . . . . 0.0 116.339 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.4 tp -59.78 -44.43 93.92 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.475 ' HB ' ' HD3' ' A' ' 148' ' ' PRO . 39.6 m -110.84 -12.8 14.23 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.642 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 55.4 mt -67.99 126.08 27.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -165.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 p -122.11 163.61 19.17 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.385 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 144' ' ' THR . 26.7 t -138.0 135.68 36.19 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.217 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.8 p -127.75 156.27 42.71 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.41 144.07 44.3 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.195 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.488 ' HB3' ' HB ' ' A' ' 142' ' ' VAL . 17.8 t -100.49 162.74 12.74 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.7 m -61.55 -28.01 69.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.761 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 37.5 t70 -90.18 -12.3 38.55 Favored 'General case' 0 C--O 1.205 -1.265 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.343 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.403 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . 120.75 8.91 7.91 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 117.978 -2.058 . . . . 0.0 113.237 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 138' ' ' SER . 51.4 t -78.89 118.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.8 tm? -115.23 133.75 55.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 135' ' ' SER . 27.5 m -121.56 130.13 53.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.841 -0.537 . . . . 0.0 111.078 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.3 m -121.03 125.53 74.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.642 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 7.9 p30 -137.27 137.52 39.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.048 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . -158.78 -143.27 3.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.29 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 132' ' ' THR . 93.7 Cg_endo -102.73 169.64 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.022 3.148 . . . . 0.0 112.589 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 61.4 ttt180 -96.36 138.03 34.56 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.435 -1.175 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.578 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.523 0.678 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.12 -52.01 21.77 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' B' ' 149' ' ' ARG . 28.4 mm-40 -149.83 170.93 17.61 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -92.4 105.25 17.47 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' B' ' 149' ' ' ARG . 2.5 m-20 142.48 159.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 129.084 2.954 . . . . 0.0 107.828 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -131.01 126.65 36.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -105.91 132.94 51.4 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.132 0.968 . . . . 0.0 111.976 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -113.76 131.19 56.3 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.79 131.35 67.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -110.47 130.51 55.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' LEU . . . . . 0.648 HD22 ' CZ ' ' B' ' 122' ' ' TYR . 11.4 mt -120.34 128.47 53.28 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.52 127.92 49.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.955 0.883 . . . . 0.0 113.108 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.524 HG23 HH12 ' B' ' 120' ' ' ARG . 39.0 t -122.32 141.9 40.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.24 -56.51 14.13 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.718 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' HIS . . . . . 0.777 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 18.2 t60 -153.97 125.74 7.69 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.255 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.42 172.06 12.29 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.267 0.485 . . . . 0.0 111.108 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 22.9 m -93.17 122.25 63.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.19 -28.3 78.68 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.938 2.425 . . . . 0.0 113.553 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -85.51 -38.52 18.46 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.787 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' B' ' 103' ' ' LYS . 35.5 mt-10 -85.22 40.17 0.81 Allowed 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.479 0.656 . . . . 0.0 109.4 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.45 HD13 ' N ' ' B' ' 90' ' ' LYS . 1.1 tm? -120.59 145.83 46.97 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.45 ' N ' HD13 ' B' ' 89' ' ' LEU . 26.1 tptp -144.18 125.74 14.97 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.07 139.09 38.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' B' ' 99' ' ' GLU . 13.5 ptmm? -144.45 135.82 25.5 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.14 116.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.447 ' O ' HG22 ' B' ' 97' ' ' VAL . 62.4 tp -119.92 90.56 3.35 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.67 -111.96 4.58 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.625 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -90.08 4.17 51.1 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 123.933 0.893 . . . . 0.0 112.192 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 94' ' ' LEU . 29.2 m -117.25 137.74 50.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.315 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 37.6 mm -112.81 120.03 61.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' B' ' 92' ' ' LYS . 15.2 mp0 -122.46 137.04 55.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 121.199 0.523 . . . . 0.0 109.842 174.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.41 HG21 HD12 ' B' ' 79' ' ' LEU . 92.4 t -130.69 127.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.64 41.86 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.78 140.88 12.76 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.551 ' HG3' ' HB3' ' B' ' 88' ' ' GLU . 13.7 ptmm? -143.33 144.75 32.22 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 117.25 0.525 . . . . 0.0 109.78 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -136.75 128.65 29.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -80.19 121.08 25.15 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.17 -73.8 0.41 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.825 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -148.58 151.3 34.82 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.326 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -111.75 119.14 37.63 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.01 -44.51 80.15 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 169.04 -74.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -94.79 -12.79 26.42 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.589 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -101.45 137.2 13.16 Favored Glycine 0 N--CA 1.411 -3.02 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.245 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.18 137.54 52.27 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 134.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 36.7 p -134.31 155.13 50.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -128.21 148.15 50.61 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -135.19 153.43 51.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.988 0.423 . . . . 0.0 109.894 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.66 125.91 46.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.5 122.19 44.01 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.524 HH12 HG23 ' B' ' 81' ' ' VAL . 41.4 ttp180 -133.27 137.82 46.2 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.757 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.48 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 32.9 mttm -139.57 130.37 26.06 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 124.293 0.995 . . . . 0.0 112.11 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' TYR . . . . . 0.648 ' CZ ' HD22 ' B' ' 79' ' ' LEU . 46.4 m-85 -126.32 136.44 52.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -117.1 98.79 6.65 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.591 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -136.43 106.43 9.27 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.331 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -88.99 -45.39 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.207 1.938 . . . . 0.0 112.869 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.8 -13.97 62.74 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.468 0.651 . . . . 0.0 112.61 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -112.36 -17.22 12.77 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.311 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 2.9 t -132.56 117.47 31.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -123.41 123.48 26.5 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.24 -1.53 3.07 Favored 'Trans proline' 0 CA--C 1.551 1.361 0 C-N-CA 123.587 2.858 . . . . 0.0 116.223 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.44 -44.44 92.94 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' B' ' 148' ' ' PRO . 48.3 m -111.23 -11.65 14.19 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 55.0 mt -68.35 126.17 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -122.63 163.04 20.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.01 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.2 t -137.51 136.58 37.81 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 121.249 0.547 . . . . 0.0 111.243 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 10.1 p -128.5 156.64 42.94 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.74 143.67 43.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.125 0.488 . . . . 0.0 111.265 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' B' ' 142' ' ' VAL . 14.4 t -100.72 162.64 12.78 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.5 m -61.61 -27.39 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -168.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' ASP . . . . . 0.777 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 36.8 t70 -90.59 -12.61 36.47 Favored 'General case' 0 C--O 1.203 -1.349 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.329 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.17 9.06 7.52 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 118.095 -2.002 . . . . 0.0 113.222 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 138' ' ' SER . 56.8 t -78.84 118.49 26.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.9 tm? -115.15 133.8 55.72 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' B' ' 135' ' ' SER . 31.1 m -121.57 129.97 53.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.834 -0.541 . . . . 0.0 110.974 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 19.1 m -120.92 125.16 73.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ASN . . . . . 0.649 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 7.8 p30 -136.95 137.6 39.69 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.225 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.577 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . -158.79 -143.51 3.68 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.121 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' B' ' 132' ' ' THR . 96.9 Cg_endo -102.7 169.69 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.938 3.092 . . . . 0.0 112.586 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ARG . . . . . 0.587 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 62.9 ttt180 -96.28 138.25 34.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.715 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.928 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 . . . . . 0 N--CA 1.427 -1.588 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.75 131.52 35.26 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -82.87 104.67 13.27 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -85.35 106.89 17.06 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 122.555 1.169 . . . . 0.0 112.11 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -136.41 149.17 48.15 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -94.92 119.67 33.85 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -126.86 154.42 44.4 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.932 -172.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.9 p -136.86 144.84 43.79 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.553 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 42.4 t -115.3 132.49 64.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -110.79 138.4 47.24 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' A' ' 122' ' ' TYR . 5.8 mp -118.26 126.12 51.51 Favored 'General case' 0 N--CA 1.386 -3.655 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -116.32 139.26 50.58 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.22 1.008 . . . . 0.0 110.551 -175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' HB ' ' NH1' ' A' ' 120' ' ' ARG . 8.4 p -155.06 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.464 ' H ' HG22 ' A' ' 81' ' ' VAL . 72.9 mmtt -85.68 -163.39 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 119.139 0.881 . . . . 0.0 110.806 176.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.588 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 74.7 m80 -78.54 124.44 28.16 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.612 0.72 . . . . 0.0 111.693 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -149.89 150.43 31.9 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 p -80.89 119.1 75.13 Favored Pre-proline 0 C--N 1.287 -2.123 0 C-N-CA 123.351 0.66 . . . . 0.0 112.432 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.06 -28.54 14.05 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 124.789 3.66 . . . . 0.0 115.122 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.55 -27.59 51.59 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 122.095 -0.378 . . . . 0.0 111.629 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.34 8.27 28.35 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.52 150.43 40.85 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.065 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -130.25 131.81 45.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 100' ' ' VAL . 32.6 m -103.32 138.11 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 -176.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 78.3 mttt -114.25 130.82 56.64 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.7 111.07 21.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.4 95.66 3.12 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.15 -111.53 3.54 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.598 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -99.45 4.14 45.99 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.105 0.962 . . . . 0.0 111.221 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -113.5 137.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.983 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 145' ' ' VAL . 26.3 mt -130.31 120.48 48.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 43.7 mt-10 -136.74 149.69 47.98 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.675 0.274 . . . . 0.0 110.368 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 91' ' ' VAL . 61.8 t -126.32 114.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -115.22 131.01 57.06 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.09 147.97 19.5 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -143.28 131.8 22.34 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 122.393 0.277 . . . . 0.0 110.784 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -136.66 128.88 29.81 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.21 -0.307 . . . . 0.0 110.274 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -80.82 121.36 25.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -79.99 -52.14 8.2 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.779 0.323 . . . . 0.0 110.886 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 114' ' ' ILE . 11.2 ptt180 -148.56 147.11 28.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.96 136.94 50.64 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.804 0.812 . . . . 0.0 111.63 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -90.77 -166.29 1.55 Allowed 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.09 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -47.63 -65.65 0.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.254 1.422 . . . . 0.0 111.41 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -141.78 39.22 1.66 Allowed 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.46 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -137.3 144.44 15.94 Favored Glycine 2 N--CA 1.382 -4.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 108.198 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.83 149.89 45.19 Favored 'General case' 0 C--N 1.245 -3.966 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 107' ' ' ARG . 5.5 pt -122.87 134.74 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.4 m -135.03 162.33 32.76 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.374 0.607 . . . . 0.0 110.688 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.72 147.56 49.95 Favored 'General case' 0 N--CA 1.39 -3.447 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 56.2 mt-10 -136.92 151.64 49.28 Favored 'General case' 0 C--N 1.261 -3.241 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -126.07 126.65 44.56 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -129.75 121.91 27.81 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' NH1' ' HB ' ' A' ' 81' ' ' VAL . 37.7 ttp180 -125.51 136.77 53.69 Favored 'General case' 0 C--N 1.263 -3.182 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.461 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 45.9 mtmt -138.49 129.82 27.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 123.399 0.437 . . . . 0.0 110.827 -169.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.508 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 73.2 m-85 -131.7 143.45 50.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.165 0.586 . . . . 0.0 111.171 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -128.2 98.59 5.14 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 167.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.5 pt -137.06 105.54 8.75 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.998 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.69 -40.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.383 2.055 . . . . 0.0 113.26 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 149' ' ' ARG . . . -69.41 -33.87 73.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.954 0.407 . . . . 0.0 111.454 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -88.77 -17.1 30.53 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.655 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 78.8 t -127.36 120.49 55.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.354 0.597 . . . . 0.0 111.894 -175.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -115.7 119.62 37.3 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.512 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 97.7 Cg_endo -74.28 19.46 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.024 2.483 . . . . 0.0 116.305 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.96 -47.87 12.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.219 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 148' ' ' PRO 0.362 8.9 t -121.82 10.88 10.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.554 HG23 ' HD2' ' A' ' 148' ' ' PRO . 1.2 pp -67.7 135.21 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.1 p -125.83 166.56 16.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.421 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 144' ' ' THR . 17.4 m -127.54 133.82 49.79 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.03 0.443 . . . . 0.0 110.175 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.3 m -116.67 133.48 55.96 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.26 128.2 53.8 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.6 m -97.56 162.02 13.49 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.1 m -68.33 -15.25 63.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.468 1.107 . . . . 0.0 113.491 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 10.2 t70 -90.6 -12.72 36.12 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.06 -2.04 35.4 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.65 137.13 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.401 ' CD1' HG13 ' A' ' 145' ' ' VAL . 3.3 tm? -127.0 134.43 50.35 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -173.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 135' ' ' SER . 58.1 m -115.54 120.5 39.68 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.0 m -101.57 121.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 13.0 p30 -133.89 137.43 44.95 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.833 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.43 -133.65 2.87 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 133' ' ' ILE . 60.8 Cg_endo -98.59 160.2 0.72 Allowed 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.976 2.45 . . . . 0.0 113.474 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 126' ' ' ALA . 57.9 ttt-85 -110.0 163.41 13.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 4.0 ttmp? . . . . . 0 C--N 1.311 -1.09 0 CA-C-O 118.801 -0.619 . . . . 0.0 109.846 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 . . . . . 0 N--CA 1.428 -1.557 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.6 131.92 35.56 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -83.35 105.28 14.18 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -85.71 107.18 17.47 Favored 'General case' 0 N--CA 1.412 -2.354 0 CA-C-O 122.373 1.082 . . . . 0.0 112.17 -167.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -136.95 148.98 47.28 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -94.71 119.58 33.56 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -126.75 154.68 43.88 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.972 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 20.1 p -137.04 144.82 43.41 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.554 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 42.7 t -115.29 132.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.28 138.61 46.43 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' B' ' 122' ' ' TYR . 5.8 mp -118.1 126.13 51.65 Favored 'General case' 0 N--CA 1.383 -3.798 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -116.25 139.24 50.58 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 124.239 1.016 . . . . 0.0 110.572 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.52 ' HB ' ' NH1' ' B' ' 120' ' ' ARG . 8.4 p -154.89 -174.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.474 ' H ' HG22 ' B' ' 81' ' ' VAL . 73.1 mmtt -85.74 -163.49 0.87 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 119.159 0.89 . . . . 0.0 110.991 175.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 74.9 m80 -78.4 124.43 28.11 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 121.631 0.729 . . . . 0.0 111.664 -172.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -150.25 150.1 31.07 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 1.6 p -80.7 119.0 74.94 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 123.27 0.628 . . . . 0.0 112.522 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.1 -28.88 14.9 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 124.685 3.59 . . . . 0.0 115.148 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.3 -26.94 52.78 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 122.138 -0.351 . . . . 0.0 111.729 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.86 8.25 30.14 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.957 -0.464 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.51 150.47 40.78 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.98 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.468 HG12 HG22 ' B' ' 100' ' ' VAL . 31.8 m -104.4 138.56 28.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.525 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' B' ' 98' ' ' ILE . 78.0 mttt -114.6 130.77 56.82 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 50.2 t -129.88 111.0 20.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -137.45 95.97 3.17 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.92 -111.54 3.56 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.468 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.84 4.24 45.08 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.846 0.858 . . . . 0.0 111.263 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.25 136.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.969 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.455 HD13 HG21 ' B' ' 145' ' ' VAL . 25.8 mt -130.18 120.54 49.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 43.9 mt-10 -136.84 149.7 47.85 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.795 0.331 . . . . 0.0 110.379 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG12 ' B' ' 91' ' ' VAL . 61.4 t -126.27 114.09 36.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -114.87 130.72 56.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.27 148.14 19.77 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' B' ' 103' ' ' LYS . 11.7 ptmt -143.41 132.4 22.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 122.412 0.285 . . . . 0.0 110.822 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -136.97 129.48 30.1 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -81.12 121.21 25.81 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.56 -52.09 8.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.914 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.45 ' HG2' HD11 ' B' ' 114' ' ' ILE . 11.6 ptt180 -149.05 146.71 27.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.57 137.22 49.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.793 0.806 . . . . 0.0 111.739 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -91.19 -166.22 1.53 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.127 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -46.59 -66.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.394 1.478 . . . . 0.0 111.302 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -141.69 39.83 1.69 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.508 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -138.47 144.24 15.31 Favored Glycine 2 N--CA 1.384 -4.779 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.101 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.81 150.24 44.74 Favored 'General case' 1 C--N 1.243 -4.028 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.45 HD11 ' HG2' ' B' ' 107' ' ' ARG . 5.5 pt -123.11 134.85 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m -135.01 162.16 33.25 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-O 121.368 0.604 . . . . 0.0 110.619 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.87 147.39 50.06 Favored 'General case' 0 N--CA 1.392 -3.355 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 55.9 mt-10 -136.88 151.24 48.86 Favored 'General case' 0 C--N 1.26 -3.317 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -125.61 127.05 45.72 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -130.14 121.79 26.97 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.52 ' NH1' ' HB ' ' B' ' 81' ' ' VAL . 37.7 ttp180 -125.43 136.73 53.71 Favored 'General case' 0 C--N 1.26 -3.286 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.455 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 45.6 mtmt -138.41 129.84 27.55 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.344 0.403 . . . . 0.0 110.825 -169.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' TYR . . . . . 0.46 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 74.6 m-85 -131.57 143.8 50.62 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.681 0.613 . . . . 0.0 111.147 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -128.42 98.59 5.1 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 167.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.6 pt -137.18 105.42 8.66 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.01 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -90.7 -40.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.377 2.052 . . . . 0.0 113.143 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.06 74.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.867 0.365 . . . . 0.0 111.451 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.63 -17.04 30.92 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.61 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 80.8 t -127.16 120.24 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.531 0.681 . . . . 0.0 111.901 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.38 119.24 38.55 Favored Pre-proline 0 C--N 1.287 -2.131 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.506 ' HA ' ' CG1' ' B' ' 133' ' ' ILE . 82.8 Cg_endo -74.21 19.72 0.43 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.005 2.47 . . . . 0.0 116.277 -171.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.99 -47.83 12.2 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.989 -1.084 . . . . 0.0 112.267 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' THR . . . . . 0.537 HG22 ' HG3' ' B' ' 148' ' ' PRO 0.368 8.9 t -121.99 10.97 10.21 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ILE . . . . . 0.548 HG23 ' HD2' ' B' ' 148' ' ' PRO . 1.2 pp -67.76 134.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 2.7 p -125.36 166.87 15.78 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.474 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' B' ' 144' ' ' THR . 17.9 m -127.48 133.61 49.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 15.1 m -116.65 133.09 56.43 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 5.8 mp -105.92 128.25 53.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 17.0 m -97.02 161.76 13.68 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.9 m -68.17 -14.04 62.68 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.426 1.09 . . . . 0.0 113.468 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 9.3 t70 -91.46 -12.74 33.79 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.71 -2.09 36.32 Favored Glycine 0 C--O 1.261 1.825 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 89.3 t -73.74 137.26 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.404 ' CD1' HG13 ' B' ' 145' ' ' VAL . 3.3 tm? -127.21 134.52 50.1 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 135' ' ' SER . 57.9 m -115.63 120.68 40.21 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' VAL . . . . . 0.554 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 5.8 m -101.8 121.89 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -133.65 137.17 45.23 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.722 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.01 -133.46 2.78 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' B' ' 133' ' ' ILE . 92.8 Cg_endo -98.04 160.33 0.84 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.28 2.653 . . . . 0.0 113.6 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -110.64 163.19 13.99 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' B' ' 150' ' ' LYS . 4.1 ttmp? . . . . . 0 C--N 1.308 -1.229 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.291 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 C--O 1.215 -0.739 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.8 mt -168.63 112.24 0.57 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 126.564 1.946 . . . . 0.0 107.675 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 149' ' ' ARG . 36.1 tt0 -149.43 72.28 1.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 149' ' ' ARG . 58.6 mtpt -99.3 106.16 18.24 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 77.96 157.38 0.17 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.993 1.717 . . . . 0.0 109.983 -174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -105.52 131.32 53.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 22.7 t80 -110.07 134.8 51.78 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.415 -171.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.9 m -113.13 129.71 56.42 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.0 t -114.97 130.76 68.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.73 155.91 24.75 Favored 'General case' 0 C--N 1.264 -3.152 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 143' ' ' LEU . 31.5 tp -118.2 127.56 53.87 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.89 136.17 52.84 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -177.07 168.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -87.37 -175.14 5.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.623 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -77.73 125.61 29.61 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.993 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.05 160.65 38.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.613 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 14.3 m -66.56 107.9 1.96 Allowed Pre-proline 0 CA--C 1.554 1.102 0 O-C-N 124.523 1.14 . . . . 0.0 112.89 -170.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 54.4 Cg_exo -57.26 -28.3 79.01 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.314 3.343 . . . . 0.0 113.968 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -86.75 -9.44 55.87 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.777 0.323 . . . . 0.0 111.063 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 24.8 mm-40 -113.47 19.75 16.64 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.351 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 3.9 pp -120.82 153.8 36.61 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.318 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.73 125.86 45.5 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.723 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -109.35 122.18 63.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -125.73 131.37 52.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.529 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.46 HG23 HG12 ' A' ' 98' ' ' ILE . 3.4 p -124.01 113.03 35.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.37 91.23 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA2' ' HG3' ' A' ' 130' ' ' PRO . . . 66.65 -111.92 4.5 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.11 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.51 9.26 39.21 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.248 1.019 . . . . 0.0 111.612 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.12 136.03 61.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.536 -0.727 . . . . 0.0 109.535 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 93' ' ' VAL . 44.6 mt -130.37 121.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 47.4 mt-10 -132.24 148.35 52.45 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.635 -178.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.51 127.43 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.203 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -136.37 120.01 17.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.26 162.01 27.24 Favored Glycine 0 CA--C 1.482 -2.015 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.93 143.83 51.02 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -120.77 135.19 55.22 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.48 129.11 34.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 116' ' ' ARG . 42.5 mt-10 -105.0 -76.08 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.414 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 48.7 mtm-85 -141.15 141.82 34.1 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -112.0 136.52 51.24 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.202 0.525 . . . . 0.0 110.922 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 112' ' ' GLY . 33.4 m-20 -97.12 -155.46 0.49 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 173.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.46 -57.18 3.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' B' ' 123' ' ' ARG . 57.3 m80 -100.52 -11.0 20.49 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.482 -176.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -112.3 139.71 15.79 Favored Glycine 1 N--CA 1.395 -4.085 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.428 -176.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -130.14 140.0 50.83 Favored 'General case' 0 C--N 1.256 -3.487 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.411 HG12 ' HG3' ' B' ' 120' ' ' ARG . 3.1 mt -123.73 132.94 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -136.43 158.28 44.81 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.491 ' HB2' ' OE2' ' A' ' 106' ' ' GLU . 22.8 ttm180 -127.04 148.44 50.12 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.3 mt-10 -125.0 150.78 46.35 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.08 124.75 37.78 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -131.79 132.34 43.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.876 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.423 HH21 ' CG ' ' B' ' 109' ' ' ASP . 44.4 ttt180 -130.35 137.88 50.13 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 27.7 mtpp -122.86 127.14 48.62 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.303 1.2 p90 -134.36 115.61 14.25 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' B' ' 111' ' ' HIS . 68.8 ttt180 -102.5 99.69 9.74 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.356 0.598 . . . . 0.0 109.764 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.0 pt -124.08 105.54 31.68 Favored Pre-proline 0 C--N 1.288 -2.107 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.458 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -90.13 -52.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.144 2.562 . . . . 0.0 113.163 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.9 64.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.351 0.596 . . . . 0.0 111.364 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.09 -18.14 17.88 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.321 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 57.4 t -132.15 113.48 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 17.2 t70 -100.16 128.39 30.79 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.428 ' HG3' ' HA2' ' A' ' 95' ' ' GLY . 72.3 Cg_endo -71.04 16.71 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.664 2.243 . . . . 0.0 116.442 -171.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 tp -82.02 -46.97 13.22 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.257 14.3 t -120.36 9.99 11.12 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -68.44 130.3 33.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.8 t -137.75 163.0 32.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.454 ' HB2' HD11 ' A' ' 143' ' ' LEU . 16.8 p -128.0 133.0 49.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.8 t -125.89 129.56 49.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.06 135.06 48.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.453 0.644 . . . . 0.0 111.855 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.1 m -100.82 163.45 12.31 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.025 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.4 m -60.29 -21.85 62.44 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.21 7.37 41.05 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 121.383 0.611 . . . . 0.0 111.385 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.15 -6.12 61.57 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.534 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -73.95 112.76 11.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 144' ' ' THR . 1.9 tp -122.34 134.67 54.64 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.266 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.566 ' N ' HD12 ' A' ' 143' ' ' LEU . 17.8 m -117.75 117.92 30.65 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 134' ' ' THR . 31.8 t -101.65 121.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 8.9 p30 -135.38 144.07 46.4 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.396 -0.815 . . . . 0.0 111.164 -174.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.01 -136.45 2.17 Favored Glycine 0 N--CA 1.425 -2.087 0 O-C-N 123.806 0.691 . . . . 0.0 111.552 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.402 ' HG2' ' HB3' ' A' ' 129' ' ' ASP . 94.4 Cg_endo -96.73 142.77 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.149 2.566 . . . . 0.0 113.632 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.502 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 67.8 ttt180 -92.84 133.41 36.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 C--N 1.291 -1.967 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.314 -172.816 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 . . . . . 0 C--O 1.218 -0.563 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 23.9 mt -168.95 111.68 0.52 Allowed 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.529 1.932 . . . . 0.0 107.768 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 149' ' ' ARG . 34.3 tt0 -149.23 72.38 1.16 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' B' ' 149' ' ' ARG . 58.0 mtpt -99.21 106.18 18.31 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 78.44 157.16 0.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.711 1.604 . . . . 0.0 109.83 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -105.74 130.02 53.83 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 21.4 t80 -108.91 132.29 54.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.205 0.526 . . . . 0.0 110.915 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 26.9 m -110.45 129.58 55.74 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.008 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.89 130.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -113.41 155.83 24.56 Favored 'General case' 0 C--N 1.261 -3.268 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' B' ' 143' ' ' LEU . 31.3 tp -118.11 127.64 53.97 Favored 'General case' 0 N--CA 1.387 -3.598 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -113.2 136.03 53.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -177.38 168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -86.49 -175.34 5.42 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.718 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -77.63 125.66 29.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.124 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.23 160.97 37.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.436 -1.257 . . . . 0.0 107.624 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 15.8 m -66.36 107.38 1.56 Allowed Pre-proline 0 C--N 1.311 -1.095 0 O-C-N 124.536 1.148 . . . . 0.0 112.972 -170.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.443 ' HA ' ' CD2' ' B' ' 89' ' ' LEU . 50.8 Cg_exo -57.15 -28.37 78.81 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.071 3.181 . . . . 0.0 114.024 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.96 -9.64 55.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' B' ' 85' ' ' SER . 22.1 mm-40 -112.7 19.45 17.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.402 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.443 ' CD2' ' HA ' ' B' ' 86' ' ' PRO . 3.9 pp -120.87 153.34 37.3 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.323 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -123.09 126.02 46.28 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.935 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.76 122.32 64.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.99 131.62 52.2 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.475 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.471 HG23 HG12 ' B' ' 98' ' ' ILE . 3.4 p -124.15 112.95 34.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 84.5 mt -127.16 91.17 3.27 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.443 ' HA2' ' HG3' ' B' ' 130' ' ' PRO . . . 67.0 -112.1 4.62 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.874 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.52 9.09 39.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 124.371 1.068 . . . . 0.0 111.701 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.96 136.12 60.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.639 -0.663 . . . . 0.0 109.359 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.471 HG12 HG23 ' B' ' 93' ' ' VAL . 46.2 mt -130.72 121.38 50.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 46.6 mt-10 -132.26 148.44 52.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.095 0.474 . . . . 0.0 111.592 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.43 127.53 62.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.144 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -136.59 120.05 17.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 161.86 27.27 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.477 ' HB3' ' HG2' ' B' ' 117' ' ' GLU . 0.0 OUTLIER -130.45 143.95 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -120.71 135.37 55.15 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.81 128.01 33.17 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.487 ' OE2' ' HB2' ' B' ' 116' ' ' ARG . 42.9 mt-10 -103.7 -77.4 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 -139.86 142.56 36.57 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -112.19 136.14 51.97 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.634 0.73 . . . . 0.0 111.265 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' B' ' 112' ' ' GLY . 37.1 m-20 -96.83 -155.79 0.5 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 172.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.8 -57.31 3.03 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 122.037 0.922 . . . . 0.0 108.617 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' A' ' 123' ' ' ARG . 54.0 m80 -101.66 -11.13 19.42 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.178 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -111.12 139.57 15.62 Favored Glycine 0 N--CA 1.396 -3.981 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.591 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.22 139.68 50.79 Favored 'General case' 0 C--N 1.257 -3.437 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.16 133.18 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 46.8 m -136.44 158.18 45.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.487 ' HB2' ' OE2' ' B' ' 106' ' ' GLU . 22.4 ttm180 -127.19 148.25 50.19 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 36.9 mt-10 -125.02 150.85 46.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -128.16 124.89 37.97 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -131.87 132.09 43.34 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.411 ' HG3' HG12 ' A' ' 114' ' ' ILE . 43.9 ttt180 -130.19 137.91 50.32 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.515 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.6 mtpp -122.65 127.11 48.91 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' TYR . . . . . . . . . . . . 0.3 1.3 p90 -134.39 115.27 13.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 111' ' ' HIS . 71.0 ttt180 -101.95 99.73 9.94 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.394 0.616 . . . . 0.0 109.948 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.0 pt -123.99 105.52 31.92 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.538 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -90.01 -53.14 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 123.013 2.475 . . . . 0.0 113.136 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 -18.9 65.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.58 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -99.57 -18.1 17.53 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.265 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 60.0 t -132.21 113.8 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ASP . . . . . 0.408 ' HB3' ' HG2' ' B' ' 148' ' ' PRO . 17.5 t70 -100.81 128.31 30.12 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.443 ' HG3' ' HA2' ' B' ' 95' ' ' GLY . 72.1 Cg_endo -71.09 16.39 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.837 2.358 . . . . 0.0 116.415 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.76 -46.66 13.91 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' THR . . . . . 0.416 HG22 ' HG3' ' B' ' 148' ' ' PRO . 13.9 t -120.97 10.23 10.77 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.0 OUTLIER -68.36 130.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 134' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 11.9 t -137.84 162.99 32.54 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.449 ' HB2' HD11 ' B' ' 143' ' ' LEU . 15.0 p -127.79 133.14 49.44 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.257 0.551 . . . . 0.0 112.148 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -126.45 129.36 48.54 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.41 134.73 48.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.098 0.475 . . . . 0.0 111.68 -174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 20.1 m -100.72 163.36 12.36 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.138 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -60.47 -21.18 62.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -91.95 8.01 39.49 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.515 0.674 . . . . 0.0 111.171 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.87 -5.85 61.99 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.496 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 67.1 t -74.16 112.98 11.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.264 0.554 . . . . 0.0 109.506 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.57 HD12 ' N ' ' B' ' 144' ' ' THR . 1.8 tp -122.67 134.43 54.48 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.123 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.57 ' N ' HD12 ' B' ' 143' ' ' LEU . 16.6 m -117.22 118.24 31.77 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 134' ' ' THR . 35.5 t -102.24 121.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.4 p30 -134.97 144.17 47.26 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.305 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.88 -136.61 2.2 Favored Glycine 0 N--CA 1.423 -2.202 0 O-C-N 123.654 0.596 . . . . 0.0 111.738 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.416 ' HG3' HG22 ' B' ' 132' ' ' THR . 93.1 Cg_endo -96.72 142.63 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.265 2.644 . . . . 0.0 113.505 -176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 71.0 ttt180 -92.9 133.86 35.67 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 84.3 tttt . . . . . 0 C--N 1.29 -1.998 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.243 -172.422 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 31.3 t70 . . . . . 0 CA--C 1.484 -1.563 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -94.37 117.57 30.32 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' ASN . 51.0 t80 -110.7 142.65 42.33 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.6 m -137.58 131.57 31.85 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.382 0.61 . . . . 0.0 111.641 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.644 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 47.6 t -118.9 141.68 37.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -111.78 143.82 42.09 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.974 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 3.1 mm? -119.99 127.6 52.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' B' ' 107' ' ' ARG . 0.6 OUTLIER -117.2 127.26 53.93 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.597 -175.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.85 116.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 103.344 -2.836 . . . . 0.0 103.344 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.4 -54.34 41.97 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.316 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -150.43 121.97 7.97 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.41 171.65 18.69 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 126.943 2.097 . . . . 0.0 106.983 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 20.3 m -112.87 141.13 24.95 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 85' ' ' SER . 80.6 Cg_exo -48.89 -28.31 13.0 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 125.131 3.887 . . . . 0.0 116.361 -172.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -73.98 -19.78 60.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.042 0.449 . . . . 0.0 111.227 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 3.0 mp0 -98.25 18.1 17.11 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.921 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.18 147.96 44.26 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.499 0.666 . . . . 0.0 111.166 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -138.24 124.7 20.66 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 p -109.83 129.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' HG3' ' HB2' ' A' ' 99' ' ' GLU . 17.5 ptmt -129.96 130.67 45.36 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 121.384 0.611 . . . . 0.0 111.244 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.8 117.81 52.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.64 90.94 2.71 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.312 0.577 . . . . 0.0 109.727 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 -111.82 4.44 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.855 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.87 -4.91 59.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.77 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.03 137.61 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 122' ' ' TYR . 4.0 tp -124.72 119.94 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 35.5 mt-10 -138.18 149.71 46.09 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.357 -173.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.415 HG22 ' HB3' ' A' ' 120' ' ' ARG . 19.5 m -124.33 134.23 67.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -123.92 124.71 43.22 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.901 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 88' ' ' GLU . . . -124.25 142.65 14.26 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -143.04 126.56 16.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -136.32 141.01 43.76 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.531 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.21 120.81 26.28 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -82.22 -62.47 1.61 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 123.562 0.745 . . . . 0.0 111.289 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.514 ' HB2' HD12 ' A' ' 114' ' ' ILE . 39.3 mtm180 -141.67 125.13 16.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.867 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 131.24 49.54 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.47 171.96 13.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 119.255 -0.403 . . . . 0.0 110.378 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 13.59 -83.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 127.652 2.381 . . . . 0.0 114.468 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.24 30.06 1.05 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -131.86 131.05 6.15 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.448 -1.705 . . . . 0.0 109.32 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -121.35 149.47 42.91 Favored 'General case' 1 C--N 1.238 -4.265 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 107' ' ' ARG . 16.5 mt -123.3 132.97 70.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.1 m -129.23 158.42 39.1 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.109 0.481 . . . . 0.0 110.33 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -133.97 148.52 51.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 49.2 mt-10 -132.49 150.24 52.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.78 125.06 42.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -132.16 122.12 24.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.741 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.472 ' HG3' HG12 ' B' ' 114' ' ' ILE . 70.1 ttt180 -112.27 137.4 50.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 24.7 pttm -129.51 129.94 45.18 Favored 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.76 0.662 . . . . 0.0 110.76 -172.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.543 ' HB2' HG23 ' A' ' 98' ' ' ILE . 5.6 m-85 -128.63 145.1 51.25 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -128.05 98.91 5.28 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.9 pt -136.26 105.13 9.41 Favored Pre-proline 0 C--N 1.285 -2.219 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.259 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.82 -40.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.462 2.108 . . . . 0.0 112.021 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.07 -19.52 64.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.4 ' HB3' ' CE2' ' A' ' 75' ' ' PHE . 16.2 m-20 -108.45 -17.3 14.02 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 64.6 t -128.31 121.11 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' HB2' ' HD2' ' A' ' 150' ' ' LYS . 12.1 t70 -122.23 121.17 27.93 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 168.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.93 -15.53 39.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 114.777 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.34 -25.28 36.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.974 0.416 . . . . 0.0 111.384 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.458 HG22 ' HB3' ' A' ' 129' ' ' ASP . 8.1 t -119.19 -21.31 7.63 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.3 126.91 42.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 34.4 p -122.47 168.04 12.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.644 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 m -126.27 133.72 51.36 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.152 0.501 . . . . 0.0 111.164 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.457 ' O ' HD22 ' A' ' 143' ' ' LEU . 24.1 p -118.7 150.51 39.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.8 142.34 42.93 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.783 0.72 . . . . 0.0 112.477 -174.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.4 t -100.38 161.59 13.5 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -68.85 -20.12 64.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.834 0.853 . . . . 0.0 112.9 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -85.79 -10.67 55.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 112.06 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.28 1.11 23.59 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.532 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.5 t -77.2 124.23 35.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 2.7 tm? -119.5 132.25 55.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.1 m -121.34 127.42 51.25 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 121.639 -0.663 . . . . 0.0 110.749 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.644 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 19.2 m -102.01 122.64 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 3.9 p-10 -138.58 155.48 48.31 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.782 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.11 171.69 17.32 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 41.5 Cg_exo -51.1 142.59 34.6 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.759 2.306 . . . . 0.0 111.995 171.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 11.2 ptm180 -90.66 165.97 13.42 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.37 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.527 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 76.6 tttt . . . . . 0 C--O 1.271 2.226 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.669 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 31.0 t70 . . . . . 0 CA--C 1.482 -1.644 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -95.02 117.35 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' B' ' 146' ' ' ASN . 50.7 t80 -110.62 142.92 41.82 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' B' ' 145' ' ' VAL . 35.1 m -137.82 131.2 30.78 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.243 0.544 . . . . 0.0 111.641 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.653 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 52.7 t -118.72 141.77 36.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.5 144.27 41.0 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.164 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' B' ' 143' ' ' LEU . 3.1 mm? -120.02 127.52 52.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 107' ' ' ARG . 0.6 OUTLIER -117.15 127.77 54.45 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.419 -1.312 . . . . 0.0 112.717 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -118.83 117.15 53.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 167.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.72 -54.21 44.92 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.265 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -150.44 121.7 7.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.57 171.87 18.18 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.796 2.038 . . . . 0.0 107.103 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.1 m -113.2 141.21 25.32 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.15 -28.09 13.71 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 125.044 3.83 . . . . 0.0 116.362 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.53 -20.34 60.68 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.353 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . 0.408 ' O ' ' HA2' ' B' ' 102' ' ' GLY . 2.9 mp0 -98.37 18.43 16.5 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.723 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.34 147.75 44.62 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.829 0.823 . . . . 0.0 111.273 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -138.05 124.53 20.72 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -109.63 129.58 64.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' B' ' 99' ' ' GLU . 17.8 ptmt -130.36 130.72 44.76 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.417 0.627 . . . . 0.0 111.091 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.91 118.16 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.5 tp -135.48 91.18 2.69 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-O 121.17 0.51 . . . . 0.0 109.716 -173.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.05 -111.92 4.53 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.022 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -86.56 -4.79 59.23 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.227 1.011 . . . . 0.0 112.022 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.84 137.74 47.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.535 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 122' ' ' TYR . 4.0 tp -124.87 120.03 57.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 174.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.413 ' HB2' ' HG3' ' B' ' 92' ' ' LYS . 35.4 mt-10 -138.16 149.72 46.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.151 0.501 . . . . 0.0 110.323 -173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' B' ' 120' ' ' ARG . 20.1 m -124.22 134.34 66.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -123.95 124.66 43.08 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 88' ' ' GLU . . . -124.04 142.87 14.5 Favored Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 173.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -143.08 126.36 16.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -136.23 140.6 43.61 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.548 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -82.48 120.73 25.85 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -81.9 -63.76 1.32 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 123.512 0.725 . . . . 0.0 111.008 -173.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.485 ' HB2' HD12 ' B' ' 114' ' ' ILE . 39.8 mtm180 -140.9 125.42 17.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.961 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -103.24 130.4 50.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -139.16 172.47 12.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.39 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 12.86 -84.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 127.673 2.389 . . . . 0.0 114.27 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -145.85 30.19 1.08 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -132.1 130.18 5.83 Favored Glycine 0 N--CA 1.403 -3.53 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.403 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -120.43 149.86 41.7 Favored 'General case' 1 C--N 1.24 -4.156 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' B' ' 107' ' ' ARG . 16.9 mt -123.61 133.34 69.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.8 m -129.98 159.14 37.57 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.049 0.452 . . . . 0.0 110.174 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -134.17 148.55 50.94 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 48.8 mt-10 -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -126.03 125.03 41.97 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -132.06 122.22 25.1 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.785 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' HG12 ' A' ' 114' ' ' ILE . 70.0 ttt180 -112.3 137.36 50.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 24.1 pttm -129.37 129.83 45.27 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.717 0.635 . . . . 0.0 110.72 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' TYR . . . . . 0.552 ' HB2' HG23 ' B' ' 98' ' ' ILE . 6.1 m-85 -128.25 145.57 51.0 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.489 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -128.19 98.86 5.24 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 3.9 pt -136.38 105.2 9.3 Favored Pre-proline 0 C--N 1.284 -2.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.193 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.49 -40.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.542 2.161 . . . . 0.0 112.081 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.01 -19.86 64.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 111.513 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' B' ' 75' ' ' PHE . 15.0 m-20 -108.36 -17.18 14.06 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.444 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 63.6 t -128.46 121.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . 0.528 ' HB2' ' HD2' ' B' ' 150' ' ' LYS . 12.2 t70 -122.35 121.32 27.78 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 168.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.17 -15.2 38.31 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.466 2.777 . . . . 0.0 114.632 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 tp -81.47 -25.87 35.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.461 . . . . 0.0 111.157 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' THR . . . . . 0.471 HG22 ' HB3' ' B' ' 129' ' ' ASP . 9.7 t -119.05 -21.14 7.79 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.14 127.12 42.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 33.4 p -122.5 167.72 13.0 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.839 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.7 m -126.28 133.96 51.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.446 ' O ' HD22 ' B' ' 143' ' ' LEU . 14.8 p -119.13 149.61 41.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 142.66 44.24 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.465 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.62 161.6 13.49 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -68.81 -19.59 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.603 0.761 . . . . 0.0 112.953 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.68 -10.14 54.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.041 0.448 . . . . 0.0 111.734 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.3 0.75 23.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.43 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.62 124.11 34.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 2.7 tm? -119.59 132.27 55.68 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 35.3 m -121.46 126.99 50.61 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.6 -0.688 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . 0.653 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 19.0 m -101.71 122.65 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' B' ' 75' ' ' PHE . 4.0 p-10 -138.51 154.97 48.8 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.775 -173.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.13 18.22 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 50.3 Cg_exo -50.8 142.3 33.12 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 122.745 2.297 . . . . 0.0 111.973 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' B' ' 75' ' ' PHE . 11.0 ptm180 -90.18 165.8 13.74 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.413 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' LYS . . . . . 0.528 ' HD2' ' HB2' ' B' ' 129' ' ' ASP . 76.2 tttt . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.414 ' OD2' ' HD3' ' A' ' 149' ' ' ARG . 31.5 t70 . . . . . 0 CA--C 1.492 -1.258 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 52.7 t80 -128.72 145.28 51.21 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.793 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 t -116.67 130.44 56.73 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.566 ' HB ' HG23 ' A' ' 145' ' ' VAL . 23.7 t -114.46 131.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.15 147.05 35.75 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 81' ' ' VAL . 6.7 mp -118.5 129.06 55.15 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -74.22 125.27 28.03 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.542 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 82' ' ' LYS . 32.9 t -138.97 142.67 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.66 ' O ' HG12 ' A' ' 81' ' ' VAL . 16.7 tptm -98.33 -177.34 3.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.567 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 7.8 t60 -77.63 124.98 28.64 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.841 -1.543 . . . . 0.0 113.412 -167.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -132.67 172.45 12.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.148 172.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 15.1 m -77.57 117.82 68.03 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -53.09 -27.76 38.11 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 124.024 3.149 . . . . 0.0 114.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -87.14 -35.31 18.7 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.343 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 18.5 mm-40 -91.35 58.91 3.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.296 0.57 . . . . 0.0 110.593 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 pp -143.21 160.43 40.48 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.09 0.471 . . . . 0.0 111.175 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -135.63 124.61 24.22 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.18 122.87 58.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -129.07 133.29 47.63 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.416 0.626 . . . . 0.0 111.948 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.73 122.1 59.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.96 91.71 3.09 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.29 -112.12 4.17 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.751 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -93.2 -0.25 56.92 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.689 1.196 . . . . 0.0 110.96 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.7 136.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.574 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 145' ' ' VAL . 16.6 mt -125.1 120.66 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.81 149.22 49.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.2 0.524 . . . . 0.0 110.84 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -129.8 120.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -113.56 120.06 39.67 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.428 ' HA3' ' CD2' ' A' ' 84' ' ' PHE . . . -136.98 154.79 22.4 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -138.56 143.28 39.35 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 117.454 0.627 . . . . 0.0 111.05 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 84' ' ' PHE . 81.1 t60 -137.97 127.86 25.52 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 170.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 32.1 mt-10 -86.01 121.33 28.48 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 23.7 mt-10 -55.06 -80.82 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -166.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 51.5 mtm-85 -147.63 153.82 39.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -83.01 128.19 34.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -94.39 -172.32 2.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -39.87 -66.16 0.33 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.361 1.464 . . . . 0.0 112.634 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -142.74 28.06 1.62 Allowed 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' B' ' 122' ' ' TYR . . . -132.95 153.53 20.75 Favored Glycine 1 N--CA 1.369 -5.788 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.39 149.05 30.8 Favored 'General case' 1 C--N 1.243 -4.025 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.482 HG23 ' HG2' ' B' ' 120' ' ' ARG . 35.5 mm -124.25 135.48 63.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.987 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 12.0 m -128.18 140.97 51.62 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -128.65 147.04 50.71 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.13 150.73 51.14 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.058 0.456 . . . . 0.0 110.105 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 84' ' ' PHE . 73.2 m-85 -124.96 133.67 52.93 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -127.1 121.94 32.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.61 ' CZ ' ' HA ' ' A' ' 81' ' ' VAL . 67.2 mtt-85 -117.02 136.88 52.62 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.4 tttp -134.82 128.38 32.65 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.756 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.458 ' CD1' ' HA3' ' B' ' 112' ' ' GLY . 13.3 m-85 -131.42 135.2 46.96 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.867 0.867 . . . . 0.0 110.543 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -128.23 98.7 5.18 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.637 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 5.0 pt -135.94 106.43 9.67 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.73 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -87.67 -39.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.027 1.818 . . . . 0.0 112.508 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.42 72.26 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 121.451 0.643 . . . . 0.0 111.76 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 149' ' ' ARG . 9.3 m-20 -91.99 -16.25 26.78 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.709 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.637 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 12.6 t -131.38 120.42 46.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -171.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.68 111.73 35.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.63 13.46 0.46 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.403 2.735 . . . . 0.0 116.215 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.79 -45.23 75.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.403 HG22 ' HD3' ' A' ' 148' ' ' PRO . 10.5 t -120.45 9.49 10.95 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 121.609 -0.682 . . . . 0.0 112.564 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' A' ' 128' ' ' VAL . 50.2 mt -67.8 132.51 32.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.418 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.8 p -121.58 165.89 15.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.901 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 144' ' ' THR . 15.1 m -130.09 134.06 47.1 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 120.971 0.415 . . . . 0.0 111.14 -177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.5 m -116.52 145.44 43.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.7 tp -121.74 137.17 54.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.505 0.193 . . . . 0.0 110.756 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -96.62 164.24 12.68 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.528 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.4 t -60.21 -33.97 72.99 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.523 1.056 . . . . 0.0 113.055 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 19.7 t70 -81.25 -11.09 59.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.542 0.687 . . . . 0.0 110.331 -177.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 8.13 24.07 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.437 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 43.7 t -71.68 132.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.33 134.39 55.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -168.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 135' ' ' SER . 20.3 m -121.51 128.1 51.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 77' ' ' VAL . 15.7 m -114.86 125.4 72.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.6 p-10 -132.25 138.62 47.97 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.505 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.77 -144.8 6.45 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.529 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 132' ' ' THR . 10.6 Cg_endo -91.66 139.03 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.069 2.513 . . . . 0.0 114.392 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.464 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 73.9 ttt180 -103.76 137.41 41.82 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--N 1.297 -1.702 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -175.493 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 CA--C 1.497 -1.063 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -96.08 125.74 40.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 53.0 t80 -128.88 145.81 51.11 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.738 -170.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.4 t -117.6 130.06 56.15 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.543 ' HB ' HG23 ' B' ' 145' ' ' VAL . 23.2 t -114.32 131.03 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -111.09 147.15 35.46 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' LEU . . . . . 0.478 ' O ' HG23 ' B' ' 81' ' ' VAL . 6.7 mp -118.5 128.83 54.96 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -73.67 125.32 27.78 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.402 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.656 HG12 ' O ' ' B' ' 82' ' ' LYS . 31.6 t -139.23 142.18 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 O-C-N 123.911 0.757 . . . . 0.0 109.107 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.656 ' O ' HG12 ' B' ' 81' ' ' VAL . 16.9 tptm -97.72 -177.42 3.77 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 7.6 t60 -77.7 124.76 28.37 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 117.89 -1.524 . . . . 0.0 113.4 -167.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.622 ' HA ' ' HB2' ' B' ' 104' ' ' HIS . 0.0 OUTLIER -132.55 172.5 12.43 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.174 172.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 15.3 m -77.54 118.05 69.49 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.2 -27.69 38.79 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 124.045 3.163 . . . . 0.0 114.036 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -87.22 -35.18 18.68 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.461 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' B' ' 85' ' ' SER . 16.1 mm-40 -92.04 58.51 3.37 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.543 0.687 . . . . 0.0 110.42 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.51 160.34 40.47 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.153 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -135.67 124.56 24.08 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.78 122.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -129.04 134.3 48.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.279 0.562 . . . . 0.0 111.744 -174.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 p -128.45 120.86 53.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.0 tp -129.93 91.78 3.19 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.63 -111.99 4.19 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.944 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -93.17 0.06 57.06 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 124.45 1.1 . . . . 0.0 111.003 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 97.6 t -110.06 136.33 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.526 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . 0.499 HD13 HG21 ' B' ' 145' ' ' VAL . 17.1 mt -125.07 120.53 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.55 149.09 49.34 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.23 0.538 . . . . 0.0 110.759 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 94.0 t -129.54 120.93 51.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -113.52 120.14 39.96 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' B' ' 84' ' ' PHE . . . -137.07 154.59 22.35 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.33 143.26 39.83 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.508 0.67 . . . . 0.0 110.998 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' B' ' 84' ' ' PHE . 82.0 t60 -137.92 127.72 25.4 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 170.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 34.7 mt-10 -85.5 121.14 27.77 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.415 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 23.3 mt-10 -54.88 -80.7 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -166.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 51.6 mtm-85 -148.0 153.72 39.35 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -83.31 129.09 34.98 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -94.71 -172.53 2.76 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -39.5 -66.4 0.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.131 1.372 . . . . 0.0 112.958 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -142.69 27.95 1.64 Allowed 'General case' 0 CA--C 1.461 -2.472 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 122' ' ' TYR . . . -132.81 153.57 20.74 Favored Glycine 1 N--CA 1.37 -5.761 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -177.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -110.41 149.04 30.83 Favored 'General case' 1 C--N 1.244 -4.018 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' B' ' 105' ' ' GLU . 34.8 mm -124.21 135.53 63.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.127 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 9.6 m -128.18 141.09 51.57 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -128.64 147.17 50.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.3 150.44 50.98 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.128 0.489 . . . . 0.0 110.139 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' B' ' 84' ' ' PHE . 72.5 m-85 -124.77 133.92 52.98 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -127.38 121.88 32.14 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.593 ' CZ ' ' HA ' ' B' ' 81' ' ' VAL . 67.6 mtt-85 -117.18 137.02 52.62 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -135.16 128.3 31.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.774 -1.17 . . . . 0.0 110.697 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' TYR . . . . . 0.47 ' CE1' ' HA3' ' A' ' 112' ' ' GLY . 13.5 m-85 -131.46 134.99 46.75 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.973 0.909 . . . . 0.0 110.672 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -127.78 98.67 5.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.643 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 5.0 pt -135.72 106.59 9.85 Favored Pre-proline 0 C--N 1.29 -1.979 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.739 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -40.32 0.06 OUTLIER 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.26 1.973 . . . . 0.0 112.544 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.69 -32.05 71.58 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.612 0.72 . . . . 0.0 111.794 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . 0.428 ' HA ' ' HG3' ' B' ' 149' ' ' ARG . 9.9 m-20 -92.15 -16.08 26.78 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.927 -0.483 . . . . 0.0 110.783 -176.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 13.0 t -131.45 119.88 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -170.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.05 111.68 36.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.82 15.29 0.38 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 123.456 2.771 . . . . 0.0 115.887 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.06 -45.13 71.14 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.101 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' THR . . . . . 0.406 HG22 ' HG3' ' B' ' 148' ' ' PRO . 12.8 t -120.61 9.88 10.93 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' B' ' 128' ' ' VAL . 50.0 mt -68.11 132.92 32.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.393 -170.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.7 p -121.98 166.18 14.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.733 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' B' ' 144' ' ' THR . 14.5 m -130.97 134.05 46.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.97 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 19.7 m -116.35 145.32 43.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -121.97 137.0 54.96 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 25.3 m -96.39 164.41 12.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.435 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -60.44 -34.07 73.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.448 1.022 . . . . 0.0 113.077 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 19.9 t70 -81.39 -10.73 59.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.43 0.633 . . . . 0.0 110.342 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.09 8.33 23.88 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.349 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.439 ' HA ' ' HB ' ' B' ' 81' ' ' VAL . 46.2 t -71.85 132.75 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.66 134.37 55.11 Favored 'General case' 0 C--O 1.209 -1.066 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.178 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' B' ' 135' ' ' SER . 20.1 m -121.4 127.87 51.62 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . 0.543 HG23 ' HB ' ' B' ' 77' ' ' VAL . 15.7 m -114.88 125.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 21.8 p-10 -132.47 138.14 47.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.522 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 179.69 -144.52 6.09 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.406 ' HG3' HG22 ' B' ' 132' ' ' THR . 9.8 Cg_endo -91.64 139.15 2.22 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.145 2.563 . . . . 0.0 114.383 -177.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 71.5 ttt180 -103.8 137.89 41.18 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.492 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.866 0.365 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -113.09 120.17 40.37 Favored 'General case' 0 CA--C 1.471 -2.063 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.34 150.64 25.02 Favored 'General case' 0 N--CA 1.393 -3.323 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.595 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 p -137.13 144.34 42.96 Favored 'General case' 0 N--CA 1.402 -2.851 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.087 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 32.8 t -116.05 132.55 65.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -110.97 136.89 49.3 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.465 HD22 HD11 ' A' ' 143' ' ' LEU . 6.0 mp -119.67 128.08 53.49 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.78 138.73 50.85 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 122.727 0.411 . . . . 0.0 109.911 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.42 165.99 5.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.72 -164.75 0.09 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.483 0.583 . . . . 0.0 110.441 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -77.41 123.94 27.21 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.003 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.58 143.11 15.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 m -74.02 124.73 90.33 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 123.477 0.485 . . . . 0.0 110.983 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 139' ' ' SER . 10.3 Cg_endo -55.43 -30.96 75.75 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.865 3.043 . . . . 0.0 114.046 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -74.59 -26.58 60.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.861 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.81 0.84 51.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.291 0.567 . . . . 0.0 111.398 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.22 147.67 44.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -126.21 126.26 43.76 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.38 126.69 52.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -129.57 138.37 51.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.438 0.637 . . . . 0.0 109.417 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.16 90.44 3.34 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.91 -112.17 4.73 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.148 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.4 -0.55 57.31 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.355 1.062 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.407 HG12 ' HG3' ' A' ' 99' ' ' GLU . 65.3 t -105.69 135.74 42.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.44 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 59.0 mt -122.0 119.53 58.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 39.1 mt-10 -136.38 137.02 40.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.61 0.719 . . . . 0.0 111.705 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.468 HG11 HH21 ' A' ' 120' ' ' ARG . 60.6 t -119.05 124.78 73.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -127.76 128.74 45.86 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.84 156.66 27.11 Favored Glycine 0 C--N 1.283 -2.384 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -143.37 134.16 25.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 124.056 0.504 . . . . 0.0 109.921 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.437 ' CD2' ' HG2' ' A' ' 106' ' ' GLU . 62.4 t60 -136.77 127.72 27.59 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.55 0.34 . . . . 0.0 110.327 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 12.5 pt-20 -87.03 137.05 32.68 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.437 ' HG2' ' CD2' ' A' ' 104' ' ' HIS . 28.3 mt-10 -106.78 -53.98 2.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.331 -173.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -148.34 152.92 37.88 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 47.7 tt0 -111.76 122.24 47.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.453 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -75.2 -67.35 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -179.22 106.19 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 37.6 m80 60.1 25.29 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.027 0.918 . . . . 0.0 109.208 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.66 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -156.4 119.13 0.89 Allowed Glycine 1 N--CA 1.39 -4.392 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -175.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' GLN . 11.7 p90 -119.28 153.54 34.88 Favored 'General case' 1 C--N 1.243 -4.033 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.416 HG22 ' HG2' ' B' ' 120' ' ' ARG . 1.9 pt -121.04 140.87 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 15.5 m -134.44 157.09 47.34 Favored 'General case' 0 N--CA 1.404 -2.749 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.974 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.9 ttp85 -126.65 146.46 50.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.7 mt-10 -136.87 153.69 50.69 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -128.54 133.6 48.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 26.6 t-80 -131.56 122.48 26.16 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.483 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.468 HH21 HG11 ' A' ' 100' ' ' VAL . 30.8 mtm180 -115.72 138.4 51.15 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.627 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 51.0 tttp -136.03 128.04 29.61 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.702 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 30.3 m-85 -132.17 142.32 49.42 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.104 0.878 . . . . 0.0 109.024 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -128.48 98.57 5.08 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.7 pt -137.33 106.21 8.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.328 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.49 -45.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.886 0 C-N-CA 122.642 2.228 . . . . 0.0 113.366 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 150' ' ' LYS . . . -67.54 -28.19 67.59 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -91.16 -18.0 25.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 77.8 t -132.81 127.6 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.77 ' H ' ' HB3' ' A' ' 148' ' ' PRO . 5.6 m-20 -121.62 109.6 34.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.233 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.55 ' HA ' ' CG2' ' A' ' 133' ' ' ILE . 20.8 Cg_endo -59.92 -12.26 18.08 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 124.239 3.293 . . . . 0.0 114.744 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.55 -40.34 96.74 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.177 0.513 . . . . 0.0 111.237 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.1 t -118.42 9.16 12.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.663 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.55 ' CG2' ' HA ' ' A' ' 130' ' ' PRO . 10.4 tt -77.26 141.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.992 0.425 . . . . 0.0 110.065 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 4.9 p -138.79 154.77 48.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 144' ' ' THR . 22.9 t -131.02 133.21 45.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.169 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 p -119.64 130.33 55.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 137' ' ' LEU . 1.4 pt? -130.13 137.23 50.04 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.01 0.434 . . . . 0.0 112.099 -169.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.3 p -99.91 168.0 10.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.358 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 11.4 m -67.13 -10.97 55.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.38 1.472 . . . . 0.0 112.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.38 20.07 19.42 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-O 121.789 0.804 . . . . 0.0 110.516 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.21 -5.34 63.51 Favored Glycine 0 C--O 1.261 1.791 0 CA-C-N 115.568 -0.742 . . . . 0.0 114.813 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.8 119.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.465 HD11 HD22 ' A' ' 79' ' ' LEU . 3.9 pp -129.94 135.55 48.45 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 135' ' ' SER . 13.5 p -107.31 133.08 52.38 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.483 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 134' ' ' THR . 12.5 m -111.82 121.52 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -137.38 164.75 27.88 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.361 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.505 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . 128.1 -49.06 0.94 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.41 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.77 ' HB3' ' H ' ' A' ' 129' ' ' ASP . 55.5 Cg_endo -62.29 169.72 7.55 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 123.241 2.628 . . . . 0.0 114.989 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -106.26 154.88 20.1 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 126' ' ' ALA . 81.5 tttt . . . . . 0 C--N 1.285 -2.207 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.117 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' B' ' 149' ' ' ARG . 4.2 t70 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.038 0.447 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -112.87 120.04 40.06 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.43 150.7 25.04 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.57 -172.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.7 p -137.36 144.24 42.41 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.186 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 33.3 t -116.0 132.91 64.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.35 136.72 50.06 Favored 'General case' 0 C--N 1.269 -2.928 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' LEU . . . . . 0.47 ' HG ' ' OH ' ' B' ' 122' ' ' TYR . 6.0 mp -119.53 128.16 53.68 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.76 138.63 50.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.48 165.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.37 -164.46 0.08 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.444 0.565 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -77.67 124.22 27.66 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.807 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.77 142.62 15.29 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.5 m -73.5 124.49 90.45 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 123.349 0.405 . . . . 0.0 111.057 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 139' ' ' SER . 9.3 Cg_endo -55.4 -31.2 76.54 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.725 2.95 . . . . 0.0 113.993 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.77 -26.42 60.64 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.47 0.91 53.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.133 0.492 . . . . 0.0 111.398 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.29 147.52 44.89 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -125.98 125.89 43.43 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -98.5 127.14 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.808 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -129.88 140.01 51.06 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 117.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.95 90.19 3.28 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.34 -112.31 4.87 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.65 -0.19 56.53 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 124.417 1.087 . . . . 0.0 111.946 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' B' ' 99' ' ' GLU . 65.3 t -106.22 135.91 42.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.591 -0.693 . . . . 0.0 110.314 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 59.3 mt -122.18 119.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 39.1 mt-10 -136.23 136.91 40.29 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.661 0.743 . . . . 0.0 111.637 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.464 HG11 HH21 ' B' ' 120' ' ' ARG . 61.1 t -118.99 124.41 73.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -127.25 128.73 46.5 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.15 156.62 27.07 Favored Glycine 0 C--N 1.286 -2.242 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -143.31 134.0 25.14 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 122.648 0.379 . . . . 0.0 110.024 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' HIS . . . . . 0.43 ' CD2' ' HG2' ' B' ' 106' ' ' GLU . 61.2 t60 -136.63 127.68 27.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 122.561 0.344 . . . . 0.0 110.311 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 12.0 pt-20 -86.72 137.05 32.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.43 ' HG2' ' CD2' ' B' ' 104' ' ' HIS . 27.8 mt-10 -106.74 -54.33 2.49 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.254 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -148.13 153.11 38.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' B' ' 113' ' ' PHE . 46.9 tt0 -111.7 122.64 48.34 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.593 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.98 -67.99 0.59 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.769 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -178.7 106.16 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 39.1 m80 60.61 24.17 13.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.937 0.875 . . . . 0.0 109.158 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.702 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -154.99 120.26 1.0 Allowed Glycine 2 N--CA 1.389 -4.485 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -177.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 108' ' ' GLN . 11.8 p90 -119.34 153.6 34.87 Favored 'General case' 1 C--N 1.241 -4.146 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.403 HG22 ' HG2' ' A' ' 120' ' ' ARG . 1.8 pt -121.06 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 14.5 m -134.4 157.08 47.32 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.108 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -126.42 146.49 50.05 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 37.1 mt-10 -136.83 153.59 50.75 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -172.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -128.63 133.43 48.27 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 121.186 0.517 . . . . 0.0 110.669 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 28.2 t-80 -131.49 122.43 26.18 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.469 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.464 HH21 HG11 ' B' ' 100' ' ' VAL . 30.1 mtm180 -115.81 138.43 51.15 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.628 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 50.3 tttp -136.13 128.06 29.44 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.312 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' TYR . . . . . 0.66 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 29.9 m-85 -132.22 142.56 49.47 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 124.013 0.821 . . . . 0.0 108.92 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -128.41 98.57 5.1 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -137.26 106.19 8.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.499 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -89.46 -44.53 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.638 2.225 . . . . 0.0 113.403 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' B' ' 150' ' ' LYS . . . -68.12 -27.74 66.73 Favored 'General case' 0 C--O 1.198 -1.639 0 O-C-N 122.049 -0.407 . . . . 0.0 111.959 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.66 -18.17 24.39 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 76.7 t -132.75 127.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . 0.766 ' H ' ' HB3' ' B' ' 148' ' ' PRO . 7.1 m-20 -121.34 110.42 34.22 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.164 168.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.534 ' HA ' ' CG2' ' B' ' 133' ' ' ILE . 20.7 Cg_endo -60.66 -12.02 19.71 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 124.026 3.151 . . . . 0.0 114.737 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.93 -40.14 95.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.093 0.473 . . . . 0.0 111.078 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 6.9 t -118.14 9.02 12.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . 0.534 ' CG2' ' HA ' ' B' ' 130' ' ' PRO . 10.9 tt -76.84 141.9 15.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.6 p -138.92 154.43 48.35 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.629 0.772 . . . . 0.0 109.2 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.0 t -130.82 132.9 45.5 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.19 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 2.6 p -119.74 130.09 54.82 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . 0.498 HD23 ' H ' ' B' ' 137' ' ' LEU . 1.4 pt? -130.06 136.97 49.95 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -169.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 76.8 p -99.55 168.14 10.15 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.487 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' B' ' 86' ' ' PRO . 6.9 m -67.62 -11.15 57.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.397 1.479 . . . . 0.0 112.092 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.22 20.04 19.53 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.677 0.751 . . . . 0.0 110.424 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.12 -4.72 65.53 Favored Glycine 0 C--O 1.26 1.725 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.28 119.79 33.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.458 HD11 HD22 ' B' ' 79' ' ' LEU . 4.0 pp -130.12 135.77 48.57 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.828 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' B' ' 135' ' ' SER . 11.6 p -107.49 133.29 52.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.271 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' B' ' 134' ' ' THR . 12.4 m -111.85 121.56 64.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -137.56 164.82 27.82 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 122.179 -0.326 . . . . 0.0 110.163 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.496 ' N ' ' HD2' ' B' ' 148' ' ' PRO . . . 127.93 -49.03 0.94 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.785 -1.197 . . . . 0.0 114.311 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.766 ' HB3' ' H ' ' B' ' 129' ' ' ASP . 55.6 Cg_endo -62.88 169.48 8.78 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.953 2.435 . . . . 0.0 115.05 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 36.0 ptt180 -105.22 155.51 18.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 79.9 tttt . . . . . 0 C--N 1.285 -2.217 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 74' ' ' ARG . 25.5 mtm180 -95.5 139.76 31.31 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.472 ' CE2' HG22 ' A' ' 128' ' ' VAL . 20.2 t80 -106.62 140.02 40.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.727 -170.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 t -137.91 129.14 27.6 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.71 130.79 72.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.44 155.95 22.39 Favored 'General case' 0 C--N 1.257 -3.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 16.6 tp -118.67 127.86 53.97 Favored 'General case' 0 N--CA 1.381 -3.916 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -104.32 130.27 52.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 p -156.56 162.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.494 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -93.42 -162.89 0.98 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.367 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.714 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 62.3 t-80 -76.58 123.78 26.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 117.334 -1.746 . . . . 0.0 112.296 -169.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.37 133.72 19.59 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -73.6 149.14 88.28 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HA ' HD21 ' A' ' 137' ' ' LEU . 93.4 Cg_exo -47.74 -34.79 22.13 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.921 2.414 . . . . 0.0 115.513 -171.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.31 -17.99 53.48 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.61 -20.06 44.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 89' ' ' LEU . 2.5 pt? -120.95 151.12 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.426 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.19 136.2 36.38 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.03 139.97 37.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.588 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.55 139.51 47.89 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.241 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 98' ' ' ILE . 2.4 p -129.94 112.96 25.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.77 101.78 5.04 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.97 -111.74 4.0 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.002 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 125' ' ' PRO . 8.4 p-10 -93.94 -5.92 46.7 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 124.731 1.212 . . . . 0.0 111.431 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.92 135.57 54.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.071 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 93' ' ' VAL . 3.0 mp -131.81 120.05 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.8 mt-10 -133.43 147.87 51.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 120.992 0.425 . . . . 0.0 111.686 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 79' ' ' LEU . 39.9 t -126.65 129.44 71.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -136.0 133.37 37.42 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.95 147.0 17.92 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.02 134.52 45.66 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -130.53 131.14 44.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.3 pt-20 -87.18 120.85 28.88 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.604 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 30.5 mm-40 -67.6 -70.68 0.24 Allowed 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.308 -173.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.604 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 0.8 OUTLIER -144.17 154.89 43.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -111.26 128.59 55.98 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 110' ' ' GLU . 61.2 m-20 -93.88 -168.44 1.88 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 3.6 mp0 -57.6 -68.72 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.967 1.307 . . . . 0.0 109.539 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -122.18 14.84 10.59 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' B' ' 122' ' ' TYR . . . -115.54 142.32 17.51 Favored Glycine 1 N--CA 1.384 -4.773 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.393 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.75 139.57 53.85 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 107' ' ' ARG . 5.6 mt -123.7 131.98 72.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 23.3 t -137.16 157.46 46.61 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.093 0.473 . . . . 0.0 110.545 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -134.1 147.72 50.9 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 171.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -130.94 154.35 48.21 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 122.19 0.196 . . . . 0.0 110.483 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -122.1 128.28 51.13 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -131.25 122.04 25.82 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -126.63 137.86 53.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.514 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 23.6 mtpp -134.57 127.11 30.61 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.173 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.48 ' HB3' ' CA ' ' B' ' 112' ' ' GLY 0.305 1.3 p90 -134.7 133.72 40.31 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 173.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -109.9 101.68 10.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.448 0.642 . . . . 0.0 110.557 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.46 HG13 HD13 ' A' ' 98' ' ' ILE . 2.4 pt -135.52 106.91 10.01 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.463 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 59.2 Cg_endo -108.95 -37.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 122.7 2.267 . . . . 0.0 116.154 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.402 ' H ' ' HD2' ' A' ' 125' ' ' PRO . . . -68.03 -29.76 68.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.763 -0.585 . . . . 0.0 112.382 -172.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.06 8.18 20.01 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.525 0.679 . . . . 0.0 109.37 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 75' ' ' PHE . 56.3 t -131.16 127.43 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.644 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.68 103.36 40.74 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.21 8.85 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 123.684 2.923 . . . . 0.0 116.167 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.91 -39.81 95.67 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 148' ' ' PRO . 14.6 t -119.36 9.29 11.59 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.388 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.539 HG12 ' HA3' ' A' ' 147' ' ' GLY . 42.9 mt -68.36 122.46 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.703 0.763 . . . . 0.0 112.296 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.76 167.27 18.33 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.034 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 143' ' ' LEU . 19.0 p -127.2 135.64 50.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -116.46 129.54 56.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 86' ' ' PRO . 60.1 tp -129.29 127.95 42.2 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 123.16 0.288 . . . . 0.0 111.111 -171.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 14.8 m -99.84 163.98 12.22 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.643 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.0 m -55.14 -30.64 60.23 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.714 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 25.3 t70 -88.33 -11.79 45.32 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.841 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.35 62.01 0.81 Allowed Glycine 0 N--CA 1.409 -3.127 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 46.8 t -121.23 122.28 67.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 174.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 135' ' ' SER . 15.9 tp -127.2 134.93 50.06 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -173.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.451 ' N ' HD12 ' A' ' 143' ' ' LEU . 41.3 m -121.43 118.93 30.64 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.368 171.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.463 HG12 ' CG2' ' A' ' 133' ' ' ILE . 13.6 t -106.72 120.39 57.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 9.4 p30 -139.47 159.69 41.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.9 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.539 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.69 -136.66 2.97 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 132' ' ' THR . 61.1 Cg_endo -104.28 149.74 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.449 2.766 . . . . 0.0 113.72 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -101.11 153.94 19.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 150' ' ' LYS . 36.3 ttmt . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 23.7 t0 . . . . . 0 N--CA 1.437 -1.106 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -95.31 140.14 30.63 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.482 ' CE2' HG22 ' B' ' 128' ' ' VAL . 19.7 t80 -107.19 139.95 40.83 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.686 -170.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -137.92 129.3 27.81 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.4 HG11 ' CE2' ' B' ' 122' ' ' TYR . 46.2 t -118.12 130.92 72.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.39 155.98 22.3 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' B' ' 143' ' ' LEU . 16.6 tp -118.66 127.68 53.8 Favored 'General case' 1 N--CA 1.379 -4.002 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.76 130.47 51.28 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.08 162.04 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.254 -3.548 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.96 -162.81 0.97 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.157 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . 0.732 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 61.4 t-80 -76.59 123.73 26.53 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 117.65 -1.62 . . . . 0.0 112.417 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -147.48 134.06 19.84 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -73.81 148.74 87.51 Favored Pre-proline 0 C--N 1.283 -2.314 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.69 -34.69 21.55 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.91 2.406 . . . . 0.0 115.556 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.22 -17.86 54.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 120.843 0.354 . . . . 0.0 111.624 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.89 -20.08 42.98 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.448 HD23 ' H ' ' B' ' 89' ' ' LEU . 2.5 pt? -121.01 150.45 41.12 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.545 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.4 135.88 37.35 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 p -113.56 139.94 36.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.714 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.62 139.88 47.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.269 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.525 HG23 HG13 ' B' ' 98' ' ' ILE . 2.4 p -129.98 112.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.533 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.67 102.77 5.4 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.324 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.66 -111.55 4.04 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.009 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' B' ' 125' ' ' PRO . 8.6 p-10 -94.12 -5.9 46.19 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 124.499 1.12 . . . . 0.0 111.519 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.74 135.53 54.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.026 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . 0.525 HG13 HG23 ' B' ' 93' ' ' VAL . 3.0 mp -131.64 120.01 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 37.1 mt-10 -133.47 147.42 51.67 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.665 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.413 HG11 ' CD2' ' B' ' 79' ' ' LEU . 40.0 t -126.02 129.58 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -136.1 133.34 37.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.82 147.56 18.82 Favored Glycine 0 C--N 1.286 -2.228 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.96 134.3 45.47 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -130.16 132.06 45.9 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.5 pt-20 -88.34 120.51 29.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.603 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 31.7 mm-40 -67.09 -71.14 0.21 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 112.683 -2.053 . . . . 0.0 110.281 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.603 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 0.7 OUTLIER -143.71 154.99 44.05 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.19 128.68 55.99 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' B' ' 110' ' ' GLU . 63.6 m-20 -94.13 -169.09 1.99 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' B' ' 110' ' ' GLU . 3.5 mp0 -56.95 -68.4 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.117 1.367 . . . . 0.0 109.635 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -122.33 14.93 10.47 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 122' ' ' TYR . . . -115.51 142.59 17.69 Favored Glycine 1 N--CA 1.385 -4.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.328 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.3 139.27 54.07 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' B' ' 107' ' ' ARG . 5.6 mt -123.7 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 22.8 t -137.03 157.56 46.45 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.265 0.555 . . . . 0.0 110.611 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -134.18 147.75 50.8 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 171.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -131.01 154.26 48.37 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -121.77 128.13 51.39 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -131.11 121.7 25.38 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -126.07 138.04 53.68 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.5 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 23.7 mtpp -134.68 127.07 30.35 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.226 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' TYR . . . . . 0.455 ' HB3' ' CA ' ' A' ' 112' ' ' GLY 0.312 1.3 p90 -134.72 134.05 40.62 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 174.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -110.53 101.51 10.18 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.452 0.644 . . . . 0.0 110.299 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.449 HG13 HD13 ' B' ' 98' ' ' ILE . 2.4 pt -135.58 106.9 9.96 Favored Pre-proline 0 C--N 1.292 -1.915 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.494 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.524 ' HB3' ' HB3' ' B' ' 96' ' ' ASP . 59.1 Cg_endo -109.03 -37.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.691 2.261 . . . . 0.0 116.455 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.401 ' H ' ' HD2' ' B' ' 125' ' ' PRO . . . -68.24 -29.44 68.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.98 8.24 20.16 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.731 0.777 . . . . 0.0 109.409 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.482 HG22 ' CE2' ' B' ' 75' ' ' PHE . 53.3 t -131.44 127.19 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.716 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -121.7 103.33 40.74 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.14 8.46 1.41 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.775 2.983 . . . . 0.0 116.166 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.56 -39.43 93.65 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' THR . . . . . 0.444 HG22 ' HD3' ' B' ' 148' ' ' PRO . 14.7 t -119.57 9.17 11.42 Favored 'General case' 0 C--O 1.252 1.189 0 O-C-N 121.229 -0.919 . . . . 0.0 111.233 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . 0.524 HG12 ' HA3' ' B' ' 147' ' ' GLY . 42.7 mt -68.4 121.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.886 0.85 . . . . 0.0 112.342 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.74 167.13 17.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.52 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.543 ' HB2' HD11 ' B' ' 143' ' ' LEU . 21.9 p -126.99 135.71 51.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t -116.72 129.91 56.41 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 60.6 tp -130.19 127.02 38.83 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.682 0.277 . . . . 0.0 111.07 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 13.7 m -98.64 163.95 12.44 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.676 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.2 m -55.17 -30.49 59.97 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -169.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . 0.732 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 22.8 t70 -88.92 -11.67 43.84 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.554 0.692 . . . . 0.0 110.713 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.57 61.82 0.8 Allowed Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -172.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 46.7 t -120.72 121.94 66.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 174.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' B' ' 135' ' ' SER . 16.1 tp -126.85 135.03 50.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.448 ' N ' HD12 ' B' ' 143' ' ' LEU . 42.4 m -121.66 118.21 28.59 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.352 171.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . 0.459 HG12 ' CG2' ' B' ' 133' ' ' ILE . 13.1 t -106.09 120.53 57.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.1 p30 -139.54 160.09 40.67 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.839 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.524 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 178.2 -136.91 3.12 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' B' ' 132' ' ' THR . 64.5 Cg_endo -104.06 150.29 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.443 2.762 . . . . 0.0 113.644 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -101.74 154.25 19.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' B' ' 150' ' ' LYS . 36.2 ttmt . . . . . 0 C--N 1.292 -1.896 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 65.5 mtp180 -94.42 119.17 32.74 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -124.85 155.38 39.55 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.659 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.3 p -129.44 140.28 51.36 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.191 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.472 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 45.4 t -115.37 136.26 52.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -111.14 139.49 46.47 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 143' ' ' LEU . 6.1 mp -119.93 128.55 53.71 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.38 119.43 25.09 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 141' ' ' GLY . 40.4 t -133.67 141.08 45.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 174.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -83.33 -171.15 3.41 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.538 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -76.13 125.04 28.4 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -158.16 166.63 31.94 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -74.97 113.41 24.54 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 123.719 0.637 . . . . 0.0 110.294 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.94 -29.81 83.68 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.787 2.991 . . . . 0.0 115.055 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.39 -7.98 57.11 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.999 -0.438 . . . . 0.0 111.392 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 88' ' ' GLU . 5.5 mm-40 -93.18 2.74 56.54 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.679 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.58 147.25 45.44 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -124.26 126.61 46.36 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.89 122.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.17 131.12 54.89 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.143 0.497 . . . . 0.0 111.07 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.518 HG22 HD13 ' A' ' 98' ' ' ILE . 58.3 t -115.13 125.03 72.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.98 91.73 2.72 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.569 0.7 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.76 -112.4 4.73 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.742 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -95.26 11.48 32.35 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.743 0.817 . . . . 0.0 111.515 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.34 137.21 55.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.821 -0.549 . . . . 0.0 110.314 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 122' ' ' TYR . 2.3 tp -125.99 120.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.497 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.3 mt-10 -132.2 150.04 52.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.138 0.494 . . . . 0.0 110.453 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.7 t -126.84 124.2 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -128.36 133.19 48.6 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.63 150.94 23.24 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 128.07 17.69 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -138.27 134.16 34.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 111.216 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -80.89 120.45 24.73 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.17 -55.94 5.0 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.024 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.651 ' HG2' HD11 ' A' ' 114' ' ' ILE . 30.7 ptt180 -148.59 155.38 41.02 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -82.24 113.58 20.16 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 114' ' ' ILE . 13.1 t70 -93.98 -148.86 0.27 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.891 -164.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -72.85 83.62 1.21 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.496 0.589 . . . . 0.0 109.786 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 74.53 -52.65 0.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.076 1.75 . . . . 0.0 110.321 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.36 173.22 54.27 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.189 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.91 149.27 41.86 Favored 'General case' 0 C--N 1.255 -3.517 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.651 HD11 ' HG2' ' A' ' 107' ' ' ARG . 38.1 pt -122.88 137.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.195 -175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -134.47 154.24 51.51 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.22 0.533 . . . . 0.0 111.244 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.409 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 6.8 ttp180 -127.3 147.05 50.24 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -134.13 153.45 51.82 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.51 ' HD2' ' NH1' ' A' ' 120' ' ' ARG . 50.1 m-85 -128.26 126.41 40.82 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.494 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.75 122.52 27.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.534 ' NH2' HD12 ' B' ' 114' ' ' ILE . 26.3 mtt85 -126.94 138.21 53.25 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -138.66 128.88 25.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.908 0.755 . . . . 0.0 111.541 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.765 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.7 m-85 -133.1 123.67 26.15 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.084 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -107.56 99.42 8.92 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 4.3 pt -135.93 105.8 9.68 Favored Pre-proline 0 C--N 1.303 -1.452 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.774 -177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.53 -38.67 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.91 2.407 . . . . 0.0 112.122 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 150' ' ' LYS . . . -68.63 -32.32 72.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.292 0.567 . . . . 0.0 111.338 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.99 -18.27 22.06 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.727 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 70.3 t -131.71 114.38 24.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.42 127.04 27.91 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 168.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 79.9 Cg_endo -73.32 16.01 0.48 Allowed 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 122.665 2.244 . . . . 0.0 116.402 -172.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.1 tp -81.84 -48.18 11.88 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.277 3.0 t -122.27 10.74 9.99 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.2 pp -67.28 129.28 31.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.1 p -132.56 166.38 22.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.417 ' HB3' HG12 ' A' ' 145' ' ' VAL . 52.9 p -127.87 134.12 49.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 121.03 0.443 . . . . 0.0 110.912 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -125.09 129.96 51.29 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.8 148.46 44.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.5 m -100.37 163.86 12.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.9 m -64.32 -21.57 66.65 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.767 0.827 . . . . 0.0 112.384 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.83 5.15 22.62 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 121.274 0.559 . . . . 0.0 110.467 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 81' ' ' VAL . . . 96.64 -20.54 50.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.868 173.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.85 123.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.766 0.793 . . . . 0.0 110.454 -175.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 79' ' ' LEU . 4.1 pp -129.65 136.26 49.51 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.583 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.0 t -109.72 135.68 50.26 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.472 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 31.1 m -105.9 122.16 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 3.6 p-10 -132.89 143.48 49.53 Favored 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.171 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' ARG . . . 174.34 -138.09 4.27 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -91.76 147.08 3.25 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.379 2.053 . . . . 0.0 112.813 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -100.57 151.47 21.56 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 126' ' ' ALA . 87.1 tttt . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 N--CA 1.441 -0.908 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' B' ' 147' ' ' GLY . 66.3 mtp180 -94.3 119.08 32.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -124.99 154.87 40.55 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.697 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.3 p -128.56 140.34 51.84 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.428 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 44.6 t -115.24 136.57 51.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -111.14 139.65 46.35 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' LEU . . . . . 0.477 HD22 HD11 ' B' ' 143' ' ' LEU . 6.1 mp -120.12 128.63 53.62 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -84.5 119.24 24.93 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.641 ' HB ' ' O ' ' B' ' 141' ' ' GLY . 41.0 t -134.1 140.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 103.01 -2.959 . . . . 0.0 103.01 174.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -82.87 -170.93 3.26 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.671 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -75.9 125.11 28.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -158.24 166.62 31.92 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -74.82 113.29 23.05 Favored Pre-proline 0 N--CA 1.435 -1.211 0 O-C-N 123.777 0.673 . . . . 0.0 110.253 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.93 -30.07 84.65 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.806 3.004 . . . . 0.0 114.969 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.25 -7.15 58.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.023 0.44 . . . . 0.0 111.476 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' B' ' 88' ' ' GLU . 5.4 mm-40 -94.26 2.82 55.84 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.14 0.495 . . . . 0.0 111.53 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.35 147.01 45.58 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.84 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -124.57 125.71 44.62 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -96.27 122.05 47.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -120.34 130.96 54.65 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.505 HG22 HD13 ' B' ' 98' ' ' ILE . 58.0 t -114.67 125.14 71.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 172.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -135.84 91.87 2.75 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.0 -112.26 4.6 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.898 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.64 11.43 33.32 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.548 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.51 137.21 55.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.452 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . 0.757 HG23 ' HB2' ' B' ' 122' ' ' TYR . 2.3 tp -125.99 120.25 56.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 174.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 38.2 mt-10 -132.33 149.93 52.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.11 0.481 . . . . 0.0 110.467 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 88.0 t -126.64 124.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -128.17 132.97 48.86 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.0 151.0 23.35 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.407 ' HD3' ' H ' ' B' ' 103' ' ' LYS . 0.0 OUTLIER -143.93 128.09 17.65 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -138.29 134.12 33.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.405 -0.809 . . . . 0.0 111.208 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.73 120.58 24.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -77.21 -55.98 4.95 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.061 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' B' ' 114' ' ' ILE . 30.2 ptt180 -148.65 155.46 41.08 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -82.06 113.6 20.05 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.413 ' HB2' HG23 ' B' ' 114' ' ' ILE . 13.8 t70 -94.09 -148.53 0.27 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.928 -163.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.55 82.57 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.602 0.637 . . . . 0.0 110.021 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 75.41 -51.46 0.65 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.245 1.818 . . . . 0.0 110.078 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.4 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -77.53 173.2 55.08 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.142 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -118.65 149.59 41.14 Favored 'General case' 0 C--N 1.255 -3.52 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.671 HD11 ' HG2' ' B' ' 107' ' ' ARG . 37.7 pt -122.92 137.03 57.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.315 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -134.59 153.92 51.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.411 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 6.3 ttp180 -127.11 147.05 50.18 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.05 153.35 51.85 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.515 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.5 ' HD2' ' NH1' ' B' ' 120' ' ' ARG . 49.9 m-85 -128.23 126.75 41.54 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.356 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -131.03 122.62 27.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.524 ' NH2' HD12 ' A' ' 114' ' ' ILE . 25.8 mtt85 -126.96 138.1 53.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -138.36 128.88 26.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 124.023 0.827 . . . . 0.0 111.474 -177.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' TYR . . . . . 0.757 ' HB2' HG23 ' B' ' 98' ' ' ILE . 4.1 m-85 -133.11 124.7 28.03 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.027 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -108.79 99.27 8.64 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.492 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 4.1 pt -136.06 106.0 9.58 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.772 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 124' ' ' ILE . 5.4 Cg_exo -84.9 -38.83 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 111.92 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' B' ' 150' ' ' LYS . . . -67.84 -32.32 72.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.73 -18.14 21.55 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.582 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 70.7 t -131.87 114.31 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -174.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -109.3 127.56 27.01 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.414 ' HA ' ' CG1' ' B' ' 133' ' ' ILE . 86.9 Cg_endo -73.55 15.96 0.52 Allowed 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 122.759 2.306 . . . . 0.0 116.374 -172.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -81.9 -48.39 11.58 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' THR . . . . . 0.4 HG22 ' HG3' ' B' ' 148' ' ' PRO 0.272 4.4 t -122.14 10.55 10.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.2 pp -67.46 128.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -175.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 12.1 p -130.6 166.7 20.08 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.653 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.42 ' HB3' HG12 ' B' ' 145' ' ' VAL . 55.9 p -127.67 134.69 49.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.065 0.46 . . . . 0.0 110.859 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 18.4 m -125.37 129.81 50.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . 0.41 ' HB3' ' HB3' ' B' ' 143' ' ' LEU . 3.8 pp -122.3 148.32 45.16 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 16.3 m -100.07 163.73 12.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 18.6 m -64.1 -21.87 66.71 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 112.439 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.43 4.19 25.16 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 123.182 0.593 . . . . 0.0 110.484 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.641 ' O ' ' HB ' ' B' ' 81' ' ' VAL . . . 97.3 -20.34 51.14 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.755 173.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.79 123.64 26.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.757 0.789 . . . . 0.0 110.432 -175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.477 HD11 HD22 ' B' ' 79' ' ' LEU . 4.1 pp -129.71 136.12 49.3 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.475 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -109.29 135.65 50.03 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . 0.475 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 31.5 m -105.74 122.24 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 3.6 p-10 -133.02 142.73 48.97 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.941 0.401 . . . . 0.0 111.349 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' B' ' 74' ' ' ARG . . . 174.76 -138.02 4.17 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.4 ' HG3' HG22 ' B' ' 132' ' ' THR . 21.7 Cg_endo -91.65 146.9 3.31 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.474 2.116 . . . . 0.0 112.887 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -100.62 151.41 21.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' B' ' 126' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.108 0.48 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -112.43 149.6 32.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 9.3 t80 -134.22 158.66 43.15 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.908 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.3 t -131.85 133.81 45.06 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.95 137.77 47.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -110.2 135.27 51.24 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.647 HD22 ' CE1' ' A' ' 122' ' ' TYR . 1.8 mt -120.46 128.86 53.54 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -107.45 134.88 49.84 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.878 0.847 . . . . 0.0 111.82 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.23 -179.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 172.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 54.9 mtpt -100.08 -163.21 1.01 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 120.325 1.421 . . . . 0.0 110.666 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -77.78 125.9 30.04 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.156 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 47.9 m-85 -142.47 146.75 35.1 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.876 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 m -66.54 129.41 94.13 Favored Pre-proline 0 N--CA 1.407 -2.599 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.473 ' HB3' HD21 ' A' ' 137' ' ' LEU . 72.9 Cg_exo -48.87 -31.96 21.38 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.229 3.286 . . . . 0.0 115.094 -173.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.37 -4.45 58.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.4 mm-40 -100.11 -0.14 39.57 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.407 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 4.0 pp -121.56 147.53 45.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.34 126.03 30.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.49 122.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.02 137.5 53.49 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.079 0.466 . . . . 0.0 110.831 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 98' ' ' ILE . 85.6 t -124.51 115.5 44.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.934 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.67 95.01 4.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.67 -112.81 4.86 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.045 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -95.92 11.23 34.6 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 123.186 0.594 . . . . 0.0 111.394 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.42 135.79 57.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.297 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 27.1 mm -121.68 120.57 62.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 46.4 mt-10 -136.46 136.9 39.87 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.701 0.682 . . . . 0.0 112.753 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 46.8 t -107.25 117.17 52.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -113.67 119.05 36.1 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 89' ' ' LEU . . . -123.83 135.64 9.87 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 25.4 ttpp -120.21 133.41 55.49 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -134.6 128.67 33.66 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.59 120.92 35.58 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -75.1 -66.26 0.78 Allowed 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.873 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -139.51 124.38 18.61 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.192 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.89 112.62 21.31 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 103.02 -2.956 . . . . 0.0 103.02 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 112' ' ' GLY . 5.4 t70 -114.35 -163.06 0.84 Allowed 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.138 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -74.24 -76.58 0.13 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.051 0.54 . . . . 0.0 111.237 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -109.87 -15.54 14.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 109' ' ' ASP . . . -130.58 113.58 1.45 Allowed Glycine 0 C--O 1.2 -1.995 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.659 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -94.07 137.22 33.51 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 120' ' ' ARG . 3.0 tt -125.24 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -131.56 162.76 29.55 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.485 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -127.58 149.61 50.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.631 1.172 . . . . 0.0 108.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 36.6 tt0 -135.83 141.18 44.65 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.463 ' CZ ' ' HD3' ' A' ' 82' ' ' LYS . 9.2 m-85 -126.73 124.96 40.97 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.0 p80 -133.05 125.58 29.96 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.063 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' B' ' 114' ' ' ILE . 24.8 ttt85 -112.63 136.91 51.64 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.449 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 28.1 mtmm -130.05 130.45 44.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.78 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE1' HD22 ' A' ' 79' ' ' LEU . 45.4 m-85 -121.55 131.6 54.23 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 123.418 0.687 . . . . 0.0 110.089 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -117.82 99.07 6.69 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.567 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 9.0 pt -135.48 105.51 10.05 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.099 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.67 -33.54 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.443 2.096 . . . . 0.0 111.341 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 150' ' ' LYS . . . -69.23 -22.95 63.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.731 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -108.11 -13.75 14.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.633 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.575 HG11 HD11 ' A' ' 98' ' ' ILE . 16.8 t -130.47 134.74 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.23 116.2 42.19 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 38.2 Cg_endo -65.13 -6.0 12.15 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.204 2.603 . . . . 0.0 116.381 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.0 tp -81.7 -45.06 16.24 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.769 -176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.6 t -112.77 8.72 18.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.473 ' O ' HD12 ' A' ' 133' ' ' ILE . 2.0 pp -68.75 136.95 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.804 170.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER -130.38 166.27 20.8 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 144' ' ' THR . 14.8 m -136.41 141.35 43.62 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 118.899 0.772 . . . . 0.0 111.809 -176.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.9 t -131.67 140.83 49.44 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -126.79 137.73 53.25 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.909 -177.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 t -100.12 161.63 13.49 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.0 m -67.89 -21.01 65.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.28 7.72 36.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.826 0.822 . . . . 0.0 110.83 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.37 33.49 11.65 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.501 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.1 112.46 32.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -108.68 129.43 55.35 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -175.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 135' ' ' SER . 5.2 p -117.64 129.0 55.47 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 175.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 134' ' ' THR . 62.1 t -103.18 122.42 55.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 134' ' ' THR . 24.1 p-10 -126.79 148.27 49.94 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.31 -118.3 0.9 Allowed Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.566 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -85.84 170.61 8.62 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 124.186 3.257 . . . . 0.0 114.19 -172.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 61.8 ttt180 -141.44 151.2 43.2 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 88.9 tttt . . . . . 0 C--N 1.294 -1.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.083 0.468 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -113.16 149.86 33.03 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.523 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 9.4 t80 -134.78 158.91 42.96 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.819 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 14.7 t -132.26 133.79 44.52 Favored 'General case' 0 N--CA 1.399 -3.015 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.0 137.65 47.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -109.82 135.24 51.04 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' LEU . . . . . 0.651 HD22 ' CE1' ' B' ' 122' ' ' TYR . 1.7 mt -120.22 128.92 53.81 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -107.56 135.38 49.11 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 121.664 0.745 . . . . 0.0 111.802 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.93 -179.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 54.0 mtpt -99.76 -163.3 1.02 Allowed 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 120.301 1.409 . . . . 0.0 110.746 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -77.63 125.8 29.9 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 117.712 -1.595 . . . . 0.0 112.188 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' B' ' 118' ' ' PHE . 47.3 m-85 -142.06 146.51 35.56 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.701 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 14.6 m -66.53 129.61 94.13 Favored Pre-proline 0 N--CA 1.412 -2.342 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.474 ' HB3' HD21 ' B' ' 137' ' ' LEU . 69.9 Cg_exo -48.56 -31.98 19.87 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 124.517 3.478 . . . . 0.0 115.094 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -88.27 -4.68 58.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' B' ' 103' ' ' LYS . 11.3 mm-40 -100.47 -0.02 38.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.433 0.635 . . . . 0.0 110.606 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.402 ' HA ' ' HA2' ' B' ' 102' ' ' GLY . 4.0 pp -121.07 147.7 45.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -133.41 125.92 30.13 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.152 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.79 122.45 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.964 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -118.91 136.39 54.09 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 120.952 0.406 . . . . 0.0 110.737 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.478 HG13 HD13 ' B' ' 98' ' ' ILE . 86.8 t -123.27 116.08 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.77 94.2 4.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.417 ' HA2' ' HG3' ' B' ' 130' ' ' PRO . . . 69.73 -112.62 4.55 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.067 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.38 11.11 35.96 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.075 0.55 . . . . 0.0 111.257 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -117.98 135.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.407 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . 0.593 HD11 HG11 ' B' ' 128' ' ' VAL . 27.5 mm -121.8 120.65 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 46.7 mt-10 -136.53 137.11 39.94 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 118.71 0.686 . . . . 0.0 112.799 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' B' ' 119' ' ' HIS . 46.7 t -107.33 117.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -113.68 119.11 36.31 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 89' ' ' LEU . . . -123.74 135.65 9.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' B' ' 88' ' ' GLU . 25.5 ttpp -120.02 133.48 55.53 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -134.71 129.02 34.09 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.01 120.83 35.89 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -74.55 -65.69 0.83 Allowed 'General case' 0 CA--C 1.478 -1.798 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.083 -168.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 -140.3 124.27 17.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.141 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 112.41 21.11 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' B' ' 112' ' ' GLY . 5.2 t70 -113.87 -163.05 0.84 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.285 -163.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -73.62 -76.1 0.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 123.315 0.646 . . . . 0.0 111.215 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -110.6 -17.51 13.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' B' ' 109' ' ' ASP . . . -129.33 114.39 1.72 Allowed Glycine 0 C--O 1.2 -2.026 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.974 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -94.22 137.3 33.55 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' ARG . 3.1 tt -125.11 137.26 58.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 15.8 m -132.76 162.7 30.79 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.514 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -127.54 149.65 50.04 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.638 1.175 . . . . 0.0 108.164 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 37.1 tt0 -135.84 141.09 44.62 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.462 ' CZ ' ' HD3' ' B' ' 82' ' ' LYS . 9.2 m-85 -126.72 124.95 40.95 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 2.0 p80 -133.1 125.75 30.25 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.914 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 24.7 ttt85 -112.66 137.02 51.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.443 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.9 mtmm -130.03 130.26 44.72 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.772 -173.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' TYR . . . . . 0.651 ' CE1' HD22 ' B' ' 79' ' ' LEU . 45.2 m-85 -121.35 131.97 54.5 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 123.704 0.628 . . . . 0.0 110.111 176.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -118.0 98.92 6.57 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 165.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 8.9 pt -135.37 105.5 10.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.055 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -92.59 -33.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.511 2.141 . . . . 0.0 111.386 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' B' ' 150' ' ' LYS . . . -69.29 -23.45 63.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.096 0.558 . . . . 0.0 111.628 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -107.47 -14.3 14.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.593 HG11 HD11 ' B' ' 98' ' ' ILE . 16.6 t -129.87 134.53 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -172.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -114.74 116.25 43.32 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.417 ' HG3' ' HA2' ' B' ' 95' ' ' GLY . 34.9 Cg_endo -65.16 -5.49 11.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.056 2.504 . . . . 0.0 116.249 -174.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.91 -45.29 15.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.614 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 8.8 t -113.02 9.05 18.62 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . 0.478 ' O ' HD12 ' B' ' 133' ' ' ILE . 2.0 pp -68.77 136.73 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.774 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 0.2 OUTLIER -130.6 166.15 21.26 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 144' ' ' THR . 16.5 m -136.43 141.38 43.59 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 118.853 0.751 . . . . 0.0 111.746 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 29.6 t -132.1 139.73 48.57 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -125.58 138.2 53.93 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.063 -177.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.24 161.68 13.45 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 13.2 m -67.56 -20.51 65.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -170.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.32 8.19 37.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.791 0.805 . . . . 0.0 110.558 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.27 33.27 12.04 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.713 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.94 112.78 33.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 0.8 OUTLIER -108.87 129.52 55.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -175.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 135' ' ' SER . 7.2 p -117.76 128.76 55.19 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' B' ' 134' ' ' THR . 61.7 t -102.89 122.53 55.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -126.7 148.67 49.84 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.04 -118.5 0.92 Allowed Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 119.775 -1.202 . . . . 0.0 112.761 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -85.47 170.65 9.08 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.391 3.394 . . . . 0.0 114.288 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ARG . . . . . 0.523 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 61.2 ttt180 -141.77 151.1 42.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 88.2 tttt . . . . . 0 C--N 1.294 -1.807 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 2.8 m-20 . . . . . 0 CA--C 1.505 -0.76 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -118.14 131.52 56.4 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.58 160.28 40.93 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.476 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -137.25 133.41 35.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.507 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 46.4 t -116.02 148.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.83 152.71 27.59 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.668 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.663 ' HA ' ' HD2' ' A' ' 120' ' ' ARG . 71.0 mt -120.17 142.14 49.25 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' B' ' 107' ' ' ARG . 13.5 t70 -105.59 120.17 40.98 Favored 'General case' 0 CA--C 1.493 -1.235 0 O-C-N 123.526 0.516 . . . . 0.0 111.898 -166.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 83' ' ' HIS . 20.9 t -140.78 96.85 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 170.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.02 9.7 1.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.456 ' O ' HG12 ' A' ' 81' ' ' VAL . 4.1 m80 -150.19 173.07 14.33 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.445 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 33.9 p90 -103.94 119.02 38.05 Favored 'General case' 0 C--N 1.282 -2.37 0 C-N-CA 117.851 -1.539 . . . . 0.0 113.797 -166.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 104' ' ' HIS . 50.8 m -119.56 65.16 8.74 Favored Pre-proline 0 N--CA 1.422 -1.841 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.826 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 84' ' ' PHE . 35.6 Cg_exo -58.06 -40.37 77.82 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.118 1.879 . . . . 0.0 112.074 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.6 -37.72 16.57 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.266 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 28.3 mt-10 -93.02 28.39 2.14 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -169.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 85' ' ' SER . 3.1 pp -128.66 153.67 47.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.519 174.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.69 129.47 34.83 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.46 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.46 HG21 HD21 ' A' ' 143' ' ' LEU . 19.3 t -107.24 132.82 53.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.11 131.36 47.24 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.399 0.618 . . . . 0.0 111.623 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.57 117.62 55.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -129.12 91.02 3.12 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.18 -113.94 5.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.934 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.27 11.09 39.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 108.971 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.13 137.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.305 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.434 HG13 HG21 ' A' ' 128' ' ' VAL . 36.5 mm -125.08 121.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 30.0 mt-10 -134.36 147.92 50.61 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.884 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.633 ' HB ' HD13 ' A' ' 79' ' ' LEU . 8.5 p -124.75 134.76 66.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -124.14 118.2 26.36 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.2 135.43 6.66 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -133.43 130.53 38.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.518 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 69.7 t60 -139.25 135.95 34.43 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.749 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.8 pt-20 -81.85 120.46 25.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -134.35 -5.29 2.63 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -124.33 124.02 41.48 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -112.99 136.05 53.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.262 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.425 ' CG ' HH12 ' B' ' 120' ' ' ARG . 3.6 m-20 -120.44 -170.1 1.92 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -55.55 -74.66 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -120.34 24.74 10.23 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.46 127.65 4.39 Favored Glycine 0 N--CA 1.402 -3.573 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.37 150.6 29.53 Favored 'General case' 0 C--N 1.261 -3.239 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' B' ' 120' ' ' ARG . 3.0 mt -123.78 137.24 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 17.0 m -120.52 150.35 40.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.821 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 35.9 tt0 -137.34 142.37 41.81 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.46 128.25 53.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 12.7 t-80 -131.61 125.97 33.55 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.42 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.663 ' HD2' ' HA ' ' A' ' 79' ' ' LEU . 64.5 mtt-85 -111.22 146.25 37.26 Favored 'General case' 0 CA--C 1.465 -2.302 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 25.0 ttmm -125.82 128.81 48.24 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -128.6 133.04 48.21 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.192 0.597 . . . . 0.0 110.827 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -122.76 98.46 5.92 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.536 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.0 pt -135.59 105.08 9.97 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.146 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.461 ' O ' ' HE2' ' A' ' 150' ' ' LYS . 10.3 Cg_exo -80.45 -39.91 0.23 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.347 2.031 . . . . 0.0 110.237 174.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . -67.44 -17.56 64.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.964 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.41 ' HB2' HD12 ' A' ' 124' ' ' ILE . 3.9 m-20 -113.13 -17.9 12.28 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.006 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.536 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 55.3 t -131.34 126.12 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.32 126.66 26.15 Favored Pre-proline 0 N--CA 1.428 -1.569 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 165.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.6 -24.41 53.83 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 123.931 3.087 . . . . 0.0 115.172 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.3 -24.31 37.29 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 148' ' ' PRO . 11.1 t -116.94 -17.22 10.45 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.88 -1.128 . . . . 0.0 113.197 -172.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.7 mm -81.3 125.22 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.947 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 11.2 p -122.01 167.19 13.39 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.904 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -126.99 133.76 50.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.917 0.389 . . . . 0.0 111.347 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 p -121.24 145.38 47.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.378 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 65.8 tp -123.88 131.52 53.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.431 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 11.7 m -96.76 162.91 13.22 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.1 t -67.43 -13.45 62.04 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -98.45 0.29 44.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.588 0.709 . . . . 0.0 110.465 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.54 4.51 52.54 Favored Glycine 0 C--N 1.316 -0.58 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.171 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 47.5 t -73.18 113.38 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.3 tm? -107.61 132.23 53.52 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.75 124.75 44.95 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.594 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.507 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 26.8 m -99.19 122.31 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -128.12 142.69 51.12 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.65 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.18 176.79 28.71 Favored Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.584 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 50.4 Cg_exo -62.72 141.13 84.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.902 3.068 . . . . 0.0 113.724 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 56.8 mtp180 -80.0 163.32 24.32 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 125' ' ' PRO . 36.4 ttpt . . . . . 0 C--N 1.298 -1.671 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.422 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 2.4 m-20 . . . . . 0 CA--C 1.506 -0.725 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -120.23 130.73 54.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.32 160.31 40.75 Favored 'General case' 0 N--CA 1.42 -1.942 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.513 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -137.29 132.67 34.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.954 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.505 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 46.5 t -115.95 148.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -111.58 152.58 27.42 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.686 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' LEU . . . . . 0.644 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 70.7 mt -120.22 142.23 49.2 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.54 119.82 40.07 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -166.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 83' ' ' HIS . 20.5 t -139.79 97.94 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 102.465 -3.161 . . . . 0.0 102.465 169.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -75.77 9.75 2.16 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . 0.453 ' O ' HG12 ' B' ' 81' ' ' VAL . 3.7 m80 -150.13 173.28 14.08 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' B' ' 86' ' ' PRO . 34.8 p90 -104.0 118.99 37.99 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 117.804 -1.558 . . . . 0.0 113.787 -166.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.52 ' OG ' ' HB2' ' B' ' 104' ' ' HIS . 49.3 m -119.44 65.26 8.42 Favored Pre-proline 0 N--CA 1.421 -1.895 0 CA-C-N 113.492 -1.686 . . . . 0.0 108.879 170.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' B' ' 84' ' ' PHE . 48.8 Cg_exo -57.45 -40.81 78.25 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.159 1.906 . . . . 0.0 112.07 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -88.01 -38.12 15.76 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 85' ' ' SER . 27.8 mt-10 -91.79 27.56 2.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -170.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' B' ' 85' ' ' SER . 3.1 pp -128.31 154.17 46.22 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.56 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.48 130.01 34.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.289 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.452 HG21 HD21 ' B' ' 143' ' ' LEU . 20.3 t -108.25 132.61 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -128.96 131.38 47.48 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.647 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.59 117.37 54.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tt -129.37 90.67 3.05 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.6 -114.23 5.53 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.98 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -100.65 11.2 40.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.842 0.83 . . . . 0.0 108.968 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.3 137.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.222 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . 0.432 HG13 HG21 ' B' ' 128' ' ' VAL . 36.4 mm -125.08 120.94 59.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 29.7 mt-10 -134.41 147.89 50.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.923 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.625 ' HB ' HD13 ' B' ' 79' ' ' LEU . 9.1 p -124.62 134.72 66.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -123.84 118.39 27.02 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.35 135.37 6.58 Favored Glycine 0 CA--C 1.491 -1.419 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -133.41 130.29 38.5 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' HIS . . . . . 0.52 ' HB2' ' OG ' ' B' ' 85' ' ' SER . 70.0 t60 -139.03 135.94 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.852 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.7 pt-20 -81.68 120.34 24.98 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.57 -5.28 2.55 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 80' ' ' ASP . 66.6 mtp180 -124.61 123.99 41.25 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -112.98 136.16 52.96 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.284 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.414 ' CG ' HH12 ' A' ' 120' ' ' ARG . 4.1 m-20 -120.86 -168.34 1.64 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.44 -74.29 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.521 0.729 . . . . 0.0 112.344 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -118.95 24.2 10.97 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -134.1 128.09 4.79 Favored Glycine 0 N--CA 1.402 -3.61 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -111.56 150.6 29.77 Favored 'General case' 0 C--N 1.263 -3.164 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.495 HG12 ' HG2' ' A' ' 120' ' ' ARG . 3.1 mt -123.9 137.07 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 15.6 m -120.42 150.3 41.01 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.689 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -127.29 148.56 50.23 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 36.0 tt0 -137.47 142.35 41.54 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.42 128.34 53.94 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 12.9 t-80 -131.52 125.82 33.36 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.423 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.644 ' HD2' ' HA ' ' B' ' 79' ' ' LEU . 62.4 mtt-85 -111.04 146.29 36.99 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.451 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 24.8 ttmm -126.15 128.89 48.0 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.93 132.33 47.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 123.203 0.601 . . . . 0.0 110.833 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -121.87 98.49 5.97 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 168.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.9 pt -135.39 104.96 10.14 Favored Pre-proline 0 C--N 1.293 -1.886 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.152 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.469 ' O ' ' HE2' ' B' ' 150' ' ' LYS . 7.9 Cg_exo -80.09 -39.74 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.278 1.985 . . . . 0.0 110.321 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' B' ' 149' ' ' ARG . . . -67.26 -17.98 65.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.861 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . 0.409 ' HB2' HD12 ' B' ' 124' ' ' ILE . 4.0 m-20 -113.17 -17.99 12.23 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.109 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 55.4 t -131.35 125.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -169.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -122.35 126.43 26.22 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 165.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.69 -24.06 52.7 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.937 3.091 . . . . 0.0 115.152 -171.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 82.3 mt -81.25 -23.94 37.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' THR . . . . . 0.442 ' OG1' ' HD2' ' B' ' 148' ' ' PRO . 8.3 t -117.43 -17.81 9.98 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.779 -1.168 . . . . 0.0 113.102 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.6 mm -81.07 125.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.06 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 14.6 p -122.09 167.6 12.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.649 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -126.95 134.05 50.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 7.0 p -121.16 146.09 47.14 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.858 0.863 . . . . 0.0 109.139 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 66.3 tp -124.98 130.5 52.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.673 0.273 . . . . 0.0 111.387 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 7.4 m -95.89 163.12 13.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -67.66 -14.32 62.84 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -96.63 -0.69 48.17 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.541 0.686 . . . . 0.0 110.628 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.63 5.16 51.79 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.713 -1.232 . . . . 0.0 112.008 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 46.9 t -73.31 113.66 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.3 tm? -107.8 132.0 53.87 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.7 124.79 45.09 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.576 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . 0.505 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 26.9 m -99.15 122.39 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.858 -171.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.03 177.47 29.26 Favored Glycine 0 N--CA 1.415 -2.749 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.638 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 52.2 Cg_exo -62.98 140.74 80.81 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.892 3.061 . . . . 0.0 113.793 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 56.4 mtp180 -79.81 163.25 24.57 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.039 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' B' ' 125' ' ' PRO . 35.9 ttpt . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.618 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' A' ' 149' ' ' ARG . 2.8 m-20 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -130.65 126.59 36.97 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -105.92 132.93 51.43 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.962 0.887 . . . . 0.0 112.078 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 146' ' ' ASN . 15.7 m -114.38 131.07 56.69 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.61 131.44 66.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -110.4 130.53 55.53 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.657 HD22 ' CZ ' ' A' ' 122' ' ' TYR . 11.9 mt -120.24 128.3 53.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -103.01 128.26 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.002 0.906 . . . . 0.0 113.01 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.516 HG23 HH12 ' A' ' 120' ' ' ARG . 38.9 t -122.28 142.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -64.31 -56.7 12.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.597 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 18.2 t60 -153.96 125.84 7.74 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.261 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.403 ' CE2' ' HA2' ' A' ' 141' ' ' GLY . 0.3 OUTLIER -130.48 172.17 12.19 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.257 0.48 . . . . 0.0 111.167 177.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 20.9 m -93.16 121.92 64.45 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.93 -28.64 78.79 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.957 2.438 . . . . 0.0 113.483 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.98 -38.64 19.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.632 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.564 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 35.8 mt-10 -85.42 40.08 0.82 Allowed 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.585 0.707 . . . . 0.0 109.519 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 90' ' ' LYS . 1.1 tm? -120.51 145.81 46.92 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -174.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.447 ' N ' HD13 ' A' ' 89' ' ' LEU . 25.9 tptp -144.0 125.88 15.27 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 138.68 40.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.492 ' HG3' ' HB2' ' A' ' 99' ' ' GLU . 13.1 ptmm? -144.34 135.51 25.36 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.601 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.41 116.12 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 97' ' ' VAL . 62.3 tp -120.04 90.86 3.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.99 -111.96 4.56 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.849 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -90.01 4.2 50.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.941 0.896 . . . . 0.0 112.106 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 94' ' ' LEU . 35.4 m -117.48 137.75 50.38 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.349 -0.94 . . . . 0.0 113.195 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 37.2 mm -112.85 119.89 61.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 14.8 mp0 -122.33 136.95 54.99 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.171 0.51 . . . . 0.0 109.867 174.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.6 126.95 61.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.88 42.69 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.01 140.74 12.58 Favored Glycine 0 CA--C 1.477 -2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.564 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 13.9 ptmm? -143.19 144.69 32.28 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 117.214 0.507 . . . . 0.0 109.733 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -136.74 128.82 29.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.56 120.95 25.19 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 21.9 mt-10 -83.95 -74.18 0.39 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.757 -167.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 18.2 ptt-85 -148.57 151.34 34.91 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.103 -173.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -111.48 119.73 39.77 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 -44.29 77.96 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 168.83 -75.34 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -94.23 -12.58 27.92 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.559 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -101.48 137.19 13.15 Favored Glycine 0 N--CA 1.411 -3.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.243 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.2 137.69 52.19 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.33 134.02 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.4 p -134.31 155.23 50.59 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -128.19 148.06 50.6 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -135.05 153.52 52.02 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.039 0.447 . . . . 0.0 109.997 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -122.62 125.99 46.76 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.51 122.11 43.75 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.516 HH12 HG23 ' A' ' 81' ' ' VAL . 41.3 ttp180 -133.11 138.0 46.52 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.878 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.492 ' HG2' ' HG3' ' A' ' 99' ' ' GLU . 33.1 mttm -139.87 130.46 25.69 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.099 0.875 . . . . 0.0 112.157 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CZ ' HD22 ' A' ' 79' ' ' LEU . 44.0 m-85 -126.15 136.95 53.48 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -117.32 98.63 6.53 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.598 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.8 pt -136.41 106.16 9.29 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.267 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -88.79 -45.88 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.193 1.929 . . . . 0.0 112.873 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.92 -13.03 62.19 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.488 0.661 . . . . 0.0 112.596 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -112.1 -17.65 12.78 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 2.9 t -132.6 117.67 31.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.57 123.27 26.43 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.15 -1.57 3.05 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.633 2.888 . . . . 0.0 116.339 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.4 tp -59.78 -44.43 93.92 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.475 ' HB ' ' HD3' ' A' ' 148' ' ' PRO . 39.6 m -110.84 -12.8 14.23 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.642 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 55.4 mt -67.99 126.08 27.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -165.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 p -122.11 163.61 19.17 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.385 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 144' ' ' THR . 26.7 t -138.0 135.68 36.19 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.217 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.8 p -127.75 156.27 42.71 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.41 144.07 44.3 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.195 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.488 ' HB3' ' HB ' ' A' ' 142' ' ' VAL . 17.8 t -100.49 162.74 12.74 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.7 m -61.55 -28.01 69.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.761 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 37.5 t70 -90.18 -12.3 38.55 Favored 'General case' 0 C--O 1.205 -1.265 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.343 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.403 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . 120.75 8.91 7.91 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 117.978 -2.058 . . . . 0.0 113.237 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 138' ' ' SER . 51.4 t -78.89 118.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.8 tm? -115.23 133.75 55.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 135' ' ' SER . 27.5 m -121.56 130.13 53.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.841 -0.537 . . . . 0.0 111.078 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.3 m -121.03 125.53 74.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.642 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 7.9 p30 -137.27 137.52 39.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.048 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . -158.78 -143.27 3.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.29 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 132' ' ' THR . 93.7 Cg_endo -102.73 169.64 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.022 3.148 . . . . 0.0 112.589 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.439 ' CD ' ' HB2' ' A' ' 73' ' ' ASP . 61.4 ttt180 -96.36 138.03 34.56 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.435 -1.175 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.578 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' B' ' 149' ' ' ARG . 2.5 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -131.01 126.65 36.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -105.91 132.94 51.4 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.132 0.968 . . . . 0.0 111.976 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -113.76 131.19 56.3 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.79 131.35 67.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -110.47 130.51 55.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' LEU . . . . . 0.648 HD22 ' CZ ' ' B' ' 122' ' ' TYR . 11.4 mt -120.34 128.47 53.28 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.52 127.92 49.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.955 0.883 . . . . 0.0 113.108 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.524 HG23 HH12 ' B' ' 120' ' ' ARG . 39.0 t -122.32 141.9 40.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.24 -56.51 14.13 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.718 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . 0.777 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 18.2 t60 -153.97 125.74 7.69 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.255 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.42 172.06 12.29 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.267 0.485 . . . . 0.0 111.108 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 22.9 m -93.17 122.25 63.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.19 -28.3 78.68 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.938 2.425 . . . . 0.0 113.553 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -85.51 -38.52 18.46 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.787 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' B' ' 103' ' ' LYS . 35.5 mt-10 -85.22 40.17 0.81 Allowed 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.479 0.656 . . . . 0.0 109.4 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.45 HD13 ' N ' ' B' ' 90' ' ' LYS . 1.1 tm? -120.59 145.83 46.97 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.45 ' N ' HD13 ' B' ' 89' ' ' LEU . 26.1 tptp -144.18 125.74 14.97 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.07 139.09 38.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' B' ' 99' ' ' GLU . 13.5 ptmm? -144.45 135.82 25.5 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.14 116.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.447 ' O ' HG22 ' B' ' 97' ' ' VAL . 62.4 tp -119.92 90.56 3.35 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.67 -111.96 4.58 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.625 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -90.08 4.17 51.1 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 123.933 0.893 . . . . 0.0 112.192 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 94' ' ' LEU . 29.2 m -117.25 137.74 50.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.315 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 37.6 mm -112.81 120.03 61.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' B' ' 92' ' ' LYS . 15.2 mp0 -122.46 137.04 55.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 121.199 0.523 . . . . 0.0 109.842 174.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.41 HG21 HD12 ' B' ' 79' ' ' LEU . 92.4 t -130.69 127.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.64 41.86 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.78 140.88 12.76 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.551 ' HG3' ' HB3' ' B' ' 88' ' ' GLU . 13.7 ptmm? -143.33 144.75 32.22 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 117.25 0.525 . . . . 0.0 109.78 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -136.75 128.65 29.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -80.19 121.08 25.15 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.17 -73.8 0.41 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.825 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -148.58 151.3 34.82 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.326 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -111.75 119.14 37.63 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.01 -44.51 80.15 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 169.04 -74.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -94.79 -12.79 26.42 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.589 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -101.45 137.2 13.16 Favored Glycine 0 N--CA 1.411 -3.02 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.245 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.18 137.54 52.27 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 134.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 36.7 p -134.31 155.13 50.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -128.21 148.15 50.61 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -135.19 153.43 51.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.988 0.423 . . . . 0.0 109.894 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.66 125.91 46.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.5 122.19 44.01 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.524 HH12 HG23 ' B' ' 81' ' ' VAL . 41.4 ttp180 -133.27 137.82 46.2 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.757 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.48 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 32.9 mttm -139.57 130.37 26.06 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 124.293 0.995 . . . . 0.0 112.11 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' TYR . . . . . 0.648 ' CZ ' HD22 ' B' ' 79' ' ' LEU . 46.4 m-85 -126.32 136.44 52.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -117.1 98.79 6.65 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.591 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -136.43 106.43 9.27 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.331 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -88.99 -45.39 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.207 1.938 . . . . 0.0 112.869 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.8 -13.97 62.74 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.468 0.651 . . . . 0.0 112.61 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -112.36 -17.22 12.77 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.311 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 2.9 t -132.56 117.47 31.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -123.41 123.48 26.5 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.24 -1.53 3.07 Favored 'Trans proline' 0 CA--C 1.551 1.361 0 C-N-CA 123.587 2.858 . . . . 0.0 116.223 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.44 -44.44 92.94 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' B' ' 148' ' ' PRO . 48.3 m -111.23 -11.65 14.19 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 55.0 mt -68.35 126.17 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -122.63 163.04 20.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.01 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.2 t -137.51 136.58 37.81 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 121.249 0.547 . . . . 0.0 111.243 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 10.1 p -128.5 156.64 42.94 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.74 143.67 43.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.125 0.488 . . . . 0.0 111.265 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' B' ' 142' ' ' VAL . 14.4 t -100.72 162.64 12.78 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.5 m -61.61 -27.39 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -168.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . 0.777 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 36.8 t70 -90.59 -12.61 36.47 Favored 'General case' 0 C--O 1.203 -1.349 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.329 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.17 9.06 7.52 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 118.095 -2.002 . . . . 0.0 113.222 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 138' ' ' SER . 56.8 t -78.84 118.49 26.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.9 tm? -115.15 133.8 55.72 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' B' ' 135' ' ' SER . 31.1 m -121.57 129.97 53.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.834 -0.541 . . . . 0.0 110.974 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 19.1 m -120.92 125.16 73.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' ASN . . . . . 0.649 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 7.8 p30 -136.95 137.6 39.69 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.225 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.577 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . -158.79 -143.51 3.68 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.121 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' B' ' 132' ' ' THR . 96.9 Cg_endo -102.7 169.69 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.938 3.092 . . . . 0.0 112.586 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ARG . . . . . 0.428 ' CD ' ' HB2' ' B' ' 73' ' ' ASP . 62.9 ttt180 -96.28 138.25 34.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.715 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.928 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 . . . . . 0 N--CA 1.421 -1.913 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -94.92 119.67 33.85 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -126.86 154.42 44.4 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.932 -172.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.9 p -136.86 144.84 43.79 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.553 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 42.4 t -115.3 132.49 64.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -110.79 138.4 47.24 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' A' ' 122' ' ' TYR . 5.8 mp -118.26 126.12 51.51 Favored 'General case' 0 N--CA 1.386 -3.655 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -116.32 139.26 50.58 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.22 1.008 . . . . 0.0 110.551 -175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' HB ' ' NH1' ' A' ' 120' ' ' ARG . 8.4 p -155.06 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.464 ' H ' HG22 ' A' ' 81' ' ' VAL . 72.9 mmtt -85.68 -163.39 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 119.139 0.881 . . . . 0.0 110.806 176.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.588 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 74.7 m80 -78.54 124.44 28.16 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.612 0.72 . . . . 0.0 111.693 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -149.89 150.43 31.9 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 p -80.89 119.1 75.13 Favored Pre-proline 0 C--N 1.287 -2.123 0 C-N-CA 123.351 0.66 . . . . 0.0 112.432 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.06 -28.54 14.05 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 124.789 3.66 . . . . 0.0 115.122 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.55 -27.59 51.59 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 122.095 -0.378 . . . . 0.0 111.629 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.34 8.27 28.35 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.52 150.43 40.85 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.065 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -130.25 131.81 45.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 100' ' ' VAL . 32.6 m -103.32 138.11 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 -176.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 78.3 mttt -114.25 130.82 56.64 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.7 111.07 21.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.4 95.66 3.12 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.15 -111.53 3.54 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.598 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -99.45 4.14 45.99 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.105 0.962 . . . . 0.0 111.221 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -113.5 137.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.983 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 145' ' ' VAL . 26.3 mt -130.31 120.48 48.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 43.7 mt-10 -136.74 149.69 47.98 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.675 0.274 . . . . 0.0 110.368 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 91' ' ' VAL . 61.8 t -126.32 114.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -115.22 131.01 57.06 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.09 147.97 19.5 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -143.28 131.8 22.34 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 122.393 0.277 . . . . 0.0 110.784 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -136.66 128.88 29.81 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.21 -0.307 . . . . 0.0 110.274 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -80.82 121.36 25.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -79.99 -52.14 8.2 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.779 0.323 . . . . 0.0 110.886 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 114' ' ' ILE . 11.2 ptt180 -148.56 147.11 28.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.96 136.94 50.64 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.804 0.812 . . . . 0.0 111.63 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -90.77 -166.29 1.55 Allowed 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.09 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -47.63 -65.65 0.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.254 1.422 . . . . 0.0 111.41 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -141.78 39.22 1.66 Allowed 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.46 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -137.3 144.44 15.94 Favored Glycine 2 N--CA 1.382 -4.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 108.198 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.83 149.89 45.19 Favored 'General case' 0 C--N 1.245 -3.966 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 107' ' ' ARG . 5.5 pt -122.87 134.74 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.4 m -135.03 162.33 32.76 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.374 0.607 . . . . 0.0 110.688 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.72 147.56 49.95 Favored 'General case' 0 N--CA 1.39 -3.447 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 56.2 mt-10 -136.92 151.64 49.28 Favored 'General case' 0 C--N 1.261 -3.241 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -126.07 126.65 44.56 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -129.75 121.91 27.81 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' NH1' ' HB ' ' A' ' 81' ' ' VAL . 37.7 ttp180 -125.51 136.77 53.69 Favored 'General case' 0 C--N 1.263 -3.182 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.461 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 45.9 mtmt -138.49 129.82 27.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 123.399 0.437 . . . . 0.0 110.827 -169.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.508 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 73.2 m-85 -131.7 143.45 50.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.165 0.586 . . . . 0.0 111.171 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -128.2 98.59 5.14 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 167.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.5 pt -137.06 105.54 8.75 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.998 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.69 -40.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.383 2.055 . . . . 0.0 113.26 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 149' ' ' ARG . . . -69.41 -33.87 73.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.954 0.407 . . . . 0.0 111.454 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -88.77 -17.1 30.53 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.655 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 78.8 t -127.36 120.49 55.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.354 0.597 . . . . 0.0 111.894 -175.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -115.7 119.62 37.3 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.512 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 97.7 Cg_endo -74.28 19.46 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.024 2.483 . . . . 0.0 116.305 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.96 -47.87 12.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.219 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 148' ' ' PRO 0.362 8.9 t -121.82 10.88 10.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.554 HG23 ' HD2' ' A' ' 148' ' ' PRO . 1.2 pp -67.7 135.21 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.1 p -125.83 166.56 16.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.421 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 144' ' ' THR . 17.4 m -127.54 133.82 49.79 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.03 0.443 . . . . 0.0 110.175 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.3 m -116.67 133.48 55.96 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.26 128.2 53.8 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.6 m -97.56 162.02 13.49 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.1 m -68.33 -15.25 63.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.468 1.107 . . . . 0.0 113.491 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 10.2 t70 -90.6 -12.72 36.12 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.06 -2.04 35.4 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.65 137.13 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.401 ' CD1' HG13 ' A' ' 145' ' ' VAL . 3.3 tm? -127.0 134.43 50.35 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -173.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 135' ' ' SER . 58.1 m -115.54 120.5 39.68 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.0 m -101.57 121.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 13.0 p30 -133.89 137.43 44.95 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.833 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.43 -133.65 2.87 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 133' ' ' ILE . 60.8 Cg_endo -98.59 160.2 0.72 Allowed 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.976 2.45 . . . . 0.0 113.474 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 126' ' ' ALA . 57.9 ttt-85 -110.0 163.41 13.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 4.0 ttmp? . . . . . 0 C--N 1.311 -1.09 0 CA-C-O 118.801 -0.619 . . . . 0.0 109.846 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -94.71 119.58 33.56 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -126.75 154.68 43.88 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.972 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 20.1 p -137.04 144.82 43.41 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.554 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 42.7 t -115.29 132.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.28 138.61 46.43 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' B' ' 122' ' ' TYR . 5.8 mp -118.1 126.13 51.65 Favored 'General case' 0 N--CA 1.383 -3.798 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -116.25 139.24 50.58 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 124.239 1.016 . . . . 0.0 110.572 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.52 ' HB ' ' NH1' ' B' ' 120' ' ' ARG . 8.4 p -154.89 -174.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.474 ' H ' HG22 ' B' ' 81' ' ' VAL . 73.1 mmtt -85.74 -163.49 0.87 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 119.159 0.89 . . . . 0.0 110.991 175.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 74.9 m80 -78.4 124.43 28.11 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 121.631 0.729 . . . . 0.0 111.664 -172.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -150.25 150.1 31.07 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 1.6 p -80.7 119.0 74.94 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 123.27 0.628 . . . . 0.0 112.522 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.1 -28.88 14.9 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 124.685 3.59 . . . . 0.0 115.148 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.3 -26.94 52.78 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 122.138 -0.351 . . . . 0.0 111.729 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.86 8.25 30.14 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.957 -0.464 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.51 150.47 40.78 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.98 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.468 HG12 HG22 ' B' ' 100' ' ' VAL . 31.8 m -104.4 138.56 28.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.525 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' B' ' 98' ' ' ILE . 78.0 mttt -114.6 130.77 56.82 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 50.2 t -129.88 111.0 20.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -137.45 95.97 3.17 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.92 -111.54 3.56 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.468 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.84 4.24 45.08 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.846 0.858 . . . . 0.0 111.263 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.25 136.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.969 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . 0.455 HD13 HG21 ' B' ' 145' ' ' VAL . 25.8 mt -130.18 120.54 49.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 43.9 mt-10 -136.84 149.7 47.85 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.795 0.331 . . . . 0.0 110.379 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG12 ' B' ' 91' ' ' VAL . 61.4 t -126.27 114.09 36.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -114.87 130.72 56.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.27 148.14 19.77 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' B' ' 103' ' ' LYS . 11.7 ptmt -143.41 132.4 22.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 122.412 0.285 . . . . 0.0 110.822 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -136.97 129.48 30.1 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -81.12 121.21 25.81 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.56 -52.09 8.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.914 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.45 ' HG2' HD11 ' B' ' 114' ' ' ILE . 11.6 ptt180 -149.05 146.71 27.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.57 137.22 49.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.793 0.806 . . . . 0.0 111.739 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -91.19 -166.22 1.53 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.127 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -46.59 -66.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.394 1.478 . . . . 0.0 111.302 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -141.69 39.83 1.69 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.508 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -138.47 144.24 15.31 Favored Glycine 2 N--CA 1.384 -4.779 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.101 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.81 150.24 44.74 Favored 'General case' 1 C--N 1.243 -4.028 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.45 HD11 ' HG2' ' B' ' 107' ' ' ARG . 5.5 pt -123.11 134.85 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m -135.01 162.16 33.25 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-O 121.368 0.604 . . . . 0.0 110.619 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.87 147.39 50.06 Favored 'General case' 0 N--CA 1.392 -3.355 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 55.9 mt-10 -136.88 151.24 48.86 Favored 'General case' 0 C--N 1.26 -3.317 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -125.61 127.05 45.72 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -130.14 121.79 26.97 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.52 ' NH1' ' HB ' ' B' ' 81' ' ' VAL . 37.7 ttp180 -125.43 136.73 53.71 Favored 'General case' 0 C--N 1.26 -3.286 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.455 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 45.6 mtmt -138.41 129.84 27.55 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.344 0.403 . . . . 0.0 110.825 -169.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' TYR . . . . . 0.46 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 74.6 m-85 -131.57 143.8 50.62 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.681 0.613 . . . . 0.0 111.147 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -128.42 98.59 5.1 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 167.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.6 pt -137.18 105.42 8.66 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.01 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -90.7 -40.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.377 2.052 . . . . 0.0 113.143 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.06 74.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.867 0.365 . . . . 0.0 111.451 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.63 -17.04 30.92 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.61 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 80.8 t -127.16 120.24 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.531 0.681 . . . . 0.0 111.901 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.38 119.24 38.55 Favored Pre-proline 0 C--N 1.287 -2.131 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.506 ' HA ' ' CG1' ' B' ' 133' ' ' ILE . 82.8 Cg_endo -74.21 19.72 0.43 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.005 2.47 . . . . 0.0 116.277 -171.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.99 -47.83 12.2 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.989 -1.084 . . . . 0.0 112.267 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' THR . . . . . 0.537 HG22 ' HG3' ' B' ' 148' ' ' PRO 0.368 8.9 t -121.99 10.97 10.21 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . 0.548 HG23 ' HD2' ' B' ' 148' ' ' PRO . 1.2 pp -67.76 134.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 2.7 p -125.36 166.87 15.78 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.474 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' B' ' 144' ' ' THR . 17.9 m -127.48 133.61 49.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 15.1 m -116.65 133.09 56.43 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 5.8 mp -105.92 128.25 53.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 17.0 m -97.02 161.76 13.68 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.9 m -68.17 -14.04 62.68 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.426 1.09 . . . . 0.0 113.468 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 9.3 t70 -91.46 -12.74 33.79 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.71 -2.09 36.32 Favored Glycine 0 C--O 1.261 1.825 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 89.3 t -73.74 137.26 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.404 ' CD1' HG13 ' B' ' 145' ' ' VAL . 3.3 tm? -127.21 134.52 50.1 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 135' ' ' SER . 57.9 m -115.63 120.68 40.21 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . 0.554 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 5.8 m -101.8 121.89 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -133.65 137.17 45.23 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.722 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.01 -133.46 2.78 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' B' ' 133' ' ' ILE . 92.8 Cg_endo -98.04 160.33 0.84 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.28 2.653 . . . . 0.0 113.6 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -110.64 163.19 13.99 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' B' ' 150' ' ' LYS . 4.1 ttmp? . . . . . 0 C--N 1.308 -1.229 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.291 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.474 0.654 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -105.52 131.32 53.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 22.7 t80 -110.07 134.8 51.78 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.415 -171.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.9 m -113.13 129.71 56.42 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.0 t -114.97 130.76 68.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.73 155.91 24.75 Favored 'General case' 0 C--N 1.264 -3.152 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 143' ' ' LEU . 31.5 tp -118.2 127.56 53.87 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.89 136.17 52.84 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -177.07 168.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -87.37 -175.14 5.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.623 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -77.73 125.61 29.61 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.993 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.05 160.65 38.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.613 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 14.3 m -66.56 107.9 1.96 Allowed Pre-proline 0 CA--C 1.554 1.102 0 O-C-N 124.523 1.14 . . . . 0.0 112.89 -170.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 54.4 Cg_exo -57.26 -28.3 79.01 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.314 3.343 . . . . 0.0 113.968 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -86.75 -9.44 55.87 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.777 0.323 . . . . 0.0 111.063 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 24.8 mm-40 -113.47 19.75 16.64 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.351 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 3.9 pp -120.82 153.8 36.61 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.318 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.73 125.86 45.5 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.723 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -109.35 122.18 63.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -125.73 131.37 52.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.529 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.46 HG23 HG12 ' A' ' 98' ' ' ILE . 3.4 p -124.01 113.03 35.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.37 91.23 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA2' ' HG3' ' A' ' 130' ' ' PRO . . . 66.65 -111.92 4.5 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.11 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.51 9.26 39.21 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.248 1.019 . . . . 0.0 111.612 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.12 136.03 61.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.536 -0.727 . . . . 0.0 109.535 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 93' ' ' VAL . 44.6 mt -130.37 121.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 47.4 mt-10 -132.24 148.35 52.45 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.635 -178.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.51 127.43 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.203 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -136.37 120.01 17.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.26 162.01 27.24 Favored Glycine 0 CA--C 1.482 -2.015 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.93 143.83 51.02 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -120.77 135.19 55.22 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.48 129.11 34.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 116' ' ' ARG . 42.5 mt-10 -105.0 -76.08 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.414 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 48.7 mtm-85 -141.15 141.82 34.1 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -112.0 136.52 51.24 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.202 0.525 . . . . 0.0 110.922 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 112' ' ' GLY . 33.4 m-20 -97.12 -155.46 0.49 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 173.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.46 -57.18 3.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' B' ' 123' ' ' ARG . 57.3 m80 -100.52 -11.0 20.49 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.482 -176.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -112.3 139.71 15.79 Favored Glycine 1 N--CA 1.395 -4.085 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.428 -176.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -130.14 140.0 50.83 Favored 'General case' 0 C--N 1.256 -3.487 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.411 HG12 ' HG3' ' B' ' 120' ' ' ARG . 3.1 mt -123.73 132.94 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -136.43 158.28 44.81 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.491 ' HB2' ' OE2' ' A' ' 106' ' ' GLU . 22.8 ttm180 -127.04 148.44 50.12 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.3 mt-10 -125.0 150.78 46.35 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.08 124.75 37.78 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -131.79 132.34 43.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.876 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.423 HH21 ' CG ' ' B' ' 109' ' ' ASP . 44.4 ttt180 -130.35 137.88 50.13 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 27.7 mtpp -122.86 127.14 48.62 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.303 1.2 p90 -134.36 115.61 14.25 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' B' ' 111' ' ' HIS . 68.8 ttt180 -102.5 99.69 9.74 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.356 0.598 . . . . 0.0 109.764 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.0 pt -124.08 105.54 31.68 Favored Pre-proline 0 C--N 1.288 -2.107 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.458 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -90.13 -52.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.144 2.562 . . . . 0.0 113.163 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.9 64.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.351 0.596 . . . . 0.0 111.364 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.09 -18.14 17.88 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.321 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 57.4 t -132.15 113.48 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 17.2 t70 -100.16 128.39 30.79 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.428 ' HG3' ' HA2' ' A' ' 95' ' ' GLY . 72.3 Cg_endo -71.04 16.71 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.664 2.243 . . . . 0.0 116.442 -171.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 tp -82.02 -46.97 13.22 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.257 14.3 t -120.36 9.99 11.12 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -68.44 130.3 33.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.8 t -137.75 163.0 32.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.454 ' HB2' HD11 ' A' ' 143' ' ' LEU . 16.8 p -128.0 133.0 49.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.8 t -125.89 129.56 49.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.06 135.06 48.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.453 0.644 . . . . 0.0 111.855 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.1 m -100.82 163.45 12.31 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.025 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.4 m -60.29 -21.85 62.44 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.21 7.37 41.05 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 121.383 0.611 . . . . 0.0 111.385 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.15 -6.12 61.57 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.534 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -73.95 112.76 11.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 144' ' ' THR . 1.9 tp -122.34 134.67 54.64 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.266 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.566 ' N ' HD12 ' A' ' 143' ' ' LEU . 17.8 m -117.75 117.92 30.65 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 134' ' ' THR . 31.8 t -101.65 121.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 8.9 p30 -135.38 144.07 46.4 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.396 -0.815 . . . . 0.0 111.164 -174.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.01 -136.45 2.17 Favored Glycine 0 N--CA 1.425 -2.087 0 O-C-N 123.806 0.691 . . . . 0.0 111.552 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.402 ' HG2' ' HB3' ' A' ' 129' ' ' ASP . 94.4 Cg_endo -96.73 142.77 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.149 2.566 . . . . 0.0 113.632 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.502 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 67.8 ttt180 -92.84 133.41 36.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 C--N 1.291 -1.967 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.314 -172.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 121.542 0.686 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -105.74 130.02 53.83 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 21.4 t80 -108.91 132.29 54.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.205 0.526 . . . . 0.0 110.915 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 26.9 m -110.45 129.58 55.74 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.008 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.89 130.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -113.41 155.83 24.56 Favored 'General case' 0 C--N 1.261 -3.268 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' B' ' 143' ' ' LEU . 31.3 tp -118.11 127.64 53.97 Favored 'General case' 0 N--CA 1.387 -3.598 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -113.2 136.03 53.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -177.38 168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -86.49 -175.34 5.42 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.718 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -77.63 125.66 29.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.124 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.23 160.97 37.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.436 -1.257 . . . . 0.0 107.624 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 15.8 m -66.36 107.38 1.56 Allowed Pre-proline 0 C--N 1.311 -1.095 0 O-C-N 124.536 1.148 . . . . 0.0 112.972 -170.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.443 ' HA ' ' CD2' ' B' ' 89' ' ' LEU . 50.8 Cg_exo -57.15 -28.37 78.81 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.071 3.181 . . . . 0.0 114.024 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.96 -9.64 55.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' B' ' 85' ' ' SER . 22.1 mm-40 -112.7 19.45 17.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.402 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.443 ' CD2' ' HA ' ' B' ' 86' ' ' PRO . 3.9 pp -120.87 153.34 37.3 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.323 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -123.09 126.02 46.28 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.935 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.76 122.32 64.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.99 131.62 52.2 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.475 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.471 HG23 HG12 ' B' ' 98' ' ' ILE . 3.4 p -124.15 112.95 34.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 84.5 mt -127.16 91.17 3.27 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.443 ' HA2' ' HG3' ' B' ' 130' ' ' PRO . . . 67.0 -112.1 4.62 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.874 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.52 9.09 39.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 124.371 1.068 . . . . 0.0 111.701 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.96 136.12 60.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.639 -0.663 . . . . 0.0 109.359 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . 0.471 HG12 HG23 ' B' ' 93' ' ' VAL . 46.2 mt -130.72 121.38 50.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 46.6 mt-10 -132.26 148.44 52.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.095 0.474 . . . . 0.0 111.592 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.43 127.53 62.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.144 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -136.59 120.05 17.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 161.86 27.27 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.477 ' HB3' ' HG2' ' B' ' 117' ' ' GLU . 0.0 OUTLIER -130.45 143.95 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -120.71 135.37 55.15 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.81 128.01 33.17 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.487 ' OE2' ' HB2' ' B' ' 116' ' ' ARG . 42.9 mt-10 -103.7 -77.4 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 -139.86 142.56 36.57 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -112.19 136.14 51.97 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.634 0.73 . . . . 0.0 111.265 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' B' ' 112' ' ' GLY . 37.1 m-20 -96.83 -155.79 0.5 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 172.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.8 -57.31 3.03 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 122.037 0.922 . . . . 0.0 108.617 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' A' ' 123' ' ' ARG . 54.0 m80 -101.66 -11.13 19.42 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.178 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -111.12 139.57 15.62 Favored Glycine 0 N--CA 1.396 -3.981 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.591 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.22 139.68 50.79 Favored 'General case' 0 C--N 1.257 -3.437 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.16 133.18 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 46.8 m -136.44 158.18 45.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.487 ' HB2' ' OE2' ' B' ' 106' ' ' GLU . 22.4 ttm180 -127.19 148.25 50.19 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 36.9 mt-10 -125.02 150.85 46.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -128.16 124.89 37.97 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -131.87 132.09 43.34 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.411 ' HG3' HG12 ' A' ' 114' ' ' ILE . 43.9 ttt180 -130.19 137.91 50.32 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.515 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.6 mtpp -122.65 127.11 48.91 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' TYR . . . . . . . . . . . . 0.3 1.3 p90 -134.39 115.27 13.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 111' ' ' HIS . 71.0 ttt180 -101.95 99.73 9.94 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.394 0.616 . . . . 0.0 109.948 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.0 pt -123.99 105.52 31.92 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.538 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -90.01 -53.14 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 123.013 2.475 . . . . 0.0 113.136 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 -18.9 65.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.58 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -99.57 -18.1 17.53 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.265 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 60.0 t -132.21 113.8 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . 0.408 ' HB3' ' HG2' ' B' ' 148' ' ' PRO . 17.5 t70 -100.81 128.31 30.12 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.443 ' HG3' ' HA2' ' B' ' 95' ' ' GLY . 72.1 Cg_endo -71.09 16.39 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.837 2.358 . . . . 0.0 116.415 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.76 -46.66 13.91 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' THR . . . . . 0.416 HG22 ' HG3' ' B' ' 148' ' ' PRO . 13.9 t -120.97 10.23 10.77 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.0 OUTLIER -68.36 130.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 11.9 t -137.84 162.99 32.54 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.449 ' HB2' HD11 ' B' ' 143' ' ' LEU . 15.0 p -127.79 133.14 49.44 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.257 0.551 . . . . 0.0 112.148 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -126.45 129.36 48.54 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.41 134.73 48.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.098 0.475 . . . . 0.0 111.68 -174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 20.1 m -100.72 163.36 12.36 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.138 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -60.47 -21.18 62.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -91.95 8.01 39.49 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.515 0.674 . . . . 0.0 111.171 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.87 -5.85 61.99 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.496 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 67.1 t -74.16 112.98 11.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.264 0.554 . . . . 0.0 109.506 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.57 HD12 ' N ' ' B' ' 144' ' ' THR . 1.8 tp -122.67 134.43 54.48 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.123 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.57 ' N ' HD12 ' B' ' 143' ' ' LEU . 16.6 m -117.22 118.24 31.77 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 134' ' ' THR . 35.5 t -102.24 121.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.4 p30 -134.97 144.17 47.26 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.305 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.88 -136.61 2.2 Favored Glycine 0 N--CA 1.423 -2.202 0 O-C-N 123.654 0.596 . . . . 0.0 111.738 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.416 ' HG3' HG22 ' B' ' 132' ' ' THR . 93.1 Cg_endo -96.72 142.63 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.265 2.644 . . . . 0.0 113.505 -176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 71.0 ttt180 -92.9 133.86 35.67 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 84.3 tttt . . . . . 0 C--N 1.29 -1.998 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.243 -172.422 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 . . . . . 0 N--CA 1.438 -1.041 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.6 tp 56.72 51.19 11.32 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 24.0 mm-40 42.37 110.04 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 111.848 -2.433 . . . . 0.0 116.772 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -86.95 106.32 17.72 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 31.3 t70 -177.61 138.11 0.21 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -94.37 117.57 30.32 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 146' ' ' ASN . 51.0 t80 -110.7 142.65 42.33 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -175.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.6 m -137.58 131.57 31.85 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.382 0.61 . . . . 0.0 111.641 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.644 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 47.6 t -118.9 141.68 37.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 172.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -111.78 143.82 42.09 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.974 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 3.1 mm? -119.99 127.6 52.78 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' B' ' 107' ' ' ARG . 0.6 OUTLIER -117.2 127.26 53.93 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.658 -1.217 . . . . 0.0 112.597 -175.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.0 t -118.85 116.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 103.344 -2.836 . . . . 0.0 103.344 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.4 -54.34 41.97 Favored 'General case' 0 C--O 1.192 -1.935 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.316 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -150.43 121.97 7.97 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.41 171.65 18.69 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 126.943 2.097 . . . . 0.0 106.983 171.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 20.3 m -112.87 141.13 24.95 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 85' ' ' SER . 80.6 Cg_exo -48.89 -28.31 13.0 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 125.131 3.887 . . . . 0.0 116.361 -172.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -73.98 -19.78 60.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.042 0.449 . . . . 0.0 111.227 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 3.0 mp0 -98.25 18.1 17.11 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.921 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.18 147.96 44.26 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.499 0.666 . . . . 0.0 111.166 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -138.24 124.7 20.66 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.8 p -109.83 129.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' HG3' ' HB2' ' A' ' 99' ' ' GLU . 17.5 ptmt -129.96 130.67 45.36 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 121.384 0.611 . . . . 0.0 111.244 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.8 117.81 52.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.64 90.94 2.71 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.312 0.577 . . . . 0.0 109.727 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 -111.82 4.44 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.855 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.87 -4.91 59.23 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.77 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.03 137.61 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.518 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 122' ' ' TYR . 4.0 tp -124.72 119.94 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 35.5 mt-10 -138.18 149.71 46.09 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.357 -173.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.415 HG22 ' HB3' ' A' ' 120' ' ' ARG . 19.5 m -124.33 134.23 67.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -123.92 124.71 43.22 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.901 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 88' ' ' GLU . . . -124.25 142.65 14.26 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -143.04 126.56 16.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -136.32 141.01 43.76 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.664 0.269 . . . . 0.0 110.531 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.21 120.81 26.28 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -82.22 -62.47 1.61 Allowed 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 123.562 0.745 . . . . 0.0 111.289 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.514 ' HB2' HD12 ' A' ' 114' ' ' ILE . 39.3 mtm180 -141.67 125.13 16.64 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.867 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.64 131.24 49.54 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.47 171.96 13.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 119.255 -0.403 . . . . 0.0 110.378 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 13.59 -83.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 127.652 2.381 . . . . 0.0 114.468 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.24 30.06 1.05 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -131.86 131.05 6.15 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.448 -1.705 . . . . 0.0 109.32 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -121.35 149.47 42.91 Favored 'General case' 1 C--N 1.238 -4.265 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 107' ' ' ARG . 16.5 mt -123.3 132.97 70.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.1 m -129.23 158.42 39.1 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.109 0.481 . . . . 0.0 110.33 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -133.97 148.52 51.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 49.2 mt-10 -132.49 150.24 52.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -125.78 125.06 42.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -132.16 122.12 24.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.741 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.472 ' HG3' HG12 ' B' ' 114' ' ' ILE . 70.1 ttt180 -112.27 137.4 50.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 24.7 pttm -129.51 129.94 45.18 Favored 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.76 0.662 . . . . 0.0 110.76 -172.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.543 ' HB2' HG23 ' A' ' 98' ' ' ILE . 5.6 m-85 -128.63 145.1 51.25 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -128.05 98.91 5.28 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.9 pt -136.26 105.13 9.41 Favored Pre-proline 0 C--N 1.285 -2.219 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.259 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.82 -40.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.462 2.108 . . . . 0.0 112.021 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.07 -19.52 64.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.057 0.456 . . . . 0.0 111.749 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.4 ' HB3' ' CE2' ' A' ' 75' ' ' PHE . 16.2 m-20 -108.45 -17.3 14.02 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 64.6 t -128.31 121.11 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' HB2' ' HD2' ' A' ' 150' ' ' LYS . 12.1 t70 -122.23 121.17 27.93 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 168.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.93 -15.53 39.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 114.777 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.34 -25.28 36.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.974 0.416 . . . . 0.0 111.384 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.458 HG22 ' HB3' ' A' ' 129' ' ' ASP . 8.1 t -119.19 -21.31 7.63 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.3 126.91 42.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 34.4 p -122.47 168.04 12.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.644 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 m -126.27 133.72 51.36 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.152 0.501 . . . . 0.0 111.164 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.457 ' O ' HD22 ' A' ' 143' ' ' LEU . 24.1 p -118.7 150.51 39.62 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.8 142.34 42.93 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.783 0.72 . . . . 0.0 112.477 -174.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.4 t -100.38 161.59 13.5 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -68.85 -20.12 64.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.834 0.853 . . . . 0.0 112.9 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -85.79 -10.67 55.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 112.06 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.28 1.11 23.59 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.532 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.5 t -77.2 124.23 35.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 2.7 tm? -119.5 132.25 55.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.1 m -121.34 127.42 51.25 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 121.639 -0.663 . . . . 0.0 110.749 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.644 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 19.2 m -102.01 122.64 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 3.9 p-10 -138.58 155.48 48.31 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.782 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.11 171.69 17.32 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 41.5 Cg_exo -51.1 142.59 34.6 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.759 2.306 . . . . 0.0 111.995 171.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 11.2 ptm180 -90.66 165.97 13.42 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.37 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.527 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 76.6 tttt . . . . . 0 C--O 1.271 2.226 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 . . . . . 0 N--CA 1.434 -1.256 0 CA-C-O 119.533 -0.27 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 45.4 tp 57.06 51.53 10.33 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.584 ' HB2' ' O ' ' B' ' 149' ' ' ARG . 21.0 mm-40 41.74 110.09 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 127.608 2.363 . . . . 0.0 116.932 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -86.98 105.74 17.34 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.669 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 31.0 t70 -176.54 138.99 0.31 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -95.02 117.35 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' B' ' 146' ' ' ASN . 50.7 t80 -110.62 142.92 41.82 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' B' ' 145' ' ' VAL . 35.1 m -137.82 131.2 30.78 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.243 0.544 . . . . 0.0 111.641 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.653 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 52.7 t -118.72 141.77 36.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.5 144.27 41.0 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.164 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' B' ' 143' ' ' LEU . 3.1 mm? -120.02 127.52 52.68 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 107' ' ' ARG . 0.6 OUTLIER -117.15 127.77 54.45 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.419 -1.312 . . . . 0.0 112.717 -176.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -118.83 117.15 53.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 167.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -54.72 -54.21 44.92 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.265 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -150.44 121.7 7.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -160.57 171.87 18.18 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 126.796 2.038 . . . . 0.0 107.103 172.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.1 m -113.2 141.21 25.32 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.15 -28.09 13.71 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 125.044 3.83 . . . . 0.0 116.362 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.53 -20.34 60.68 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.353 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . 0.408 ' O ' ' HA2' ' B' ' 102' ' ' GLY . 2.9 mp0 -98.37 18.43 16.5 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.723 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -120.34 147.75 44.62 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.829 0.823 . . . . 0.0 111.273 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -138.05 124.53 20.72 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -109.63 129.58 64.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' B' ' 99' ' ' GLU . 17.8 ptmt -130.36 130.72 44.76 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.417 0.627 . . . . 0.0 111.091 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.91 118.16 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.5 tp -135.48 91.18 2.69 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-O 121.17 0.51 . . . . 0.0 109.716 -173.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.05 -111.92 4.53 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.022 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -86.56 -4.79 59.23 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.227 1.011 . . . . 0.0 112.022 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.84 137.74 47.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.535 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 122' ' ' TYR . 4.0 tp -124.87 120.03 57.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 174.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.413 ' HB2' ' HG3' ' B' ' 92' ' ' LYS . 35.4 mt-10 -138.16 149.72 46.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.151 0.501 . . . . 0.0 110.323 -173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' B' ' 120' ' ' ARG . 20.1 m -124.22 134.34 66.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -123.95 124.66 43.08 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 88' ' ' GLU . . . -124.04 142.87 14.5 Favored Glycine 0 N--CA 1.423 -2.169 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 173.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -143.08 126.36 16.57 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -136.23 140.6 43.61 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.548 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -82.48 120.73 25.85 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -81.9 -63.76 1.32 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 123.512 0.725 . . . . 0.0 111.008 -173.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.485 ' HB2' HD12 ' B' ' 114' ' ' ILE . 39.8 mtm180 -140.9 125.42 17.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.961 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -103.24 130.4 50.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -139.16 172.47 12.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.39 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 12.86 -84.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 127.673 2.389 . . . . 0.0 114.27 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -145.85 30.19 1.08 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -132.1 130.18 5.83 Favored Glycine 0 N--CA 1.403 -3.53 0 CA-C-N 113.389 -1.732 . . . . 0.0 109.403 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -120.43 149.86 41.7 Favored 'General case' 1 C--N 1.24 -4.156 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' B' ' 107' ' ' ARG . 16.9 mt -123.61 133.34 69.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.8 m -129.98 159.14 37.57 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.049 0.452 . . . . 0.0 110.174 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -134.17 148.55 50.94 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 48.8 mt-10 -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -126.03 125.03 41.97 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -132.06 122.22 25.1 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.785 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' HG12 ' A' ' 114' ' ' ILE . 70.0 ttt180 -112.3 137.36 50.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 24.1 pttm -129.37 129.83 45.27 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.717 0.635 . . . . 0.0 110.72 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' TYR . . . . . 0.552 ' HB2' HG23 ' B' ' 98' ' ' ILE . 6.1 m-85 -128.25 145.57 51.0 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.489 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -128.19 98.86 5.24 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 3.9 pt -136.38 105.2 9.3 Favored Pre-proline 0 C--N 1.284 -2.279 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.193 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.49 -40.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.542 2.161 . . . . 0.0 112.081 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.01 -19.86 64.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 111.513 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' B' ' 75' ' ' PHE . 15.0 m-20 -108.36 -17.18 14.06 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.444 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 63.6 t -128.46 121.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . 0.528 ' HB2' ' HD2' ' B' ' 150' ' ' LYS . 12.2 t70 -122.35 121.32 27.78 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 168.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.17 -15.2 38.31 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.466 2.777 . . . . 0.0 114.632 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 tp -81.47 -25.87 35.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.461 . . . . 0.0 111.157 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' THR . . . . . 0.471 HG22 ' HB3' ' B' ' 129' ' ' ASP . 9.7 t -119.05 -21.14 7.79 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.14 127.12 42.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 33.4 p -122.5 167.72 13.0 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.839 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.7 m -126.28 133.96 51.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.446 ' O ' HD22 ' B' ' 143' ' ' LEU . 14.8 p -119.13 149.61 41.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 142.66 44.24 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.465 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.62 161.6 13.49 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -68.81 -19.59 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.603 0.761 . . . . 0.0 112.953 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.68 -10.14 54.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.041 0.448 . . . . 0.0 111.734 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.3 0.75 23.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.43 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.62 124.11 34.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 2.7 tm? -119.59 132.27 55.68 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 35.3 m -121.46 126.99 50.61 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.6 -0.688 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . 0.653 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 19.0 m -101.71 122.65 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' B' ' 75' ' ' PHE . 4.0 p-10 -138.51 154.97 48.8 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.775 -173.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.13 18.22 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 50.3 Cg_exo -50.8 142.3 33.12 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 122.745 2.297 . . . . 0.0 111.973 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 11.0 ptm180 -90.18 165.8 13.74 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.413 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' LYS . . . . . 0.528 ' HD2' ' HB2' ' B' ' 129' ' ' ASP . 76.2 tttt . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 123.194 1.474 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tt -143.24 94.23 2.59 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.26 137.14 46.56 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.112 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -111.79 116.54 30.86 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.901 0.858 . . . . 0.0 110.296 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.414 ' OD2' ' HD3' ' A' ' 149' ' ' ARG . 31.5 t70 -147.7 140.54 24.84 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 52.7 t80 -128.72 145.28 51.21 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.793 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.2 t -116.67 130.44 56.73 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.566 ' HB ' HG23 ' A' ' 145' ' ' VAL . 23.7 t -114.46 131.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.15 147.05 35.75 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 81' ' ' VAL . 6.7 mp -118.5 129.06 55.15 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -74.22 125.27 28.03 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.542 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 82' ' ' LYS . 32.9 t -138.97 142.67 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.66 ' O ' HG12 ' A' ' 81' ' ' VAL . 16.7 tptm -98.33 -177.34 3.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.567 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 7.8 t60 -77.63 124.98 28.64 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.841 -1.543 . . . . 0.0 113.412 -167.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -132.67 172.45 12.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.148 172.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 15.1 m -77.57 117.82 68.03 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -53.09 -27.76 38.11 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 124.024 3.149 . . . . 0.0 114.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -87.14 -35.31 18.7 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.343 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 18.5 mm-40 -91.35 58.91 3.75 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.296 0.57 . . . . 0.0 110.593 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 pp -143.21 160.43 40.48 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.09 0.471 . . . . 0.0 111.175 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -135.63 124.61 24.22 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.18 122.87 58.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -129.07 133.29 47.63 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.416 0.626 . . . . 0.0 111.948 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.73 122.1 59.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.2 tp -130.96 91.71 3.09 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.29 -112.12 4.17 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.751 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -93.2 -0.25 56.92 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.689 1.196 . . . . 0.0 110.96 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.7 136.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.574 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 145' ' ' VAL . 16.6 mt -125.1 120.66 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.81 149.22 49.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.2 0.524 . . . . 0.0 110.84 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -129.8 120.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -113.56 120.06 39.67 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.428 ' HA3' ' CD2' ' A' ' 84' ' ' PHE . . . -136.98 154.79 22.4 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -138.56 143.28 39.35 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 117.454 0.627 . . . . 0.0 111.05 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 84' ' ' PHE . 81.1 t60 -137.97 127.86 25.52 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 170.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 32.1 mt-10 -86.01 121.33 28.48 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 23.7 mt-10 -55.06 -80.82 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -166.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 51.5 mtm-85 -147.63 153.82 39.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -83.01 128.19 34.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -94.39 -172.32 2.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -39.87 -66.16 0.33 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.361 1.464 . . . . 0.0 112.634 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -142.74 28.06 1.62 Allowed 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' B' ' 122' ' ' TYR . . . -132.95 153.53 20.75 Favored Glycine 1 N--CA 1.369 -5.788 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.39 149.05 30.8 Favored 'General case' 1 C--N 1.243 -4.025 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.482 HG23 ' HG2' ' B' ' 120' ' ' ARG . 35.5 mm -124.25 135.48 63.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.987 -172.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 12.0 m -128.18 140.97 51.62 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -128.65 147.04 50.71 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.13 150.73 51.14 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.058 0.456 . . . . 0.0 110.105 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 84' ' ' PHE . 73.2 m-85 -124.96 133.67 52.93 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -127.1 121.94 32.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.61 ' CZ ' ' HA ' ' A' ' 81' ' ' VAL . 67.2 mtt-85 -117.02 136.88 52.62 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.4 tttp -134.82 128.38 32.65 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.756 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.458 ' CD1' ' HA3' ' B' ' 112' ' ' GLY . 13.3 m-85 -131.42 135.2 46.96 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.867 0.867 . . . . 0.0 110.543 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -128.23 98.7 5.18 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.637 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 5.0 pt -135.94 106.43 9.67 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.73 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -87.67 -39.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.027 1.818 . . . . 0.0 112.508 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.42 72.26 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 121.451 0.643 . . . . 0.0 111.76 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 149' ' ' ARG . 9.3 m-20 -91.99 -16.25 26.78 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.709 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.637 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 12.6 t -131.38 120.42 46.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -171.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.68 111.73 35.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.63 13.46 0.46 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.403 2.735 . . . . 0.0 116.215 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.79 -45.23 75.4 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.403 HG22 ' HD3' ' A' ' 148' ' ' PRO . 10.5 t -120.45 9.49 10.95 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 121.609 -0.682 . . . . 0.0 112.564 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' A' ' 128' ' ' VAL . 50.2 mt -67.8 132.51 32.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.418 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.8 p -121.58 165.89 15.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.901 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 144' ' ' THR . 15.1 m -130.09 134.06 47.1 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 120.971 0.415 . . . . 0.0 111.14 -177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.5 m -116.52 145.44 43.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.7 tp -121.74 137.17 54.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.505 0.193 . . . . 0.0 110.756 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -96.62 164.24 12.68 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.528 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.4 t -60.21 -33.97 72.99 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.523 1.056 . . . . 0.0 113.055 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 19.7 t70 -81.25 -11.09 59.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.542 0.687 . . . . 0.0 110.331 -177.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.12 8.13 24.07 Favored Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.437 ' HA ' ' HB ' ' A' ' 81' ' ' VAL . 43.7 t -71.68 132.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.33 134.39 55.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -168.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 135' ' ' SER . 20.3 m -121.51 128.1 51.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 77' ' ' VAL . 15.7 m -114.86 125.4 72.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.6 p-10 -132.25 138.62 47.97 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.505 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.77 -144.8 6.45 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.529 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 132' ' ' THR . 10.6 Cg_endo -91.66 139.03 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.069 2.513 . . . . 0.0 114.392 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.464 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 73.9 ttt180 -103.76 137.41 41.82 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--N 1.297 -1.702 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -175.493 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 123.108 1.432 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 tt -142.71 95.12 2.73 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.88 137.42 45.63 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.277 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -112.17 114.14 26.79 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 121.704 0.764 . . . . 0.0 110.528 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -145.14 141.22 28.58 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -96.08 125.74 40.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 53.0 t80 -128.88 145.81 51.11 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.738 -170.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.4 t -117.6 130.06 56.15 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.543 ' HB ' HG23 ' B' ' 145' ' ' VAL . 23.2 t -114.32 131.03 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -111.09 147.15 35.46 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' LEU . . . . . 0.478 ' O ' HG23 ' B' ' 81' ' ' VAL . 6.7 mp -118.5 128.83 54.96 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -73.67 125.32 27.78 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-N 113.388 -1.733 . . . . 0.0 107.402 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.656 HG12 ' O ' ' B' ' 82' ' ' LYS . 31.6 t -139.23 142.18 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 O-C-N 123.911 0.757 . . . . 0.0 109.107 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.656 ' O ' HG12 ' B' ' 81' ' ' VAL . 16.9 tptm -97.72 -177.42 3.77 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 7.6 t60 -77.7 124.76 28.37 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 117.89 -1.524 . . . . 0.0 113.4 -167.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.622 ' HA ' ' HB2' ' B' ' 104' ' ' HIS . 0.0 OUTLIER -132.55 172.5 12.43 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.174 172.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 15.3 m -77.54 118.05 69.49 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.2 -27.69 38.79 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 124.045 3.163 . . . . 0.0 114.036 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -87.22 -35.18 18.68 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.461 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' B' ' 85' ' ' SER . 16.1 mm-40 -92.04 58.51 3.37 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.543 0.687 . . . . 0.0 110.42 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.51 160.34 40.47 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.153 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -135.67 124.56 24.08 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.78 122.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -129.04 134.3 48.06 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.279 0.562 . . . . 0.0 111.744 -174.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 p -128.45 120.86 53.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 48.0 tp -129.93 91.78 3.19 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.63 -111.99 4.19 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.944 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -93.17 0.06 57.06 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 124.45 1.1 . . . . 0.0 111.003 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 97.6 t -110.06 136.33 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.526 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.499 HD13 HG21 ' B' ' 145' ' ' VAL . 17.1 mt -125.07 120.53 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.55 149.09 49.34 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.23 0.538 . . . . 0.0 110.759 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 94.0 t -129.54 120.93 51.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -113.52 120.14 39.96 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' B' ' 84' ' ' PHE . . . -137.07 154.59 22.35 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.33 143.26 39.83 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.508 0.67 . . . . 0.0 110.998 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' B' ' 84' ' ' PHE . 82.0 t60 -137.92 127.72 25.4 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 170.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 34.7 mt-10 -85.5 121.14 27.77 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.415 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 23.3 mt-10 -54.88 -80.7 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -166.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 51.6 mtm-85 -148.0 153.72 39.35 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 -173.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -83.31 129.09 34.98 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -94.71 -172.53 2.76 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -39.5 -66.4 0.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.131 1.372 . . . . 0.0 112.958 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -142.69 27.95 1.64 Allowed 'General case' 0 CA--C 1.461 -2.472 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 122' ' ' TYR . . . -132.81 153.57 20.74 Favored Glycine 1 N--CA 1.37 -5.761 0 N-CA-C 108.649 -1.781 . . . . 0.0 108.649 -177.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -110.41 149.04 30.83 Favored 'General case' 1 C--N 1.244 -4.018 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' B' ' 105' ' ' GLU . 34.8 mm -124.21 135.53 63.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.127 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 9.6 m -128.18 141.09 51.57 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -128.64 147.17 50.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -134.3 150.44 50.98 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.128 0.489 . . . . 0.0 110.139 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' B' ' 84' ' ' PHE . 72.5 m-85 -124.77 133.92 52.98 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -127.38 121.88 32.14 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.593 ' CZ ' ' HA ' ' B' ' 81' ' ' VAL . 67.6 mtt-85 -117.18 137.02 52.62 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -135.16 128.3 31.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.774 -1.17 . . . . 0.0 110.697 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' TYR . . . . . 0.47 ' CE1' ' HA3' ' A' ' 112' ' ' GLY . 13.5 m-85 -131.46 134.99 46.75 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.973 0.909 . . . . 0.0 110.672 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -127.78 98.67 5.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.643 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 5.0 pt -135.72 106.59 9.85 Favored Pre-proline 0 C--N 1.29 -1.979 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.739 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -40.32 0.06 OUTLIER 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.26 1.973 . . . . 0.0 112.544 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.69 -32.05 71.58 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.612 0.72 . . . . 0.0 111.794 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . 0.428 ' HA ' ' HG3' ' B' ' 149' ' ' ARG . 9.9 m-20 -92.15 -16.08 26.78 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.927 -0.483 . . . . 0.0 110.783 -176.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 13.0 t -131.45 119.88 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -170.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -119.05 111.68 36.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.82 15.29 0.38 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 123.456 2.771 . . . . 0.0 115.887 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.06 -45.13 71.14 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.101 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' THR . . . . . 0.406 HG22 ' HG3' ' B' ' 148' ' ' PRO . 12.8 t -120.61 9.88 10.93 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . 0.555 ' CD1' HG13 ' B' ' 128' ' ' VAL . 50.0 mt -68.11 132.92 32.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.393 -170.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.7 p -121.98 166.18 14.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.733 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' B' ' 144' ' ' THR . 14.5 m -130.97 134.05 46.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.97 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 19.7 m -116.35 145.32 43.29 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 49.7 tp -121.97 137.0 54.96 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 25.3 m -96.39 164.41 12.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.435 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -60.44 -34.07 73.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.448 1.022 . . . . 0.0 113.077 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 19.9 t70 -81.39 -10.73 59.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.43 0.633 . . . . 0.0 110.342 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.09 8.33 23.88 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.349 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.439 ' HA ' ' HB ' ' B' ' 81' ' ' VAL . 46.2 t -71.85 132.75 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -115.66 134.37 55.11 Favored 'General case' 0 C--O 1.209 -1.066 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.178 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' B' ' 135' ' ' SER . 20.1 m -121.4 127.87 51.62 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . 0.543 HG23 ' HB ' ' B' ' 77' ' ' VAL . 15.7 m -114.88 125.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 21.8 p-10 -132.47 138.14 47.47 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -175.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.522 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 179.69 -144.52 6.09 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.406 ' HG3' HG22 ' B' ' 132' ' ' THR . 9.8 Cg_endo -91.64 139.15 2.22 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.145 2.563 . . . . 0.0 114.383 -177.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 71.5 ttt180 -103.8 137.89 41.18 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.492 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.15 -172.1 3.77 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.02 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 68.6 28.37 5.81 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.948 1.699 . . . . 0.0 108.097 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -127.47 150.45 49.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -170.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.2 t70 67.93 178.1 0.24 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.325 1.45 . . . . 0.0 111.198 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -113.09 120.17 40.37 Favored 'General case' 0 CA--C 1.471 -2.063 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.34 150.64 25.02 Favored 'General case' 0 N--CA 1.393 -3.323 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.595 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 p -137.13 144.34 42.96 Favored 'General case' 0 N--CA 1.402 -2.851 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.087 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 32.8 t -116.05 132.55 65.23 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -110.97 136.89 49.3 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.465 HD22 HD11 ' A' ' 143' ' ' LEU . 6.0 mp -119.67 128.08 53.49 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.78 138.73 50.85 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 122.727 0.411 . . . . 0.0 109.911 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.42 165.99 5.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.72 -164.75 0.09 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.483 0.583 . . . . 0.0 110.441 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -77.41 123.94 27.21 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.003 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.58 143.11 15.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 m -74.02 124.73 90.33 Favored Pre-proline 0 C--N 1.307 -1.267 0 O-C-N 123.477 0.485 . . . . 0.0 110.983 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 139' ' ' SER . 10.3 Cg_endo -55.43 -30.96 75.75 Favored 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 123.865 3.043 . . . . 0.0 114.046 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -74.59 -26.58 60.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.861 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.81 0.84 51.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.291 0.567 . . . . 0.0 111.398 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.22 147.67 44.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -126.21 126.26 43.76 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 p -99.38 126.69 52.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -129.57 138.37 51.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.438 0.637 . . . . 0.0 109.417 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.16 90.44 3.34 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.91 -112.17 4.73 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.148 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.4 -0.55 57.31 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.355 1.062 . . . . 0.0 111.632 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.407 HG12 ' HG3' ' A' ' 99' ' ' GLU . 65.3 t -105.69 135.74 42.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.44 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 59.0 mt -122.0 119.53 58.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 39.1 mt-10 -136.38 137.02 40.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.61 0.719 . . . . 0.0 111.705 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.468 HG11 HH21 ' A' ' 120' ' ' ARG . 60.6 t -119.05 124.78 73.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -127.76 128.74 45.86 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.84 156.66 27.11 Favored Glycine 0 C--N 1.283 -2.384 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -143.37 134.16 25.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 124.056 0.504 . . . . 0.0 109.921 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.437 ' CD2' ' HG2' ' A' ' 106' ' ' GLU . 62.4 t60 -136.77 127.72 27.59 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.55 0.34 . . . . 0.0 110.327 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 12.5 pt-20 -87.03 137.05 32.68 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.437 ' HG2' ' CD2' ' A' ' 104' ' ' HIS . 28.3 mt-10 -106.78 -53.98 2.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.331 -173.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -148.34 152.92 37.88 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 47.7 tt0 -111.76 122.24 47.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.453 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -75.2 -67.35 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -179.22 106.19 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 37.6 m80 60.1 25.29 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.027 0.918 . . . . 0.0 109.208 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.66 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -156.4 119.13 0.89 Allowed Glycine 1 N--CA 1.39 -4.392 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -175.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' GLN . 11.7 p90 -119.28 153.54 34.88 Favored 'General case' 1 C--N 1.243 -4.033 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.416 HG22 ' HG2' ' B' ' 120' ' ' ARG . 1.9 pt -121.04 140.87 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 15.5 m -134.44 157.09 47.34 Favored 'General case' 0 N--CA 1.404 -2.749 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.974 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.9 ttp85 -126.65 146.46 50.18 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.7 mt-10 -136.87 153.69 50.69 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -128.54 133.6 48.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 26.6 t-80 -131.56 122.48 26.16 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.483 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.468 HH21 HG11 ' A' ' 100' ' ' VAL . 30.8 mtm180 -115.72 138.4 51.15 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.627 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 51.0 tttp -136.03 128.04 29.61 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.702 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 30.3 m-85 -132.17 142.32 49.42 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.104 0.878 . . . . 0.0 109.024 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -128.48 98.57 5.08 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.7 pt -137.33 106.21 8.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.328 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.49 -45.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.886 0 C-N-CA 122.642 2.228 . . . . 0.0 113.366 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 150' ' ' LYS . . . -67.54 -28.19 67.59 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -91.16 -18.0 25.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 77.8 t -132.81 127.6 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.77 ' H ' ' HB3' ' A' ' 148' ' ' PRO . 5.6 m-20 -121.62 109.6 34.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.233 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.55 ' HA ' ' CG2' ' A' ' 133' ' ' ILE . 20.8 Cg_endo -59.92 -12.26 18.08 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 124.239 3.293 . . . . 0.0 114.744 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.55 -40.34 96.74 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.177 0.513 . . . . 0.0 111.237 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.1 t -118.42 9.16 12.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.663 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.55 ' CG2' ' HA ' ' A' ' 130' ' ' PRO . 10.4 tt -77.26 141.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.992 0.425 . . . . 0.0 110.065 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 4.9 p -138.79 154.77 48.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 144' ' ' THR . 22.9 t -131.02 133.21 45.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.169 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 p -119.64 130.33 55.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 137' ' ' LEU . 1.4 pt? -130.13 137.23 50.04 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.01 0.434 . . . . 0.0 112.099 -169.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 74.3 p -99.91 168.0 10.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.358 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 11.4 m -67.13 -10.97 55.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.38 1.472 . . . . 0.0 112.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.38 20.07 19.42 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-O 121.789 0.804 . . . . 0.0 110.516 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.21 -5.34 63.51 Favored Glycine 0 C--O 1.261 1.791 0 CA-C-N 115.568 -0.742 . . . . 0.0 114.813 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.8 119.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.465 HD11 HD22 ' A' ' 79' ' ' LEU . 3.9 pp -129.94 135.55 48.45 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 135' ' ' SER . 13.5 p -107.31 133.08 52.38 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.483 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 134' ' ' THR . 12.5 m -111.82 121.52 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -137.38 164.75 27.88 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.361 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.505 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . 128.1 -49.06 0.94 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.667 -1.254 . . . . 0.0 114.41 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.77 ' HB3' ' H ' ' A' ' 129' ' ' ASP . 55.5 Cg_endo -62.29 169.72 7.55 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 123.241 2.628 . . . . 0.0 114.989 -177.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -106.26 154.88 20.1 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 126' ' ' ALA . 81.5 tttt . . . . . 0 C--N 1.285 -2.207 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.117 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 . . . . . 0 N--CA 1.425 -1.707 0 CA-C-O 121.506 0.669 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.7 -171.48 3.62 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.781 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 68.03 28.9 6.61 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.742 1.617 . . . . 0.0 108.163 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -128.08 150.13 50.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -170.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' B' ' 149' ' ' ARG . 4.2 t70 68.49 177.98 0.25 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.412 1.485 . . . . 0.0 111.139 172.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -112.87 120.04 40.06 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -105.43 150.7 25.04 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.57 -172.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.7 p -137.36 144.24 42.41 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.186 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 33.3 t -116.0 132.91 64.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.35 136.72 50.06 Favored 'General case' 0 C--N 1.269 -2.928 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' LEU . . . . . 0.47 ' HG ' ' OH ' ' B' ' 122' ' ' TYR . 6.0 mp -119.53 128.16 53.68 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.76 138.63 50.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.48 165.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -70.37 -164.46 0.08 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.444 0.565 . . . . 0.0 110.434 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -77.67 124.22 27.66 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.807 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -158.77 142.62 15.29 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.5 m -73.5 124.49 90.45 Favored Pre-proline 0 C--N 1.306 -1.311 0 O-C-N 123.349 0.405 . . . . 0.0 111.057 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 139' ' ' SER . 9.3 Cg_endo -55.4 -31.2 76.54 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.725 2.95 . . . . 0.0 113.993 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -73.77 -26.42 60.64 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.47 0.91 53.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.133 0.492 . . . . 0.0 111.398 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.29 147.52 44.89 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -125.98 125.89 43.43 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 p -98.5 127.14 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.808 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -129.88 140.01 51.06 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 117.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.95 90.19 3.28 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.34 -112.31 4.87 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.65 -0.19 56.53 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 124.417 1.087 . . . . 0.0 111.946 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' B' ' 99' ' ' GLU . 65.3 t -106.22 135.91 42.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.591 -0.693 . . . . 0.0 110.314 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 59.3 mt -122.18 119.47 58.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 39.1 mt-10 -136.23 136.91 40.29 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.661 0.743 . . . . 0.0 111.637 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.464 HG11 HH21 ' B' ' 120' ' ' ARG . 61.1 t -118.99 124.41 73.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -127.25 128.73 46.5 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.15 156.62 27.07 Favored Glycine 0 C--N 1.286 -2.242 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -143.31 134.0 25.14 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 122.648 0.379 . . . . 0.0 110.024 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' HIS . . . . . 0.43 ' CD2' ' HG2' ' B' ' 106' ' ' GLU . 61.2 t60 -136.63 127.68 27.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 122.561 0.344 . . . . 0.0 110.311 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 12.0 pt-20 -86.72 137.05 32.76 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.43 ' HG2' ' CD2' ' B' ' 104' ' ' HIS . 27.8 mt-10 -106.74 -54.33 2.49 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.254 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -148.13 153.11 38.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' B' ' 113' ' ' PHE . 46.9 tt0 -111.7 122.64 48.34 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.593 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.98 -67.99 0.59 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.769 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -178.7 106.16 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 39.1 m80 60.61 24.17 13.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.937 0.875 . . . . 0.0 109.158 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.702 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -154.99 120.26 1.0 Allowed Glycine 2 N--CA 1.389 -4.485 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 -177.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 108' ' ' GLN . 11.8 p90 -119.34 153.6 34.87 Favored 'General case' 1 C--N 1.241 -4.146 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.403 HG22 ' HG2' ' A' ' 120' ' ' ARG . 1.8 pt -121.06 140.65 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 14.5 m -134.4 157.08 47.32 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.108 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -126.42 146.49 50.05 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 37.1 mt-10 -136.83 153.59 50.75 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -172.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -128.63 133.43 48.27 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 121.186 0.517 . . . . 0.0 110.669 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 28.2 t-80 -131.49 122.43 26.18 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.469 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.464 HH21 HG11 ' B' ' 100' ' ' VAL . 30.1 mtm180 -115.81 138.43 51.15 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.628 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 50.3 tttp -136.13 128.06 29.44 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.044 -0.663 . . . . 0.0 109.312 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' TYR . . . . . 0.66 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 29.9 m-85 -132.22 142.56 49.47 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 124.013 0.821 . . . . 0.0 108.92 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -128.41 98.57 5.1 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -137.26 106.19 8.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.499 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -89.46 -44.53 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.638 2.225 . . . . 0.0 113.403 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' B' ' 150' ' ' LYS . . . -68.12 -27.74 66.73 Favored 'General case' 0 C--O 1.198 -1.639 0 O-C-N 122.049 -0.407 . . . . 0.0 111.959 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.66 -18.17 24.39 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 76.7 t -132.75 127.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -171.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . 0.766 ' H ' ' HB3' ' B' ' 148' ' ' PRO . 7.1 m-20 -121.34 110.42 34.22 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.164 168.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.534 ' HA ' ' CG2' ' B' ' 133' ' ' ILE . 20.7 Cg_endo -60.66 -12.02 19.71 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 124.026 3.151 . . . . 0.0 114.737 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.93 -40.14 95.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.093 0.473 . . . . 0.0 111.078 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 6.9 t -118.14 9.02 12.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . 0.534 ' CG2' ' HA ' ' B' ' 130' ' ' PRO . 10.9 tt -76.84 141.9 15.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 5.6 p -138.92 154.43 48.35 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.629 0.772 . . . . 0.0 109.2 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.0 t -130.82 132.9 45.5 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.19 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 2.6 p -119.74 130.09 54.82 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . 0.498 HD23 ' H ' ' B' ' 137' ' ' LEU . 1.4 pt? -130.06 136.97 49.95 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -169.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 76.8 p -99.55 168.14 10.15 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.487 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' B' ' 86' ' ' PRO . 6.9 m -67.62 -11.15 57.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.397 1.479 . . . . 0.0 112.092 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.22 20.04 19.53 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.677 0.751 . . . . 0.0 110.424 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.12 -4.72 65.53 Favored Glycine 0 C--O 1.26 1.725 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.28 119.79 33.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.458 HD11 HD22 ' B' ' 79' ' ' LEU . 4.0 pp -130.12 135.77 48.57 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.808 0.337 . . . . 0.0 110.828 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' B' ' 135' ' ' SER . 11.6 p -107.49 133.29 52.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.271 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' B' ' 134' ' ' THR . 12.4 m -111.85 121.56 64.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -137.56 164.82 27.82 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 122.179 -0.326 . . . . 0.0 110.163 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.496 ' N ' ' HD2' ' B' ' 148' ' ' PRO . . . 127.93 -49.03 0.94 Allowed Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.785 -1.197 . . . . 0.0 114.311 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.766 ' HB3' ' H ' ' B' ' 129' ' ' ASP . 55.6 Cg_endo -62.88 169.48 8.78 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.953 2.435 . . . . 0.0 115.05 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 36.0 ptt180 -105.22 155.51 18.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 79.9 tttt . . . . . 0 C--N 1.285 -2.217 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HG ' ' HG3' ' A' ' 150' ' ' LYS . 5.4 mp -106.19 105.96 16.25 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -89.89 141.77 28.33 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -87.16 105.65 17.34 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 118.878 -1.129 . . . . 0.0 108.752 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -159.96 141.91 13.03 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 74' ' ' ARG . 25.5 mtm180 -95.5 139.76 31.31 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' CE2' HG22 ' A' ' 128' ' ' VAL . 20.2 t80 -106.62 140.02 40.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.727 -170.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 t -137.91 129.14 27.6 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.71 130.79 72.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.44 155.95 22.39 Favored 'General case' 0 C--N 1.257 -3.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 16.6 tp -118.67 127.86 53.97 Favored 'General case' 0 N--CA 1.381 -3.916 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -104.32 130.27 52.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 p -156.56 162.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.494 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -93.42 -162.89 0.98 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.367 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.714 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 62.3 t-80 -76.58 123.78 26.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 117.334 -1.746 . . . . 0.0 112.296 -169.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.37 133.72 19.59 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -73.6 149.14 88.28 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HA ' HD21 ' A' ' 137' ' ' LEU . 93.4 Cg_exo -47.74 -34.79 22.13 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 122.921 2.414 . . . . 0.0 115.513 -171.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.31 -17.99 53.48 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.61 -20.06 44.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 89' ' ' LEU . 2.5 pt? -120.95 151.12 40.09 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.426 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.19 136.2 36.38 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.03 139.97 37.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.588 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.55 139.51 47.89 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.241 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 98' ' ' ILE . 2.4 p -129.94 112.96 25.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.77 101.78 5.04 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.97 -111.74 4.0 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.002 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 125' ' ' PRO . 8.4 p-10 -93.94 -5.92 46.7 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 124.731 1.212 . . . . 0.0 111.431 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.92 135.57 54.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.071 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 93' ' ' VAL . 3.0 mp -131.81 120.05 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.8 mt-10 -133.43 147.87 51.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 120.992 0.425 . . . . 0.0 111.686 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 79' ' ' LEU . 39.9 t -126.65 129.44 71.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -136.0 133.37 37.42 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.95 147.0 17.92 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.02 134.52 45.66 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -130.53 131.14 44.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.3 pt-20 -87.18 120.85 28.88 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.604 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 30.5 mm-40 -67.6 -70.68 0.24 Allowed 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.308 -173.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.604 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 0.8 OUTLIER -144.17 154.89 43.62 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -111.26 128.59 55.98 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 110' ' ' GLU . 61.2 m-20 -93.88 -168.44 1.88 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 3.6 mp0 -57.6 -68.72 0.21 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.967 1.307 . . . . 0.0 109.539 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -122.18 14.84 10.59 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' B' ' 122' ' ' TYR . . . -115.54 142.32 17.51 Favored Glycine 1 N--CA 1.384 -4.773 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.393 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.75 139.57 53.85 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 107' ' ' ARG . 5.6 mt -123.7 131.98 72.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 23.3 t -137.16 157.46 46.61 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.093 0.473 . . . . 0.0 110.545 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -134.1 147.72 50.9 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 171.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -130.94 154.35 48.21 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 122.19 0.196 . . . . 0.0 110.483 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -122.1 128.28 51.13 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -131.25 122.04 25.82 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -126.63 137.86 53.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.514 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 23.6 mtpp -134.57 127.11 30.61 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.173 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.48 ' HB3' ' CA ' ' B' ' 112' ' ' GLY 0.305 1.3 p90 -134.7 133.72 40.31 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 173.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -109.9 101.68 10.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.448 0.642 . . . . 0.0 110.557 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.46 HG13 HD13 ' A' ' 98' ' ' ILE . 2.4 pt -135.52 106.91 10.01 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.463 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 59.2 Cg_endo -108.95 -37.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 122.7 2.267 . . . . 0.0 116.154 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.402 ' H ' ' HD2' ' A' ' 125' ' ' PRO . . . -68.03 -29.76 68.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.763 -0.585 . . . . 0.0 112.382 -172.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.06 8.18 20.01 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.525 0.679 . . . . 0.0 109.37 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 75' ' ' PHE . 56.3 t -131.16 127.43 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.644 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.68 103.36 40.74 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.21 8.85 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 123.684 2.923 . . . . 0.0 116.167 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.91 -39.81 95.67 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 148' ' ' PRO . 14.6 t -119.36 9.29 11.59 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.388 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.539 HG12 ' HA3' ' A' ' 147' ' ' GLY . 42.9 mt -68.36 122.46 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.703 0.763 . . . . 0.0 112.296 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.76 167.27 18.33 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.034 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 143' ' ' LEU . 19.0 p -127.2 135.64 50.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.7 t -116.46 129.54 56.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 86' ' ' PRO . 60.1 tp -129.29 127.95 42.2 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 123.16 0.288 . . . . 0.0 111.111 -171.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 14.8 m -99.84 163.98 12.22 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.643 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.0 m -55.14 -30.64 60.23 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.714 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 25.3 t70 -88.33 -11.79 45.32 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.841 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.35 62.01 0.81 Allowed Glycine 0 N--CA 1.409 -3.127 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 46.8 t -121.23 122.28 67.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 174.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 135' ' ' SER . 15.9 tp -127.2 134.93 50.06 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -173.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.451 ' N ' HD12 ' A' ' 143' ' ' LEU . 41.3 m -121.43 118.93 30.64 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.368 171.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.463 HG12 ' CG2' ' A' ' 133' ' ' ILE . 13.6 t -106.72 120.39 57.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 9.4 p30 -139.47 159.69 41.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.9 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.539 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . 178.69 -136.66 2.97 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.437 ' HD3' HG22 ' A' ' 132' ' ' THR . 61.1 Cg_endo -104.28 149.74 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.449 2.766 . . . . 0.0 113.72 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -101.11 153.94 19.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.435 ' HG3' ' HG ' ' A' ' 70' ' ' LEU . 36.3 ttmt . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.438 ' HG ' ' HG3' ' B' ' 150' ' ' LYS . 5.3 mp -105.66 106.23 16.64 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.06 141.03 29.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -87.04 105.6 17.27 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 118.417 -1.313 . . . . 0.0 108.782 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -158.77 142.32 15.05 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -95.31 140.14 30.63 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.482 ' CE2' HG22 ' B' ' 128' ' ' VAL . 19.7 t80 -107.19 139.95 40.83 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.686 -170.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -137.92 129.3 27.81 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.4 HG11 ' CE2' ' B' ' 122' ' ' TYR . 46.2 t -118.12 130.92 72.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -111.39 155.98 22.3 Favored 'General case' 0 C--N 1.256 -3.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' B' ' 143' ' ' LEU . 16.6 tp -118.66 127.68 53.8 Favored 'General case' 1 N--CA 1.379 -4.002 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.76 130.47 51.28 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.08 162.04 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.254 -3.548 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.96 -162.81 0.97 Allowed 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.157 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . 0.732 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 61.4 t-80 -76.59 123.73 26.53 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 117.65 -1.62 . . . . 0.0 112.417 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -147.48 134.06 19.84 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -73.81 148.74 87.51 Favored Pre-proline 0 C--N 1.283 -2.314 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.69 -34.69 21.55 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.91 2.406 . . . . 0.0 115.556 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.22 -17.86 54.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 120.843 0.354 . . . . 0.0 111.624 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.89 -20.08 42.98 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.448 HD23 ' H ' ' B' ' 89' ' ' LEU . 2.5 pt? -121.01 150.45 41.12 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.545 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.4 135.88 37.35 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 p -113.56 139.94 36.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.714 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.62 139.88 47.97 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.269 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.525 HG23 HG13 ' B' ' 98' ' ' ILE . 2.4 p -129.98 112.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.533 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.67 102.77 5.4 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.324 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.66 -111.55 4.04 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.009 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' B' ' 125' ' ' PRO . 8.6 p-10 -94.12 -5.9 46.19 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 124.499 1.12 . . . . 0.0 111.519 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.74 135.53 54.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.026 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.525 HG13 HG23 ' B' ' 93' ' ' VAL . 3.0 mp -131.64 120.01 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 37.1 mt-10 -133.47 147.42 51.67 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.665 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.413 HG11 ' CD2' ' B' ' 79' ' ' LEU . 40.0 t -126.02 129.58 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -136.1 133.34 37.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.82 147.56 18.82 Favored Glycine 0 C--N 1.286 -2.228 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.96 134.3 45.47 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -130.16 132.06 45.9 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.5 pt-20 -88.34 120.51 29.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.603 ' HB3' ' NH1' ' B' ' 107' ' ' ARG . 31.7 mm-40 -67.09 -71.14 0.21 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 112.683 -2.053 . . . . 0.0 110.281 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.603 ' NH1' ' HB3' ' B' ' 106' ' ' GLU . 0.7 OUTLIER -143.71 154.99 44.05 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.19 128.68 55.99 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' B' ' 110' ' ' GLU . 63.6 m-20 -94.13 -169.09 1.99 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' B' ' 110' ' ' GLU . 3.5 mp0 -56.95 -68.4 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.117 1.367 . . . . 0.0 109.635 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -122.33 14.93 10.47 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 122' ' ' TYR . . . -115.51 142.59 17.69 Favored Glycine 1 N--CA 1.385 -4.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.328 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.3 139.27 54.07 Favored 'General case' 0 C--N 1.257 -3.428 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' B' ' 107' ' ' ARG . 5.6 mt -123.7 132.01 72.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 22.8 t -137.03 157.56 46.45 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.265 0.555 . . . . 0.0 110.611 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -134.18 147.75 50.8 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 171.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -131.01 154.26 48.37 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -121.77 128.13 51.39 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -131.11 121.7 25.38 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -126.07 138.04 53.68 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.5 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 23.7 mtpp -134.68 127.07 30.35 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.226 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' TYR . . . . . 0.455 ' HB3' ' CA ' ' A' ' 112' ' ' GLY 0.312 1.3 p90 -134.72 134.05 40.62 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 174.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -110.53 101.51 10.18 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.452 0.644 . . . . 0.0 110.299 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.449 HG13 HD13 ' B' ' 98' ' ' ILE . 2.4 pt -135.58 106.9 9.96 Favored Pre-proline 0 C--N 1.292 -1.915 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.494 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.524 ' HB3' ' HB3' ' B' ' 96' ' ' ASP . 59.1 Cg_endo -109.03 -37.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.691 2.261 . . . . 0.0 116.455 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.401 ' H ' ' HD2' ' B' ' 125' ' ' PRO . . . -68.24 -29.44 68.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.98 8.24 20.16 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.731 0.777 . . . . 0.0 109.409 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.482 HG22 ' CE2' ' B' ' 75' ' ' PHE . 53.3 t -131.44 127.19 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.716 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -121.7 103.33 40.74 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.14 8.46 1.41 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.775 2.983 . . . . 0.0 116.166 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.56 -39.43 93.65 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' THR . . . . . 0.444 HG22 ' HD3' ' B' ' 148' ' ' PRO . 14.7 t -119.57 9.17 11.42 Favored 'General case' 0 C--O 1.252 1.189 0 O-C-N 121.229 -0.919 . . . . 0.0 111.233 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . 0.524 HG12 ' HA3' ' B' ' 147' ' ' GLY . 42.7 mt -68.4 121.77 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.886 0.85 . . . . 0.0 112.342 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.74 167.13 17.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.52 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.543 ' HB2' HD11 ' B' ' 143' ' ' LEU . 21.9 p -126.99 135.71 51.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t -116.72 129.91 56.41 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 60.6 tp -130.19 127.02 38.83 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.682 0.277 . . . . 0.0 111.07 -170.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 13.7 m -98.64 163.95 12.44 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.676 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.2 m -55.17 -30.49 59.97 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -169.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . 0.732 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 22.8 t70 -88.92 -11.67 43.84 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.554 0.692 . . . . 0.0 110.713 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.57 61.82 0.8 Allowed Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -172.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 46.7 t -120.72 121.94 66.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 174.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' B' ' 135' ' ' SER . 16.1 tp -126.85 135.03 50.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.448 ' N ' HD12 ' B' ' 143' ' ' LEU . 42.4 m -121.66 118.21 28.59 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.352 171.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . 0.459 HG12 ' CG2' ' B' ' 133' ' ' ILE . 13.1 t -106.09 120.53 57.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.1 p30 -139.54 160.09 40.67 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.839 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.524 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . 178.2 -136.91 3.12 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' B' ' 132' ' ' THR . 64.5 Cg_endo -104.06 150.29 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.443 2.762 . . . . 0.0 113.644 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -101.74 154.25 19.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' LYS . . . . . 0.438 ' HG3' ' HG ' ' B' ' 70' ' ' LEU . 36.2 ttmt . . . . . 0 C--N 1.292 -1.896 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.0 tp -90.83 84.27 5.8 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 59.39 50.37 7.74 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.234 0.959 . . . . 0.0 109.833 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -86.06 107.45 17.81 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.953 -173.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -138.43 159.36 42.27 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 113.462 -1.699 . . . . 0.0 106.921 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 65.5 mtp180 -94.42 119.17 32.74 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -124.85 155.38 39.55 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.659 -172.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.3 p -129.44 140.28 51.36 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.191 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.472 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 45.4 t -115.37 136.26 52.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -111.14 139.49 46.47 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 143' ' ' LEU . 6.1 mp -119.93 128.55 53.71 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.38 119.43 25.09 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 141' ' ' GLY . 40.4 t -133.67 141.08 45.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 174.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -83.33 -171.15 3.41 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.538 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -76.13 125.04 28.4 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -158.16 166.63 31.94 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -74.97 113.41 24.54 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 123.719 0.637 . . . . 0.0 110.294 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.94 -29.81 83.68 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.787 2.991 . . . . 0.0 115.055 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.39 -7.98 57.11 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.999 -0.438 . . . . 0.0 111.392 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 88' ' ' GLU . 5.5 mm-40 -93.18 2.74 56.54 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.679 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.58 147.25 45.44 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -124.26 126.61 46.36 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.89 122.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.17 131.12 54.89 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.143 0.497 . . . . 0.0 111.07 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.518 HG22 HD13 ' A' ' 98' ' ' ILE . 58.3 t -115.13 125.03 72.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.98 91.73 2.72 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.569 0.7 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.76 -112.4 4.73 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.742 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -95.26 11.48 32.35 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.743 0.817 . . . . 0.0 111.515 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.34 137.21 55.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.821 -0.549 . . . . 0.0 110.314 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 122' ' ' TYR . 2.3 tp -125.99 120.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.497 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 38.3 mt-10 -132.2 150.04 52.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.138 0.494 . . . . 0.0 110.453 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.7 t -126.84 124.2 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -128.36 133.19 48.6 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.63 150.94 23.24 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 128.07 17.69 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -138.27 134.16 34.02 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 111.216 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -80.89 120.45 24.73 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.17 -55.94 5.0 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.024 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.651 ' HG2' HD11 ' A' ' 114' ' ' ILE . 30.7 ptt180 -148.59 155.38 41.02 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -82.24 113.58 20.16 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 114' ' ' ILE . 13.1 t70 -93.98 -148.86 0.27 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.891 -164.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -72.85 83.62 1.21 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.496 0.589 . . . . 0.0 109.786 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 74.53 -52.65 0.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.076 1.75 . . . . 0.0 110.321 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.36 173.22 54.27 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.189 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.91 149.27 41.86 Favored 'General case' 0 C--N 1.255 -3.517 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.651 HD11 ' HG2' ' A' ' 107' ' ' ARG . 38.1 pt -122.88 137.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.195 -175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -134.47 154.24 51.51 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.22 0.533 . . . . 0.0 111.244 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.409 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 6.8 ttp180 -127.3 147.05 50.24 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -134.13 153.45 51.82 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.51 ' HD2' ' NH1' ' A' ' 120' ' ' ARG . 50.1 m-85 -128.26 126.41 40.82 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.494 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.75 122.52 27.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.534 ' NH2' HD12 ' B' ' 114' ' ' ILE . 26.3 mtt85 -126.94 138.21 53.25 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -138.66 128.88 25.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.908 0.755 . . . . 0.0 111.541 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.765 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.7 m-85 -133.1 123.67 26.15 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.084 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -107.56 99.42 8.92 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 4.3 pt -135.93 105.8 9.68 Favored Pre-proline 0 C--N 1.303 -1.452 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.774 -177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.53 -38.67 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.91 2.407 . . . . 0.0 112.122 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 150' ' ' LYS . . . -68.63 -32.32 72.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.292 0.567 . . . . 0.0 111.338 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.99 -18.27 22.06 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.727 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 70.3 t -131.71 114.38 24.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.42 127.04 27.91 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 168.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 79.9 Cg_endo -73.32 16.01 0.48 Allowed 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 122.665 2.244 . . . . 0.0 116.402 -172.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.1 tp -81.84 -48.18 11.88 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.277 3.0 t -122.27 10.74 9.99 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.2 pp -67.28 129.28 31.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.1 p -132.56 166.38 22.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.417 ' HB3' HG12 ' A' ' 145' ' ' VAL . 52.9 p -127.87 134.12 49.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 121.03 0.443 . . . . 0.0 110.912 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -125.09 129.96 51.29 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.8 148.46 44.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.5 m -100.37 163.86 12.19 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.9 m -64.32 -21.57 66.65 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.767 0.827 . . . . 0.0 112.384 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.83 5.15 22.62 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-O 121.274 0.559 . . . . 0.0 110.467 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 81' ' ' VAL . . . 96.64 -20.54 50.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.868 173.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.85 123.75 26.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.766 0.793 . . . . 0.0 110.454 -175.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 79' ' ' LEU . 4.1 pp -129.65 136.26 49.51 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.583 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.0 t -109.72 135.68 50.26 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.472 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 31.1 m -105.9 122.16 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 3.6 p-10 -132.89 143.48 49.53 Favored 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.171 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' ARG . . . 174.34 -138.09 4.27 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -91.76 147.08 3.25 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.379 2.053 . . . . 0.0 112.813 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -100.57 151.47 21.56 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 126' ' ' ALA . 87.1 tttt . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 43.1 tp -90.6 83.28 5.8 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.11 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 59.8 50.81 6.64 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.31 1.006 . . . . 0.0 109.643 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -86.2 107.39 17.88 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 122.532 1.158 . . . . 0.0 109.843 -173.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -137.89 159.32 42.32 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.32 -1.764 . . . . 0.0 106.954 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' B' ' 147' ' ' GLY . 66.3 mtp180 -94.3 119.08 32.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -124.99 154.87 40.55 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.697 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.3 p -128.56 140.34 51.84 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.428 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 44.6 t -115.24 136.57 51.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -111.14 139.65 46.35 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' LEU . . . . . 0.477 HD22 HD11 ' B' ' 143' ' ' LEU . 6.1 mp -120.12 128.63 53.62 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -84.5 119.24 24.93 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.641 ' HB ' ' O ' ' B' ' 141' ' ' GLY . 41.0 t -134.1 140.38 46.3 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 103.01 -2.959 . . . . 0.0 103.01 174.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -82.87 -170.93 3.26 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.671 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -75.9 125.11 28.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -158.24 166.62 31.92 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -172.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -74.82 113.29 23.05 Favored Pre-proline 0 N--CA 1.435 -1.211 0 O-C-N 123.777 0.673 . . . . 0.0 110.253 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.93 -30.07 84.65 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.806 3.004 . . . . 0.0 114.969 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.25 -7.15 58.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.023 0.44 . . . . 0.0 111.476 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' B' ' 88' ' ' GLU . 5.4 mm-40 -94.26 2.82 55.84 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.14 0.495 . . . . 0.0 111.53 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.35 147.01 45.58 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.84 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -124.57 125.71 44.62 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -96.27 122.05 47.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -120.34 130.96 54.65 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.505 HG22 HD13 ' B' ' 98' ' ' ILE . 58.0 t -114.67 125.14 71.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 172.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -135.84 91.87 2.75 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.0 -112.26 4.6 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.898 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.64 11.43 33.32 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.793 0.837 . . . . 0.0 111.548 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.51 137.21 55.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.452 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.757 HG23 ' HB2' ' B' ' 122' ' ' TYR . 2.3 tp -125.99 120.25 56.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 174.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 38.2 mt-10 -132.33 149.93 52.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.11 0.481 . . . . 0.0 110.467 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 88.0 t -126.64 124.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -128.17 132.97 48.86 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.0 151.0 23.35 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.407 ' HD3' ' H ' ' B' ' 103' ' ' LYS . 0.0 OUTLIER -143.93 128.09 17.65 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -138.29 134.12 33.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.405 -0.809 . . . . 0.0 111.208 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.73 120.58 24.81 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -77.21 -55.98 4.95 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.061 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' B' ' 114' ' ' ILE . 30.2 ptt180 -148.65 155.46 41.08 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -82.06 113.6 20.05 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 171.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.413 ' HB2' HG23 ' B' ' 114' ' ' ILE . 13.8 t70 -94.09 -148.53 0.27 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.928 -163.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.55 82.57 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.602 0.637 . . . . 0.0 110.021 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 75.41 -51.46 0.65 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.245 1.818 . . . . 0.0 110.078 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.4 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -77.53 173.2 55.08 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.142 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -118.65 149.59 41.14 Favored 'General case' 0 C--N 1.255 -3.52 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.671 HD11 ' HG2' ' B' ' 107' ' ' ARG . 37.7 pt -122.92 137.03 57.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.315 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -134.59 153.92 51.73 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.411 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 6.3 ttp180 -127.11 147.05 50.18 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.05 153.35 51.85 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.515 -175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.5 ' HD2' ' NH1' ' B' ' 120' ' ' ARG . 49.9 m-85 -128.23 126.75 41.54 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.356 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -131.03 122.62 27.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.524 ' NH2' HD12 ' A' ' 114' ' ' ILE . 25.8 mtt85 -126.96 138.1 53.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -138.36 128.88 26.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 124.023 0.827 . . . . 0.0 111.474 -177.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' TYR . . . . . 0.757 ' HB2' HG23 ' B' ' 98' ' ' ILE . 4.1 m-85 -133.11 124.7 28.03 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.027 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -108.79 99.27 8.64 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.492 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 4.1 pt -136.06 106.0 9.58 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.772 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 124' ' ' ILE . 5.4 Cg_exo -84.9 -38.83 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 111.92 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' B' ' 150' ' ' LYS . . . -67.84 -32.32 72.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.73 -18.14 21.55 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.582 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 70.7 t -131.87 114.31 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -174.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -109.3 127.56 27.01 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.414 ' HA ' ' CG1' ' B' ' 133' ' ' ILE . 86.9 Cg_endo -73.55 15.96 0.52 Allowed 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 122.759 2.306 . . . . 0.0 116.374 -172.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -81.9 -48.39 11.58 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' THR . . . . . 0.4 HG22 ' HG3' ' B' ' 148' ' ' PRO 0.272 4.4 t -122.14 10.55 10.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.2 pp -67.46 128.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -175.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 12.1 p -130.6 166.7 20.08 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.653 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.42 ' HB3' HG12 ' B' ' 145' ' ' VAL . 55.9 p -127.67 134.69 49.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.065 0.46 . . . . 0.0 110.859 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 18.4 m -125.37 129.81 50.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . 0.41 ' HB3' ' HB3' ' B' ' 143' ' ' LEU . 3.8 pp -122.3 148.32 45.16 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 16.3 m -100.07 163.73 12.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 18.6 m -64.1 -21.87 66.71 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 112.439 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.43 4.19 25.16 Favored 'General case' 0 C--O 1.207 -1.162 0 C-N-CA 123.182 0.593 . . . . 0.0 110.484 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.641 ' O ' ' HB ' ' B' ' 81' ' ' VAL . . . 97.3 -20.34 51.14 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.755 173.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -71.79 123.64 26.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.757 0.789 . . . . 0.0 110.432 -175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.477 HD11 HD22 ' B' ' 79' ' ' LEU . 4.1 pp -129.71 136.12 49.3 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.475 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -109.29 135.65 50.03 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . 0.475 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 31.5 m -105.74 122.24 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 3.6 p-10 -133.02 142.73 48.97 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.941 0.401 . . . . 0.0 111.349 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' B' ' 74' ' ' ARG . . . 174.76 -138.02 4.17 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.4 ' HG3' HG22 ' B' ' 132' ' ' THR . 21.7 Cg_endo -91.65 146.9 3.31 Favored 'Trans proline' 0 N--CA 1.439 -1.692 0 C-N-CA 122.474 2.116 . . . . 0.0 112.887 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -100.62 151.41 21.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' B' ' 126' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.66 125.5 24.16 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.964 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 149' ' ' ARG . 12.6 pt-20 -145.95 53.1 1.15 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.511 -174.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -88.15 114.01 24.35 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.739 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 77.88 168.21 0.22 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.462 1.505 . . . . 0.0 110.39 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -112.43 149.6 32.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 9.3 t80 -134.22 158.66 43.15 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.908 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.3 t -131.85 133.81 45.06 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.95 137.77 47.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -110.2 135.27 51.24 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.647 HD22 ' CE1' ' A' ' 122' ' ' TYR . 1.8 mt -120.46 128.86 53.54 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -107.45 134.88 49.84 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.878 0.847 . . . . 0.0 111.82 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.23 -179.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 N-CA-C 103.358 -2.831 . . . . 0.0 103.358 172.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 118' ' ' PHE . 54.9 mtpt -100.08 -163.21 1.01 Allowed 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 120.325 1.421 . . . . 0.0 110.666 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -77.78 125.9 30.04 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 117.903 -1.519 . . . . 0.0 112.156 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 47.9 m-85 -142.47 146.75 35.1 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.876 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 m -66.54 129.41 94.13 Favored Pre-proline 0 N--CA 1.407 -2.599 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.473 ' HB3' HD21 ' A' ' 137' ' ' LEU . 72.9 Cg_exo -48.87 -31.96 21.38 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.229 3.286 . . . . 0.0 115.094 -173.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.37 -4.45 58.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.4 mm-40 -100.11 -0.14 39.57 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.68 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.407 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 4.0 pp -121.56 147.53 45.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.34 126.03 30.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.49 122.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.02 137.5 53.49 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.079 0.466 . . . . 0.0 110.831 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 98' ' ' ILE . 85.6 t -124.51 115.5 44.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.934 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mp -125.67 95.01 4.29 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.67 -112.81 4.86 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.045 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -95.92 11.23 34.6 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 123.186 0.594 . . . . 0.0 111.394 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.42 135.79 57.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.297 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 27.1 mm -121.68 120.57 62.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 46.4 mt-10 -136.46 136.9 39.87 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.701 0.682 . . . . 0.0 112.753 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 46.8 t -107.25 117.17 52.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -113.67 119.05 36.1 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 89' ' ' LEU . . . -123.83 135.64 9.87 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 25.4 ttpp -120.21 133.41 55.49 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -134.6 128.67 33.66 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.59 120.92 35.58 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -75.1 -66.26 0.78 Allowed 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.873 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -139.51 124.38 18.61 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.192 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.89 112.62 21.31 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 103.02 -2.956 . . . . 0.0 103.02 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 112' ' ' GLY . 5.4 t70 -114.35 -163.06 0.84 Allowed 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.138 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -74.24 -76.58 0.13 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.051 0.54 . . . . 0.0 111.237 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -109.87 -15.54 14.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.335 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 109' ' ' ASP . . . -130.58 113.58 1.45 Allowed Glycine 0 C--O 1.2 -1.995 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.659 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -94.07 137.22 33.51 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 120' ' ' ARG . 3.0 tt -125.24 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -131.56 162.76 29.55 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.485 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -127.58 149.61 50.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.631 1.172 . . . . 0.0 108.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 36.6 tt0 -135.83 141.18 44.65 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.463 ' CZ ' ' HD3' ' A' ' 82' ' ' LYS . 9.2 m-85 -126.73 124.96 40.97 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 2.0 p80 -133.05 125.58 29.96 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.063 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' B' ' 114' ' ' ILE . 24.8 ttt85 -112.63 136.91 51.64 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.449 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 28.1 mtmm -130.05 130.45 44.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.78 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE1' HD22 ' A' ' 79' ' ' LEU . 45.4 m-85 -121.55 131.6 54.23 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 123.418 0.687 . . . . 0.0 110.089 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -117.82 99.07 6.69 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.567 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 9.0 pt -135.48 105.51 10.05 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.099 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.67 -33.54 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.443 2.096 . . . . 0.0 111.341 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 150' ' ' LYS . . . -69.23 -22.95 63.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.731 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -108.11 -13.75 14.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.633 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.575 HG11 HD11 ' A' ' 98' ' ' ILE . 16.8 t -130.47 134.74 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.23 116.2 42.19 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 38.2 Cg_endo -65.13 -6.0 12.15 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.204 2.603 . . . . 0.0 116.381 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.0 tp -81.7 -45.06 16.24 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.769 -176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.6 t -112.77 8.72 18.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.473 ' O ' HD12 ' A' ' 133' ' ' ILE . 2.0 pp -68.75 136.95 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.804 170.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER -130.38 166.27 20.8 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 144' ' ' THR . 14.8 m -136.41 141.35 43.62 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 118.899 0.772 . . . . 0.0 111.809 -176.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.9 t -131.67 140.83 49.44 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -126.79 137.73 53.25 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.909 -177.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 t -100.12 161.63 13.49 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.0 m -67.89 -21.01 65.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.28 7.72 36.88 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.826 0.822 . . . . 0.0 110.83 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.37 33.49 11.65 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.501 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.1 112.46 32.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -108.68 129.43 55.35 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -175.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 135' ' ' SER . 5.2 p -117.64 129.0 55.47 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 175.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 134' ' ' THR . 62.1 t -103.18 122.42 55.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 134' ' ' THR . 24.1 p-10 -126.79 148.27 49.94 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.31 -118.3 0.9 Allowed Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.566 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -85.84 170.61 8.62 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 124.186 3.257 . . . . 0.0 114.19 -172.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 61.8 ttt180 -141.44 151.2 43.2 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 88.9 tttt . . . . . 0 C--N 1.294 -1.809 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 . . . . . 0 N--CA 1.432 -1.366 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.406 ' HB3' ' HG3' ' B' ' 150' ' ' LYS . 59.6 tp -63.1 125.72 24.97 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.902 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' B' ' 149' ' ' ARG . 12.8 pt-20 -146.37 52.98 1.12 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.445 -174.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -87.97 113.75 23.92 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.736 -1.186 . . . . 0.0 110.676 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 78.67 168.23 0.2 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.99 1.316 . . . . 0.0 110.301 -175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -113.16 149.86 33.03 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.523 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 9.4 t80 -134.78 158.91 42.96 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.819 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 14.7 t -132.26 133.79 44.52 Favored 'General case' 0 N--CA 1.399 -3.015 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.0 137.65 47.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -109.82 135.24 51.04 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' LEU . . . . . 0.651 HD22 ' CE1' ' B' ' 122' ' ' TYR . 1.7 mt -120.22 128.92 53.81 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -107.56 135.38 49.11 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 121.664 0.745 . . . . 0.0 111.802 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.93 -179.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' B' ' 118' ' ' PHE . 54.0 mtpt -99.76 -163.3 1.02 Allowed 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 120.301 1.409 . . . . 0.0 110.746 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -77.63 125.8 29.9 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 117.712 -1.595 . . . . 0.0 112.188 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' B' ' 118' ' ' PHE . 47.3 m-85 -142.06 146.51 35.56 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.701 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 14.6 m -66.53 129.61 94.13 Favored Pre-proline 0 N--CA 1.412 -2.342 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.474 ' HB3' HD21 ' B' ' 137' ' ' LEU . 69.9 Cg_exo -48.56 -31.98 19.87 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 124.517 3.478 . . . . 0.0 115.094 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -88.27 -4.68 58.66 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' B' ' 103' ' ' LYS . 11.3 mm-40 -100.47 -0.02 38.79 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.433 0.635 . . . . 0.0 110.606 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.402 ' HA ' ' HA2' ' B' ' 102' ' ' GLY . 4.0 pp -121.07 147.7 45.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -133.41 125.92 30.13 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.152 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.79 122.45 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.964 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -118.91 136.39 54.09 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 120.952 0.406 . . . . 0.0 110.737 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.478 HG13 HD13 ' B' ' 98' ' ' ILE . 86.8 t -123.27 116.08 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mp -125.77 94.2 4.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.417 ' HA2' ' HG3' ' B' ' 130' ' ' PRO . . . 69.73 -112.62 4.55 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.067 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.38 11.11 35.96 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 123.075 0.55 . . . . 0.0 111.257 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -117.98 135.77 57.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.407 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.593 HD11 HG11 ' B' ' 128' ' ' VAL . 27.5 mm -121.8 120.65 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 46.7 mt-10 -136.53 137.11 39.94 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 118.71 0.686 . . . . 0.0 112.799 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' B' ' 119' ' ' HIS . 46.7 t -107.33 117.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -113.68 119.11 36.31 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 89' ' ' LEU . . . -123.74 135.65 9.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' B' ' 88' ' ' GLU . 25.5 ttpp -120.02 133.48 55.53 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -134.71 129.02 34.09 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.01 120.83 35.89 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -74.55 -65.69 0.83 Allowed 'General case' 0 CA--C 1.478 -1.798 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.083 -168.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 -140.3 124.27 17.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.141 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 112.41 21.11 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' B' ' 112' ' ' GLY . 5.2 t70 -113.87 -163.05 0.84 Allowed 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.285 -163.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -73.62 -76.1 0.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 123.315 0.646 . . . . 0.0 111.215 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -110.6 -17.51 13.39 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' B' ' 109' ' ' ASP . . . -129.33 114.39 1.72 Allowed Glycine 0 C--O 1.2 -2.026 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.974 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -94.22 137.3 33.55 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' ARG . 3.1 tt -125.11 137.26 58.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 15.8 m -132.76 162.7 30.79 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.514 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -127.54 149.65 50.04 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.638 1.175 . . . . 0.0 108.164 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 37.1 tt0 -135.84 141.09 44.62 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.462 ' CZ ' ' HD3' ' B' ' 82' ' ' LYS . 9.2 m-85 -126.72 124.95 40.95 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 2.0 p80 -133.1 125.75 30.25 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.914 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 24.7 ttt85 -112.66 137.02 51.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.443 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.9 mtmm -130.03 130.26 44.72 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.772 -173.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' TYR . . . . . 0.651 ' CE1' HD22 ' B' ' 79' ' ' LEU . 45.2 m-85 -121.35 131.97 54.5 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 123.704 0.628 . . . . 0.0 110.111 176.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -118.0 98.92 6.57 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 165.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 8.9 pt -135.37 105.5 10.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.055 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -92.59 -33.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.511 2.141 . . . . 0.0 111.386 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' B' ' 150' ' ' LYS . . . -69.29 -23.45 63.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.096 0.558 . . . . 0.0 111.628 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -107.47 -14.3 14.88 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.593 HG11 HD11 ' B' ' 98' ' ' ILE . 16.6 t -129.87 134.53 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -172.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -114.74 116.25 43.32 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.417 ' HG3' ' HA2' ' B' ' 95' ' ' GLY . 34.9 Cg_endo -65.16 -5.49 11.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.056 2.504 . . . . 0.0 116.249 -174.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.91 -45.29 15.65 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.614 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' THR . . . . . . . . . . . . . 8.8 t -113.02 9.05 18.62 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . 0.478 ' O ' HD12 ' B' ' 133' ' ' ILE . 2.0 pp -68.77 136.73 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.774 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 0.2 OUTLIER -130.6 166.15 21.26 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 144' ' ' THR . 16.5 m -136.43 141.38 43.59 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 118.853 0.751 . . . . 0.0 111.746 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 29.6 t -132.1 139.73 48.57 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -125.58 138.2 53.93 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.063 -177.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -100.24 161.68 13.45 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 13.2 m -67.56 -20.51 65.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -170.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.32 8.19 37.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.791 0.805 . . . . 0.0 110.558 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.27 33.27 12.04 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.713 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.94 112.78 33.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 0.8 OUTLIER -108.87 129.52 55.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -175.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 135' ' ' SER . 7.2 p -117.76 128.76 55.19 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' B' ' 134' ' ' THR . 61.7 t -102.89 122.53 55.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -126.7 148.67 49.84 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.04 -118.5 0.92 Allowed Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 119.775 -1.202 . . . . 0.0 112.761 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -85.47 170.65 9.08 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.391 3.394 . . . . 0.0 114.288 -172.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 61.2 ttt180 -141.77 151.1 42.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 88.2 tttt . . . . . 0 C--N 1.294 -1.807 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 45.1 mt 63.15 -166.88 0.22 Allowed 'General case' 0 C--O 1.242 0.659 0 O-C-N 124.318 1.012 . . . . 0.0 108.975 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -64.08 -68.82 0.32 Allowed 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.248 171.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -140.62 146.37 37.87 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.806 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 2.8 m-20 -54.29 -73.15 0.05 Allowed 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -118.14 131.52 56.4 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.58 160.28 40.93 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.476 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -137.25 133.41 35.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.507 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 46.4 t -116.02 148.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.83 152.71 27.59 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.668 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.663 ' HA ' ' HD2' ' A' ' 120' ' ' ARG . 71.0 mt -120.17 142.14 49.25 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' B' ' 107' ' ' ARG . 13.5 t70 -105.59 120.17 40.98 Favored 'General case' 0 CA--C 1.493 -1.235 0 O-C-N 123.526 0.516 . . . . 0.0 111.898 -166.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 83' ' ' HIS . 20.9 t -140.78 96.85 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 170.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.02 9.7 1.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.456 ' O ' HG12 ' A' ' 81' ' ' VAL . 4.1 m80 -150.19 173.07 14.33 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.445 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 33.9 p90 -103.94 119.02 38.05 Favored 'General case' 0 C--N 1.282 -2.37 0 C-N-CA 117.851 -1.539 . . . . 0.0 113.797 -166.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 104' ' ' HIS . 50.8 m -119.56 65.16 8.74 Favored Pre-proline 0 N--CA 1.422 -1.841 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.826 170.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 84' ' ' PHE . 35.6 Cg_exo -58.06 -40.37 77.82 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.118 1.879 . . . . 0.0 112.074 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.6 -37.72 16.57 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.266 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 28.3 mt-10 -93.02 28.39 2.14 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -169.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 85' ' ' SER . 3.1 pp -128.66 153.67 47.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.519 174.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -134.69 129.47 34.83 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.46 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.46 HG21 HD21 ' A' ' 143' ' ' LEU . 19.3 t -107.24 132.82 53.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.11 131.36 47.24 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.399 0.618 . . . . 0.0 111.623 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.57 117.62 55.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -129.12 91.02 3.12 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.18 -113.94 5.47 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.934 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.27 11.09 39.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 108.971 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.13 137.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.305 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.434 HG13 HG21 ' A' ' 128' ' ' VAL . 36.5 mm -125.08 121.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 30.0 mt-10 -134.36 147.92 50.61 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.884 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.633 ' HB ' HD13 ' A' ' 79' ' ' LEU . 8.5 p -124.75 134.76 66.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -124.14 118.2 26.36 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.2 135.43 6.66 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -133.43 130.53 38.79 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.518 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 69.7 t60 -139.25 135.95 34.43 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.749 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 9.8 pt-20 -81.85 120.46 25.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -134.35 -5.29 2.63 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -124.33 124.02 41.48 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -112.99 136.05 53.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.262 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' CG ' HH12 ' B' ' 120' ' ' ARG . 3.6 m-20 -120.44 -170.1 1.92 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -55.55 -74.66 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -120.34 24.74 10.23 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.46 127.65 4.39 Favored Glycine 0 N--CA 1.402 -3.573 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.37 150.6 29.53 Favored 'General case' 0 C--N 1.261 -3.239 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' B' ' 120' ' ' ARG . 3.0 mt -123.78 137.24 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 17.0 m -120.52 150.35 40.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.821 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 35.9 tt0 -137.34 142.37 41.81 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.46 128.25 53.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 12.7 t-80 -131.61 125.97 33.55 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.42 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.663 ' HD2' ' HA ' ' A' ' 79' ' ' LEU . 64.5 mtt-85 -111.22 146.25 37.26 Favored 'General case' 0 CA--C 1.465 -2.302 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 99' ' ' GLU . 25.0 ttmm -125.82 128.81 48.24 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -128.6 133.04 48.21 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.192 0.597 . . . . 0.0 110.827 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -122.76 98.46 5.92 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.536 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 3.0 pt -135.59 105.08 9.97 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.146 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.461 ' O ' ' HE2' ' A' ' 150' ' ' LYS . 10.3 Cg_exo -80.45 -39.91 0.23 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.347 2.031 . . . . 0.0 110.237 174.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . -67.44 -17.56 64.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.964 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.41 ' HB2' HD12 ' A' ' 124' ' ' ILE . 3.9 m-20 -113.13 -17.9 12.28 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.006 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.536 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 55.3 t -131.34 126.12 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.32 126.66 26.15 Favored Pre-proline 0 N--CA 1.428 -1.569 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 165.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.6 -24.41 53.83 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 123.931 3.087 . . . . 0.0 115.172 -171.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.3 -24.31 37.29 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 148' ' ' PRO . 11.1 t -116.94 -17.22 10.45 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.88 -1.128 . . . . 0.0 113.197 -172.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.7 mm -81.3 125.22 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.947 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 11.2 p -122.01 167.19 13.39 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.904 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.8 m -126.99 133.76 50.49 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.917 0.389 . . . . 0.0 111.347 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.4 p -121.24 145.38 47.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.378 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 65.8 tp -123.88 131.52 53.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.431 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 11.7 m -96.76 162.91 13.22 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.1 t -67.43 -13.45 62.04 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -98.45 0.29 44.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.588 0.709 . . . . 0.0 110.465 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.54 4.51 52.54 Favored Glycine 0 C--N 1.316 -0.58 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.171 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 138' ' ' SER . 47.5 t -73.18 113.38 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.3 tm? -107.61 132.23 53.52 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.75 124.75 44.95 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.594 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.507 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 26.8 m -99.19 122.31 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -128.12 142.69 51.12 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.65 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.18 176.79 28.71 Favored Glycine 0 N--CA 1.413 -2.864 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.584 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 73' ' ' ASP . 50.4 Cg_exo -62.72 141.13 84.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.902 3.068 . . . . 0.0 113.724 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 56.8 mtp180 -80.0 163.32 24.32 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 125' ' ' PRO . 36.4 ttpt . . . . . 0 C--N 1.298 -1.671 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.422 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 . . . . . 0 C--O 1.25 1.128 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 47.1 mt 63.61 -166.67 0.22 Allowed 'General case' 0 C--O 1.254 1.303 0 O-C-N 124.186 0.929 . . . . 0.0 108.896 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -63.69 -69.65 0.26 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.28 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.34 146.08 38.0 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.662 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' B' ' 148' ' ' PRO . 2.4 m-20 -53.58 -71.5 0.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -120.23 130.73 54.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -143.32 160.31 40.75 Favored 'General case' 0 N--CA 1.42 -1.942 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.513 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 53.3 m -137.29 132.67 34.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.954 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.505 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 46.5 t -115.95 148.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -111.58 152.58 27.42 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.686 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' LEU . . . . . 0.644 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 70.7 mt -120.22 142.23 49.2 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.54 119.82 40.07 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -166.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 83' ' ' HIS . 20.5 t -139.79 97.94 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 102.465 -3.161 . . . . 0.0 102.465 169.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -75.77 9.75 2.16 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . 0.453 ' O ' HG12 ' B' ' 81' ' ' VAL . 3.7 m80 -150.13 173.28 14.08 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' B' ' 86' ' ' PRO . 34.8 p90 -104.0 118.99 37.99 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 117.804 -1.558 . . . . 0.0 113.787 -166.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.52 ' OG ' ' HB2' ' B' ' 104' ' ' HIS . 49.3 m -119.44 65.26 8.42 Favored Pre-proline 0 N--CA 1.421 -1.895 0 CA-C-N 113.492 -1.686 . . . . 0.0 108.879 170.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' B' ' 84' ' ' PHE . 48.8 Cg_exo -57.45 -40.81 78.25 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.159 1.906 . . . . 0.0 112.07 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -88.01 -38.12 15.76 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 85' ' ' SER . 27.8 mt-10 -91.79 27.56 2.04 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -170.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' B' ' 85' ' ' SER . 3.1 pp -128.31 154.17 46.22 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.56 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.48 130.01 34.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.289 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.452 HG21 HD21 ' B' ' 143' ' ' LEU . 20.3 t -108.25 132.61 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -128.96 131.38 47.48 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.647 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.59 117.37 54.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tt -129.37 90.67 3.05 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.6 -114.23 5.53 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.98 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -100.65 11.2 40.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.842 0.83 . . . . 0.0 108.968 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.3 137.04 41.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.222 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.432 HG13 HG21 ' B' ' 128' ' ' VAL . 36.4 mm -125.08 120.94 59.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 29.7 mt-10 -134.41 147.89 50.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.923 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.625 ' HB ' HD13 ' B' ' 79' ' ' LEU . 9.1 p -124.62 134.72 66.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -123.84 118.39 27.02 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.35 135.37 6.58 Favored Glycine 0 CA--C 1.491 -1.419 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -133.41 130.29 38.5 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' HIS . . . . . 0.52 ' HB2' ' OG ' ' B' ' 85' ' ' SER . 70.0 t60 -139.03 135.94 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.852 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' B' ' 115' ' ' SER . 9.7 pt-20 -81.68 120.34 24.98 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.57 -5.28 2.55 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 80' ' ' ASP . 66.6 mtp180 -124.61 123.99 41.25 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -112.98 136.16 52.96 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.284 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.414 ' CG ' HH12 ' A' ' 120' ' ' ARG . 4.1 m-20 -120.86 -168.34 1.64 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.44 -74.29 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.521 0.729 . . . . 0.0 112.344 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -118.95 24.2 10.97 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -134.1 128.09 4.79 Favored Glycine 0 N--CA 1.402 -3.61 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -111.56 150.6 29.77 Favored 'General case' 0 C--N 1.263 -3.164 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.495 HG12 ' HG2' ' A' ' 120' ' ' ARG . 3.1 mt -123.9 137.07 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' B' ' 105' ' ' GLU . 15.6 m -120.42 150.3 41.01 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.689 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -127.29 148.56 50.23 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 36.0 tt0 -137.47 142.35 41.54 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.42 128.34 53.94 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' B' ' 100' ' ' VAL . 12.9 t-80 -131.52 125.82 33.36 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.423 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.644 ' HD2' ' HA ' ' B' ' 79' ' ' LEU . 62.4 mtt-85 -111.04 146.29 36.99 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.451 ' HA ' ' HG2' ' B' ' 99' ' ' GLU . 24.8 ttmm -126.15 128.89 48.0 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.93 132.33 47.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 123.203 0.601 . . . . 0.0 110.833 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -121.87 98.49 5.97 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 168.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.9 pt -135.39 104.96 10.14 Favored Pre-proline 0 C--N 1.293 -1.886 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.152 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.469 ' O ' ' HE2' ' B' ' 150' ' ' LYS . 7.9 Cg_exo -80.09 -39.74 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.278 1.985 . . . . 0.0 110.321 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' B' ' 149' ' ' ARG . . . -67.26 -17.98 65.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.861 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . 0.409 ' HB2' HD12 ' B' ' 124' ' ' ILE . 4.0 m-20 -113.17 -17.99 12.23 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.109 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 55.4 t -131.35 125.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -169.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -122.35 126.43 26.22 Favored Pre-proline 0 N--CA 1.428 -1.555 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 165.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.69 -24.06 52.7 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.937 3.091 . . . . 0.0 115.152 -171.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 82.3 mt -81.25 -23.94 37.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' THR . . . . . 0.442 ' OG1' ' HD2' ' B' ' 148' ' ' PRO . 8.3 t -117.43 -17.81 9.98 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.779 -1.168 . . . . 0.0 113.102 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.6 mm -81.07 125.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.06 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 14.6 p -122.09 167.6 12.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.649 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -126.95 134.05 50.49 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 7.0 p -121.16 146.09 47.14 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 123.858 0.863 . . . . 0.0 109.139 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 66.3 tp -124.98 130.5 52.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.673 0.273 . . . . 0.0 111.387 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 7.4 m -95.89 163.12 13.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -67.66 -14.32 62.84 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -171.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -96.63 -0.69 48.17 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.541 0.686 . . . . 0.0 110.628 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 101.63 5.16 51.79 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.713 -1.232 . . . . 0.0 112.008 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 46.9 t -73.31 113.66 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.3 tm? -107.8 132.0 53.87 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 16.6 m -121.7 124.79 45.09 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.576 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . 0.505 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 26.9 m -99.15 122.39 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -128.38 142.29 51.16 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.858 -171.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.03 177.47 29.26 Favored Glycine 0 N--CA 1.415 -2.749 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.638 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' B' ' 73' ' ' ASP . 52.2 Cg_exo -62.98 140.74 80.81 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.892 3.061 . . . . 0.0 113.793 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' B' ' 126' ' ' ALA . 56.4 mtp180 -79.81 163.25 24.57 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.039 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' B' ' 125' ' ' PRO . 35.9 ttpt . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 118.786 -0.626 . . . . 0.0 110.618 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.455 0.645 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.5 tp -72.09 -51.96 19.05 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.596 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 32.5 mm-40 -150.0 170.21 19.39 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 126.182 1.793 . . . . 0.0 106.254 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -91.54 104.93 17.37 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.349 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' A' ' 149' ' ' ARG . 2.8 m-20 143.16 159.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 129.262 3.025 . . . . 0.0 108.095 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -130.65 126.59 36.97 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -105.92 132.93 51.43 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.962 0.887 . . . . 0.0 112.078 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 146' ' ' ASN . 15.7 m -114.38 131.07 56.69 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.61 131.44 66.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -110.4 130.53 55.53 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.657 HD22 ' CZ ' ' A' ' 122' ' ' TYR . 11.9 mt -120.24 128.3 53.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -103.01 128.26 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.002 0.906 . . . . 0.0 113.01 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.516 HG23 HH12 ' A' ' 120' ' ' ARG . 38.9 t -122.28 142.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -64.31 -56.7 12.72 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.597 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 18.2 t60 -153.96 125.84 7.74 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.261 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.403 ' CE2' ' HA2' ' A' ' 141' ' ' GLY . 0.3 OUTLIER -130.48 172.17 12.19 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.257 0.48 . . . . 0.0 111.167 177.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 20.9 m -93.16 121.92 64.45 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.93 -28.64 78.79 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.957 2.438 . . . . 0.0 113.483 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.98 -38.64 19.03 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.632 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.564 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 35.8 mt-10 -85.42 40.08 0.82 Allowed 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.585 0.707 . . . . 0.0 109.519 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 90' ' ' LYS . 1.1 tm? -120.51 145.81 46.92 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -174.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.447 ' N ' HD13 ' A' ' 89' ' ' LEU . 25.9 tptp -144.0 125.88 15.27 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 138.68 40.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.492 ' HG3' ' HB2' ' A' ' 99' ' ' GLU . 13.1 ptmm? -144.34 135.51 25.36 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.905 0.383 . . . . 0.0 110.601 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.41 116.12 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 97' ' ' VAL . 62.3 tp -120.04 90.86 3.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.99 -111.96 4.56 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.849 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -90.01 4.2 50.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.941 0.896 . . . . 0.0 112.106 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 94' ' ' LEU . 35.4 m -117.48 137.75 50.38 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 C-N-CA 119.349 -0.94 . . . . 0.0 113.195 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 122' ' ' TYR . 37.2 mm -112.85 119.89 61.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 14.8 mp0 -122.33 136.95 54.99 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.171 0.51 . . . . 0.0 109.867 174.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.6 126.95 61.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.88 42.69 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.01 140.74 12.58 Favored Glycine 0 CA--C 1.477 -2.308 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.564 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 13.9 ptmm? -143.19 144.69 32.28 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 117.214 0.507 . . . . 0.0 109.733 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -136.74 128.82 29.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.56 120.95 25.19 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HB3' ' NH1' ' A' ' 107' ' ' ARG . 21.9 mt-10 -83.95 -74.18 0.39 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.757 -167.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 106' ' ' GLU . 18.2 ptt-85 -148.57 151.34 34.91 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.103 -173.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -111.48 119.73 39.77 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 -44.29 77.96 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 168.83 -75.34 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -94.23 -12.58 27.92 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.559 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -101.48 137.19 13.15 Favored Glycine 0 N--CA 1.411 -3.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.243 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.2 137.69 52.19 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.33 134.02 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.4 p -134.31 155.23 50.59 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -128.19 148.06 50.6 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -135.05 153.52 52.02 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.039 0.447 . . . . 0.0 109.997 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -122.62 125.99 46.76 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.51 122.11 43.75 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.516 HH12 HG23 ' A' ' 81' ' ' VAL . 41.3 ttp180 -133.11 138.0 46.52 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.878 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.492 ' HG2' ' HG3' ' A' ' 99' ' ' GLU . 33.1 mttm -139.87 130.46 25.69 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.099 0.875 . . . . 0.0 112.157 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CZ ' HD22 ' A' ' 79' ' ' LEU . 44.0 m-85 -126.15 136.95 53.48 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -117.32 98.63 6.53 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.598 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.8 pt -136.41 106.16 9.29 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.267 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -88.79 -45.88 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.193 1.929 . . . . 0.0 112.873 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.92 -13.03 62.19 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.488 0.661 . . . . 0.0 112.596 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -112.1 -17.65 12.78 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 2.9 t -132.6 117.67 31.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.57 123.27 26.43 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.15 -1.57 3.05 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.633 2.888 . . . . 0.0 116.339 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.4 tp -59.78 -44.43 93.92 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.475 ' HB ' ' HD3' ' A' ' 148' ' ' PRO . 39.6 m -110.84 -12.8 14.23 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.642 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 55.4 mt -67.99 126.08 27.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -165.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 p -122.11 163.61 19.17 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.385 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 144' ' ' THR . 26.7 t -138.0 135.68 36.19 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.217 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.8 p -127.75 156.27 42.71 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.41 144.07 44.3 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.195 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.488 ' HB3' ' HB ' ' A' ' 142' ' ' VAL . 17.8 t -100.49 162.74 12.74 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.7 m -61.55 -28.01 69.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.761 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 37.5 t70 -90.18 -12.3 38.55 Favored 'General case' 0 C--O 1.205 -1.265 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.343 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.403 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . 120.75 8.91 7.91 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 117.978 -2.058 . . . . 0.0 113.237 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 138' ' ' SER . 51.4 t -78.89 118.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 1.8 tm? -115.23 133.75 55.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 135' ' ' SER . 27.5 m -121.56 130.13 53.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.841 -0.537 . . . . 0.0 111.078 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.3 m -121.03 125.53 74.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.642 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 7.9 p30 -137.27 137.52 39.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.048 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 133' ' ' ILE . . . -158.78 -143.27 3.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.29 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 132' ' ' THR . 93.7 Cg_endo -102.73 169.64 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.022 3.148 . . . . 0.0 112.589 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 61.4 ttt180 -96.36 138.03 34.56 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.435 -1.175 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.578 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.523 0.678 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.12 -52.01 21.77 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' B' ' 149' ' ' ARG . 28.4 mm-40 -149.83 170.93 17.61 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -92.4 105.25 17.47 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' B' ' 149' ' ' ARG . 2.5 m-20 142.48 159.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 129.084 2.954 . . . . 0.0 107.828 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -131.01 126.65 36.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -105.91 132.94 51.4 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 122.132 0.968 . . . . 0.0 111.976 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -113.76 131.19 56.3 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.79 131.35 67.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -110.47 130.51 55.54 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' LEU . . . . . 0.648 HD22 ' CZ ' ' B' ' 122' ' ' TYR . 11.4 mt -120.34 128.47 53.28 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.52 127.92 49.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.955 0.883 . . . . 0.0 113.108 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.524 HG23 HH12 ' B' ' 120' ' ' ARG . 39.0 t -122.32 141.9 40.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.24 -56.51 14.13 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.718 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . 0.777 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 18.2 t60 -153.97 125.74 7.69 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.255 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.42 172.06 12.29 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.267 0.485 . . . . 0.0 111.108 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 22.9 m -93.17 122.25 63.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.19 -28.3 78.68 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.938 2.425 . . . . 0.0 113.553 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -85.51 -38.52 18.46 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.787 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' B' ' 103' ' ' LYS . 35.5 mt-10 -85.22 40.17 0.81 Allowed 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.479 0.656 . . . . 0.0 109.4 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.45 HD13 ' N ' ' B' ' 90' ' ' LYS . 1.1 tm? -120.59 145.83 46.97 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -174.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.45 ' N ' HD13 ' B' ' 89' ' ' LEU . 26.1 tptp -144.18 125.74 14.97 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.07 139.09 38.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' B' ' 99' ' ' GLU . 13.5 ptmm? -144.45 135.82 25.5 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.14 116.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.447 ' O ' HG22 ' B' ' 97' ' ' VAL . 62.4 tp -119.92 90.56 3.35 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.67 -111.96 4.58 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.625 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -90.08 4.17 51.1 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 123.933 0.893 . . . . 0.0 112.192 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 94' ' ' LEU . 29.2 m -117.25 137.74 50.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.315 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' B' ' 122' ' ' TYR . 37.6 mm -112.81 120.03 61.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' B' ' 92' ' ' LYS . 15.2 mp0 -122.46 137.04 55.0 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 121.199 0.523 . . . . 0.0 109.842 174.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.41 HG21 HD12 ' B' ' 79' ' ' LEU . 92.4 t -130.69 127.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.28 120.64 41.86 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.78 140.88 12.76 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.551 ' HG3' ' HB3' ' B' ' 88' ' ' GLU . 13.7 ptmm? -143.33 144.75 32.22 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 117.25 0.525 . . . . 0.0 109.78 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -136.75 128.65 29.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -80.19 121.08 25.15 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.17 -73.8 0.41 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.825 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -148.58 151.3 34.82 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.326 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -111.75 119.14 37.63 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.01 -44.51 80.15 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 169.04 -74.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -94.79 -12.79 26.42 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.589 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -101.45 137.2 13.16 Favored Glycine 0 N--CA 1.411 -3.02 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.245 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.18 137.54 52.27 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 134.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 36.7 p -134.31 155.13 50.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -128.21 148.15 50.61 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -135.19 153.43 51.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.988 0.423 . . . . 0.0 109.894 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.66 125.91 46.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -116.5 122.19 44.01 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.524 HH12 HG23 ' B' ' 81' ' ' VAL . 41.4 ttp180 -133.27 137.82 46.2 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.757 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.48 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 32.9 mttm -139.57 130.37 26.06 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 124.293 0.995 . . . . 0.0 112.11 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' TYR . . . . . 0.648 ' CZ ' HD22 ' B' ' 79' ' ' LEU . 46.4 m-85 -126.32 136.44 52.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -117.1 98.79 6.65 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.591 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.8 pt -136.43 106.43 9.27 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.331 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -88.99 -45.39 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.207 1.938 . . . . 0.0 112.869 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.8 -13.97 62.74 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.468 0.651 . . . . 0.0 112.61 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -112.36 -17.22 12.77 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.311 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 2.9 t -132.56 117.47 31.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -123.41 123.48 26.5 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.24 -1.53 3.07 Favored 'Trans proline' 0 CA--C 1.551 1.361 0 C-N-CA 123.587 2.858 . . . . 0.0 116.223 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 50.5 tp -59.44 -44.44 92.94 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' B' ' 148' ' ' PRO . 48.3 m -111.23 -11.65 14.19 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 55.0 mt -68.35 126.17 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -122.63 163.04 20.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.01 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' B' ' 144' ' ' THR . 23.2 t -137.51 136.58 37.81 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 121.249 0.547 . . . . 0.0 111.243 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 10.1 p -128.5 156.64 42.94 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.74 143.67 43.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.125 0.488 . . . . 0.0 111.265 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' B' ' 142' ' ' VAL . 14.4 t -100.72 162.64 12.78 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.5 m -61.61 -27.39 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -168.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . 0.777 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 36.8 t70 -90.59 -12.61 36.47 Favored 'General case' 0 C--O 1.203 -1.349 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.329 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.17 9.06 7.52 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 118.095 -2.002 . . . . 0.0 113.222 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' B' ' 138' ' ' SER . 56.8 t -78.84 118.49 26.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' B' ' 79' ' ' LEU . 1.9 tm? -115.15 133.8 55.72 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' B' ' 135' ' ' SER . 31.1 m -121.57 129.97 53.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.834 -0.541 . . . . 0.0 110.974 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 19.1 m -120.92 125.16 73.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ASN . . . . . 0.649 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 7.8 p30 -136.95 137.6 39.69 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.225 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.577 ' HA3' HG12 ' B' ' 133' ' ' ILE . . . -158.79 -143.51 3.68 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.121 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' B' ' 132' ' ' THR . 96.9 Cg_endo -102.7 169.69 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 123.938 3.092 . . . . 0.0 112.586 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ARG . . . . . 0.587 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 62.9 ttt180 -96.28 138.25 34.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.715 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.928 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 . . . . . 0 N--CA 1.427 -1.588 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.75 131.52 35.26 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -82.87 104.67 13.27 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -85.35 106.89 17.06 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 122.555 1.169 . . . . 0.0 112.11 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -136.41 149.17 48.15 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -94.92 119.67 33.85 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -126.86 154.42 44.4 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.932 -172.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.9 p -136.86 144.84 43.79 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.553 ' HB ' ' CG2' ' A' ' 145' ' ' VAL . 42.4 t -115.3 132.49 64.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -110.79 138.4 47.24 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' A' ' 122' ' ' TYR . 5.8 mp -118.26 126.12 51.51 Favored 'General case' 0 N--CA 1.386 -3.655 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -116.32 139.26 50.58 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 124.22 1.008 . . . . 0.0 110.551 -175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' HB ' ' NH1' ' A' ' 120' ' ' ARG . 8.4 p -155.06 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.464 ' H ' HG22 ' A' ' 81' ' ' VAL . 72.9 mmtt -85.68 -163.39 0.85 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 119.139 0.881 . . . . 0.0 110.806 176.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.588 ' HA ' ' O ' ' A' ' 140' ' ' ASP . 74.7 m80 -78.54 124.44 28.16 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.612 0.72 . . . . 0.0 111.693 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -149.89 150.43 31.9 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 p -80.89 119.1 75.13 Favored Pre-proline 0 C--N 1.287 -2.123 0 C-N-CA 123.351 0.66 . . . . 0.0 112.432 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.06 -28.54 14.05 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 124.789 3.66 . . . . 0.0 115.122 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.55 -27.59 51.59 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 122.095 -0.378 . . . . 0.0 111.629 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.34 8.27 28.35 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.52 150.43 40.85 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.065 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -130.25 131.81 45.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 100' ' ' VAL . 32.6 m -103.32 138.11 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 -176.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 78.3 mttt -114.25 130.82 56.64 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.7 111.07 21.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.4 95.66 3.12 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.15 -111.53 3.54 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.598 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -99.45 4.14 45.99 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.105 0.962 . . . . 0.0 111.221 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -113.5 137.04 47.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.983 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 145' ' ' VAL . 26.3 mt -130.31 120.48 48.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.868 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 43.7 mt-10 -136.74 149.69 47.98 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.675 0.274 . . . . 0.0 110.368 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 91' ' ' VAL . 61.8 t -126.32 114.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -115.22 131.01 57.06 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.09 147.97 19.5 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -143.28 131.8 22.34 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 122.393 0.277 . . . . 0.0 110.784 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -136.66 128.88 29.81 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.21 -0.307 . . . . 0.0 110.274 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -80.82 121.36 25.84 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -79.99 -52.14 8.2 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.779 0.323 . . . . 0.0 110.886 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 114' ' ' ILE . 11.2 ptt180 -148.56 147.11 28.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.96 136.94 50.64 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.804 0.812 . . . . 0.0 111.63 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -90.77 -166.29 1.55 Allowed 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.09 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -47.63 -65.65 0.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.254 1.422 . . . . 0.0 111.41 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -141.78 39.22 1.66 Allowed 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.46 ' HA3' ' CD2' ' B' ' 122' ' ' TYR . . . -137.3 144.44 15.94 Favored Glycine 2 N--CA 1.382 -4.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 108.198 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.83 149.89 45.19 Favored 'General case' 0 C--N 1.245 -3.966 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 107' ' ' ARG . 5.5 pt -122.87 134.74 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.4 m -135.03 162.33 32.76 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.374 0.607 . . . . 0.0 110.688 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.72 147.56 49.95 Favored 'General case' 0 N--CA 1.39 -3.447 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 56.2 mt-10 -136.92 151.64 49.28 Favored 'General case' 0 C--N 1.261 -3.241 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -126.07 126.65 44.56 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -129.75 121.91 27.81 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' NH1' ' HB ' ' A' ' 81' ' ' VAL . 37.7 ttp180 -125.51 136.77 53.69 Favored 'General case' 0 C--N 1.263 -3.182 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.461 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 45.9 mtmt -138.49 129.82 27.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 123.399 0.437 . . . . 0.0 110.827 -169.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.508 ' CD2' ' HA3' ' B' ' 112' ' ' GLY . 73.2 m-85 -131.7 143.45 50.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.165 0.586 . . . . 0.0 111.171 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -128.2 98.59 5.14 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 167.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.5 pt -137.06 105.54 8.75 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.998 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.69 -40.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.383 2.055 . . . . 0.0 113.26 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 149' ' ' ARG . . . -69.41 -33.87 73.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.954 0.407 . . . . 0.0 111.454 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -88.77 -17.1 30.53 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.655 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 78.8 t -127.36 120.49 55.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.354 0.597 . . . . 0.0 111.894 -175.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -115.7 119.62 37.3 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.512 ' HA ' ' CG1' ' A' ' 133' ' ' ILE . 97.7 Cg_endo -74.28 19.46 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.024 2.483 . . . . 0.0 116.305 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.96 -47.87 12.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.219 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 148' ' ' PRO 0.362 8.9 t -121.82 10.88 10.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.554 HG23 ' HD2' ' A' ' 148' ' ' PRO . 1.2 pp -67.7 135.21 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.1 p -125.83 166.56 16.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.421 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 144' ' ' THR . 17.4 m -127.54 133.82 49.79 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.03 0.443 . . . . 0.0 110.175 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.3 m -116.67 133.48 55.96 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.26 128.2 53.8 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.6 m -97.56 162.02 13.49 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.1 m -68.33 -15.25 63.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.468 1.107 . . . . 0.0 113.491 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 83' ' ' HIS . 10.2 t70 -90.6 -12.72 36.12 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.06 -2.04 35.4 Favored Glycine 0 C--O 1.259 1.709 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.3 t -73.65 137.13 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.401 ' CD1' HG13 ' A' ' 145' ' ' VAL . 3.3 tm? -127.0 134.43 50.35 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -173.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 135' ' ' SER . 58.1 m -115.54 120.5 39.68 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.0 m -101.57 121.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 13.0 p30 -133.89 137.43 44.95 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.833 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.43 -133.65 2.87 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 133' ' ' ILE . 60.8 Cg_endo -98.59 160.2 0.72 Allowed 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.976 2.45 . . . . 0.0 113.474 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 126' ' ' ALA . 57.9 ttt-85 -110.0 163.41 13.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 4.0 ttmp? . . . . . 0 C--N 1.311 -1.09 0 CA-C-O 118.801 -0.619 . . . . 0.0 109.846 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 . . . . . 0 N--CA 1.428 -1.557 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.6 131.92 35.56 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -83.35 105.28 14.18 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -85.71 107.18 17.47 Favored 'General case' 0 N--CA 1.412 -2.354 0 CA-C-O 122.373 1.082 . . . . 0.0 112.17 -167.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -136.95 148.98 47.28 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -94.71 119.58 33.56 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -126.75 154.68 43.88 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.972 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 20.1 p -137.04 144.82 43.41 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.554 ' HB ' ' CG2' ' B' ' 145' ' ' VAL . 42.7 t -115.29 132.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.28 138.61 46.43 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' B' ' 122' ' ' TYR . 5.8 mp -118.1 126.13 51.65 Favored 'General case' 0 N--CA 1.383 -3.798 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -116.25 139.24 50.58 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 124.239 1.016 . . . . 0.0 110.572 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.52 ' HB ' ' NH1' ' B' ' 120' ' ' ARG . 8.4 p -154.89 -174.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.474 ' H ' HG22 ' B' ' 81' ' ' VAL . 73.1 mmtt -85.74 -163.49 0.87 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 119.159 0.89 . . . . 0.0 110.991 175.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' B' ' 140' ' ' ASP . 74.9 m80 -78.4 124.43 28.11 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 121.631 0.729 . . . . 0.0 111.664 -172.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -150.25 150.1 31.07 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 1.6 p -80.7 119.0 74.94 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 123.27 0.628 . . . . 0.0 112.522 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.1 -28.88 14.9 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 124.685 3.59 . . . . 0.0 115.148 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -77.3 -26.94 52.78 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 122.138 -0.351 . . . . 0.0 111.729 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.86 8.25 30.14 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.957 -0.464 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 pp -120.51 150.47 40.78 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.98 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.468 HG12 HG22 ' B' ' 100' ' ' VAL . 31.8 m -104.4 138.56 28.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.525 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' B' ' 98' ' ' ILE . 78.0 mttt -114.6 130.77 56.82 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 50.2 t -129.88 111.0 20.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -137.45 95.97 3.17 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.92 -111.54 3.56 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.468 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.84 4.24 45.08 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.846 0.858 . . . . 0.0 111.263 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 87.2 t -113.25 136.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.969 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.455 HD13 HG21 ' B' ' 145' ' ' VAL . 25.8 mt -130.18 120.54 49.39 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 43.9 mt-10 -136.84 149.7 47.85 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.795 0.331 . . . . 0.0 110.379 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . 0.468 HG22 HG12 ' B' ' 91' ' ' VAL . 61.4 t -126.27 114.09 36.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -114.87 130.72 56.94 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.27 148.14 19.77 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' B' ' 103' ' ' LYS . 11.7 ptmt -143.41 132.4 22.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 122.412 0.285 . . . . 0.0 110.822 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -136.97 129.48 30.1 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -81.12 121.21 25.81 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.56 -52.09 8.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.914 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.45 ' HG2' HD11 ' B' ' 114' ' ' ILE . 11.6 ptt180 -149.05 146.71 27.87 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.57 137.22 49.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.793 0.806 . . . . 0.0 111.739 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -91.19 -166.22 1.53 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.127 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -46.59 -66.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.394 1.478 . . . . 0.0 111.302 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -141.69 39.83 1.69 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.508 ' HA3' ' CD2' ' A' ' 122' ' ' TYR . . . -138.47 144.24 15.31 Favored Glycine 2 N--CA 1.384 -4.779 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.101 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.81 150.24 44.74 Favored 'General case' 1 C--N 1.243 -4.028 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.45 HD11 ' HG2' ' B' ' 107' ' ' ARG . 5.5 pt -123.11 134.85 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m -135.01 162.16 33.25 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-O 121.368 0.604 . . . . 0.0 110.619 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -126.87 147.39 50.06 Favored 'General case' 0 N--CA 1.392 -3.355 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 55.9 mt-10 -136.88 151.24 48.86 Favored 'General case' 0 C--N 1.26 -3.317 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -125.61 127.05 45.72 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -130.14 121.79 26.97 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.52 ' NH1' ' HB ' ' B' ' 81' ' ' VAL . 37.7 ttp180 -125.43 136.73 53.71 Favored 'General case' 0 C--N 1.26 -3.286 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.455 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 45.6 mtmt -138.41 129.84 27.55 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.344 0.403 . . . . 0.0 110.825 -169.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' TYR . . . . . 0.46 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 74.6 m-85 -131.57 143.8 50.62 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 123.681 0.613 . . . . 0.0 111.147 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -128.42 98.59 5.1 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 167.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.6 pt -137.18 105.42 8.66 Favored Pre-proline 0 C--N 1.297 -1.685 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.01 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -90.7 -40.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.377 2.052 . . . . 0.0 113.143 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.2 -34.06 74.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.867 0.365 . . . . 0.0 111.451 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.63 -17.04 30.92 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.61 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 80.8 t -127.16 120.24 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.531 0.681 . . . . 0.0 111.901 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.38 119.24 38.55 Favored Pre-proline 0 C--N 1.287 -2.131 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.506 ' HA ' ' CG1' ' B' ' 133' ' ' ILE . 82.8 Cg_endo -74.21 19.72 0.43 Allowed 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 123.005 2.47 . . . . 0.0 116.277 -171.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.99 -47.83 12.2 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 118.989 -1.084 . . . . 0.0 112.267 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' THR . . . . . 0.537 HG22 ' HG3' ' B' ' 148' ' ' PRO 0.368 8.9 t -121.99 10.97 10.21 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . 0.548 HG23 ' HD2' ' B' ' 148' ' ' PRO . 1.2 pp -67.76 134.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' THR . . . . . . . . . . . . . 2.7 p -125.36 166.87 15.78 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.474 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' B' ' 144' ' ' THR . 17.9 m -127.48 133.61 49.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.354 0.597 . . . . 0.0 110.107 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 15.1 m -116.65 133.09 56.43 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 5.8 mp -105.92 128.25 53.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' B' ' 142' ' ' VAL . 17.0 m -97.02 161.76 13.68 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 14.9 m -68.17 -14.04 62.68 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.426 1.09 . . . . 0.0 113.468 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' B' ' 83' ' ' HIS . 9.3 t70 -91.46 -12.74 33.79 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.71 -2.09 36.32 Favored Glycine 0 C--O 1.261 1.825 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' B' ' 138' ' ' SER . 89.3 t -73.74 137.26 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.404 ' CD1' HG13 ' B' ' 145' ' ' VAL . 3.3 tm? -127.21 134.52 50.1 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 135' ' ' SER . 57.9 m -115.63 120.68 40.21 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . 0.554 ' CG2' ' HB ' ' B' ' 77' ' ' VAL . 5.8 m -101.8 121.89 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -133.65 137.17 45.23 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.722 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 171.01 -133.46 2.78 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' B' ' 133' ' ' ILE . 92.8 Cg_endo -98.04 160.33 0.84 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 123.28 2.653 . . . . 0.0 113.6 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -110.64 163.19 13.99 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' B' ' 150' ' ' LYS . 4.1 ttmp? . . . . . 0 C--N 1.308 -1.229 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.291 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 C--O 1.215 -0.739 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.8 mt -168.63 112.24 0.57 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 126.564 1.946 . . . . 0.0 107.675 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 149' ' ' ARG . 36.1 tt0 -149.43 72.28 1.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 149' ' ' ARG . 58.6 mtpt -99.3 106.16 18.24 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 77.96 157.38 0.17 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.993 1.717 . . . . 0.0 109.983 -174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -105.52 131.32 53.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 149' ' ' ARG . 22.7 t80 -110.07 134.8 51.78 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.415 -171.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.9 m -113.13 129.71 56.42 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.0 t -114.97 130.76 68.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.73 155.91 24.75 Favored 'General case' 0 C--N 1.264 -3.152 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 143' ' ' LEU . 31.5 tp -118.2 127.56 53.87 Favored 'General case' 0 N--CA 1.386 -3.651 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -112.89 136.17 52.84 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -177.07 168.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -87.37 -175.14 5.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.623 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -77.73 125.61 29.61 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.993 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.05 160.65 38.33 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.613 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 14.3 m -66.56 107.9 1.96 Allowed Pre-proline 0 CA--C 1.554 1.102 0 O-C-N 124.523 1.14 . . . . 0.0 112.89 -170.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 54.4 Cg_exo -57.26 -28.3 79.01 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.314 3.343 . . . . 0.0 113.968 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -86.75 -9.44 55.87 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.777 0.323 . . . . 0.0 111.063 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 24.8 mm-40 -113.47 19.75 16.64 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.351 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 3.9 pp -120.82 153.8 36.61 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.318 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.73 125.86 45.5 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.723 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -109.35 122.18 63.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -125.73 131.37 52.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.529 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.46 HG23 HG12 ' A' ' 98' ' ' ILE . 3.4 p -124.01 113.03 35.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.37 91.23 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA2' ' HG3' ' A' ' 130' ' ' PRO . . . 66.65 -111.92 4.5 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.11 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.51 9.26 39.21 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 124.248 1.019 . . . . 0.0 111.612 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.12 136.03 61.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.536 -0.727 . . . . 0.0 109.535 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 93' ' ' VAL . 44.6 mt -130.37 121.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 121' ' ' LYS . 47.4 mt-10 -132.24 148.35 52.45 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.635 -178.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.51 127.43 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.203 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -136.37 120.01 17.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.26 162.01 27.24 Favored Glycine 0 CA--C 1.482 -2.015 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.93 143.83 51.02 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -120.77 135.19 55.22 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.48 129.11 34.31 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 116' ' ' ARG . 42.5 mt-10 -105.0 -76.08 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.414 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 48.7 mtm-85 -141.15 141.82 34.1 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -112.0 136.52 51.24 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.202 0.525 . . . . 0.0 110.922 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 112' ' ' GLY . 33.4 m-20 -97.12 -155.46 0.49 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 173.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.46 -57.18 3.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' B' ' 123' ' ' ARG . 57.3 m80 -100.52 -11.0 20.49 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.482 -176.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' B' ' 121' ' ' LYS . . . -112.3 139.71 15.79 Favored Glycine 1 N--CA 1.395 -4.085 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.428 -176.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -130.14 140.0 50.83 Favored 'General case' 0 C--N 1.256 -3.487 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.411 HG12 ' HG3' ' B' ' 120' ' ' ARG . 3.1 mt -123.73 132.94 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -136.43 158.28 44.81 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.491 ' HB2' ' OE2' ' A' ' 106' ' ' GLU . 22.8 ttm180 -127.04 148.44 50.12 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' B' ' 117' ' ' GLU . 36.3 mt-10 -125.0 150.78 46.35 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.08 124.75 37.78 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -131.79 132.34 43.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.876 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.423 HH21 ' CG ' ' B' ' 109' ' ' ASP . 44.4 ttt180 -130.35 137.88 50.13 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' B' ' 112' ' ' GLY . 27.7 mtpp -122.86 127.14 48.62 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.303 1.2 p90 -134.36 115.61 14.25 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' B' ' 111' ' ' HIS . 68.8 ttt180 -102.5 99.69 9.74 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.356 0.598 . . . . 0.0 109.764 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 2.0 pt -124.08 105.54 31.68 Favored Pre-proline 0 C--N 1.288 -2.107 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.458 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -90.13 -52.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.144 2.562 . . . . 0.0 113.163 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.9 64.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.351 0.596 . . . . 0.0 111.364 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.09 -18.14 17.88 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.321 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 57.4 t -132.15 113.48 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 17.2 t70 -100.16 128.39 30.79 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.428 ' HG3' ' HA2' ' A' ' 95' ' ' GLY . 72.3 Cg_endo -71.04 16.71 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.664 2.243 . . . . 0.0 116.442 -171.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.0 tp -82.02 -46.97 13.22 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.257 14.3 t -120.36 9.99 11.12 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 146' ' ' ASN . 1.0 OUTLIER -68.44 130.3 33.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 12.8 t -137.75 163.0 32.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.454 ' HB2' HD11 ' A' ' 143' ' ' LEU . 16.8 p -128.0 133.0 49.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.8 t -125.89 129.56 49.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.06 135.06 48.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.453 0.644 . . . . 0.0 111.855 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.1 m -100.82 163.45 12.31 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.025 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.4 m -60.29 -21.85 62.44 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.21 7.37 41.05 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 121.383 0.611 . . . . 0.0 111.385 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.15 -6.12 61.57 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.534 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -73.95 112.76 11.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 144' ' ' THR . 1.9 tp -122.34 134.67 54.64 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.266 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.566 ' N ' HD12 ' A' ' 143' ' ' LEU . 17.8 m -117.75 117.92 30.65 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 134' ' ' THR . 31.8 t -101.65 121.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 8.9 p30 -135.38 144.07 46.4 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.396 -0.815 . . . . 0.0 111.164 -174.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.01 -136.45 2.17 Favored Glycine 0 N--CA 1.425 -2.087 0 O-C-N 123.806 0.691 . . . . 0.0 111.552 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.402 ' HG2' ' HB3' ' A' ' 129' ' ' ASP . 94.4 Cg_endo -96.73 142.77 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.149 2.566 . . . . 0.0 113.632 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.502 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 67.8 ttt180 -92.84 133.41 36.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 84.0 tttt . . . . . 0 C--N 1.291 -1.967 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.314 -172.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 . . . . . 0 C--O 1.218 -0.563 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 23.9 mt -168.95 111.68 0.52 Allowed 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.529 1.932 . . . . 0.0 107.768 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 149' ' ' ARG . 34.3 tt0 -149.23 72.38 1.16 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' B' ' 149' ' ' ARG . 58.0 mtpt -99.21 106.18 18.31 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 78.44 157.16 0.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.711 1.604 . . . . 0.0 109.83 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -105.74 130.02 53.83 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' B' ' 149' ' ' ARG . 21.4 t80 -108.91 132.29 54.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.205 0.526 . . . . 0.0 110.915 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 26.9 m -110.45 129.58 55.74 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.008 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.89 130.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -113.41 155.83 24.56 Favored 'General case' 0 C--N 1.261 -3.268 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' B' ' 143' ' ' LEU . 31.3 tp -118.11 127.64 53.97 Favored 'General case' 0 N--CA 1.387 -3.598 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -113.2 136.03 53.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 p -177.38 168.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -86.49 -175.34 5.42 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.718 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -77.63 125.66 29.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.062 -1.055 . . . . 0.0 112.124 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.23 160.97 37.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.436 -1.257 . . . . 0.0 107.624 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' B' ' 88' ' ' GLU . 15.8 m -66.36 107.38 1.56 Allowed Pre-proline 0 C--N 1.311 -1.095 0 O-C-N 124.536 1.148 . . . . 0.0 112.972 -170.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.443 ' HA ' ' CD2' ' B' ' 89' ' ' LEU . 50.8 Cg_exo -57.15 -28.37 78.81 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.071 3.181 . . . . 0.0 114.024 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.96 -9.64 55.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' B' ' 85' ' ' SER . 22.1 mm-40 -112.7 19.45 17.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.402 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.443 ' CD2' ' HA ' ' B' ' 86' ' ' PRO . 3.9 pp -120.87 153.34 37.3 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.323 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -123.09 126.02 46.28 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.935 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.76 122.32 64.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.99 131.62 52.2 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.475 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.471 HG23 HG12 ' B' ' 98' ' ' ILE . 3.4 p -124.15 112.95 34.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 84.5 mt -127.16 91.17 3.27 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.443 ' HA2' ' HG3' ' B' ' 130' ' ' PRO . . . 67.0 -112.1 4.62 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.874 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -94.52 9.09 39.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 124.371 1.068 . . . . 0.0 111.701 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.96 136.12 60.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.639 -0.663 . . . . 0.0 109.359 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.471 HG12 HG23 ' B' ' 93' ' ' VAL . 46.2 mt -130.72 121.38 50.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' B' ' 121' ' ' LYS . 46.6 mt-10 -132.26 148.44 52.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.095 0.474 . . . . 0.0 111.592 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.43 127.53 62.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.144 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -136.59 120.05 17.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 161.86 27.27 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.477 ' HB3' ' HG2' ' B' ' 117' ' ' GLU . 0.0 OUTLIER -130.45 143.95 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -120.71 135.37 55.15 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.81 128.01 33.17 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.487 ' OE2' ' HB2' ' B' ' 116' ' ' ARG . 42.9 mt-10 -103.7 -77.4 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 -139.86 142.56 36.57 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -112.19 136.14 51.97 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.634 0.73 . . . . 0.0 111.265 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' B' ' 112' ' ' GLY . 37.1 m-20 -96.83 -155.79 0.5 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 172.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.8 -57.31 3.03 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 122.037 0.922 . . . . 0.0 108.617 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' A' ' 123' ' ' ARG . 54.0 m80 -101.66 -11.13 19.42 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.178 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 121' ' ' LYS . . . -111.12 139.57 15.62 Favored Glycine 0 N--CA 1.396 -3.981 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.591 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.22 139.68 50.79 Favored 'General case' 0 C--N 1.257 -3.437 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.16 133.18 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 46.8 m -136.44 158.18 45.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.487 ' HB2' ' OE2' ' B' ' 106' ' ' GLU . 22.4 ttm180 -127.19 148.25 50.19 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 117' ' ' GLU . 36.9 mt-10 -125.02 150.85 46.32 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -128.16 124.89 37.97 Favored 'General case' 0 C--N 1.273 -2.739 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -131.87 132.09 43.34 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.411 ' HG3' HG12 ' A' ' 114' ' ' ILE . 43.9 ttt180 -130.19 137.91 50.32 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.515 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 27.6 mtpp -122.65 127.11 48.91 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' TYR . . . . . . . . . . . . 0.3 1.3 p90 -134.39 115.27 13.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 111' ' ' HIS . 71.0 ttt180 -101.95 99.73 9.94 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.394 0.616 . . . . 0.0 109.948 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' B' ' 128' ' ' VAL . 2.0 pt -123.99 105.52 31.92 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.538 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -90.01 -53.14 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 123.013 2.475 . . . . 0.0 113.136 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 -18.9 65.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.58 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -99.57 -18.1 17.53 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.265 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 124' ' ' ILE . 60.0 t -132.21 113.8 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . 0.408 ' HB3' ' HG2' ' B' ' 148' ' ' PRO . 17.5 t70 -100.81 128.31 30.12 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.443 ' HG3' ' HA2' ' B' ' 95' ' ' GLY . 72.1 Cg_endo -71.09 16.39 0.29 Allowed 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.837 2.358 . . . . 0.0 116.415 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.76 -46.66 13.91 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' THR . . . . . 0.416 HG22 ' HG3' ' B' ' 148' ' ' PRO . 13.9 t -120.97 10.23 10.77 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' B' ' 146' ' ' ASN . 1.0 OUTLIER -68.36 130.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' B' ' 145' ' ' VAL . 11.9 t -137.84 162.99 32.54 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.449 ' HB2' HD11 ' B' ' 143' ' ' LEU . 15.0 p -127.79 133.14 49.44 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.257 0.551 . . . . 0.0 112.148 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -126.45 129.36 48.54 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.41 134.73 48.0 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.098 0.475 . . . . 0.0 111.68 -174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' SER . . . . . . . . . . . . . 20.1 m -100.72 163.36 12.36 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.138 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -60.47 -21.18 62.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -91.95 8.01 39.49 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 121.515 0.674 . . . . 0.0 111.171 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.87 -5.85 61.99 Favored Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.496 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 67.1 t -74.16 112.98 11.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.264 0.554 . . . . 0.0 109.506 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.57 HD12 ' N ' ' B' ' 144' ' ' THR . 1.8 tp -122.67 134.43 54.48 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.123 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.57 ' N ' HD12 ' B' ' 143' ' ' LEU . 16.6 m -117.22 118.24 31.77 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 134' ' ' THR . 35.5 t -102.24 121.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 175.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' B' ' 133' ' ' ILE . 9.4 p30 -134.97 144.17 47.26 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.305 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.88 -136.61 2.2 Favored Glycine 0 N--CA 1.423 -2.202 0 O-C-N 123.654 0.596 . . . . 0.0 111.738 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.416 ' HG3' HG22 ' B' ' 132' ' ' THR . 93.1 Cg_endo -96.72 142.63 0.8 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.265 2.644 . . . . 0.0 113.505 -176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . 71.0 ttt180 -92.9 133.86 35.67 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' LYS . . . . . . . . . . . . . 84.3 tttt . . . . . 0 C--N 1.29 -1.998 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.243 -172.422 . . . . . . . . 0 0 . 1 stop_ save_